INSULIN & OBESITY

1. A better parameter in predicting insulin resistance: obesity plus elevated alanine aminotransferase
2. A case of familial Bardet-Biedl syndrome (obesity, slight mental retardation, polydactyly, retinitis pigmentosum and renal failure) with insulin-resistant diabetes mellitus
3. A case of insulin autoimmune syndrome that developed after topiramate anti-obesity medication
4. A central role for JNK in obesity and insulin resistance
5. A clinically confirmed family history for early myocardial infarction is associated with increased risk of obesity, insulin resistance and metabolic syndrome
6. A combination of circulating chemokines as biomarkers of obesity‐induced insulin resistance at puberty
7. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization
8. A CONNECTION BETWEEN insulin RESISTANCE AND ANDROGENS, INDEPENDENT OF obesity?
9. A cross-sectional study of the phenotypes of obesity and insulin resistance in adults with down syndrome.
10. A Distinct Population of Lipid Sensing iNKT Cells are Enriched in Fat and Protect Against Diet-Induced obesity and insulin Resistance (176.26)
11. A free-choice high-fat high-sugar diet induces glucose intolerance and insulin unresponsiveness to a glucose load not explained by obesity
12. A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome
13. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome
14. A high alanine aminotransferase/aspartate aminotransferase ratio determines insulin resistance and metabolically healthy/unhealthy obesity in a general adult …
15. A high omega-6 PUFA diet impairs hepatocyte insulin signalling during diet-induced obesity
16. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD …
17. A high-sugar diet produces obesity and insulin resistance in wild-type Drosophila
18. A ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer
19. A lower duodenal immune response is associated with an increase of insulin resistance in patients with morbid obesity
20. A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in …
21. A major role of insulin in promoting obesity-associated adipose tissue inflammation
22. A major role of insulin in promoting obesity-associated adipose tissue inflammation
23. A Meta-analysis of Effects of Aerobic Exercise on Glucose and insulin in Overweight/obesity Children and Adolescent [J]
24. A Meta-Analysis of the Impact of obesity, Metabolic Syndrome, insulin Resistance, and Microbiome on the Diagnosis of Barrett’s Esophagus
25. A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle
26. A mitochondrially encoded hormone ameliorates obesity and insulin resistance
27. A mouse model of diet-induced obesity and insulin resistance
28. A multidisciplinary intervention in childhood obesity acutely improves insulin resistance and inflammatory markers independent from body composition
29. A Multiplatform Non-targeted Metabolomics Approach to Investigate insulin Resistance Associated to obesity in Childhood
30. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity
31. A new endoscopically implantable device (SatiSphere) for treatment of obesity—efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels
32. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight …
33. A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis
34. A new tumor necrosis factor (TNF)-α regulator, lipopolysaccharides-induced TNF-α factor, is associated with obesity and insulin resistance
35. A non-invasive marker of insulin resistance in patients with obesity
36. A novel approach to childhood obesity: circulating chemokines and growth factors as biomarkers of insulin resistance
37. A novel GPCR messenger mediating cholinergic stimulation of synaptotagmin-dependent insulin exocytosis and obesity
38. A novel IKKβ inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance
39. A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer
40. A pharmacologic sympathectomy prevents the development of obesity and insulin resistance in the high fat fed rat
41. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma
42. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp …
43. A post-weaning obesogenic diet exacerbates the detrimental effects of maternal obesity on offspring insulin signaling in adipose tissue
44. A post-weaning obesogenic diet exacerbates the detrimental effects of maternal obesity on offspring insulin signaling in adipose tissue
45. A Potential New Treatment Option for Asthma in the Setting of obesity or insulin Resistance?
46. A potential role for insulin treatment during pregnancy in reducing postpartum psychological distress in maternal obesity: An administrative population health …
47. A preliminary study of insulin resistance in essential hypertension, simple obesity and acromegaly
48. A preliminary study of mechanism of periodontitis and periodontal therapy influence in insulin resistance for obesity rats
49. A prospective observational study of obesity, body composition, and insulin resistance in 18 women with bipolar disorder and 17 matched control subjects
50. A randomized control trial of the impact of LCPUFA‐ω3 supplementation on body weight and insulin resistance in pubertal children with obesity
51. A review of obesity, insulin resistance, and the role of exercise in breast cancer patients
52. A review of the carbohydrate–insulin model of obesity
53. A role for 5-lipoxygenase products in obesity-associated inflammation and insulin resistance
54. A role for EP3 and its associated G protein, Gz, in negatively regulating beta-cell function and mass in the context of insulin resistance and obesity
55. A role of lipin in human obesity and insulin resistance: relation to adipocyte glucose transport and GLUT4 expression
56. A simple and effective model to study insulin resistance in obesity and diabetes and the processes and mechanisms of in vitro aging using lymphocyte culture
57. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity
58. A study of association of sex hormones with insulin resistance and obesity for diabetes mellitus risk in adult women
59. A Study on insulin Resistance and obesity Among Women at High Risk for Breast Cancer Using Cluster Analysis.
60. A study on relation of obesity to serum lipid, leptin and insulin concentration in elementary schoolchildren
61. A study on the genetics of obesity: influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip …
62. A study on the relationship between neck circumference and obesity related indexes and metabolic disorders associated with insulin resistance
63. A Submaximal Exercise Patterns Intervention on the Plasmatic Leptin Level and insulin Resistance for Overweight/obesity Boys Adolescences
64. A three-year follow-up study on risk factors for obesity and non-insulin dependent diabetes mellitus in aging populations in China
65. A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors
66. A Uniform. Approach in the Use of U-500 Regular insulin in the Management Of Paiients with obesity and Insu] in Resistance: The Clinicia’s View.
67. A vast genomic deletion in the C56BL/6 genome affects different genes within the Ifi200 cluster on chromosome 1 and mediates obesity and insulin resistance
68. AB0025 Is Abatacept Successful in Improving insulin Resistance in A High Fat Diet Model of obesity?
69. AB0092 Effect of methotrexate, leflunomide and hydroxychloroquine on the insulin resistance and obesity associated with rheumatoid arthritis: obese mouse models …
70. AB1098 obesity and insulin resistance in fibromyalgia patients
71. ABCA1 and metabolic syndrome; a review of the ABCA1 role in HDL-VLDL production, insulin-glucose homeostasis, inflammation and obesity
72. Abdominal obesity and insulin resistance after an episode of acute pancreatitis
73. Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community: Skaraborg Hypertension and Diabetes Project
74. Abdominal obesity and insulin resistance in patients with type 2 diabetes in a Swedish community. Skaraborg hypertension and diabetes project.
75. Abdominal obesity and insulin resistance in people exposed to moderate-to-high levels of dioxin
76. Abdominal obesity and low physical activity are associated with insulin resistance in overweight adolescents: a cross-sectional study
77. Abdominal obesity as a mediator of the influence of physical activity on insulin resistance in Spanish adults
78. Abdominal obesity as important component of insulin-resistance syndrome.
79. Abdominal obesity associated with elevated serum Butyrylcholinesterase activity, insulin resistance and reduced high density lipoprotein-cholesterol levels
80. Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance
81. Abdominal obesity in older women: potential role for disrupted fatty acid reesterification in insulin resistance
82. Abdominal obesity is associated with insulin resistance and reduced glycogen synthase activity in skeletal muscle
83. Abdominal obesity is associated with insulin resistance.
84. Abdominal obesity Predicts Declining insulin Sensitivity in Non-Obese Normoglycemics
85. Abdominal obesity predicts declining insulin sensitivity in non‐obese normoglycaemics: the insulin Resistance Atherosclerosis Study (IRAS)
86. ABDOMINAL obesity, DYSLIPIDEMIA, insulin RESISTANCE, TYPE 2 DIABETES AND ATHEROSCLEROSIS: WHO IS THE RIGHT PATIENT TO BE …
87. Abdominal obesity, fatty acids and insulin resistance
88. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature …
89. Abdominal obesity, insulin resistance and hypertension: impact on left ventricular mass and function in women
90. Abdominal obesity, insulin resistance, and alterations in hemostasis
91. Abdominal obesity, insulin resistance, and cardiovascular risk in pre-diabetes and type 2 diabetes
92. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression
93. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population
94. Abdominal obesity, insulin resistance, and the metabolic syndrome: contribution of physical activity/exercise
95. Abdominal obesity, insulin resistance, and the risk of colonic adenoma
96. Abdominal obesity, insulin resistance, metabolic syndrome and cholesterol homeostasis
97. ABDOMINAL obesity, METABOLIC SYNDROME AND insulin RESISTANCE: PP. 26.340
98. Abdominal obesity, muscle composition, and insulin resistance in premenopausal women
99. Abdominal subcutaneous adipose tissue gene expression in relation to tissue-specific insulin resistance in human obesity
100. Aberrant expression of miR-214 is associated with obesity-induced insulin resistance as a biomarker and therapeutic
101. Aberrant hepatic expression of PPARγ2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis
102. Ablation of insulin-producing cells prevents obesity but not premature mortality caused by a high-sugar diet in Drosophila
103. Ablation of MARK4, an AMPK-related Kinase, Leads to insulin Hypersensitivity and Resistance to Diet-induced obesity
104. Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance
105. Abnormal liver function and insulin resistance in obesity
106. Abnormal mitochondrial metabolism in obesity and insulin resistance
107. Abnormalities of Glucose and insulin Metabolism in Exogenous obesity.
108. Abnormalities of islet B-cell function, insulin action, and fat distribution in women with histories of gestational diabetes: relationship to obesity
109. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central …
110. Abrogation of toll-like receptor 4 mitigates obesity-induced oxidative stress, proinflammation, and insulin resistance through metabolic reprogramming of mitochondria …
111. Absence of GIP secretion alleviates age-related obesity and insulin resistance
112. ABSENCE OF GUT MICROBIOTA PROTECTS AGAINST DIET-INDUCED obesity AND insulin-RESISTANCE BUT PREDISPOSES TO LIVER DAMAGE
113. Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity
114. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lepob/Lepob mice
115. Absence of the ROS Scavenger DJ-1 Paradoxically Protects Mice from obesity and insulin Resistance
116. Absence of toll‐like receptor‐2 (Tlr2) attenuates diet induced obesity and adipose tissue inflammation and insulin resistance
117. Abstract CN13-04: obesity, insulin resistance, hyperglycemia, and cancer: A novel role for metformin as an anticancer drug
118. Abstract KN01: Keynote Lecture: PI 3-kinase links obesity, insulin resistance, and cancer
119. Abstract MP55: DNA methylation mediates the effects of obesity on insulin resistance in african american youth and young adults
120. Abstract P034: Association between obesity Indices and insulin Resistance among Healthy Korean Adolescents
121. Abstract P088: obesity, Hypertension and insulin Resistance in a Primary Pediatric Setting in Southern Italy
122. Abstract P438: Staying Active improves insulin Resistance independent of the Metabolic Syndrome and obesity
123. Abstract P636: insulin Resistance in obesity Results in Postprandial Salt and Water Loss
124. Abstract WP132: Relationship Of Neck Circumference And insulin Resistance On The Cerebrovascular Reactivity In Subjects With obesity.
125. Acanthosis nigricans and obesity: acquired and intrinsic defects in insulin action
126. Acanthosis nigricans as a composite marker of cardiometabolic risk and its complex association with obesity and insulin resistance in Mexican American …
127. Acanthosis nigricans in obese children and adolescents in relation to severity of obesity and insulin resistance.
128. Acanthosis nigricans with severe obesity, insulin resistance and hypothyroidism: improvement by diet control
129. ACANTHOSIS NIGRICANS, obesity, insulin RESISTANCE AND HYPERANDROGENEMIA: NATURAL HISTORY AND PEDIATRIC PERSPECTIVE
130. Acanthosis nigricans: A valid clinical marker of insulin resistance in obesity
131. Acetylsalicylic acid modulates inflammation and insulin resistance in a mouse model of diet-induced obesity
132. Acquired obesity Changes Adipose Tissue MRNA Expression, Increases Abdominal and Liver Fat, and Causes insulin Resistance in Monozygotic Twins
133. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins
134. ACSL1 multi‐tissue knockout mice are resistant to diet‐and age‐induced obesity and insulin resistance
135. Activated glucose-6-phosphate dehydrogenase is associated with insulin resistance by upregulating pentose and pentosidine in diet-induced obesity of rats
136. Activating transcriptional factor 4 correlated with obesity and insulin resistance in polycystic ovary syndrome
137. Activation and regulation of the pattern recognition receptors in obesity-induced adipose tissue inflammation and insulin resistance
138. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling
139. Activation of malonyl‐CoA/fatty acid synthase axis is an early event in the effects of insulin in human skeletal muscle myotubes: Implication for obesity linked insulin …
140. Activation of placental insulin and mTOR signaling in a mouse model of maternal obesity associated with fetal overgrowth
141. Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes
142. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance
143. Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance
144. Activation of α7nAChR via vagus nerve prevents obesity-induced insulin resistance via suppressing endoplasmic reticulum stress-induced inflammation in Kupffer …
145. Activity of tamarindus indica pulp water extract in high carbohydrate diet rats as a treatment for obesity and insulin resistance
146. Acupuncture for Treatment of obesity and insulin Resistance
147. Acupuncture targeting SIRT1 in the hypothalamic arcuate nucleus can improve obesity in high-fat-diet-induced rats with insulin resistance via an anorectic effect
148. Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity
149. Acute regulation of insulin release by the pituitary gland in relation to hyperinsulinaemia and obesity
150. Acylcarnitine kinetics in a fasting-and obesity-induced insulin resistant mouse model
151. Adapter proteins regulate insulin resistance and lipid metabolism in obesity
152. Adapting to insulin resistance in obesity: role of insulin secretion and clearance
153. Adaptive immunity and antigen-specific activation in obesity-associated insulin resistance
154. Adaptive immunity in obesity and insulin resistance
155. ADAR1 deficiency protects against high-fat diet-induced obesity and insulin resistance in mice
156. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents
157. Additive effects of obesity, hypertension, and type 2 diabetes on insulin resistance.
158. Adenosine Triphosphate-Sensitive Potassium (KATp) Channel Activity Is Coupled with insulin Resistance in obesity and
159. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance
160. Adenylyl cyclase 3 haploinsufficiency confers susceptibility to diet-induced obesity and insulin resistance in mice
161. Adenylyl cyclase type 5 deficiency protects against diet-induced obesity and insulin resistance
162. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis
163. Adipocyte CD1d determines adipose inflammation and insulin resistance in obesity
164. Adipocyte CREB promotes insulin resistance in obesity
165. Adipocyte DIO2 expression increases in human obesity but is not related to systemic insulin sensitivity
166. Adipocyte dysfunction, inflammation, and insulin resistance in obesity
167. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
168. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in …
169. Adipocyte insulin resistance: effects of aging, obesity, exercise, and food restriction
170. Adipocyte protein carbonylation and oxidative stress in obesity-linked mitochondrial dysfunction and insulin resistance.
171. Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity
172. Adipocyte-specific CD1d-deficiency mitigates diet-induced obesity and insulin resistance in mice
173. Adipocyte-specific deficiency of NADPH oxidase 4 delays the onset of insulin resistance and attenuates adipose tissue inflammation in obesity
174. Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance
175. Adipocyte‐specific enhancement of angiotensin II type 1 receptor‐associated protein ameliorates diet‐induced visceral obesity and insulin resistance
176. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice
177. Adipocytokine profile and insulin resistance in childhood obesity
178. Adipocytokines and insulin levels in young obese subjects at risk for type II diabetes–the STYrian Juvenile obesity Study (STYJOBS)
179. Adipocytokines, insulin resistance and obesity coherence in women with previously diagnosed gestational diabetes
180. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer
181. Adipocytokines: a bridge connecting obesity and insulin resistance
182. Adipogenesis and insulin sensitivity in obesity are regulated by retinoid‐related orphan receptor gamma
183. Adipogenic miR-27a in adipose tissue upregulates macrophage activation via inhibiting PPARγ of insulin resistance induced by high-fat diet-associated obesity
184. ADIPOKINE PROFILES OFinsulin SENSITIVE obesityAND insulin RESISTANCE obesity AMONG CHINESE CHILDREN: THE BCAMS STUDY
185. Adipokines as Novel Links between obesity and insulin Resistance
186. Adipokines, Ghrelin and obesity‐Associated insulin Resistance in Nondiabetic Patients with Acute Coronary Syndrome
187. Adipokines, inflammation, and insulin resistance in obesity
188. Adipokines, systemic inflammation and inflamed adipose tissue in obesity and insulin resistance
189. Adipokines: the missing link between insulin resistance and obesity
190. Adiponectin and adiponectin receptors in obesity-linked insulin resistance
191. Adiponectin and insulin resistance in childhood obesity
192. Adiponectin and insulin resistance in obesity-related diseases
193. Adiponectin and insulin resistance responses to aerobic training in males with abdominal obesity
194. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
195. Adiponectin and its role in the obesity-induced insulin resistance and related complications
196. Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance
197. Adiponectin as novel biomarker of endothelial dysfunction in insulin resistance and obesity–a narrative review
198. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression
199. Adiponectin expression in visceral adiposity is an important determinant of insulin resistance in morbid obesity
200. Adiponectin Gene Variation-4522C/T Is Associated with Type 2 Diabetic obesity and insulin Resistance in Chinese
201. Adiponectin gene variation− 4522C/T is associated with type 2 diabetic obesity and insulin resistance in Chinese
202. Adiponectin, anthropometric measurements and insulin resistance in adolescence with obesity.
203. Adiponectin, the missing link in insulin resistance and obesity
204. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond
205. Adiponectin: A Mediator of obesity, insulin Resistance, Diabetes, and the Metabolic Syndrome
206. Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease
207. ADIPOSE AND INTESTINAL IMMUNOPATHOLOGY IN obesity RELATED insulin RESISTANCE.
208. Adipose cell and lipid turnovers in obesity and insulin resistance
209. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
210. Adipose DPP4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro
211. Adipose Estrogen and Increased Breast Cancer Risk in obesity: Regulation by Leptin and insulin
212. Adipose Expression and Regulation of Selenoprotein P in obesity and insulin Resistance
213. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance
214. Adipose extracellular matrix remodelling in obesity and insulin resistance
215. Adipose HuR protects against diet-induced obesity and insulin resistance
216. Adipose HuR protects against diet-induced obesity and insulin resistance in mice
217. Adipose hypothermia in obesity and its association with period homolog 1, insulin sensitivity, and inflammation in fat
218. Adipose inflammation: cause or consequence of obesity-related insulin resistance
219. Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity
220. Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity
221. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance
222. Adipose tissue and insulin secretion in the pathophysiology of obesity and its complications
223. Adipose tissue as a source of proinflammatory factors in obesity: The importance in the development of insulin resistance and diabetes
224. Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance
225. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance
226. Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance
227. Adipose tissue gene expression of CXCL10 and CXCL11 modulates inflammatory markers in obesity: implications for metabolic inflammation and insulin resistance
228. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines
229. Adipose tissue inflammation and systemic insulin resistance in mice with diet-induced obesity is possibly associated with disruption of PFKFB3 in hematopoietic cells
230. Adipose tissue inflammation is directly linked to obesity-induced insulin resistance, while gut dysbiosis and mitochondrial dysfunction are not required
231. Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?
232. Adipose tissue insulin resistance due to loss of PI3K p110α leads to decreased energy expenditure and obesity
233. Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first?
234. Adipose tissue macrophage phenotypes and characteristics: the key to insulin resistance in obesity and metabolic disorders
235. Adipose tissue macrophage-derived exosomal miR-29a regulates obesity-associated insulin resistance
236. Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes
237. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity
238. Adipose tissue monomethyl branched‐chain fatty acids and insulin sensitivity: Effects of obesity and weight loss
239. Adipose tissue mRNA expression of HDAC1, HDAC3 and HDAC9 in obese women in relation to obesity indices and insulin resistance
240. Adipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapy
241. Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes
242. Adipose Tissue Overexpression of a Constitutively Active Isoform of Chrebp Protects Against obesity and insulin Resistance in Mice
243. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance
244. Adipose Tissue Secretory Changes and Low-Grade Inflammation Combine With insulin Resistance and Vascular Dysfunction in Human obesity
245. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance
246. Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility
247. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance
248. Adipose Tissue VEGF‐D Overexpression Increases Lymphatic Vessel Density and Protects Against Inflammation and insulin Resistance in obesity
249. Adipose tissue, but not skeletal muscle, sirtuin 1 expression is decreased in obesity and related to insulin sensitivity
250. Adipose TNF and IL-6 expression in human obesity-associated insulin resistance
251. Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance
252. Adipose-specific deficiency of fumarate hydratase in mice protects against obesity, hepatic steatosis, and insulin resistance
253. Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance
254. Adipose-specific knockdown of Sirt1 results in obesity and insulin resistance by promoting exosomes release
255. Adipose-specific knockout of ubiquitin-conjugating enzyme E2L6 (Ube2l6) reduces diet-induced obesity, insulin resistance, and hepatic steatosis
256. Adipose‐specific deletion of Kif5b exacerbates obesity and insulin resistance in a mouse model of diet‐induced obesity
257. Adiposity in childhood predicts obesity and insulin resistance in young adulthood
258. Adolescent Metabolic/Bariatric Surgery: Effects on obesity, Comorbidities, and insulin Resistance
259. Adolescent obesity and insulin resistance: roles of ectopic fat accumulation and adipose inflammation
260. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
261. Adrenomedullin 2 improves early obesity-induced adipose insulin resistance by inhibiting the class II MHC in adipocytes
262. Adult-onset obesity reveals prenatal programming of glucose-insulin sensitivity in male sheep nutrient restricted during late gestation
263. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes
264. Adverse effects of obesity on lipid and lipoprotein levels in the patients with non-insulin dependent diabetes in the young
265. Adverse Effects of obesity, Hyperglycemia, and insulin Resistance on Cardiac Mechanics
266. Aerobic Exercise Training Prevents obesity and insulin Resistance Independent of Changes in the Skeletal Muscle ACE2/Ang 1‐7/Mas Axis.
267. Aerobic exercise training prevents obesity and insulin resistance independent of the renin angiotensin system modulation in the subcutaneous white adipose …
268. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular …
269. Aging enhances the insulin resistance in obesity through both receptor and postreceptor alterations
270. AKAP1 Deficiency Attenuates Diet‐Induced obesity and insulin Resistance by Promoting Fatty Acid Oxidation and Thermogenesis in Brown Adipocytes
271. Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with obesity and insulin resistance in Asian …
272. Ala54Thr polymorphism of fatty acid binding protein 2, role on insulin resistance and cardiovascular risk factors in presurgical morbid obesity patients
273. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat
274. Alcohol intake, insulin resistance, and abdominal obesity in elderly men
275. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor β/δ and retinoic acid receptor
276. Allelic Variant Gly1057 Asp of IRS-2 Gene Has Distinctive Effects on insulin Secretion and Sensitivity in obesity and Type 2 Diabetes
277. Allicin ameliorates obesity comorbid depressive-like behaviors: involvement of the oxidative stress, mitochondrial function, autophagy, insulin resistance and NOX …
278. Allograft Inflammatory Factor-1 Deficiency Prevents obesity and insulin Resistance by Promoting Brown and Beige Adipocyte Thermogenic Programs
279. ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance
280. ALOX5AP overexpression in adipose tissue leads to LXA4 production and protection against diet-induced obesity and insulin resistance
281. Alström syndrome: an ultra-rare monogenic disorder as a model for insulin resistance, type 2 diabetes mellitus and obesity
282. Alström syndrome: renal findings in correlation with obesity, insulin resistance, dyslipidemia and cardiomyopathy in 38 patients prospectively evaluated at the NIH …
283. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon‐like peptide 1 in diet‐induced obesity
284. Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in mice
285. Alteration of lipid metabolism and insulin secretion in ventromedial hypothalamic obesity rats
286. Alteration of local adipose tissue trace element homeostasis as a possible mechanism of obesity-related insulin resistance
287. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance
288. Alterations in Novel Signals in the Gut–Adipose Axis–A Pilot Study in insulin-Resistant Children with obesity and Biopsy-Proven Nonalcoholic Steatohepatitis
289. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.
290. Alterations in the hepatic insulin receptor kinase in genetic and acquired obesity in rats
291. Alterations in the liver of intrauterine growth retarded piglets may predispose to development of insulin resistance and obesity in later life
292. Alterations in vitamin A/retinoic acid homeostasis in diet-induced obesity and insulin resistance
293. Alterations of carbohydrate and lipoprotein metabolism in childhood obesity–impact of insulin resistance and acanthosis nigricans.
294. Alterations of mitochondrial function and insulin sensitivity in human obesity and diabetes mellitus
295. Alterations of Serum True insulin in Patients with Simple obesity and Analyses of Factors Affecting insulin Resistance [J]
296. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance
297. Altered adrenocorticotropin and cortisol secretion in abdominal obesity: implications for the insulin resistance syndrome
298. Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance
299. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
300. Altered circulating levels of retinol binding protein 4 and transthyretin in relation to insulin resistance, obesity, and glucose intolerance in Asian Indians
301. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With obesity and TNFα-Induced insulin Resistance
302. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With obesity and TNFα-Induced insulin Resistance
303. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity
304. Altered insulin response to an acute bout of exercise in pediatric obesity
305. Altered insulin-Dependent Brain Glucose Metabolism During obesity Depends On Specific Brain Areas
306. Altered interleukin-10 signaling in skeletal muscle regulates obesity-mediated inflammation and insulin resistance
307. Altered lipid metabolism associated with insulin resistance and obesity is a major contributor to the onset and progression of type 2 diabetes
308. Altered plasma insulin and glucose after obesity-producing bipiperidyl brain lesions
309. Altered temporal changes in Ser312-phosphofetuin-A concentrations in response to a glucose challenge in a mouse model of diet-induced obesity and insulin …
310. Altering adipocyte metabolism as a way to counteract obesity and insulin Resistance
311. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance
312. Alzheimer’s disease risk, obesity and tau: is insulin resistance guilty?
313. Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity
314. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II …
315. Amelioration of obesity-associated inflammation and insulin resistance in c57bl/6 mice via macrophage polarization by fish oil supplementation
316. Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats
317. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin
318. Aminotransferase and gamma-glutamyl transpeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome
319. Amniotic fluid insulin concentration as a predictor of obesity.
320. AMP-activated protein kinase (AMPK): does this master regulator of cellular energy state distinguish insulin sensitive from insulin resistant obesity?
321. AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity
322. AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes 2012; 61: 3114–3125
323. AMPK activation by metformin suppresses abnormal extracellular matrix remodeling in adipose tissue and ameliorates insulin resistance in obesity
324. AMPK β1 deletion reduces appetite, preventing obesity and hepatic insulin resistance
325. An 8-week high-fat diet induces obesity and insulin resistance with small changes in the muscle transcriptome of C57BL/6J mice
326. An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome due to coexistent obesity
327. An Analysis of the Relationships Among obesity, Plasma insulin, and Hepatic Lipogenic Enzymes in
328. An animal model of gestational obesity and prediabetes: HISS-dependent insulin resistance induced by a high sucrose diet in Sprague Dawley rats.
329. An anti-inflammatory sterol decreases obesity-related inflammation-induced insulin resistance and metabolic dysregulation
330. An evaluation of acylated ghrelin and obestatin levels in childhood obesity and their association with insulin resistance, metabolic syndrome, and oxidative stress
331. An Exploration of relationships between three main characteristics of Equine Metabolic Syndrome, obesity, insulin resistance, and laminitis
332. An extract of Urtica dioica L. mitigates obesity induced insulin resistance in mice skeletal muscle via protein phosphatase 2A (PP2A)
333. An In Vivo Screen for Genes Involved in Central Nervous System Control of obesity Identifies Diacylglycerol Kinase as a Regulator of insulin Secretion
334. An in vivo screen for neuronal genes involved in obesity identifies Diacylglycerol kinase as a regulator of insulin secretion
335. An individual participant data meta-analysis on metabolomics profiles for obesity and insulin resistance in European children
336. An insertional polymorphism of the proopiomelanocortin gene is associated with fasting insulin levels in childhood obesity
337. An investigation into the effects of aspalathin on myocardial glucose transport using cardiomyocytes from control and obesity-induced insulin resistant rats, and …
338. An investigation of the association between obesity, acanthosis nigricans, and fasting serum insulin level in 6-9 year old children living on the El Paso-Juarez United …
339. An obesity genetic risk score predicts risk of insulin resistance among Chinese children
340. An obesity risk SNP (rs17782313) near the MC4R gene is associated with cerebrocortical insulin resistance in humans
341. An update on immune dysregulation in obesity‐related insulin resistance
342. An Update to the WISP-1/CCN4 Role in obesity, insulin Resistance and Diabetes
343. Analysis of data on insulin resistance from the European group for the study of insulin resistance: focus on obesity and hypertension
344. Analysis of FTO gene variants with obesity and glucose homeostasis measures in the multiethnic insulin Resistance Atherosclerosis Study cohort
345. Analysis of metabolic profiles underlying surrogates for obesity and insulin resistance in young adults from the Western Australian Pregnancy Cohort (Raine) Study
346. Analysis of the HepG2/erythrocyte glucose transporter locus in a family with type 2 (non-insulin-dependent) diabetes and obesity
347. ANALYSIS OF THE IMPACT OF obesity ON insulin-SENSITIVITY AND METABOLIC ABNOMALITY IN TYPE 2 DIABETES MELLITUS [J]
348. Analysis of three glucose transporter genes in a Caucasian population: no associations with non‐insulin‐dependent diabetes and obesity
349. Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome
350. Androgenicity and obesity are independently associated with insulin sensitivity in postmenopausal women
351. ANDROLOGY: obesity, insulin RESISTANCE AND THEIR CORRELATION WITH TESTOSTERONE LEVELS IN MALE PATIENTS
352. Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity
353. Angiogenesis modulates obesity and insulin sensitivity
354. Angiogenic Potential, Circulating Angiogenic Factors and insulin Resistance in Subjects with obesity
355. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance
356. Angiopoietin-related growth factor antagonizes obesity and insulin resistance
357. Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice
358. Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice
359. Angiotensinogen gene polymorphism (Met235Thr) influences visceral obesity and insulin resistance in obese Japanese women
360. Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation
361. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity
362. Anthocyanin‐rich Black Elderberry Extract improves Inflammatory Markers and insulin Resistance in a High‐Fat Diet‐Induced obesity Model of Mice
363. Anthropometric measures of obesity and insulin resistance in Turkish patients with type 2 diabetes
364. Anti-diabetic and anti-obesity effects of the allosteric PTP1B inhibitor KY-226 via insulin and leptin signal enhancement
365. Anti-inflammatory effects of yerba maté extract (Ilex paraguariensis) ameliorate insulin resistance in mice with high fat diet-induced obesity
366. Anti-obesity and anti-insulin resistance effects of tomato vinegar beverage in diet-induced obese mice
367. Anti-obesity and insulin-sensitising effects of a glycosaminoglycan mix
368. Anti-obesity effects of a mixture of thiamin, arginine, caffeine, and citric acid in non-insulin dependent diabetic KK mice
369. Anti-obesity effects of DHA and EPA in high fat-induced insulin resistant mice
370. Anti‐obesity action of gingerol: effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high‐fat diet
371. Anti‐obesity and anti‐diabetic effects of carteolol in non‐insulin‐dependent diabetic mice
372. Antihypertensive drugs and insulin resistance in obesity
373. Antioxidant supplementation and obesity have independent effects on hepatic oxylipin profiles in insulin-resistant, obesity-prone rats
374. Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity
375. Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment
376. Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway
377. Apelin, a newly identified adipokine up-regulated by insulin and obesity
378. Apolipoprotein C3 deficiency results in diet-induced obesity and aggravated insulin resistance in mice
379. Apolipoprotein C3-deficiency results in diet-induced obesity and insulin resistance in mice
380. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the …
381. Appearance of acanthosis nigricans may precede obesity: an involvement of the insulin/IGF receptor signaling pathway
382. Appetite-Regulating Hormones Are Reduced After Oral Sucrose vs Glucose: Influence of obesity, insulin Resistance, and Sex
383. Appetite, hunger and obesity as a function of dietary sugar intake: Can these effects be mediated by insulin-induced hypoglycemia? A reply to commentaries
384. APPL1 counteracts obesity-induced vascular insulin resistance and endothelial dysfunction by modulating the endothelial production of nitric oxide and endothelin-1 …
385. Application of nuclear techniques in the prevention of degenerative diseases (obesity and non-insulin dependent diseases) in ageing
386. Appropriate use of stimulation tests and insulin-like growth factor-I in obesity.
387. Are insulin Hypersecretion and Food Additives a Cause of obesity and Diabetes?
388. Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?
389. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents?
390. Are racial differences in obesity and insulin resistance related to aggressive breast cancer?
391. Are racial differences in obesity and insulin resistance related to aggressive breast cancer?
392. Are racial differences in obesity and insulin resistance related to aggressive breast cancer?
393. Arsenic methylation capacity and obesity are associated with insulin resistance in obese children and adolescents
394. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of …
395. Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome
396. Arterial stiffening, insulin resistance and acanthosis nigricans in a community sample of adolescents with obesity
397. Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity
398. Assess the relationship between insulin fasting levels and healthy obesity in adults in the province of Babylon, Iraq
399. Assessing associations of cardiorespiratory fitness (CRF) and degree of obesity with insulin-resistance.
400. ASSESSING obesity AND insulin MOLECULAR PATHWAYS INVOLVED IN WEIGHT LOSS INDUCED BY ROUX-EN-Y GASTRIC BYPASS
401. Assessing risk factors for obesity between childhood and adolescence: I. Birth weight, childhood adiposity, parental obesity, insulin, and leptin
402. Assessing risk factors for obesity between childhood and adolescence. I. Birth weight, childhood adiposity, parental obesity, insulin, and leptin.
403. Assessing the Mediating Effect of obesity-Linked SNPs in Nuclear Mitochondrial Genes on Exercise-Enhanced insulin Sensitivity
404. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice
405. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice
406. Assessment of different bariatric surgeries in the treatment of obesity and insulin resistance in mice.
407. Assessment of obesity, dyslipidemia, and insulin resistance in idiopathic hirsutism: a case–control study
408. Assessment of the relationship of hepatic enzymes with obesity and insulin resistance in adults in Saudi Arabia
409. Assisted reproductive technologies predispose to insulin resistance and obesity in male mice challenged with a high-fat diet
410. Association between 14 bp insertion/deletion HLA‐G functional polymorphism and insulin resistance in a cohort of Italian children with obesity
411. Association Between Anthropometric Measures of obesity and insulin Resistance in a Self-Selected Group of Indigenous Australians
412. Association between caries, obesity and insulin resistance in Mexican adolescents
413. Association between Caries, obesity and insulin Resistance in Mexican Adolescents.
414. Association between complement component C3 and body composition: a possible obesity inflammatory biomarker for insulin resistance
415. Association between cortisol, insulin resistance and zinc in obesity: A mini-review
416. Association between dietary insulin index and load with obesity in adults
417. Association between duration of obesity and risk of non-insulin-dependent diabetes mellitus: the Sotetsu Study
418. Association Between Expanded Normal Weight obesity and insulin Resistance Among US Adults in the National Health and Nutrition Examination Survey
419. Association between four adipokines and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population
420. Association between G-protein beta3 subunit (GNB (3)) gene C825T polymorphism, hypertension, insulin resistance and obesity
421. Association between muscle mass and insulin sensitivity independent of detrimental adipose depots in young adults with overweight/obesity
422. Association between obesity and insulin resistance with UCP2–UCP3 gene variants in Spanish children and adolescents
423. Association between obesity history and hand grip strength in older adults—exploring the roles of inflammation and insulin resistance as mediating factors
424. Association between obesity indices and insulin resistance among healthy Korean adolescents: the JS high school study
425. Association between obesity phenotypes of insulin resistance and risk of type 2 diabetes in African Americans: The Jackson Heart Study
426. Association between polymorphisms of insulin and insulin receptor gene with childhood obesity in Malay population
427. Association between Serum Lipid Profile and insulin Resistance in Type 2 Diabetic Patients with obesity [J]
428. Association between Transcription Factor AP-2B genotype, obesity, insulin resistance and dietary intake in a longitudinal birth cohort study
429. Association of abdominal obesity, insulin resistance, and oxidative stress in adipose tissue in women with polycystic ovary syndrome
430. #VALUE!
431. Association of adipocytokines with obesity and insulin resistance in Korean-Chinese and Han nationality pupils of Yanbian area
432. Association of adipocytokines with obesity and insulin resistance in Korean-Chinese and Han nationality pupils of Yanbian area
433. Association of adipokines and insulin, which have a role in obesity, with colorectal cancer
434. Association of Adipokines and insulin, Which Have a Role in obesity, with Colorectal Cancer
435. Association of ADRB1 and UCP3 gene polymorphisms with insulin sensitivity but not obesity
436. Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer
437. Association of central obesity and insulin resistance with high prevalence of diabetes and cardiovascular disease in an elderly population with low fat intake and lower …
438. Association of extracellular heat shock protein 70 and insulin resistance in type 2 diabetes; independent of obesity and C-reactive protein
439. Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study
440. Association of free fatty acids with the insulin-resistant state but not with central obesity in individuals from Venezuela.
441. Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese
442. Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese
443. Association of gut microbiome with fasting triglycerides, fasting insulin and obesity status in Mexican children
444. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity
445. Association of insulin Actions with Blood Pressure in Rodent Models of obesity and Diabetes
446. Association of insulin actions with blood pressure in rodent models of obesity and diabetes.
447. Association of insulin resistance and GLP-2 secretion in obesity: a pilot study
448. Association of insulin resistance and obesity with impaired immune response to нepatitis B vaccination in health care workers
449. ASSOCIATION OF insulin RESISTANCE AND obesity WITH IMPAIRED IMMUNE RESPONSE TO НЕРАTITIS B VACCINATION IN HEALTH CARE WORKERS
450. Association of insulin resistance with obesity in children
451. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose …
452. Association of leisure time physical activity and abdominal obesity with fasting serum insulin and 2‐h postchallenge plasma glucose levels
453. Association of leptin and insulin with childhood obesity and retinal vessel diameters
454. Association of Leptin Gene G2548A Polymorphism and Leptin Resistance with insulin Resistance and obesity among Egyptians
455. Association of Leptin With obesity and insulin Resistance
456. Association of Markers of obesity with insulin Resistance and Type 2 Diabetes Mellitus in a Rural Female Population
457. Association of miR-34a and mir-149 with obesity and insulin Resistance in Obese Children and Adolescents
458. Association of MMP‐8 with obesity, smoking and insulin resistance
459. Association of monocyte CCR2 expression with obesity and insulin resistance in postmenopausal women
460. Association of nerve conduction impairment and insulin resistance in children with obesity
461. Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance
462. Association of nonalcoholic fatty liver disease with obesity and insulin resistance
463. Association of obesity and hyperandrogenemia with insulin resistance in women with polycystic ovary syndrome
464. Association of obesity and insulin resistance with asthma and aeroallergen sensitization
465. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome
466. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome
467. Association of obesity and insulin resistance with serum testosterone, sex hormone binding globulin and estradiol in older males
468. #VALUE!
469. Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical–biochemical characteristics among infertile Mexican women …
470. Association of obesity indexes of waist circumference, body mass index and WHR with insulin resistance in non-diabetic subjects
471. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion
472. Association of obesity-mediated insulin resistance and hypothalamic volumes: Possible sex differences
473. Association of obesity, diabetes, serum lipids and blood pressure regulates insulin action
474. Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults
475. Association of osteoprotegerin with obesity, insulin resistance and non-alcoholic fatty liver disease in children
476. Association of osteosarcopenic obesity and its components: osteoporosis, sarcopenia and obesity with insulin resistance
477. #VALUE!
478. Association of Peptic Ulcer Disease with obesity, Serum insulin Level and Lipid Profile
479. Association of perilipin and insulin receptor substrate-1 genes polymorphism with lipid profiles, central obesity, and type 2 diabetes in a sample of an Iranian …
480. Association of plasminogen activator inhibitor-1 with insulin resistance in Japan where obesity is rare
481. Association of Polymorphism in the Glucocorticoid Recepter Gene and Plasm Glucose, insulin, Lipids in Abdominal obesity
482. Association of Resistin Gene 3′-Untranslated Region EX4-44G–> A Polymorphism with obesity-and insulin-Related Phenotypes in Turkish Type 2 Diabetes …
483. Association of resistin gene 3′-untranslated region EX4-44G–> A polymorphism with obesity-and insulin-related phenotypes in Turkish type 2 diabetes patients.
484. Association of serum ferritin and abdominal obesity and insulin resistance
485. Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults: The Korean National …
486. #VALUE!
487. Association of serum leptin and adiponectin with anthropomorphic indices of obesity, blood lipids and insulin resistance in a Sub-Saharan African population
488. Association of serum leptin levels with homeostasis model assessment–estimated insulin resistance and metabolic syndrome: the key role of central obesity
489. Association of single nucleotide polymorphism at position 45 in adiponectin gene with plasma adiponectin level and insulin resistance in obesity
490. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea
491. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome
492. Association of SNP45 in adiponectin gene with obesity and insulin resistance
493. Association of TCF7L2 and GCG gene variants with insulin secretion, insulin resistance, and obesity in new-onset diabetes
494. Association of the C825T polymorphism of the G-protein β3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic …
495. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity
496. Association of the TG polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes
497. Association of the TNF‐α−308 G/A Promoter Polymorphism with insulin Resistance in obesity
498. Association of the− 243A> G,+ 61450C> A Polymorphisms of the Glutamate Decarboxylase 2 (GAD2) Gene with obesity and insulin Level in North Indian …
499. #VALUE!
500. Association of Trp64Arg polymorphism of beta3-adrenergic receptor with insulin resistance in Polish children with obesity.
501. Association of vitamin B12 with obesity, overweight, insulin resistance and metabolic syndrome, and body fat composition; primary care-based study
502. Association of β2-adrenergic receptor and insulin receptor substrate-1 polymorphisms with obesity in a Northern Indian population
503. Associations between Body Fat Measurement by Dual-Energy X-Ray Absorptiometry and Abdominal obesity and insulin Resistance in Korean Populations: Cross …
504. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance
505. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity
506. Associations between long self-reported sleep, obesity and insulin resistance in a cohort of premenopausal Black and White South African women
507. Associations between sleep duration and insulin resistance in European children and adolescents considering the mediating role of abdominal obesity
508. Associations of 25-hydroxyvitamin D with markers of inflammation, insulin resistance and obesity in black and white community-dwelling adults
509. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women
510. Associations of cardiac structure with obesity, blood pressure, inflammation, and insulin resistance in African-American adolescents
511. Associations of chronic inflammation, insulin resistance, and severe obesity with mortality, myocardial infarction, cancer, and chronic pulmonary disease
512. Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults
513. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
514. Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals
515. Associations of obesity-metabolic Status With insulin Resistance and Chronic Inflammation Level: Results From the CNTR Study
516. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity
517. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project
518. Associations of Serum Fatty Acid Proportions with obesity, insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study
519. Associations of the PTEN− 9C> G polymorphism with insulin sensitivity and central obesity in Chinese
520. Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome
521. Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet
522. AT1 receptor blockade attenuates insulin resistance and myocardial remodeling in rats with diet-induced obesity
523. ATF7 ablation prevents diet-induced obesity and insulin resistance
524. Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate
525. ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation with insulin Resistance in obesity [Corrigendum]
526. ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation with insulin Resistance in obesity [Corrigendum]
527. ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity
528. Attenuated insulin induced dilation in coronary arteries from obesity resistant and obesity prone high fat fed rats (1071.6)
529. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
530. Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
531. Attenuation of Diet-Induced obesity, Hypertension and insulin Resistance in Vascular Endothelial Endothelin-1 Knockout Mice
532. Attenuation of obesity and insulin resistance by fish oil supplementation is associated with improved skeletal muscle mitochondrial function in mice fed a high-fat diet
533. Attenuation of obesity-induced insulin resistance in mice with heterozygous deletion of ROCK2
534. Attenuation of obesity, insulin resistance, and inflammation in TLR4 deficient 10ScN mice in response to a diet high in saturated fat
535. Atypical PKC: a target for treating insulin-resistant disorders of obesity, the metabolic syndrome and type 2 diabetes mellitus
536. Augmentation of alimentary insulin secretion despite similar gastric inhibitory peptide (GIP) responses in juvenile obesity
537. Augmented insulin and leptin resistance of high fat diet-fed APPswe/PS1dE9 transgenic mice exacerbate obesity and glycemic dysregulation
538. Aurantio‐obtusin improves obesity and insulin resistance induced by high‐fat diet in obese mice
539. Authors’ response: Associations of obesity and circulating insulin and glucose with breast cancer risk
540. Autoimmune activation of the GnRH receptor induces insulin resistance independent of obesity in a female rat model
541. Autologous subcutaneous adipose tissue transplants improve adipose tissue metabolism and reduce insulin resistance and fatty liver in diet‐induced obesity rats
542. Autonomic Blockade Improves obesity-Associated insulin Resistance
543. Autonomic neuropathy in non‐insulin dependent (type II) diabetes mellitus. Possible influence of obesity
544. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine
545. Autophagy: a potential link between obesity and insulin resistance
546. AUTOTAXIN IS NUTRITIONALLY REGULATED AND ALTERS MITOCHONDRIAL FUNCTION IN obesity-INDUCED insulin RESISTANCE
547. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism
548. Avocatin B Protects Against Lipotoxicity and Improves insulin Sensitivity in Diet‐Induced obesity
549. B Cell Activation in insulin Resistance and obesity
550. B lymphocyte stimulator (BLyS) is a novel adipokine in humans in vivo being related to obesity but not to insulin resistance
551. B lymphocyte stimulator (BLyS) is expressed in human adipocytes in vivo and is related to obesity but not to insulin resistance
552. B Lymphocyte Stimulator (BLyS) is expressed in human adipocytes in vivo and is related to obesity but not to insulin resistance
553. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance
554. b3-adrenergic-receptor polymorphism: a genetic marker for visceral fat obesity and the insulin resistance syndrome
555. B64 EFFECTS OF obesity ON LUNG FUNCTION: insulin Excess Leads To Lung Remodeling And Features Of Asthma
556. Baccharis dracunculifolia methanol extract enhances glucose-stimulated insulin secretion in pancreatic islets of monosodium glutamate induced-obesity model rats
557. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation
558. Baicalin against obesity and insulin resistance through activation of AKT/AS160/GLUT4 pathway
559. Basal insulin and obesity
560. Basis of Impaired Coronary Metabolic Dilation in obesity and insulin Resistance
561. Bax inhibitor-1 deficiency leads to obesity by increasing Ca2+-dependent insulin secretion
562. Behavior of C-peptide and immunoreactive insulin in essential obesity
563. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet‐induced obesity mice
564. Beneficial effects of ethanol consumption on insulin resistance are only applicable to subjects without obesity or insulin resistance; drinking is not necessarily a …
565. Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet
566. Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet
567. Beneficial effects of IKKε-deficiency on body weight and insulin sensitivity are lost in high fat diet-induced obesity in mice
568. Beneficial effects of murtilla extract and madecassic acid on insulin sensitivity and endothelial function in a model of diet-induced obesity
569. Beneficial Effects of vitamin D on insulin sensitivity, blood pressure, abdominal subcutaneous fat thickness, and weight loss in refractory obesity
570. Beneficial Effects of Vitamin D on insulin Sensitivity, Blood Pressure, Abdominal Subcutaneous Fat Thickness, and Weight Loss in Refractory obesity
571. Beneficial metabolic effects of selected probiotics on diet‐induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota
572. Beta-endorphin, insulin, ACTH and cortisol plasma levels during oral glucose tolerance test in obesity after weight loss
573. Biallelic mutations in GPD1 gene in a Chinese boy mainly presented with obesity, insulin resistance, fatty liver, and short stature
574. Bif-1 deficiency impairs lipid homeostasis and causes obesity accompanied by insulin resistance
575. Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell?
576. Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines
577. Binding and molecular weight properties of the insulin receptor from omental and subcutaneous adipocytes in human obesity
578. Bioactive insulin-like growth factor-I in obesity
579. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance
580. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: relationships with obesity and insulin resistance
581. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women
582. Biochemical characteristics and risk factors for insulin resistance at different levels of obesity
583. Biochemical Effects of Anti-Diabetic Therapies on obesity and insulin Resistance Induced by Monosodium Glutamate in Male Rats
584. Biochemical studies of cutaneous damage in mouse models of insulin resistance and obesity
585. #VALUE!
586. Biocompounds attenuating the development of obesity and insulin resistance produced by a high-fat sucrose diet
587. Biomarkers of Alzheimer disease, insulin resistance, and obesity in childhood
588. Bisphenol A and diabetes, insulin resistance, cardiovascular disease and obesity: controversy in a (plastic) cup?
589. Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population
590. BITC and S-carvone restrain high-fat diet-induced obesity and ameliorate hepatic steatosis and insulin resistance
591. Black yeast beta glucan for insulin Resistance Prevention through IL-33, ST2 and Leptin Level: An In vivo Study of an obesity model using Sprague dawley Rats
592. Blockade of class IB phosphoinositide-3 kinase ameliorates obesity-induced inflammation and insulin resistance
593. Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes
594. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-α signaling protected Wistar rats from diet-induced obesity and insulin resistance
595. Blocking CD40-TRAF6 Signaling is a Novel Therapeutic Target in obesity-Associated insulin Resistance
596. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance
597. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (Proceedings of the National Academy of Sciences of the United States …
598. Blocking CXCR7-mediated adipose tissue macrophages chemotaxis attenuates insulin resistance and inflammation in obesity
599. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity
600. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice
601. Blood coagulation and aortic wall integrity in rats with obesity-induced insulin resistance
602. Blood glucose level and insulin resistance in patients with type 2 diabetic mellitus, diabetic retinopathy and obesity
603. Blood insulin levels during oral glucose tolerance tests in the obese child. Influence of age, sex, degree and duration of obesity
604. Blood pressure in 15 inbred mouse strains and its lack of relation with obesity and insulin resistance in the progeny of an NZO/HILtJ× C3H/HeJ intercross
605. Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men
606. Blood sugar and immunoreactive insulin in women with hypothalamic, maternal and simple obesity. Part I.
607. Blood viscosity in human obesity: relation to glucose tolerance and insulin status.
608. Blueberries Improve Whole‐Body insulin Action and Alter the Development of obesity in High‐Fat Fed Mice
609. Body Composition and its Association with insulin Resistance in Korea Older Population: A Focus on Sarcopenic obesity
610. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men
611. Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity
612. Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in irs2–/–mice
613. Botryosphaeran reduces obesity, hepatic steatosis, dyslipidaemia, insulin resistance and glucose intolerance in diet-induced obese rats
614. Brain and behavioral correlates of insulin resistance in youth with depression and obesity
615. Brain insulin and obesity: From Man to C. elegans
616. #VALUE!
617. Brain PPAR-γ promotes obesity and is required for the insulin–sensitizing effect of thiazolidinediones
618. Brain-Specific Disruption of the Maternal (but not Paternal) Allele of the Imprinted G [sub s] α Gene Leads to obesity and insulin Resistance.
619. Breastmilk with a high omega‐6 to omega‐3 fatty acid ratio induced cellular events similar to insulin resistance and obesity in 3T3‐L1 adipocytes
620. Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus …
621. Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance
622. Brown adipose tissue triglyceride content is associated with decreased insulin sensitivity, independently of age and obesity
623. Bypassing the duodenum does not improve insulin resistance associated with diet‐induced obesity in rodents
624. c-Abl inhibition mitigates diet-induced obesity through improving insulin sensitivity of subcutaneous fat in mice
625. C-peptide and insulin secretion in Pima Indians and Caucasians: constant fractional hepatic extraction over a wide range of insulin concentrations and in obesity
626. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose …
627. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites
628. C-reactive protein, obesity, and insulin resistance in postmenopausal women in urban slums of North India
629. C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance
630. C1q/TNF-related protein-12 (CTRP12), a novel adipokine that improves insulin sensitivity and glycemic control in mouse models of obesity and diabetes
631. C825T Polymorphism of the G Protein β3 Subunit Is Associated with obesity but Not with insulin Sensitivity
632. Ca2+ mishandling and cardiac dysfunction in obesity and insulin resistance: Role of oxidative stress
633. Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon …
634. Cafeteria diet-induced obesity is associated with a low spontaneous growth hormone secretion and normal plasma insulin-like growth factor-I concentrations
635. Calanus oil in the treatment of obesity-related low-grade inflammation, insulin resistance, and atherosclerosis
636. Caloric restriction in pregnant diabetic women: a review of maternal obesity, glucose and insulin relationships as investigated at the University of California, San Diego …
637. Calorie restriction reduced blood pressure in obesity hypertensives by improvement of autonomic nerve activity and insulin sensitivity
638. Can obesity Alone Increase Fasting Serum insulin, Fasting Serum C-Peptide and insulin Resistance?
639. Can prokineticin prevent obesity and insulin resistance?
640. Canagliflozin improves obesity and insulin resistance in a diabetic patient with Cushing’s disease undergoing postoperative steroid therapy: A case report
641. Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis
642. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity
643. Cannabis use in relation to obesity and insulin resistance in the inuit population
644. Carbohydrate intake affects insulin binding to human erythrocytes in normal weight subjects but not in subjects with family obesity
645. Carbohydrates, insulin, and obesity
646. Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4 …
647. CARD3 deficiency exacerbates diet-induced obesity, hepatosteatosis, and insulin resistance in male mice
648. Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity
649. Cardiac ischemia–reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity
650. Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies
651. #VALUE!
652. Cardiomyopathy in obesity, insulin resistance and diabetes
653. Cardiorespiratory fitness, insulin sensitivity, and perceptions of obesity treatment in obese children and adolescents
654. Cardiovascular and renal complications in obesity and obesity-related medical conditions: role of sympathetic nervous activity and insulin resistance
655. Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance
656. Cardiovascular and Renal Integration: Microvascular insulin resistance in skeletal muscle and brain occurs early in the development of juvenile obesity in pigs
657. Cardiovascular Consequences of obesity and Type 2 Diabetes: Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the …
658. Cardiovascular risk factors in adolescents: Role of insulin resistance and obesity
659. Carotid Intima-media thickness in childhood and adolescent obesity relations to abdominal obesity, high triglyceride level and insulin resistance
660. Carvedilol improves glucose tolerance and insulin sensitivity in treatment of adrenergic overdrive in high fat diet-induced obesity in mice
661. Case problem: Dietary recommendations to combat obesity, insulin resistance, and other concerns related to polycystic ovary syndrome/Response
662. Cashew apple extract inhibition of fat storage and insulin resistance in the diet-induced obesity mouse model
663. Casitas B-Lineage Lymphoma RING Domain Inhibitors Protect Mice against High-Fat Diet-Induced obesity and insulin Resistance
664. Casitas b-lineage lymphoma–deficient mice are protected against high-fat diet–induced obesity and insulin resistance
665. Caspase-12, but not caspase-11, inhibits obesity and insulin resistance
666. CATECHOL-O-METHYLTRANFERASE GENOTYPE MODULATION OF insulin RESISTANCE IN obesity, IS INDEPENDENT OF BLOOD PRESSURE LEVEL: 9B …
667. CATECHOLAMINES, obesity AND insulin—RESISTANT DIABETES: EXPERIMENTAL INSIGHTS
668. Catestatin inhibits obesity-induced macrophage infiltration and inflammation in the liver and suppresses hepatic glucose production, leading to improved insulin …
669. Cathelicidin regulates myeloid cell accumulation in adipose tissue and promotes insulin resistance during obesity
670. Causal Effects of Overall and Abdominal obesity on insulin Resistance and the Risk of Type 2 Diabetes Mellitus: A Two-Sample Mendelian Randomization …
671. Causal Relationship of Non-alcoholic Fatty Liver Disease with obesity and insulin Resistance.
672. Cbl-b is a critical regulator of macrophage activation associated with obesity-induced insulin resistance in mice
673. CC motif chemokine receptor 9 regulates obesity-induced insulin resistance via inflammation of the small intestine in mice
674. CCL2 and CCL3 chemokine gene expression and their receptors in human visceral and subcutaneous adipose tissue is associated with obesity and insulin …
675. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status
676. Ccrl2 deficiency deteriorates obesity and insulin resistance through increasing adipose tissue macrophages infiltration
677. CD11b regulates obesity-induced insulin resistance via limiting alternative activation and proliferation of adipose tissue macrophages
678. CD40 deficiency aggravates diet-induced obesity, adipose tissue inflammation, and insulin resistance in mice
679. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance
680. CD47 deficiency protects mice from diet-induced obesity and improves whole body glucose tolerance and insulin sensitivity
681. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH)
682. Cellular alterations responsible for insulin resistance in obesity and type II diabetes mellitus
683. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance
684. Cellular inflammatory responses: novel insights for obesity and insulin resistance
685. Cellular ions in hypertension, insulin resistance, obesity, and diabetes: a unifying theme.
686. Cellular mechanisms in selected states of insulin resistance: human obesity, glucocorticoid excess, and chronic renal failure
687. Central and peripheral insulin resistance in a large animal model of obesity
688. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does …
689. Central arterial stiffness and diastolic dysfunction are not increased in young women with PCOS but are associated with insulin resistance and abdominal obesity
690. Central obesity and altered peripheral adipose tissue gene expression characterize the NAFLD patient with insulin resistance: Role of nutrition and insulin challenge
691. Central obesity and hyperinsulinaemia in women are associated with polymorphism in the 5 ‘flanking region of the human insulin gene
692. Central obesity and hypertension: relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects
693. Central obesity and insulin resistance in the cardiometabolic syndrome: pathways to preclinical cardiovascular structure and function
694. Central obesity and the insulin resistance syndrome: new elements in the etiology of non-communicable diseases
695. Central obesity in rhesus monkeys: association with hyperinsulinemia, insulin resistance and hypertriglyceridemia?
696. Central obesity increases the risk of gestational diabetes partially through increasing insulin resistance
697. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort …
698. Central obesity with insulin Resistance and Type 2 Diabetes
699. Central obesity, insulin resistance, syndrome X, lipoprotein (a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore.
700. Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns
701. Central serotonin and dopamine transporters in overeating, obesity and insulin resistance
702. Cephalic phase insulin response as a predictor of body weight gain and obesity induced by a palatable cafeteria diet.
703. Ceramide kinase deficiency improves diet-induced obesity and insulin resistance
704. Ceramides, mitochondrial fission, and reactive oxygen species a novel mechanism of obesity‐induced insulin resistance (LB167)
705. CerS1-derived C18: 0 ceramide in skeletal muscle promotes obesity-induced insulin resistance
706. Changes in DNA Methylation and Gene Expression of insulin and obesity-Related Gene PIK3R1 after Roux-en-Y Gastric Bypass
707. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes.
708. Changes in insulin sensitivity after weight loss in hypertensive patients with obesity
709. Changes in insulin, somatostatin, and glucagon secretion during the development of obesity in ventromedial hypothalamic-lesioned rats
710. Changes in plasma immunoreactive insulin during thyroid treatment of obesity.
711. Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity
712. Changes of insulin Resistance and β-Cell Secrete Function in Children with Simple obesity [J]
713. Changes of serum leptin, adiponection and insulin levels in females with simple obesity
714. chapter 6–metabolic and vascular insulin sensitivity in obesity and hypertension
715. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance
716. Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity
717. Characterization of gut microbiota and adipose tissues in the regulation of obesity-induced insulin resistance
718. Characterization of inflammation and insulin resistance in high‐fat diet‐induced male C57BL/6J mouse model of obesity
719. CHARACTERIZATION OF SERUM insulin IN STUDIES OF obesity OF CUINO PIGS
720. Characterization of the insulin-like growth factor axis in term pregnancies complicated by maternal obesity
721. Characterizing the Effects of Diabetes and obesity on insulin and Leptin Levels amongst Pregnant Women
722. CHDH-PNPLA3 Gene–Gene Interactions Predict insulin Resistance in Children with obesity
723. Chemerin Serum Level and insulin Resistancein Hypertensive Patients with obesity
724. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in …
725. Chemical inducers of obesity-associated metabolic stress activate inflammation and reduce insulin sensitivity in 3T3-L1 adipocytes
726. Chemokine systems link obesity to insulin resistance
727. Childhhood obesity, insulin resistance and increased cardiovascular risk
728. Childhood obesity and insulin resistance
729. Childhood obesity and insulin resistance in a Yucatan mini-piglet model: putative roles of IGF-1 and muscle PPARs in adipose tissue activity and development
730. Childhood obesity and insulin resistance: how should it be managed?
731. Childhood obesity and insulin-resistant syndrome
732. Childhood obesity in Asian Indians: a burgeoning cause of insulin resistance, diabetes and sub-clinical inflammation.
733. Childhood obesity, insulin Resistance, and Magnesium Metabolism
734. Childhood obesity, thyroid function, and insulin resistance–is there a link? A longitudinal study
735. Childhood obesity: serum lipoproteins, glucose and insulin concentrations after an oral glucose load.
736. Childhood social preference and adolescent insulin resistance: Accounting for the indirect effects of obesity
737. Chlorogenic acid/chromium supplement rescues diet-induced insulin resistance and obesity in mice
738. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition …
739. Chromogranin A regulation of obesity and peripheral insulin sensitivity
740. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes
741. Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice
742. Chronic Exposure to Environmental Level Phenanthrene Induces Non-obesity-Dependent insulin Resistance in Male Mice
743. Chronic exposure to PCBs (Aroclor 1254) exacerbates obesity-induced insulin resistance and hyperinsulinemia in mice
744. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
745. Chronic intestinal electrical stimulation improves glucose intolerance and insulin resistance in diet‐induced obesity rats
746. Chronic kidney disease and obesity bias surrogate estimates of insulin sensitivity compared with the hyperinsulinemic euglycemic clamp
747. Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions
748. Chronic stress, glucocorticoids, insulin and obesity
749. Chronically increased glucose uptake by adipose tissue leads to lactate production and improved insulin sensitivity rather than obesity in the mouse
750. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation
751. Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity
752. Circadian disruption leads to insulin resistance and obesity
753. Circadian rhythms of cortisol and insulin in nutritional obesity in children
754. Circulating adhesion molecule serum concentrations in individuals with insulin sensitive obesity
755. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity
756. Circulating branched‐chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents
757. Circulating follistatin and activin A and their regulation by insulin in obesity and type 2 diabetes
758. Circulating High Molecular Weight Adiponectin Levels Are Related to obesity hut not to insulin Sensitivity in Healthy and Glucose Tolerant Caucasians.
759. Circulating immune complexes and insulin antibodies in obesity in children
760. Circulating levels of insulin-like growth factor-II/mannose-6-phosphate receptor in obesity and type 2 diabetes
761. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance
762. Circulating microRNA profile in insulin Resistant Childhood obesity
763. Circulating miRNA Signatures Associated with insulin Resistance in Adolescents with obesity
764. Circulating mitochondrial DNA is decreased in children and adolescents with obesity and/or insulin resistance
765. Circulating sDPP-4 is increased in obesity and insulin resistance but is not related to systemic metabolic inflammation
766. Circulating soluble IL-6 receptor concentration and visceral adipocyte size are related to insulin resistance in Taiwanese adults with morbid obesity
767. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance
768. CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity
769. Clinacal Application of Determination of insulin Receptor in NIDDM Patients with obesity
770. Clinical application of relative insulin sensitivity index in children with obesity and diabetes mellitus
771. Clinical assessment of obesity and insulin resistance in type 1 diabetes subjects seen at a center in Kolkata
772. Clinical case of the month. Natural history of morbid obesity: towards insulin-requiring type 2 diabetes and reversal after bariatric surgery
773. Clinical features of slowly progressive type 1 (insulin-dependent) diabetes mellitus: a comparative study based on degree of obesity at diagnosis of diabetes
774. Clinical features of slowly progressive type 1 (insulin-dependent) diabetes mellitus: a comparative study based on degree of obesity at diagnosis of diabetes
775. Clinical Research of Integrated Chinese and Western Medicine Therapy for Patients with obesity Hypertension Related insulin Resistance
776. Clinical significance of changes of plasma leptin and serum insulin/testosterone levels before and after treatment in patients with woman obesity of infertile
777. Clinical use of continuous subcutaneous insulin infusion for type 2 diabetic patients with obesity [J]
778. Clinical value of selected markers of angiogenesis, inflammation, insulin resistance and obesity in type 1 endometrial cancer
779. Clinico pathological study of Acanthosis Nigricans and its correlation with obesity and insulin resistance
780. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population
781. Cme instructions: Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance
782. CNS Vitamin D Improves Glucose Tolerance, Hepatic insulin Sensitivity, and Reverses Diet-Induced obesity
783. CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK
784. Cocoa polyphenols suppress adipogenesis in vitro and obesity in vivo by targeting insulin receptor
785. Coconut oil aggravates pressure overload-induced cardiomyopathy without inducing obesity, systemic insulin resistance, or cardiac steatosis
786. Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus.
787. Coffee intake mitigated inflammation and obesity-induced insulin resistance in skeletal muscle of high-fat diet-induced obese mice
788. Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1
789. Combination therapy with metformin and fenofibrate for insulin resistance in obesity
790. Combined effect of abdominal obesity and both hepatic lipase gene polymorphism and angiotensin genepolymorphism on lipid and lipoprotein levels and insulin …
791. #VALUE!
792. Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity
793. Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the Multi-Ethnic Study of Atherosclerosis
794. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes
795. Combined Influence of insulin Resistance, Overweight/obesity, and Fatty Liver as Risk Factors for Type 2 Diabetes
796. #VALUE!
797. Combining metabolic profiling of plasma and faeces as a fingerprint of insulin resistance in obesity
798. Comment on Francés et al. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, obesity, and insulin Resistance. Diabetes 2015; 64: 1522 …
799. Comment on: Cani et al.(2007) Metabolic Endotoxemia Initiates obesity and insulin Resistance: Diabetes
800. Comment on: Cani et al.(2007) Metabolic endotoxemia initiates obesity and insulin resistance: Diabetes 56: 1761–1772
801. Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, insulin Resistance, obesity, and Chronic Inflammation …
802. Commentary on the Impact of obesity and Puberty on insulin Sensitivity
803. Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis
804. Comments on: Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome. Relationships to insulin resistance and obesity.
805. Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study
806. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity
807. Common genetic variation in the SERPINF1 locus determines overall adiposity, obesity-related insulin resistance, and circulating leptin levels
808. Common Genetic Variation in the SERPINF1 Locus Determines Overall Adiposity, obesity-Related insulin Resistance, and Circulating Leptin Levels
809. Common STAT3 Variants Are Not Associated With obesity or insulin Resistance in Female Twins
810. Common variants in SOCS7 gene predict obesity, disturbances in lipid metabolism and insulin resistance
811. Common variants in the regulatory region of the insulin gene are associated with fasting plasma insulin levels in juvenile obesity
812. Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 …
813. Comparing Different Markers of insulin Resistance in Pediatric obesity
814. Comparison of Abdominal obesity and Fatty Liver and Their Association with insulin Resistance and Metabolic Syndrome in Chinese Adults
815. Comparison of Cardiometabolic Syndrome Parameters, obesity, insulin Resistance, and Elevated Alanine Aminotransferase in Current Professional Baseball and …
816. Comparison of Lipoprotein Based insulin Resistance Score and Traditional Risk Factors in Adolescents with obesity
817. Comparison of Predictive Value of obesity and Lipid Related Variables for Metabolic Syndrome and insulin Resistance in Obese Adults
818. Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity
819. Comparison of the association with sleep apnoea of obesity versus insulin resistance
820. Comparison of the effects of captopril and nicardipine on insulin sensitivity and thrombotic profile in patients with hypertension and android obesity
821. Comparison of therapeutic effects of electroacupuncture and acupoint catgut embedding in redu-cing serum leptin and insulin levels in simple obesity patients
822. Comparison of β-cell dysfunction and insulin resistance correlating obesity with type 2 diabetes: a cross-sectional study
823. Compensation for obesity-induced insulin resistance in dogs: assessment of the effects of leptin, adiponectin, and glucagon-like peptide-1 using path analysis
824. Complement 3 serum levels as a pro-inflammatory biomarker for insulin resistance in obesity
825. Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus
826. Complement activation in polycystic ovary syndrome occurs in the postprandial and fasted state and is influenced by obesity and insulin sensitivity
827. Complement component C3: relationship with obesity, insulin resistance and cardiovascular risk markers.
828. Complement factor C3 methylation and mRNA expression is associated to BMI and insulin resistance in obesity
829. Complete failure of insulin-transmitted signaling, but not obesity-induced insulin resistance, impairs respiratory chain function in muscle
830. Complex Interactions Between Diet, Exercise, and the HPA Axis on the Development of obesity, insulin Resistance, and Type 2 Diabetes
831. Composition of dietary fat affects blood pressure and insulin responses to dietary obesity in the dog
832. CONCISE REVIEW biological: Periodontal inflammation and insulin resistance—lessons from obesity
833. Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance
834. Confluent and reticulated papillomatosis: a case with concurrent acanthosis nigricans associated with obesity and insulin resistance
835. Conjugated linoleic acid, obesity, and insulin resistance: waiting for the day of liberation from chronic disease
836. Constitutive insulin sensitivity and obesity my be caused by PTEN mutations
837. Consumption of added sugars from liquid but not solid sources predicts impaired glucose homeostasis and insulin resistance among youth at risk of obesity
838. Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity
839. Continuous glucose monitoring, oral glucose tolerance, and insulin-glucose parameters in adolescents with simple obesity.
840. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population
841. Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women
842. Contribution of B cells to obesity and insulin resistance
843. Contribution of genetic, biochemical and environmental factors on insulin resistance and obesity in Mexican young adults
844. Contribution of insulin resistance to decreased baroreceptor sensitivity & cardiometabolic risks in pre-obesity & obesity
845. Contribution of leptin in the development of insulin resistance in pregnant women with obesity
846. Contribution of lipid-reactive natural killer T cells to obesity-associated inflammation and insulin resistance
847. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus
848. Contribution of the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study
849. Contribution of TNF-α to obesity-Associated insulin Resistance
850. Contribution of visceral obesity to the insulin resistance syndrome
851. Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium‐dependent vasodilation in humans
852. Convergence of leptin and insulin signaling networks in obesity
853. Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects of obesity and non-insulin-dependent diabetes mellitus
854. Copeptin and Nesfatin-1 Are Interrelated Biomarkers with Roles in the Pathogenesis of insulin Resistance in Chinese Children with obesity
855. Copeptin and Obestatin Levels in Polycystic Ovary women and their Relation to obesity, insulin metabolism and Cardiovascular diseases
856. Copeptin as a Novel Biomarker of obesity-Induced insulin Resistance and Metabolic Syndrome
857. Corepressor SMRT promotes oxidative phosphorylation in adipose tissue and protects against diet-induced obesity and insulin resistance
858. Coronavirus and obesity: could insulin resistance mediate the severity of Covid-19 infection?
859. Correction: Beneficial effects of exercise on offspring obesity and insulin resistance are reduced by maternal high-fat diet
860. Correction: insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in obesity
861. Correction: Methionine-Restricted C57BL/6J Mice Are Resistant to Diet-Induced obesity and insulin Resistance but Have Low Bone Density
862. Correction: obesity Resistance and Enhanced insulin Sensitivity in Ahnak-/- Mice Fed a High Fat Diet Are Related to Impaired Adipogenesis and Increased Energy …
863. Correction: Percentage fractions of urinary di (2-ethylhexyl) phthalate metabolites: Association with obesity and insulin resistance in Korean girls
864. Correlation analysis of serum obestatin expression with insulin resistance in childhood obesity
865. Correlation Analysis on obesity Complicated with Hyperlipidemia And Lipid, Fatty-insulin Axis, Autonomic Nerve Function
866. Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity
867. Correlation Between insulin Resistance and obesity in Normoglycemic Obese Syrian Subjects
868. Correlation between insulin resistance surrogates and echocardiographic findings in asymptomatic patients with morbid obesity: a cross-sectional study
869. Correlation between insulin-like growth factor-I and obesity index during inpatient treatment in anorexia nervosa in childhood and adolescence
870. Correlation between Mid-thigh Low Density Muscle and insulin Resistance in obesity
871. Correlation between myostatin and obesity or insulin resistance of patients with polycystic ovary syndrome
872. Correlation Between obesity, BMI and insulin Resistance in Bulgarian Children
873. Correlation Between obesity, Body Mass Index and insulin Resistance in Bulgarian Children
874. Correlation between plasma fibroblast growth factor 21 level, obesity and insulin resistance in nonalcoholic fatty liver disease patients [J]
875. Correlation between plasma fibroblast growth factor 21 level, obesity and insulin resistance in nonalcoholic fatty liver disease patients.
876. Correlation between the various measurements of obesity and the degree of resistance to insulin
877. Correlation of body mass index with serum leptin, insulin and sex hormones level in preschool obesity children
878. Correlation of childhood obesity and related insulin resistance with leptin and retinol binding protein 4
879. Correlation of Childhood obesity and Related insulin Resistance with Leptin and Retinol Binding Protein 4: Correspondence
880. Correlation of obesity and the novel adipocytokines, leptin and adiponectin with insulin resistance in type 2 diabetes
881. Correlation of obesity Status with Zinc Serum Levels and insulin Resistance in Perimenopause Obese Women
882. Correlation of obesity with C-reactive protein, leptin and insulin sensitive index in children
883. Correlation of obesity, insulin resistance and lipid profile in women with PCOS in Kims Hospital Bangalore
884. Correlation of Plasma Angiopoietin-2 and Inflammation Marker with insulin Resistence in Patients with Central obesity
885. Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients
886. Correlation of serum cytokines with insulin sensitivity and RAS system activity in patients with obesity-related hypertension
887. Correlation of serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 level with other hormones in preschool obesity children
888. Correlation of serum leptin and insulin levels of pregnant protein-restricted rats with predictive obesity variables
889. CORRELATION OF TUMOUR NECROSIS FACTOR-αWITH obesity INDUCED insulin RESISTANCE IN TYPE 2 DIABETES MELLITUS
890. Correlations between plasma insulin and body weight in obesity, anorexia nervosa and diabetes mellitus
891. Correlations of Xinjiang Kazak obesity and insulin resistance to cardiovascular risk factors
892. Corrigendum to ‘Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities’
893. Corrigendum: IL-37 protects against obesity-induced inflammation and insulin resistance
894. Corticostriatal dopamine networks mediate impulsivity in obesity and insulin resistance
895. Corylin reduces obesity and insulin resistance and promotes adipose tissue browning through SIRT-1 and β3-AR activation
896. Cost-effectiveness of exenatide versus insulin glargine in Spanish patients with obesity and type 2 diabetes mellitus
897. Could SCGF-Beta Levels Be Associated with Inflammation Markers and insulin Resistance in Male Patients Suffering from obesity-Related NAFLD?
898. Counterintuitive effects of double-heterozygous null melanocortin-4 receptor and leptin genes on diet-induced obesity and insulin resistance in C57BL/6J mice
899. COX‐2‐mediated inflammation in fat is crucial for obesity‐linked insulin resistance and fatty liver
900. CREBH improves diet-induced obesity, insulin resistance, and metabolic disturbances by FGF21-dependent and FGF21-independent mechanisms
901. CREG1 heterozygous mice are susceptible to high fat diet-induced obesity and insulin resistance
902. Cross-sectional and longitudinal relationship of sodium-lithium countertransport to insulin, obesity and blood pressure in healthy perimenopausal women.
903. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance
904. Crucial roles of N ox2‐derived oxidative stress in deteriorating the function of insulin receptors and endothelium in dietary obesity of middle‐aged mice
905. CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues
906. Cudrania tricuspidata water extract improved obesity-induced hepatic insulin resistance in db/db mice by suppressing ER stress and inflammation
907. Cudrania tricuspidata water extract improves obesity-induced hepatic insulin resistance through suppression of ER stress and inflammation in db/db mice
908. Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established rheumatoid arthritis: cross-sectional study
909. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes
910. Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway
911. Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review
912. Cx30. 2 deletion causes imbalances in testicular Cx43, Cx46, and Cx50 and insulin receptors. Reciprocally, diabetes/obesity alters Cx30. 2 in mouse testis
913. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance
914. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance
915. CXCL14 enhances insulin-dependent glucose uptake in adipocytes and is related to high-fat diet-induced obesity
916. CXCL5 is an adipose tissue derived factor that links obesity to insulin resistance
917. CXCR3 modulates obesity‐induced visceral adipose inflammation and systemic insulin resistance
918. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db/db mice via the transcription factor FoxO1
919. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance
920. Cyclocarya paliurus (Batal.) Ijinskaja aqueous extract (CPAE) ameliorates obesity by improving insulin signaling in the hypothalamus of a metabolic syndrome …
921. Cystathionine beta synthase-hydrogen sulfide system in paraventricular nucleus reduced high fatty diet induced obesity and insulin resistance by brain …
922. Cystathionine γ‐lyase deficiency aggravates obesity‐related insulin resistance via FoxO1‐dependent hepatic gluconeogenesis
923. Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance
924. d-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats
925. Daily branched‐chain amino acid intake and risks of obesity and insulin resistance in children: A cross‐sectional study
926. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study
927. Daniel Porte Jr.: a leader in our understanding of the role of defective insulin secretion and action in obesity and type 2 diabetes
928. DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis
929. DBZ is a putative PPARγ agonist that prevents high fat diet-induced obesity, insulin resistance and gut dysbiosis
930. De novo 19p13. 2 microdeletion encompassing the insulin receptor and resistin genes in a patient with obesity and learning disability
931. Debating the relevance of resistin: hormone links obesity and insulin resistance in mice, but doubts persist about impact on type 2 diabetes research.(Hot Papers)
932. Decaffeinated green coffee bean extract attenuates diet-induced obesity and insulin resistance in mice
933. Decline in physical fitness from childhood to adulthood associated with increased obesity and insulin resistance in adults
934. Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin
935. #VALUE!
936. Decreased adipose tissue oxygenation associates with insulin resistance in individuals with obesity
937. Decreased apolipoprotein A5 is implicated in insulin resistance-related hypertriglyceridemia in obesity
938. Decreased basal insulin secretion from pancreatic islets of pups in a rat model of maternal obesity
939. Decreased hepatic insulin extraction in upper body obesity: relationship to unbound androgens and sex hormone binding globulin
940. Decreased insulin removal contributes to hyperinsulinemia in obesity
941. Decreased jaw bone density and osteoblastic insulin signaling in a model of obesity
942. Decreased number of insulin receptors in obesity: studies in the obese hyperglycemic mouse (author’s transl)
943. Decreased serum CA 19‐9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux‐en‐Y …
944. Decreased sex hormone binding globulin (SHBG) and insulin‐like growth factor binding protein (IGFBP‐1) in extreme obesity
945. Decrement in resting and insulin‐stimulated soleus muscle mitochondrial respiration is an early event in diet‐induced obesity in mice
946. Dectin-1 activation exacerbates obesity and insulin resistance in the absence of MyD88
947. Defective Activation of Protein Kinase Cz in Muscle by insulin and Phosphatidylinositol-3,4,5,-(PO4)3 in obesity and Polycystic Ovary Syndrome
948. Defective autophagy causes a maladaptive cardiac phenotype to exercise that leads to premature death and FGF21‐mediated protection against obesity and insulin …
949. Defective FXR-SHP regulation in obesity aberrantly increases miR-802 expression, promoting insulin resistance and fatty liver
950. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance
951. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus
952. Defective insulin signalling, mediated by inflammation, connects obesity to Alzheimer disease; relevant pharmacological therapies and preventive dietary …
953. Deficiency in AIM2 induces inflammation and adipogenesis in white adipose tissue leading to obesity and insulin resistance
954. Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice
955. Deficiency in the extracellular signal-regulated kinase 1 (ERK1) protects leptin-deficient mice from insulin resistance without affecting obesity
956. Deficiency in the short‐chain acyl‐CoA dehydrogenase protects mice against diet‐induced obesity and insulin resistance
957. Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
958. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
959. Deficiency of phosphoinositide 3-kinase enhancer protects mice from diet-induced obesity and insulin resistance
960. Deficiency of the leukotriene B4 receptor, BLT-1, protects against systemic insulin resistance in diet-induced obesity
961. Deficiency of Tyk2 kinase in mice leads to obesity and insulin resistance
962. Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity-and age-induced peripheral insulin resistance: a study in …
963. Dehydroepiandrosterone in relation to obesity, insulin resistance and lipid spectra in Czech non-diabetic population
964. Delayed insulin absorption correlates with alterations in subcutaneous depot kinetics in rats with diet‐induced obesity
965. Deletion of ALMS1 (Alstrom Syndrome 1) enhances salt‐sensitive hypertension, and induces insulin resistance and obesity in rats.
966. Deletion of Apolipoprotein D Prevents Diet-Induced obesity and insulin Resistance.
967. Deletion of C/EBP homologous protein (Chop) in C57Bl/6 mice dissociates obesity from insulin resistance
968. Deletion of CD1d in adipocytes aggravates adipose tissue inflammation and insulin resistance in obesity
969. Deletion of class A scavenger receptor deteriorates obesity-induced insulin resistance in adipose tissue
970. Deletion of EHD2 Attenuated Adipocyte Hypertrophic Expansion and Ameliorated Diet-Induced obesity and insulin Resistance
971. Deletion of G0/G1 Switch Gene 2 prevents obesity and insulin resistance and promotes browning of white adipose tissue
972. Deletion of Gpr21 protects against obesity-associated inflammation and insulin resistance
973. Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance
974. Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity
975. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance
976. Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH
977. Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH
978. Dependence of Hypothalamic obesity on insulin, the Pituitary and the Adrenal Gland1
979. Depot-specific expression of caveolin-1 in human adipose tissue and their relationship with obesity and insulin resistance
980. Depot-specific expression of retinol-binding protein 4 in human adipose tissue and their relationship with obesity and insulin resistance
981. Depressed levels in plasma insulin-growth factor-1 (IGF-1) and binding protein-1 (IGFBP-1) in adolescence obesity. 372
982. Detection and Analysis of Leptin, insulin and Sexual Hormone in Serum of Simple obesity Boys
983. Detection of insulin sensitivity and antibody against insulin in obesity induced by antipsychotics
984. Determinants and correlates of adipose tissue insulin resistance index in Japanese women without diabetes and obesity
985. Determination of insulin, leptin and neuropeptide y by radioimmunoanalysis in patients with morbid obesity and anorexia nervosa after therapeutic intervention
986. Determination of Optimal Cut-off Points for obesity-related Measures of Metabolic Syndrome Based on insulin Resistance
987. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice
988. Development and validation of a cell based model of insulin resistance and investigation into the intracellular molecular defects induced by diabetes and obesity
989. Development of a new modified western diet to induce NASH with obesity and insulin resistance in mice
990. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase
991. Development of obesity and insulin resistance in the Israeli sand rat (Psammomys obesus). Does leptin play a role?
992. Development of obesity in Zucker rats: early insulin resistance in muscles but normal sensitivity in white adipose tissue
993. Development of obesity-induced inflammation and insulin resistance: The role of adipose tissue, fatty acids, and toll-like receptors
994. Development of VMH obesity: in vivo insulin secretion and tissue insulin sensitivity
995. Development of Yak-Sun for Excess Syndrome obesity (1) Effects of Weight, Serum Glucose, insulin and Lipid Profiles of Oriental Medicinal Herbs with Removal of …
996. Developmental programming of obesity and insulin resistance: does mitochondrial dysfunction in oocytes play a role?
997. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet
998. Diabetes and insulin resistance in pediatric obesity
999. Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose …
1000. Diabetes and obesity—Cumulative or Complementary Effects On Adipokines, Inflammation, and insulin Resistance
1001. Diabetes in pregnancy: insulin resistance, obesity and placental dysfunction
1002. Diabetes mellitus in dogs: relationship of obesity to glucose tolerance and insulin response.
1003. Diabetes-related risk factors and cognitive aging: focus on obesity, insulin resistance, and the metabolic syndrome
1004. Diabetes, obesity and hypertension: role of insulin and the sympathetic nervous system
1005. Diabetes, obesity, insulin resistance: different pathways to cancer?
1006. Diabetes: Have We Got It All Wrong?: insulin hypersecretion and food additives: cause of obesity and diabetes?
1007. Diagnosing obesity, diabetes mellitus, and insulin resistance syndrome
1008. Diagnostic accuracy of triglyceride/glucose and triglyceride/HDL index as predictors for insulin resistance in children with and without obesity
1009. Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance
1010. Diet in the Prevention and Control of obesity, insulin Resistance, and Type II Diabetes
1011. Diet-and obesity-independent improvements in insulin sensitivity in mice genetically deficient in tumor necrosis factor-α (TNF-α KO).
1012. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor–α
1013. Diet-induced maternal obesity alters insulin signalling in male mice offspring rechallenged with a high-fat diet in adulthood
1014. Diet-induced obesity and insulin resistance spur tumor growth and cancer cachexia in rats bearing the yoshida sarcoma
1015. Diet-induced obesity and weight loss alter bile acid concentrations and bile acid–sensitive gene expression in insulin target tissues of C57BL/6J mice
1016. Diet-induced obesity impairs insulin-induced vasodilation in mouse mesenteric arteries via a mechanism involving ET-1
1017. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental …
1018. Diet-induced obesity in young mice interferes with the pancreatic intrinsic nervous system maturation and alters its control of insulin secretion
1019. Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats
1020. Diet-induced obesity obstructs insulin signaling in the heart
1021. Diet-induced obesity prevents interstitial dispersion of insulin in skeletal muscle
1022. Diet‐induced central obesity and insulin resistance in rabbits
1023. Diet‐induced DNA methylation within the hypothalamic arcuate nucleus and dysregulated leptin and insulin signaling in the pathophysiology of obesity
1024. Diet‐induced obesity and impaired insulin and glucose tolerance in sterol regulatory element binding protein‐1a knock‐out mice
1025. Diet‐induced obesity and insulin resistance are associated with brown fat degeneration in SIRT 1‐deficient mice
1026. Diet‐induced obesity causes insulin resistance in mouse brown adipose tissue
1027. Diet‐Induced obesity Causes Selective insulin Resistance
1028. Diet‐induced obesity in rats decreases insulin sensitivity and baroreflex gain
1029. Diet‐induced obesity in young mice: Consequences on the pancreatic intrinsic nervous system control of insulin secretion
1030. Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach
1031. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis
1032. Diet, obesity, and metabolic control in girls with insulin dependent diabetes mellitus.
1033. Dietary 1, 3-diacylglycerol protects against diet-induced obesity and insulin resistance
1034. Dietary aloe improves insulin sensitivity via the suppression of obesity-induced inflammation in obese mice
1035. Dietary aloe QDM complex reduces obesity-induced insulin resistance and adipogenesis in obese mice fed a high-fat diet
1036. Dietary anthocyanin-rich extract of açai protects from diet-induced obesity, liver steatosis and insulin resistance with modulation of gut microbiota in mice
1037. Dietary blueberry attenuates obesity‐associated insulin resistance by reducing adipocyte death and macrophage pro‐inflammatory activation in adipose tissue of high …
1038. Dietary capsaicin reduces obesity‐induced insulin resistance and hepatic steatosis in obese mice fed a high‐fat diet
1039. Dietary effects on A2AR expression in liver and adipose tissues: A role for A2AR in protecting against inflammation and insulin resistance in obesity
1040. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The insulin Resistance Atherosclerosis Study (IRAS)
1041. Dietary fat versus carbohydrate in obesity and insulin resistance
1042. Dietary fiber, plasma insulin, and obesity
1043. Dietary guar gum supplementation does not modify insulin resistance in gross obesity
1044. Dietary iron overload induces visceral adipose tissue insulin resistance and hyper-resistinemia, and synergizes with obesity and fatty liver in inducing systemic insulin …
1045. Dietary iron overload induces visceral adipose tissue insulin resistance associated with hyper-resistinemia, and synergizes with obesity in inducing systemic insulin …
1046. DIETARY IRON OVERLOAD INDUCES VISCERAL ADIPOSE TISSUE insulin RESISTANCE: SYNERGY WITH obesity IN INDUCING SYSTEMIC insulin …
1047. Dietary isoliquiritigenin at a low dose ameliorates insulin resistance and NAFLD in diet-induced obesity in C57BL/6J mice
1048. Dietary management of obesity and insulin resistance: countering risk for laminitis
1049. Dietary n-6/n-3 FA Ratio, but Not Total Content of n-3 PUFA, Regulates Diet-induced obesity, insulin Resistance, and Metabolic Dysfunction (OR19-01-19)
1050. Dietary obesity in the rat induces endothelial dysfunction without causing insulin resistance: a possible role for triacylglycerols
1051. Dietary Phaseolus vulgaris extract alleviated diet-induced obesity, insulin resistance and hepatic steatosis and alters gut microbiota composition in mice
1052. Dietary regulation of insulin receptors in obesity
1053. Dietary supplementation with Agaricus blazei murill extract prevents diet‐induced obesity and insulin resistance in rats
1054. Dietary supplementation with evodiamine prevents obesity and improves insulin resistance in ageing mice
1055. Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut …
1056. Dietary-fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation
1057. Dietary-induced obesity in Mice results in Metabolic and Vascular insulin-like Growth Factor 1 Resistance
1058. Differences in gene expression between young and adult mice may play a protective role against insulin resistance in the setting of high fat diet-induced obesity.
1059. DIFFERENCES OF HOMEOSTASIS MODEL ASSESMENT-insulin RESISTANCE (HOMA-IR) LEVELS BETWEEN obesity PREGNANT WOMEN WITH THE …
1060. Different Expression of Duodenal Genes Related to insulin Resistance Between Nonobese Women and Those with Severe obesity
1061. Different genes for obesity are associated with insulin loss of regulation of the membrane (Ca2++ Mg2+)-ATPase in the obesity syndrome. Lessons from animal …
1062. Differential association between S100A4 levels and insulin resistance in prepubertal children and adult subjects with clinically severe obesity
1063. Differential effects of exposure to maternal obesity or maternal weight loss during the periconceptional period in the sheep on insulin signalling molecules in …
1064. Differential effects of insulin resistance on leucine and glucose kinetics in obesity
1065. Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin‐signaling pathways in the offspring
1066. Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity
1067. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity
1068. Differential impact of insulin and obesity on cardiovascular risk factors in non-diabetic subjects.
1069. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis
1070. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance
1071. Differentiation between obesity and insulin resistance in the association with C-reactive protein
1072. Difficult Intubation Rates in Relation to Diabetes, insulin Dependency, and obesity
1073. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity
1074. Diminished hepatic insulin removal in obesity
1075. Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low‐dose metformin and thiazolidinedione combination therapy in …
1076. Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway
1077. Discovery of Highly Selective Inhibitors of Calmodulin-Dependent Kinases That Restore insulin Sensitivity in the Diet-Induced obesity in Vivo Mouse Model
1078. Discrimination between obesity and insulin resistance in the relationship with adiponectin
1079. Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesity-induced insulin resistance
1080. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance
1081. Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity
1082. Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet–induced obesity and insulin resistance in mice
1083. Dissecting the relationship between obesity and hyperinsulinemia: role of insulin secretion and insulin clearance
1084. Dissociation between high fat diet-induced obesity (DIO) and insulin resistance: lessons from AHNAK knockout mice
1085. Dissociation of obesity and insulin resistance in transgenic mice with skeletal muscle expression of uncoupling protein 1
1086. Distinct gene signatures predict insulin resistance in young mice with high fat diet-induced obesity
1087. Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance
1088. Distribution of subcutaneous fat predicts insulin action in obesity in sex‐specific manner
1089. Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.
1090. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.
1091. Diurnal variation in vascular and metabolic function in diet-induced obesity: divergence of insulin resistance and loss of clock rhythm
1092. DNA methylation of FKBP5 in South African women: associations with obesity and insulin resistance
1093. DNA methylation of leptin and adiponectin promoters in children is reduced by the combined presence of obesity and insulin resistance
1094. DNA methylation of the LY86 gene is associated with obesity, insulin resistance, and inflammation
1095. DNA polymorphism of the insulin gene, diabetes, and severe obesity
1096. Do Cardiorespiratory Fitness and Abdominal obesity Mediate the Exercise-Induced Change in insulin Sensitivity in Older Adults?
1097. Do flavanols-rich natural products relieve obesity-related insulin resistance?
1098. Do nutrient–gut–microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
1099. Do obesity and non-insulin dependent diabetes mellitus aggravate exercise-induced microproteinuria?
1100. Do obesity and physical inactivity underlie the insulin resistance of aging?
1101. Does aging intensify the insulin resistance of human obesity?
1102. Does cardiorespiratory fitness attenuate the adverse effects of severe/morbid obesity on cardiometabolic risk and insulin resistance in children? A pooled analysis
1103. Does inflammation mediate the association between obesity and insulin resistance?
1104. Does insulin concentration modify the outcome of dietary intervention in young adults with obesity?
1105. Does insulin explain the relation between maternal obesity and poor lactation outcomes? An overview of the literature
1106. Does Leptin Affect Directly Blood Pressure in Obese Hypertensive Women-Influence of insulin and Different Methods of obesity Assessment
1107. Does microvascular dysfunction link obesity with insulin resistance and hypertension?
1108. Does obesity change the effect of aromatase inhibitors (AIs) on estradiol, leptin, insulin, and IGF-1 serum levels in breast cancer patients?
1109. Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance?
1110. Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity
1111. Double Incretin Receptor Knockout Mice Are Protected from Diet-Induced obesity and insulin Resistance.
1112. Double-stranded RNA-activated protein kinase is a key modulator of insulin sensitivity in physiological conditions and in obesity in mice
1113. Down-regulation of adipose 11 [beta] HSD1 mediates the insulin sensitising effects of salicylate in obesity
1114. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance
1115. DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1/M2 macrophage polarization
1116. DPP-4 inhibition by linagliptin attenuates obesity-related inflammation and insulin resistance by regulating M1/M2 macrophage polarization
1117. DPP-4 inhibitors as therapeutic modulators of immune cell function and associated cardiovascular and renal insulin resistance in obesity and diabetes
1118. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity
1119. DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway
1120. Dual CCR2/5 antagonist attenuates obesity‐induced insulin resistance by regulating macrophage recruitment and M1/M2 status
1121. Duration of obesity and risk of non-insulin-dependent diabetes mellitus
1122. Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidaemia
1123. Dynamic changes in insulin and glucagon during disease progression in rhesus monkeys with obesity‐related type 2 diabetes mellitus
1124. Dynamics of insulin secretion and the clinical implications for obesity and diabetes
1125. Dynamics of insulin secretion in obesity and diabetes
1126. Dyslipidemia, obesity, insulin Resistance and Atherosclerosis in LDL-Receptor Deficient Rats
1127. Dysregulation of glucose, insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominal obesity
1128. Dysregulation of Glycogen Synthase COOH- and NH2-Terminal Phosphorylation by insulin in obesity and Type 2 Diabetes Mellitus
1129. Dysregulation of insulin receptor substrate 2 in β cells and brain causes obesity and diabetes
1130. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice
1131. E. The Influence of obesity on insulin Signaling at
1132. E028: Leptin, obesity, insulin resistance and intraerythrocyte sodium content in hypertensive syndrome
1133. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity
1134. Early Clinical Indicators of Metabolic Syndrome and insulin Resistance in A Cohort of Greek Children with obesity
1135. Early diet, insulin-like growth factor-1, growth and later obesity
1136. Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss–results of an …
1137. Early intervention of N-acetylcysteine better improves insulin resistance in diet-induced obesity mice
1138. Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity
1139. Early mitochondrial adaptations in skeletal muscle to diet-induced obesity are strain dependent and determine oxidative stress and energy expenditure but not insulin …
1140. Early response of plasma insulin to small doses of intravenous glucose: Effect of obesity
1141. Early-life stress and the development of obesity and insulin resistance in juvenile bonnet macaques
1142. Early-onset obesity dysregulates pulmonary adipocytokine/insulin signaling and induces asthma-like disease in mice
1143. Eating competence is associated with lower prevalence of obesity and better insulin sensitivity in finnish adults with increased risk for type 2 diabetes: The stopdia …
1144. Eating habits of preschool children and the risk of obesity, insulin resistance and metabolic syndrome in adults
1145. Ecscr regulates insulin sensitivity and predisposition to obesity by modulating endothelial cell functions
1146. Ectopic UCP1 overexpression in white adipose tissue improves insulin sensitivity in Lou/C rats, a model of obesity resistance
1147. Editorial (Thematic Issue: Vascular Dysfunction in obesity and insulin Resistance)
1148. Editorial [Hot Topic: New Insight in obesity and insulin Resistance (Guest Editor: Geltrude Mingrone)]
1149. Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity
1150. Effect of 7 days of exercise on exogenous carbohydrate oxidation and insulin resistance in children with obesity
1151. EFFECT OF 8 WEEKS OF AEROBIC INTERVAL TRAINING ON LEVELS OF LIPOCALIN-2, GLUCOSE, insulin AND insulin RESISTANCE IN obesity WOMEN
1152. Effect of a high monounsaturated fatty acids diet and a Mediterranean diet on serum lipids and insulin sensitivity in adults with mild abdominal obesity
1153. Effect of a high protein/low glycaemic index diet on insulin resistance in adolescents with overweight/obesity—A PREVIEW randomized clinical trial
1154. Effect of a long term very low calorie diet on glucose/insulin metabolism in obesity. Influence of fat distribution on hepatic insulin extraction.
1155. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature
1156. Effect of acetylsalicylic acid on inflamed adipose tissue. insulin resistance and hepatic steatosis in a mouse model of diet-induced obesity
1157. Effect of acupoint catgut embedding on TNF-alpha and insulin resistance in simple obesity patients
1158. Effect of Acupoint Catgut Embedding on TNF-α and insulin Resistance in Simple obesity Patients [J]
1159. Effect of acupoint thread embedding on blood lipids and insulin in simple obesity
1160. Effect of acupoint thread embedding on the peripheral serum leptin and insulin levels in simple obesity patients
1161. Effect of acupuncture on blood serum leptin and insulin in a rat model of obesity [J]
1162. Effect of acupuncture on serum insulin level in the patient of simple obesity
1163. EFFECT OF AEROBIC TRAINING PROGRAM ON obesity AND insulin RESISTANCE IN YOUNG WOMEN WITH POLYCYSTIC OVERY SYDROME
1164. Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and growth hormone in man
1165. Effect of aging and obesity on insulin responsiveness and glut-4 glucose transporter content in skeletal muscle of Fischer 344× Brown Norway rats
1166. Effect of an alcohol-free beer enriched with isomaltulose and a resistant dextrin on insulin resistance in diabetic patients with overweight or obesity
1167. Effect of antioxidant treatment on some indicators of obesity-induced changes in insulin sensitivity and beta-cell function in New Zealand white rabbits.
1168. Effect of ARHGAP21 reduction upon glucose-insulin homeostasis and body composition of diet-induced obesity in C57BL/6 mice
1169. Effect of avocado soybean unsaponifiables on insulin secretion and insulin sensitivity in patients with obesity
1170. Effect of Bloodletting Cupping on the Serum insulin Level in Simple obesity
1171. Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity
1172. Effect of Cabergoline on Body Weight, Glycemic Control and insulin Resistance in Patient with obesity and Prediabetes
1173. Effect of combination of irbesartan with amlodipine on serum leptin level and insulin sensitivity in young obesity-associated hypertensive patients [J]
1174. Effect of common genetic variants of growth arrest-specific 6 gene on insulin resistance, obesity and type 2 diabetes in an Asian population
1175. Effect of Comprehensive Intervention Therapy of Losing Weight on Blood Leptin, Blood Lipid, Blood Glucose, insulin in Adolescent Girl Students with Simple obesity
1176. Effect of Curcuma longa L. on the obesity and insulin resistance in Sprague-Dawley rats and db/db mice
1177. #VALUE!
1178. Effect of diet-induced obesity and experimental hyperinsulinemia on insulin uptake into CSF of the rat
1179. Effect of diet-induced obesity on glucose and insulin tolerance of a rodent with a low insulin response (Acomys cahirinus)
1180. Effect of doxazosin on insulin resistance in hypertensive patients with obesity
1181. Effect of electroacupuncture and diet adjusting on insulin resistance in rats with nutrition obesity
1182. Effect of Endogenous insulin Levels on Serum Testosterone, Glycemic, and obesity Parameters in Premenopausal Women with Type 2 Diabetes Mellitus
1183. Effect of endostatin and insulin-like growth factor-1 on angiogenesis in patients with acute myocardial infarction with obesity under the influence of zofenopril
1184. Effect of experimental reducing fat on leptin resistance and insulin resistance in adolecent girl students with simple obesity
1185. Effect of high-fat-diet on serum glucose, triglyceride, leptin and insulin sensitivity in obesity-susceptible and obesity-resistant rats.[J]
1186. Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity
1187. Effect of insulin on postradiation obesity of bone marrow
1188. Effect of insulin on stimulated lipolysis in obesity with normal carbohydrate tolerance and unimpaired thyroid function.
1189. Effect of insulin therapy and obesity on colon adenoma and advanced adenoma among type II diabetes mellitus population
1190. Effect of insulin–glucose metabolism compared with obesity on adipose omentin gene expression in different models of diabetic C57BL/6 mice
1191. Effect of inulin-type carbohydrates on insulin resistance in patients with type 2 diabetes and obesity: a systematic review and meta-analysis
1192. Effect of irbesartan and hydrochlorothiazide on insulin resistance and lipid in hypertensive patients with obesity
1193. Effect of long term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity
1194. Effect of maternal obesity on insulin action in male adult offspring rats
1195. Effect of meridian tuina on serum insulin and triglyceride of 50 simple obesity patients
1196. Effect of naloxone on beta-endorphin and insulin concentrations during glucose tolerance testing in patients with simple obesity
1197. Effect of naltrexone treatment on insulin secretion, insulin action and postprandial thermogenesis in obesity
1198. Effect of obesity and body fat distribution on sex hormones and insulin in men
1199. Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients
1200. Effect of obesity and insulin on immunity in non-insulin-dependent diabetes mellitus
1201. Effect of obesity and insulin Resistance Factor on Lipid Metabolism in Women with Polycystic Ovary Syndrome
1202. Effect of obesity and insulin resistance on diabetic control
1203. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women
1204. Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man
1205. Effect of obesity and insulin sensitivity on adiponectin isoform distribution
1206. Effect of obesity and insulin Sensitivity on Adiponectin Isoform Distribution.
1207. Effect of obesity and of starvation on insulin activity
1208. Effect of obesity and type 2 diabetes on protein anabolic response to insulin in elderly women
1209. Effect of obesity and weight loss on the arginine vasopressin response to insulin‐induced hypoglycaemia
1210. Effect of obesity Intervention Programs on Adipokines, insulin Resistance, Lipid Profile and Low Grade Inflammation in 3-to 5-Year-Old Children
1211. Effect of obesity intervention programs on adipokines, insulin resistance, lipid profile, and low-grade inflammation in 3-to 5-y-old children
1212. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations
1213. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM
1214. Effect of obesity on insulin Secretion in Response to a 48-Hour Physiological Increase in Plasma FFA in Mexican-American Subjects Genetically Predisposed Type 2 …
1215. Effect of obesity on insulin sensitivity of human adipose tissue
1216. Effect of obesity on insulin signaling through JAK2 in rat aorta
1217. Effect of obesity on Left Ventricular Functions in Patients With Non insulin Dependent Diabetes Mellitus
1218. Effect of obesity on plasma insulin-like growth factor-I in cancer patients.
1219. Effect of obesity on susceptibility to fatty acid–induced peripheral tissue insulin resistance
1220. Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus
1221. Effect of obesity on Tissue Expression of Growth Hormone (GH) Receptor and insulin-like Growth Factor-I RNA
1222. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone
1223. #VALUE!
1224. Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia
1225. Effect of pharmacological suppression of insulin secretion on tissue sensitivity to insulin in subjects with moderate obesity.
1226. Effect of physical training on insulin action in obesity
1227. Effect of piperine in obesity induced insulin resistance and type-II diabetes mellitus in rats.
1228. Effect of pomegranate juice on insulin secretion and sensitivity in patients with obesity
1229. Effect of prolonged fasting glucose and insulin metabolism in exogenous obesity
1230. Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice
1231. Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obesity and diabetes
1232. Effect of seyoeum on obesity, insulin resistance, and nonalcoholic fatty liver disease of high-fat diet-fed C57BL/6 mice
1233. Effect of tea polyphones on serum leptin, insulin and blood lipids in rats with obesity [J]
1234. Effect of the intake of dietary protein on insulin resistance in subjects with obesity: a randomized controlled clinical trial
1235. Effect of ursolic acid on insulin resistance and hyperinsulinemia in rats with diet-induced obesity: role of adipokines expression
1236. Effect of ursolic acid on obesity-induced insulin resistance in rat liver
1237. Effect of Vitamin D Supplementation on obesity‐Induced insulin Resistance: A Double‐Blind, Randomized, Placebo‐Controlled Trial
1238. Effect of Weight Loss and Triiodothyronine on Plasma Growth Hormone and insulin in obesity.
1239. Effect of weight reduction on metabolic products of carbohydrate and fat metabolism and on the behaviour of serum insulin in obesity.
1240. Effects of 12-week circuit exercise program on obesity index, appetite regulating hormones, and insulin resistance in middle-aged obese females
1241. Effects of 12-week circuit exercise program on obesity index, appetite regulating hormones, and insulin resistance in middle-aged obese females
1242. Effects of 14-day infusions of growth hormone and/or insulin-like growth factor I on the obesity of growing Zucker rats
1243. Effects of a Eucaloric Low Glycemic Index Diet on insulin Sensitivity and Intramyocellular Lipid Content in Adults with Abdominal obesity
1244. Effects of acute exercise on insulin binding to monocytes in obesity
1245. Effects of Age and obesity on insulin Binding to Isolated Adipocytes12
1246. Effects of age, diet and obesity on insulin secretion from isolated perfused rat pancreas: Response to glucose, arginine and glucagon-like peptide 1 (7-37)
1247. Effects of aging and obesity on insulin secretion and sensitivity
1248. Effects of astragalus polysaccharides on insulin sensitivity in obesity rats fed with high-fat diet
1249. Effects of bariatric surgery on preclinical myocardial alterations in severe obesity and the related role of insulin resistance
1250. Effects of caloric restriction and exercise of insulin receptors in obesity: Association with changes in membrane lipids
1251. Effects of castration-induced visceral obesity and antioxidant treatment on lipid profile and insulin sensitivity in New Zealand white rabbits
1252. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery
1253. Effects of childhood malnutrition on the increase of risk factors for obesity, non-insulin dependent diabetes mellitus and coronary heart disease
1254. Effects of cholinergic blockade by pirenzepine on insulin and glucose response to oral and intravenous glucose and to arginine load in obesity
1255. Effects of Curcumin on insulin Resistance in Simple obesity Rats
1256. Effects of diet-induced obesity on protein expression in insulin signaling pathways of skeletal muscle in male Wistar rats
1257. Effects of Diet‐induced obesity on Protein Expressions of insulin Signalling Pathways in the Skeletal Muscle of Male Wistar Rats
1258. Effects of dietary fat energy restriction and fish oil feeding on hepatic metabolic abnormalities and insulin resistance in KK mice with high-fat diet-induced obesity
1259. Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity
1260. Effects of Difference Chinese Medicinal Herbs for Tonifying Spleen on obesity Degree and insulin Resistance in Diet-induced obesity Rats
1261. Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL/6 mice
1262. Effects of different intensity exercise on blood glucose, adolescent obesity rats insulin sensitivity and RBP4
1263. Effects of electroacupuncture on insulin resistance and hypothalamic insulin signal molecule in rats with diet-induced obesity
1264. Effects of electroacupuncture on insulin resistance and hypothalamic insulin signal molecule in rats with diet-induced obesity
1265. Effects of estrogen on high-fat diet-induced obesity and insulin resistance in ovariectomized rats
1266. Effects of exercise modality on insulin resistance and ectopic fat in adolescents with overweight and obesity: a randomized clinical trial
1267. Effects of fasting on insulin secretion and glucose tolerance in obesity.
1268. Effects of free fatty acids on insulin secretion in obesity
1269. Effects of FTOSNPrs9939609 on Body Composition and insulin Resistance in Overweight and obesity Male College students
1270. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity
1271. Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes
1272. Effects of insulin gene dosage on murine obesity and lifespan
1273. Effects of insulin Level on Dyslipidemia in Children with Simple obesity
1274. Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding
1275. Effects of Inula helenium on Inflammation and insulin Resistance in obesity-induced insulin Resistance Mouse by High Fat Diet
1276. Effects of Long‐Term Soy vs Casein Protein Intake and obesity on Serum insulin‐Like Growth Factor 1 (IGF‐1) and IGFBP‐3 Levels using Obese Female Zucker Rat …
1277. Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension
1278. Effects of maresin 1 on adipose tissue inflammation and insulin resistance on obesity: characterization of mechanisms involved
1279. Effects of massive obesity on insulin sensitivity and insulin clearance and the metabolic response to insulin as assessed by the euglycemic clamp technique
1280. Effects of mazindol on carbohydrate and insulin metabolism in obesity
1281. Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in obesity: A double-blind, randomized, controlled study
1282. Effects of metformin and rosiglitazone on peripheral insulin resistance and β-cell function in patients with simple obesity [J]
1283. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet
1284. Effects of monosodium glutamate‐induced obesity in mice on carbohydrate metabolism in insulin secretion
1285. Effects of morbid obesity on insulin clearance and insulin sensitivity in several aspects of metabolism as assessed by low-dose insulin infusion
1286. Effects of murine norovirus infection on a mouse model of diet-induced obesity and insulin resistance
1287. Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol in obesity–insulin resistance …
1288. Effects of naloxone-induced opiate receptors blockade on insulin secretion in obesity
1289. Effects of obesity and exercise training on mitochondrial function and insulin resistance in aging skeletal muscle
1290. Effects of obesity and exercise training on mitochondrial function and insulin resistance in aging skeletal muscle
1291. Effects of obesity and Gender on insulin Receptor Expression in Liver of SHHF/Mcc‐FACP Rats
1292. Effects of obesity and inheritance on the development of non-insulin-dependent diabetes mellitus in Otsuka-Long-Evans-Tokushima fatty rats
1293. Effects of obesity And insulin on Tissue-Specific Recycling Between Cortisol And Cortisone in Men
1294. Effects of obesity and ovarian steroids on insulin secretion and removal in sheep
1295. Effects of obesity and short‐term dietary manipulations on serum insulin and leptin levels in female Zucker rats following DMBA treatment
1296. Effects of obesity and weight reduction on serum insulin levels
1297. Effects of obesity on insulin and glucose metabolism in cyclic heifers
1298. Effects of obesity on insulin resistance in patients with hypertension
1299. Effects of obesity on insulin resistance, β-cell function and serum high-sensitivity C-reactive protein level in first-degree relatives of type 2 diabetic patients
1300. Effects of obesity on insulin sensitivity and responsiveness in sheep
1301. Effects of obesity on insulin: insulin-like growth factor 1 hybrid receptor expression and Akt phosphorylation in conduit and resistance arteries
1302. Effects of obesity on metabolic and cardiovascular outcomes following insulin initiation in patients with type 2 diabetes
1303. Effects of obesity on pancreatic β cell function and insulin function
1304. Effects of obesity on Serum insulin‐Like Growth Factor 1 (IGF‐1) Levels Using DMBA‐Induced Ovariectomized Zucker Rat Model.
1305. Effects of obesity surgery on non–insulin-dependent diabetes mellitus
1306. Effects of obesity-inducing ventromedial hypothalamic lesions on pulsatile growth hormone and insulin secretion: evidence for the existence of a growth hormone …
1307. Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men
1308. Effects of obesity, physical activity, and cardiorespiratory fitness on blood pressure, inflammation, and insulin resistance in the National Health and Nutrition Survey …
1309. Effects of Omega-3 Fatty Acids on insulin Resistance in an Ovariectomized Mouse Model of Diet-Induced obesity Treated with Chemotherapy
1310. Effects of physical activity on insulin action and glucose tolerance in obesity.
1311. Effects of Physical Activity on The Inflammatory Process Related to insulin Resistance and obesity
1312. Effects of physical exercise in molecular parameters of the route of obesity and insulin signaling
1313. Effects of pioglitazone and metformin on body weight and the insulin resistance parameters in young patients with obesity
1314. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance
1315. Effects of potassium supplementation on insulin binding and insulin action in human obesity: protein‐modified fast and refeeding
1316. Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials
1317. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity
1318. Effects of starvation and obesity on somatostatin, insulin, and glucagon release from an isolated perfused organ system
1319. Effects of sucrose vs starch diets on in vivo insulin action, thermogenesis, and obesity in rats
1320. Effects of sucrose vs starch diets on in vivo insulin action, thermogenesis, and obesity in rats14
1321. Effects of Tea Pigments on Rat Models with obesity-induced insulin Resistance [J]
1322. Effects of telmisartan on body fat, serum lipids and insulin resistance in patients with obesity hypertension [J]
1323. Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity
1324. Effects of the 11beta hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in human obesity
1325. Effects of the Magenstrasse and Mill operation for obesity on plasma leptin and insulin resistance
1326. Effects of the Magenstrasse and Mill operation for obesity on plasma plasminogen activator inhibitor type 1, tissue plasminogen activator, fibrinogen and insulin
1327. Effects of various natural sweeteners on insulin resistance, inflammation and liver steatosis in a rat model of diet‐induced obesity
1328. Effects of vitamin D supplementation and circuit training on indices of obesity and insulin resistance in T2D and vitamin D deficient elderly women
1329. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin
1330. Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity
1331. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.
1332. Effects of Zataria oxymel on obesity, insulin resistance and lipid profile: A randomized, controlled, triple-blind trial
1333. Efficacy of exenatide combined with insulin glargine in newly diagnosed type 2 diabetes patients with obesity
1334. Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance
1335. Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance
1336. Elevated alanine aminotransferase in current national football league players: correlation with cardiometabolic syndrome markers, obesity, and insulin resistance.
1337. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children
1338. Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults
1339. Elevated fasting insulin concentrations associate with impaired insulin signaling in skeletal muscle of healthy subjects independent of obesity
1340. Elevated fasting insulin levels increase the risk of abdominal obesity in Korean men
1341. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance
1342. ELEVATED INTERLUKIN-6 LEVELS AS A CONSEQUENCE, NOT THE CAUSE OF obesity AND insulin RESISTANCE
1343. Elevated LDL-Cholesterol Level Predicts Diabetes in Centrally Obese Women but Not Men Relative Roles of insulin Resistance and Central obesity
1344. Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction
1345. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2
1346. Elevated serum TNF-α is related to obesity in type 2 diabetes mellitus and is associated with glycemic control and insulin resistance
1347. Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-[alpha] system activity
1348. Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover
1349. Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance
1350. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state
1351. Emerging role of adipose tissue hypoxia in obesity and insulin resistance
1352. Emerging role of aldosterone in mediating the vicious cycle of obesity, insulin resistance and metabolic syndrome
1353. Emerging role of AMPK in brown and beige adipose tissue (BAT): implications for obesity, insulin resistance, and type 2 diabetes
1354. Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization
1355. Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet
1356. Endocrine disturbances in childhood obesity: growth-hormone and cortisol response to insulin induced hypoglycemia
1357. Endogenous epinephrine protects against obesity induced insulin resistance
1358. Endoplasmic reticulum chaperone GRP78 regulates macrophage function and insulin resistance in diet‐induced obesity
1359. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes
1360. Endoplasmic reticulum stress: another link between obesity and insulin resistance/inflammation?
1361. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
1362. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease
1363. Endothelial dysfunction, obesity and insulin resistance
1364. Endothelial nuclear factor κB in obesity and aging: is endothelial nuclear factor κB a master regulator of inflammation and insulin resistance?
1365. Endothelin‐1 in the pathophysiology of obesity and insulin resistance
1366. Endothelium-derived hyperpolarizing factors: a potential therapeutic target for vascular dysfunction in obesity and insulin resistance
1367. Endotoxemia-mediated activation of acetyltransferase P300 impairs insulin signaling in obesity
1368. Endurance training and obesity: effect on substrate metabolism and insulin sensitivity.
1369. Enhanced escape of non-esterified fatty acids from tissue uptake: its role in impaired insulin-induced lowering of total rate of appearance in obesity and Type II …
1370. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity
1371. Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and …
1372. Enhanced hepatic A-ring reduction of glucocorticoids in obesity: Regulation by glucocorticoids and insulin
1373. Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model
1374. Enhanced Lymphangiogenesis and Lymphatic Function Protects Diet‐induced obesity and insulin Resistance
1375. Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance
1376. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance
1377. ENPP1 Variants and Haplotypes Predispose to Early Onset obesity and Impaired Glucose and insulin Metabolism in German Obese Children
1378. ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity
1379. Environmental determinants of obesity and insulin-resistance
1380. EP3 signaling is decoupled from regulation of glucose-stimulated insulin secretion in β-cells compensating for obesity and insulin resistance
1381. Epicatechin downregulates adipose tissue CCL19 expression and thereby ameliorates diet-induced obesity and insulin resistance
1382. Epidemiologic study of central obesity, insulin resistance and associated disturbances in the urban population of North India.
1383. Epidemiologic study of diet and coronary risk factors in relation to central obesity and insulin levels in rural and urban populations of north India
1384. Epidemiological Study of obesity and Metabolic Syndrome in Chinese Schoolchildren: Relationship with insulin Resistance and Adipocytokins.
1385. Epidemiology, obesity, and non-insulin-dependent diabetes mellitus
1386. Epigenetic germline inheritance of diet-induced obesity and insulin resistance
1387. Epigenetics: How does obesity lead to insulin resistance?
1388. Equine obesity and its role in insulin resistance, inflammation and risk for laminitis
1389. #VALUE!
1390. #VALUE!
1391. Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting
1392. #VALUE!
1393. Erratum: Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance
1394. Erratum: Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort
1395. Erratum: Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic …
1396. Erratum: Obstructive Sleep Apnea, insulin Resistance, and Steatohepatitis in Severe obesity
1397. Erratum. APPL1 Counteracts obesity-Induced Vascular insulin Resistance and Endothelial Dysfunction by Modulating the Endothelial Production of Nitric Oxide and …
1398. Erratum. Loss of Mbd2 Protects Mice Against High-Fat Diet–Induced obesity and insulin Resistance by Regulating the Homeostasis of Energy Storage and …
1399. Esculentin-2CHa-related peptides modulate islet cell function and improve glucose tolerance in mice with diet-induced obesity and insulin resistance
1400. Essential role of protein tyrosine phosphatase 1B in obesity‐induced inflammation and peripheral insulin resistance during aging
1401. Established diet-induced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance
1402. Establishment of obesity Rat Animal Model with Leptin Resistance and insulin Resistance
1403. Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes
1404. Estimation of the correlation of insulin resistance and selected adipocytokines in children with simple obesity–preliminary study
1405. Estradiol: THE EMERGING EVIDENCE FOR A PROTECTIVE ROLE AGAINST insulin RESISTANCE AND obesity.
1406. Estrogen modulates adiposity and protects against obesity-associated inflammation, oxidative stress, and insulin resistance
1407. Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity
1408. Ethanol extract of propolis prevents high-fat diet-induced insulin resistance and obesity in association with modulation of gut microbiota in mice
1409. Ethnic differences in inflammation: Association with obesity and insulin resistance
1410. Ethnic differences in insulin resistance, adiponectin levels and abdominal obesity: Haitian Americans and African Americans, with and without type 2 diabetes …
1411. Ethnic disparity in the relationship between obesity and plasma insulin-like growth factors: the multiethnic cohort
1412. Ethnicity modifies the effect of obesity on insulin resistance in pregnancy: a comparison of Asian, South Asian, and Caucasian women
1413. Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population
1414. Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity
1415. Evaluating a pragmatic estimate of insulin sensitivity in Latino youth with obesity
1416. Evaluation of B-cell secretion and peripheral insulin resistance during pregnancy and after delivery in gestational diabetes mellitus with obesity
1417. Evaluation of existing and candidate measures of obesity for detection of insulin resistance and cardiometabolic risk among Asian Indians: Development of two …
1418. Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity
1419. Evaluation of Ghrelin Levels in Polycystic Ovary Syndrome and the Correlation with obesity, insulin Resistance and Other Biochemical Features
1420. #VALUE!
1421. Evaluation of insulin resistance in children and adolescent with moderate and severe obesity.
1422. Evaluation of Mn-superoxide dismutase and catalase gene expression in childhood obesity: its association with insulin resistance
1423. Evaluation of neck circumference as a predictor of central obesity and insulin resistance in Chinese adults
1424. Evaluation of ovulation regularity in relation to insulin hematic levels, androgens and obesity in polycistic ovary syndrome
1425. Evaluation of TG-HDL Ratio Instead of HOMA Ratio as insulin Resistance Marker in Overweight and Children with obesity.
1426. EVALUATION OF THE OF insulin RESISTANCE EFFECTS ON obesity AND RELATED PARAMETERS
1427. Evaluation of the Relationship between insulin, Vitamin D Levels and Dietary Habits in Adults with Normal Weight and obesity
1428. Evaluation of visfatin in patients with obesity, metabolic syndrome, insulin resistance and impaired glucose tolerance; case-control study
1429. Evidence for association between insulin resistance and premature carotid atherosclerosis in childhood obesity
1430. Evidence for recent increases in obesity and non‐insulin‐dependent diabetes mellitus in a Navajo community
1431. Evidence for two types of juvenile obesity on the basis of body composition and insulin release following small doses of glucose
1432. Evidence in obese children: contribution of hyperlipidemia, obesity-inflammation, and insulin sensitivity
1433. Evidence in obese children: contribution of tri-ponderal mass index or body mass index to dyslipidemia, obesity-inflammation, and insulin sensitivity
1434. Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children
1435. Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients
1436. Evidence that insulin resistance is responsible for the decreased thermic effect of glucose in human obesity.
1437. Evolution of obesity and insulin resistance: relevance to PCOS
1438. Evolutionary Aspects of obesity, insulin Resistance, and Cardiovascular Risk
1439. Exaggerated insulin response to glucagon in simple obesity
1440. Excessive gestational weight gain and obesity contribute to altered expression of maternal insulin-like growth factor binding protein-3
1441. Excessive serum insulin response to oral glucose in obesity and mild diabetes study of 501 patients
1442. Exenatide therapy in insulin-treated type 2 diabetes and obesity
1443. Exercise alleviates cognitive functions by enhancing hippocampal insulin signaling and neuroplasticity in high-fat diet-induced obesity
1444. Exercise and dietary change ameliorate high fat diet induced obesity and insulin resistance via mTOR signaling pathway
1445. Exercise and obesity-induced insulin resistance in skeletal muscle
1446. Exercise and obesity-Induced insulin Resistance in Skeletal Muscle
1447. Exercise in aging: its important role in mortality, obesity and insulin resistance
1448. Exercise modifies microvascular reactivity to insulin in the OLETF rat, a rodent model of hyperphagia‐induced obesity and type II diabetes
1449. Exercise Program Improves insulin Resistance and Functional Limitation in Sedentary Elderly Patients with obesity
1450. Exercise Reverses Diet-Induced obesity and obesity-Associated insulin Resistance through the IKKβ/NF-KB Pathway
1451. Exercise Training Attenuates Sarcopenic obesity‐Induced insulin Resistance and Mitochondrial Dysfunction in the Rat Skeletal Muscle
1452. Exercise training reduces insulin resistance and upregulates the mTOR/p70S6k pathway in cardiac muscle of diet‐induced obesity rats
1453. Exercise-induced improvement in vasodilatory function accompanies increased insulin sensitivity in obesity and type 2 diabetes mellitus
1454. Exercise‐induced reduction in obesity and insulin resistance in women: a randomized controlled trial
1455. Exosomal transfer of obesity adipose tissue for decreased miR-141-3p mediate insulin resistance of hepatocytes
1456. Expanded normal weight obesity and insulin resistance in US adults of the National Health and Nutrition Examination Survey
1457. Expansive vascular remodeling and increased vascular calcification response to cholecalciferol in a murine model of obesity and insulin resistance
1458. Experimental hypothalamic or genetic obesity in the non-insulin-dependent diabetic rat
1459. Experimental obesity in Man: Hyperaminoacidemia and Diminished Effectiveness of insulin in Regulating Peripheral Amino Acid Release.
1460. Experimental study on the mechanism of raspberry ketone on simple obesity and insulin resistance relevant to obesity
1461. Exploring Phytotherapeutic Alternatives for obesity, insulin Resistance and Diabetes Mellitus
1462. Exploring the use of adjusted body mass index thresholds based on equivalent insulin resistance for defining overweight and obesity in UK South Asian …
1463. Exposure to maternal obesity during suckling outweighs in utero exposure in programming for post-weaning adiposity and insulin resistance in rats
1464. Expression of a mutant prohibitin from the aP2 gene promoter leads to obesity-linked tumor development in insulin resistance-dependent manner
1465. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes
1466. Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance
1467. Expression of FOXC2 in adipose tissues and its correlation with obesity and insulin resistance
1468. Expression of S6K1 in human visceral adipose tissue is upregulated in obesity and related to insulin resistance and inflammation
1469. Expression of Sirtuin 1 in visceral adipose tissue in Tibetan mini-pigs with obesity and insulin resistance induced by high fat/cholesterol diet
1470. Expression of the central obesity and type 2 diabetes mellitus genes is associated with insulin resistance in young obese children
1471. Expression of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) in obesity and insulin …
1472. F-DIO obesity-prone rat is insulin resistant before obesity onset
1473. FABP4-Cre mediated expression of constitutively active ChREBP protects against obesity, fatty liver, and insulin resistance
1474. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality
1475. Factors associated with insulin resistance and fasting plasma ghrelin levels in adolescents with obesity and family history of type 2 diabetes
1476. Factors associated with insulin resistance in patients with chronic HCV genotype 1 infection without obesity or type 2 diabetes
1477. Factors Associated with insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without obesity or Type 2 Diabetes
1478. Factors Governing Development of Non-Alcoholic Fatty Liver Disease and insulin Resistance in obesity
1479. Factors governing development of nonalcoholic fatty liver disease and insulin resistance in obesity
1480. Familial and individual predictors of obesity and insulin resistance in urban H ispanic children
1481. Familial Diabetes Mellitus in Mice, Associated with insulin Resistance obesity, and Hyperplasia of the Islands of Langerhans
1482. Familial juvenile autoimmune hypothyroidism, pituitary enlargement, obesity, and insulin resistance
1483. Family with Sequence Similarity 13, Member A Protects Against obesity-Related Metabolic Disorder by Modulating the Adipocyte insulin Signaling
1484. Family with Sequence Similarity 13, Member A Protects Against obesity-Related Metabolic Disorder by Modulating the Adipocyte insulin Signaling
1485. Fanconi anemia links reactive oxygen species to insulin resistance and obesity
1486. Fas (CD 95) expression in myeloid cells promotes obesity‐induced muscle insulin resistance
1487. Fas and FasL Expression in Human Adipose Tissue Is Related to obesity, insulin Resistance, and Type 2 Diabetes
1488. Fast food, central nervous system insulin resistance, and obesity
1489. Fasting insulin and obesity-related phenotypes are linked to chromosome 2p: the Strong Heart Family Study
1490. Fasting insulin level in obese children: relationship to comorbidities of childhood obesity
1491. Fasting insulin resistance affects the prevalence of metabolically healthy obesity in Brazilian adolescents
1492. Fasting insulin, Glucose, and HbA1c Among Young Adults with Overweight and obesity
1493. Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle-aged Japanese men
1494. Fasting‐based estimates of insulin sensitivity in overweight and obesity: a critical appraisal
1495. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
1496. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats
1497. Fat metabolism in obesity, with special emphasis on the insulin resistance and elevated lipid mobilization in visceral obesity
1498. Fat versus carbohydrate in insulin resistance, obesity, diabetes and cardiovascular disease
1499. Fat-depot specific differences in adipose tissue inflammation in the setting of obesity and insulin resistance
1500. Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance
1501. Fat-specific Sirt6 ablation sensitizes mice to high-fat diet–induced obesity and insulin resistance by inhibiting lipolysis
1502. FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity
1503. Fatty acid binding protein 2 (FABP-2) polymorphism, obesity and insulin resistance
1504. Fatty acid composition of skeletal muscle membrane phospholipids, insulin resistance and obesity
1505. Fatty acids, obesity and insulin resistance
1506. Fatty acids, obesity, and insulin resistance: time for a reevaluation
1507. Fatty liver, insulin resistance, and obesity: relationships with increase in coronary artery calcium over time
1508. Fatty pancreas in relation to insulin resistance and metabolic syndrome in children with obesity
1509. Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels
1510. FDP-E induces adipocyte inflammation and suppresses insulin-stimulated glucose disposal: effect of inflammation and obesity on fibrinogen Bβ mRNA
1511. Features of some anthropometric indices and indices of insulin resistance in patients with non-alcoholic steatohepatitis on the background of obesity and …
1512. Febrile neutropenia induces changes in insulin sensitivity similar to obesity
1513. Fecal microbiota signatures of insulin resistance, inflammation and metabolic syndrome in youth with obesity. A pilot study.
1514. Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance
1515. Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity.
1516. Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity
1517. Feeding high oleic acid Canola oil or olive oil alters inflammation, insulin resistance and lipid metabolism in a rodent model of diet induced obesity
1518. Female 5 [beta]-reductase knockout mice are protected from diet induced obesity, insulin resistance, and glucose intolerance
1519. Female obesity: testosteronemia is positively correlated with peripheral insulin resistance
1520. Female offspring born to obese and insulin-resistant dams are not at increased risk for obesity and metabolic dysfunction during early development
1521. Fenfluramine in chilhood obesity: clinical experience and effects of fenfluramine and weight loss on blood glucose, plasma insulin and plasma growth hormone …
1522. Fenugreek attenuates obesity-induced inflammation and improves insulin resistance through downregulation of iRhom2/TACE
1523. Ferriman-Gallwey Score correlates with obesity and insulin level in Polycystic Ovary Syndrome–an observational study
1524. Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity
1525. Fetal origins of insulin resistance and obesity
1526. Fetuin-null mice are protected against obesity and insulin resistance associated with aging
1527. FGF21 deficiency is associated with childhood obesity, insulin resistance and hypoadiponectinaemia: the BCAMS Study
1528. FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance
1529. FGF21 gene therapy as treatment for obesity and insulin resistance
1530. Fiber intake and insulin resistance in 6374 adults: The role of abdominal obesity
1531. Fibre, satiety and insulin-a new approach to overnutrition and obesity
1532. Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance
1533. Fibroblast growth factor receptor 4 (FGFR4) deficiency improves insulin resistance and glucose metabolism under diet-induced obesity conditions
1534. Finding Links between obesity and Diabetes: Using Diacylglycerol Kinase to Regulate insulin Signaling
1535. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity
1536. Fish oil in a high lard diet prevents obesity, hyperlipemia, and adipocyte insulin resistance in rats
1537. Fitness, insulin sensitivity, and frontal lobe integrity in adults with overweight and obesity
1538. Five genes influenced by obesity may contribute to the development of thyroid cancer through the regulation of insulin levels
1539. FKBP5 polymorphism is associated with insulin resistance in children and adolescents with obesity
1540. Flavonoid-rich extract of Paulownia fortunei flowers attenuates diet-induced hyperlipidemia, hepatic steatosis and insulin resistance in obesity mice by AMPK pathway
1541. Flow motion dynamics of microvascular blood flow and oxygenation: Evidence of adaptive changes in obesity and type 2 diabetes mellitus/insulin resistance
1542. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity
1543. Folate and vitamin B12 status is associated with insulin resistance and metabolic syndrome in morbid obesity
1544. Food-related sensory stimuli are able to promote pancreatic polypeptide elevation without evident cephalic phase insulin secretion in human obesity
1545. Food, obesity and non-insulin-dependent diabetes: are there molecular links?
1546. Forearm metabolism in obesity and its response to intra-arterial insulin. Characterization of insulin resistance and evidence for adaptive hyperinsulinism
1547. Forkhead box O-1 modulation improves endothelial insulin resistance in human obesity
1548. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary‐induced obesity and insulin …
1549. FOXC2 and CAPN10 as candidate genes for obesity, insulin resistance and type 2 diabetes
1550. FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance
1551. Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy
1552. Free fatty acid oxidation in insulin resistance and obesity
1553. Free fatty acids (FFA), a link between obesity and insulin resistance
1554. Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients
1555. Free fatty acids in insulin‐resistant individuals are associated with the insulin‐resistant state but not with central obesity
1556. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction
1557. Free fatty acids—the link between obesity and insulin resistance
1558. Free Fatty Acids, A Major Link Between obesity, insulin Resistance, Inflammation, and Atherosclerotic Vascular Disease
1559. Free fatty acids, insulin resistance, and corrected qt intervals in morbid obesity: effect of weight loss during 6 months with differing dietary interventions
1560. Free insulin-like growth factors in human obesity
1561. Free triiodothyronine is associated with smoking habit, independently of obesity, body fat distribution, insulin, and metabolic parameters
1562. Freeze-dried strawberry and blueberry attenuates diet-induced obesity and insulin resistance in rats by inhibiting adipogenesis and lipogenesis
1563. Frequency of insulin resistance in nondiabetic adult Bangladeshi individuals of different obesity phenotypes
1564. Frequency of obesity, insulin resistance, cardio-metabolic risk factors and genetic variation in the genes encoding ADIPOQ and PPAR-[gamma] in urban adults
1565. From immune senescence and insulin resistance to obesity and sarcopenia: iNKT cell as bridge?
1566. From insulin receptor signalling to Glut 4 translocation abnormalities in obesity and insulin resistance
1567. From obesity to type 2 diabetes: the interplay between insulin resistance and impaired insulin secretion
1568. From Starvation to obesity: How insulin Resistance Affects Global Health
1569. Fructose transport and metabolism in adipose tissue of Zucker rats: diminished GLUT5 activity during obesity and insulin resistance
1570. FT–IR Saliva Profiling in Patients with obesity and obesity–Related insulin Resistance
1571. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-α-mediated insulin resistance in genetic obesity
1572. Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment
1573. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance
1574. Further evidence for insulin hypersecretion not as an initial event but as a consequence of body growth and maturation in juvenile-onset obesity
1575. G protein–coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity
1576. G protein–coupled receptors targeting insulin resistance, obesity, and type 2 diabetes mellitus
1577. G Proteins Regulating insulin Action and obesity
1578. GABA type B receptor signaling in proopiomelanocortin neurons protects against obesity, insulin resistance, and hypothalamic inflammation in male mice on a high-fat …
1579. GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance
1580. Galacto-oligosaccharides supplementation decreases obesity and improves insulin sensitivity in mice fed a Western-type diet
1581. Galectin-3 is a potential biomarker to insulin resistance and obesity in women with polycystic ovary syndrome
1582. Gamma tocotrienol improves high fat diet‐induced obesity and insulin resistance by inhibiting adipose inflammation and macrophage recruitment (383.4)
1583. Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment
1584. Ganglioside GM3 as a gatekeeper of obesity-associated insulin resistance: Evidence and mechanisms
1585. Ganoderic Acid A improves high fat diet-induced obesity, lipid accumulation and insulin sensitivity through regulating SREBP pathway
1586. Gastric Bypass in an Adolescent with obesity, insulin Resistance, and Type 1 Diabetes
1587. Gastric inhibitory polypeptide (GIP) and insulin in obesity: II. Reversal of increased response to stimulation by starvation or food restriction
1588. Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels
1589. Gastric sleeve surgery alleviates obesity-associated insulin resistance and suppresses endoplasmic reticulum stress in adipose tissue of db/db mice
1590. Gender differences in association of plasma adiponectin with obesity reflect resultant insulin resistance in non‐diabetic Japanese patients with schizophrenia
1591. GENDER DIFFERENCES OF VITAMIN D LEVELS AND ITS ASSOCIATION WITH SELECTED obesity MARKERS, insulin RESISTANCE IN YOUNG …
1592. Gender-specific effect of-102G> a polymorphism in insulin induced gene 2 on obesity in Chinese children
1593. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM
1594. Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats
1595. Genetic ablation of calcium-independent phospholipase A2γ prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and …
1596. Genetic Ablation of GIP Producing K Cells Reduces Diet Induced obesity (OB) and insulin Resistance (IR) in Mice.
1597. Genetic Ablation of Liver CPT-1A Gene Protects Mice against High-Fat Diet–Induced obesity and insulin Resistance
1598. Genetic ablation of lymphocytes and cytokine signaling in nonobese diabetic mice prevents diet‐induced obesity and insulin resistance
1599. Genetic ablation of miR-33 increases food intake, enhances adipose tissue expansion, and promotes obesity and insulin resistance
1600. Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evicence for polygenic control
1601. Genetic analysis of the IRS: pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures
1602. Genetic deconstruction of complex traits related to the cardiovascular complications of insulin resistance in multigenic obesity mouse models
1603. Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistance
1604. Genetic deletion of mast cell serotonin synthesis prevents the development of obesity and insulin resistance
1605. Genetic determinants of energy expenditure and insulin resistance in diet-induced obesity in mice
1606. Genetic engineering of the skeletal muscle to counteract insulin resistance and obesity
1607. Genetic evidence that carbohydrate-stimulated insulin secretion leads to obesity
1608. Genetic models of human obesity and non-insulin dependent diabetes in animals: problem of adequacy.
1609. Genetic Nicotinamide N-Methyltransferase (Nnmt) deficiency in male mice improves insulin sensitivity in diet-induced obesity but does not affect glucose tolerance
1610. Genetic obesity and dietary sucrose decrease hepatic glucagon and insulin receptors in LA/N-corpulent rats
1611. Genetic predisposition to obesity is associated with insulin secretion in Chinese adults: the Cardiometabolic Risk in Chinese (CRC) study
1612. Genetic reduction of circulating insulin-like growth factor (IGF)-1 inhibits obesity-promoted colon tumorigenesis in mice
1613. Genetic reduction of circulating insulin-like growth factor (IGF)-1 inhibits obesity-promoted colon tumorigenesis in mice and alters microRNA expression
1614. Genetic Variants Associated With obesity and insulin
1615. Genetic variants associated with obesity and insulin resistance in Hispanic boys with nonalcoholic fatty liver disease
1616. Genetic variants of retinol-binding protein 4 in adolescents are associated with liver function and inflammatory markers but not with obesity and insulin resistance
1617. Genetic Variation in β3-Adrenergic Receptor and obesity, Type 2 Diabetes, insulin Resistance in Chinese Pedigrees
1618. Genetics of gene expression of the insulin signaling pathway in polygenic obesity
1619. Genetics of Paediatric Type 2 Diabetes: ABCC8 Mutation in obesity-Associated insulin Secretion Defects
1620. Genotype C/C 13910 of the Lactase Gene as a Risk Factor for the Formation of insulin-Resistant obesity in Children
1621. Genotype screening of APLN rs3115757 variant in Egyptian women population reveals an association with obesity and insulin resistance
1622. Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepatic insulin Insensitivity, obesity, and Metabolic Syndrome in Adult Female Offspring
1623. Gestational oxidative stress protects against adult obesity and insulin resistance
1624. #VALUE!
1625. GH receptor deficiency in Ecuadorian adults is associated with obesity and enhanced insulin sensitivity
1626. Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice
1627. #VALUE!
1628. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet
1629. Global Tudor‐SN transgenic mice are protected from obesity‐induced hepatic steatosis and insulin resistance
1630. Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity
1631. GLP-1 responses are heritable and blunted in acquired obesity with high liver fat and insulin resistance
1632. Glucocorticoid metabolism in human obesity; increased 5 [alpha]-reductase activity is associated with insulin resistance in both men and women
1633. Glucocorticoid Receptor Is Instrumental for the Mechanism of Beta-Cell Compensation for insulin Resistance in Dietary obesity
1634. Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice
1635. Glucoraphanin ameliorates obesity and insulin resistance through adipose tissue browning and reduction of metabolic endotoxemia in mice
1636. Glucoraphanin: a broccoli sprout extract that ameliorates obesity-induced inflammation and insulin resistance
1637. Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance …
1638. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity
1639. Glucose and insulin values in an adolescent outpatient population with a high prevalence of obesity and risk factors for diabetes mellitus type 2
1640. Glucose impairments and insulin resistance in prostate cancer: The role of obesity, nutrition and exercise
1641. Glucose intolerance in monosodium glutamate obesity is linked to hyperglucagonemia and insulin resistance in α cells
1642. Glucose intolerance, insulin resistance and metabolic syndrome in patients with stable angina pectoris. obesity predicts coronary atherosclerosis and …
1643. Glucose Intolerance, insulin Resistance and obesity Risk in Children with Family History of Type II Diabetes
1644. Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity …
1645. Glucose metabolism and the response to insulin by human adipose tissue in spontaneous and experimental obesity: effects of dietary composition and adipose cell …
1646. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus
1647. Glucose tolerance and insulin sensitivity define adipocyte transcriptional programs in human obesity
1648. Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs.
1649. Glucose tolerance and serum insulin levels in an animal model of obesity induced by the antipsychotic drug, sulpiride
1650. Glucose tolerance, plasma insulin, and plasma glucagon in relation to obesity in chickens
1651. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men
1652. Glucose Tolerance, Plasma insulin, HDL Cholesterol and obesity: 12-year Follow-Up and Development of Coronary Heart Disease in Edinburgh Men
1653. Glucose uptake of the muscle and adipose tissues in diabetes and obesity disease models: evaluation of insulin and β3-adrenergic receptor agonist effects by 18 F …
1654. Glucose-6-phosphate dehydrogenase deficiency improves insulin resistance with reduced adipose tissue inflammation in obesity
1655. Glucose–insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity
1656. Glucose, insulin concentrations and obesity in childhood and adolescence as predictors of NIDDM
1657. GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1 GT/GT, a mouse model for obesity and insulin resistance
1658. Glutamate interactions with obesity, insulin resistance, cognition and gut microbiota composition
1659. Glutathione depletion prevents diet‐induced obesity and enhances insulin sensitivity
1660. Glycaemic control, insulin resistance and obesity
1661. Glycated hemoglobin, but not insulin sensitivity, is associated with memory in subjects with obesity
1662. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity
1663. Glycerol-3-phosphate dehydrogenase activity in human lymphocytes: effects of insulin, obesity and weight loss
1664. Glycogen Synthase Kinase-3a Contributes to the Development of Cardiac Dysfunction During obesity and insulin Resistance Through Regulation of Peroxisome …
1665. Goat’s milk intake prevents obesity, hepatic steatosis and insulin resistance in mice fed A high-fat diet by reducing inflammatory markers and increasing energy …
1666. Gonadal white adipose tissue-derived exosomal MiR-222 promotes obesity-associated insulin resistance
1667. Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens
1668. Good fats versus bad fats: a comparison of fatty acids in the promotion of insulin resistance, inflammation, and obesity
1669. Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance
1670. GPR105 ablation prevents inflammation and improves insulin sensitivity in mice with diet-induced obesity
1671. GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance.
1672. Gr-1+ CD11b+ myeloid-derived suppressor cells suppress inflammation and promote insulin sensitivity in obesity
1673. Gravidity, obesity, and non-insulin-dependent diabetes among Pima Indian women
1674. Green tea prevents obesity by increasing expression of insulin-like growth factor binding protein-1 in adipose tissue of high-fat diet-fed mice
1675. Growth and obesity and its association with plasma level of steroid hormones and insulin-like growth factor-I (IGF-I) in Slovak female students.
1676. Growth hormone is necessary for the p53-mediated, obesity-induced insulin resistance in male C57BL/6J× CBA mice
1677. Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia
1678. Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity
1679. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition
1680. Growth hormone, insulin, and prolactin secretion in anorexia nervosa and obesity during bromocriptine treatment.
1681. Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance
1682. Guarana supplementation attenuated obesity, insulin resistance, and adipokines dysregulation induced by a standardized human Western diet via brown adipose …
1683. Guenther Boden, MD (1935–2015): A Pioneer in Human Studies of Nutrition and obesity—And the Mystery of insulin Resistance for Handling Glucose
1684. Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice
1685. Gut inflammation as a contributing factor for the development of insulin resistance in obesity
1686. Gut microbiome and its role in obesity and insulin resistance
1687. Gut microbiota as a key player in triggering obesity, systemic inflammation and insulin resistance
1688. Gut microbiota composition and its effects on obesity and insulin resistance
1689. Gut microbiota impairs insulin clearance during obesity
1690. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
1691. Gut microbiota interacts with markers of adipose tissue browning, insulin action and plasma acetate in morbid obesity
1692. Gut-associated IgA+ immune cells regulate obesity-related insulin resistance
1693. Gut-specific delivery of T-helper 17 cells reduces obesity and insulin resistance in mice
1694. Haploinsufficiency of the retinoblastoma protein gene reduces diet-induced obesity, insulin resistance, and hepatosteatosis in mice
1695. Haptoglobin Phenotypes Are Associated with the Postload Glucose and insulin Levels in Pediatric obesity
1696. Heart Rate, insulin resistance, obesity and blood Pressure in Croatian Rural Population
1697. Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity
1698. Hematopoietic kit deficiency, rather than lack of mast cells, protects mice from obesity and insulin resistance
1699. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats
1700. Hemodynamic factors in the insulin resistance of obesity and hyperlipidemia
1701. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?
1702. Hepatic adenylate cyclase 3 is upregulated by Liraglutide and subsequently plays a protective role in insulin resistance and obesity
1703. Hepatic Apolipoprotein M Overexpression Increased Total Sphingosine 1-phosphate Mass and Ameliorate insulin Resistance in Diet Induced obesity Mice
1704. Hepatic atypical protein kinase C: an inherited survival-longevity gene that now fuels insulin-resistant syndromes of obesity, the metabolic syndrome and type …
1705. Hepatic Bax inhibitor-1 inhibits IRE1α and protects from obesity-associated insulin resistance and glucose intolerance
1706. Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity, and insulin resistance
1707. Hepatic insulin dynamics. Effects of male gender and obesity: Role of free fatty acids.
1708. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression
1709. Hepatic mTORC1 opposes impaired insulin action to control mitochondrial metabolism in obesity
1710. Hepatic NF-κB essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis
1711. Hepatic oncostatin M receptor β regulates obesity-induced steatosis and insulin resistance
1712. Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2
1713. Hepatic protein tyrosine phosphatase receptor gamma links obesity-induced inflammation to insulin resistance
1714. Hepatic Stearoyl-CoA Desaturase-1 Deficiency does not Protect Mice from Diet-Induced obesity and insulin Resistance
1715. Hepatic Steatosis is Common in Adolescents with obesity and PCOS and Relates to De Novo Lipogenesis but not insulin Resistance
1716. Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity
1717. Hepatocyte DACH1 is increased in obesity via nuclear exclusion of HDAC4 and promotes hepatic insulin resistance
1718. Hepatocyte growth factor prevented high-fat diet-induced obesity and improved insulin resistance in mice
1719. Hepatocyte Toll-like receptor 4 regulates obesity-induced inflammation and insulin resistance
1720. Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
1721. Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
1722. Hepatocyte-specific Ptpn6 deletion protects from obesity-linked hepatic insulin resistance
1723. Herbal formula HT048 attenuates diet-induced obesity by improving hepatic lipid metabolism and insulin resistance in obese rats
1724. Hereditary postprandial hypertriglyceridemic rabbit exhibits insulin resistance and central obesity: a novel model of metabolic syndrome
1725. Heritability of insulin sensitivity and lipid profile depend on BMI: evidence for gene–obesity interaction
1726. Heterogeneity in insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people with obesity
1727. Heterogeneity of plasma insulin and triglyceride levels in obesity demonstrated by family study
1728. Heterozygous knockout of the IRS-1 gene in mice enhances obesity-linked insulin resistance: a possible model for the development of type 2 diabetes
1729. Heterozygous p53 knockout affects development of obesity, insulin resistance and non-alcoholic steatohepatitis in mice fed with a Western type diet
1730. Hexosamines as mediators of nutrient sensing: relevance to obesity, insulin resistance, and diabetes
1731. High density lipoprotein cholesterol, insulin and obesity in Samoans
1732. High Early Childhood insulin Increases Asthma Risk Independent of obesity
1733. High Expression Level of PPARγ in CD24 Knockout Mice and Gender-Specific Metabolic Changes: A Model of insulin-Sensitive obesity
1734. High fat diet induces central obesity, insulin resistance and microvascular dysfunction in hamsters
1735. High fat-induced obesity associated with insulin-resistance increases FGF-2 content and causes stromal hyperplasia in rat ventral prostate
1736. High incidence of obesity and elevated serum immunoreactive insulin level in patients with paravertebral ligamentous ossification: a relationship to the development of …
1737. High incidence of obesity and insulin resistance in prepubertal children, born too small for their gestational age
1738. High prevalence of overweight, obesity, insulin resistance and metabolic syndrome in rural children and adolescents
1739. High serum fasting peptide YY (3–36) is associated with obesity-associated insulin resistance and type 2 diabetes
1740. High serum selenium levels are associated with increased risk for diabetes mellitus independent of central obesity and insulin resistance
1741. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels
1742. High-density lipoprotein composition in obesity: interrelationships with plasma insulin levels and body weight.
1743. High-fat diet is associated with obesity-mediated insulin resistance and β-cell dysfunction in Mexican Americans
1744. High-fat diet-induced obesity and insulin resistance are characterized by differential beta oscillatory signaling of the limbic cortico-basal ganglia loop
1745. High-fat diet-induced obesity and insulin resistance in CYP4a14 Ϫ/Ϫ mice is mediated by 20-HETE
1746. High-fat diet-induced obesity and insulin resistance in CYP4a14−/− mice is mediated by 20-HETE
1747. High-fat diet-induced obesity impairs insulin signaling in lungs of allergen-challenged mice: Improvement by resveratrol
1748. High-fat diet–induced obesity and insulin resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice
1749. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse
1750. High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons
1751. High-fructose diet in pregnancy leads to fetal programming of hypertension, insulin resistance, and obesity in adult offspring
1752. High-intensity interval training improves markers of oxidative metabolism in skeletal muscle of individuals with obesity and insulin resistance
1753. High-normal TSH values in obesity depends on adipose tissue rather than insulin resistance
1754. High‐fat diet obesity associated with insulin resistance increases cell proliferation, estrogen receptor, and PI3K proteins in rat ventral prostate
1755. High‐fat Diet‐induced Ultradian Leptin and insulin Hypersecretion are Absent in obesity‐resistant Rats
1756. High‐normal tsh values in obesity: Is it insulin resistance or adipose tissue’s guilt?
1757. Higher Concentrations of Glucose or insulin Increase the Risk of Various Types of Cancer in obesity or Type 2 Diabetes by Decreasing the Expression of …
1758. Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort
1759. Higher levels of ANGPTL5 in the circulation of subjects with obesity and type 2 diabetes are associated with insulin resistance
1760. Higher PDCD4 expression is associated with obesity, insulin resistance, lipid metabolism disorders, and granulosa cell apoptosis in polycystic ovary syndrome
1761. Hippocampal insulin resistance and altered food decision-making as players on obesity risk
1762. Hippocampal insulin resistance links maternal obesity with impaired neuronal plasticity in adult offspring
1763. HIS-388, a novel orally active and long-acting 11β-HSD1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and non-genetic type …
1764. HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance
1765. HOMA, QUICKI and MF fm to Measure insulin Resistance in Morbid obesity
1766. Homeostasis model assessment of insulin resistance in a general adult population in Korea: additive association of sarcopenia and obesity with insulin resistance
1767. Homeostatic model assessment of insulin resistance as a predictor of metabolic syndrome: consequences of obesity in children and adolescents
1768. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women
1769. Hormone resistance in diabetes and obesity: insulin, leptin, and FGF21
1770. Hormones and obesity: changes in insulin and growth hormone secretion following surgically induced weight loss
1771. How much variance in insulin resistance is explained by obesity?
1772. How much variance in insulin resistance is explained by obesity?
1773. How the association between obesity and inflammation may lead to insulin resistance and cancer
1774. HSP72 protects against obesity-induced insulin resistance
1775. Huangjinya Black Tea Alleviates obesity and insulin Resistance via Modulating Fecal Metabolome in High‐Fat Diet‐Fed Mice
1776. Human growth gene family chromosomal architecture is affected by maternal obesity, gestational diabetes and insulin treatment
1777. Human muscle fiber type–specific insulin signaling: Impact of obesity and type 2 diabetes
1778. Human obesity and insulin Resistance
1779. Human obesity and insulin resistance: lessons from experiments of nature
1780. Human obesity and thinness, hyperlipidemia, hyperglycemia, and insulin resistance associated with HIV1 protease inhibitors Prevention by alternating several …
1781. Human obesity relationship with Ad36 adenovirus and insulin resistance
1782. Human plasma resistin level relate to insulin resistance and obesity
1783. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro
1784. Huperzine A ameliorates obesity-related cognitive performance impairments involving neuronal insulin signaling pathway in mice
1785. Hydrodynamic delivery of adiponectin and adiponectin receptor 2 gene blocks high-fat diet-induced obesity and insulin resistance
1786. Hydrodynamic delivery of IL-38 gene alleviates obesity-induced inflammation and insulin resistance
1787. Hydroxychloroquine improves obesity-associated insulin resistance and hepatic steatosis by regulating lipid metabolism
1788. Hydroxytyrosol ameliorates insulin resistance by modulating endoplasmic reticulum stress and prevents hepatic steatosis in diet-induced obesity mice
1789. Hydroxytyrosol improves obesity and insulin resistance by modulating gut microbiota in high-fat diet-induced obese mice
1790. Hyperactivity of the hypothalamo‐pituitary‐adrenal axis in obesity: a study of ACTH, AVP, β‐lipotrophin and Cortisol responses to insulin‐induced hypoglycaemia
1791. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired …
1792. Hyperglycemia and obesity as Determinants of Glucose, insulin, and Glucagon Responses to β-Endorphin in Human Diabetes Mellitus
1793. Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes
1794. Hyperinsulinaemia in obesity is not accompanied by an increase in serum proinsulin/insulin ratio in groups of human subjects with and without glucose intolerance
1795. Hyperinsulinemia and its impact on obesity and insulin resistance.
1796. Hyperinsulinemia does not compensate for peripheral insulin resistance in obesity
1797. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production
1798. Hyperinsulinemia due to altered insulin secretion contributes to insulin resistance in chronic intermittent hypoxia independently of obesity
1799. Hyperinsulinemia in individuals with obesity: role of insulin clearance
1800. Hyperinsulinemia Leads the Elevation of Plasma Aldosterone Concentration Independently with obesity, Dyslipidemia, and insulin Resistance in Patients with Type 2 …
1801. Hyperinsulinemia of obesity is due to decreased clearance of insulin
1802. Hyperinsulinemia, insulin resistance and free fatty acids. The dog model in diabetes and obesity research
1803. Hyperleptinemia and insulin resistance in obesity-associated sleep apnoea: Sex-dependent effects of CPAP application
1804. Hyperleptinemia: an early sign of juvenile obesity. Relations to body fat depots and insulin concentrations
1805. Hypertension and coronary heart disease in patients with type 2 (non insulin dependent) diabetes: influence of overweight and obesity.
1806. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy
1807. Hypertension and Dyslipidemia, but Not Fasting Blood Glucose, Dissociate From Central obesity and insulin Resistance With Advancing Age
1808. Hypertension and Metabolic Disarray: Diabetes Mellitus, insulin Resistance, and obesity Hypertension: Kidney, Sodium, and the Renin-Angiotensin System
1809. Hypertension in obesity and NIDDM: role of insulin and sympathetic nervous system
1810. Hypertension, hyperlipidemia, and abdominal obesity and the development of microalbuminuria in patients with non-insulin-dependent diabetes mellitus
1811. Hypertension, serum insulin, obesity and the metabolic syndrome
1812. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia
1813. Hypoadiponectinemia in obesity: association with insulin resistance
1814. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
1815. Hypomagnesemia and obesity in Relation to insulin Resistance and Glycemic Control in Type 2 Diabetic Patients
1816. Hyposialylated IgG activates endothelial IgG receptor FcγRIIB to promote obesity-induced insulin resistance
1817. Hypothalamic insulin resistance in obesity: effects on glucose homeostasis
1818. Hypothalamic insulin-sensitizing effect of exenatide in dietary induced rat model of obesity
1819. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist
1820. Hypothalamic obesity is due to insulin Hypersecretion: Reversal With Octreotide• 455
1821. Hypothalamic or central obesity is associated with an early rise in plasma insulin concentration
1822. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled ‘hypertensive …
1823. Hypothesis: postprandial remnant lipoproteins are the causal factors that induce the insulin resistance associated with obesity
1824. Identification and functional characterization of a missense mutation in resistin in 2 patients with severe obesity and insulin resistance Running Title: A missense …
1825. Identification and functional characterization of a missense mutation in resistin in two patients with severe obesity and insulin resistance
1826. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients
1827. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q.
1828. Identification of early transcriptome signatures in placenta exposed to insulin and obesity
1829. Identification of early transcriptome signatures in placenta exposed to insulin and obesity
1830. Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity
1831. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient-and obesity-induced insulin resistance
1832. Identification of novel alleles associated with insulin resistance in childhood obesity using pooled-DNA genome-wide association study approach
1833. Identification of Susceptibility Loci for obesity, insulin Resistance, and Hyperglycemia in a Backcross Model of New Zealand Obese (NZO) and Lean SJL Mice
1834. Identifying genetic modifiers of obesity and insulin sensitivity
1835. Identifying the links between obesity, insulin resistance and β‐cell function: potential role of adipocyte‐derived cytokines in the pathogenesis of type 2 diabetes
1836. IF1 connects obesity and insulin resistance through mitochondrial reprogramming in association with ANT2
1837. IGF-1 levels link estimated glomerular filtration rate to insulin resistance in obesity: a study in obese, but metabolically healthy, subjects and obese, insulin-resistant …
1838. IGF-binding protein-2 protects against the development of obesity and insulin resistance
1839. IGF-Binding Protein-2 Protects Against the Development of obesity and insulin Resistance
1840. IGFBP-1: A vasculoprotective peptide in obesity and insulin resistance
1841. IGFBP-3 interacts with the vitamin D receptor in insulin signaling associated with obesity in visceral adipose tissue
1842. IKK-β links inflammation to obesity-induced insulin resistance
1843. IKKε is key to induction of insulin resistance in the hypothalamus, and its inhibition reverses obesity
1844. IL-14. Small Molecule insulin Mimetics with Potential Utilities as Anti-diabetic and Anti-obesity Therapies
1845. IL-29 promoted obesity-induced inflammation and insulin resistance
1846. IL-33 reverses an obesity-induced deficit in visceral adipose tissue ST2+ T regulatory cells and ameliorates adipose tissue inflammation and insulin resistance
1847. IL-34 is associated with obesity, chronic inflammation, and insulin resistance
1848. IL-37 protects against obesity-induced inflammation and insulin resistance
1849. IL-7 receptor deletion ameliorates diet-induced obesity and insulin resistance in mice
1850. Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure
1851. Imbalanced insulin actions in obesity and type 2 diabetes: key mouse models of insulin signaling pathway
1852. Immune and inflammatory processes in obesity, insulin resistance, diabetes, and related cardiometabolic complications
1853. Immunity as a link between obesity and insulin resistance
1854. Immunologic shifts in inhabitants of the Tian’-Shan’lowlands and highlands, suffering from obesity and non-insulin-dependent diabetes mellitus
1855. Immunoreactive insulin and obesity in women.
1856. Immunoreative insulin in obesity of adult women.
1857. Impact of Aldose Reductase on Endothelial Function and Vascular insulin Resistance in Diet-Induced obesity
1858. Impact of alpha-lipoic acid on insulin sensitivity in individuals with obesity and impaired glucose tolerance [J]
1859. Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities
1860. Impact of bariatric surgery on heme oxygenase-1, inflammation, and insulin resistance in morbid obesity with obstructive sleep apnea
1861. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT
1862. Impact of changes in obesity parameters on glucose metabolism and insulin resistance over a one-year period
1863. Impact of Chromosome 2 obesity Loci on Cardiovascular Complications of insulin Resistance in LDL Receptor–Deficient C57BL/6 Mice
1864. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable …
1865. Impact of degree of obesity on surrogate estimates of insulin resistance
1866. Impact of diet-induced obesity on intestinal stem cells: hyperproliferation but impaired intrinsic function that requires insulin/IGF1
1867. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity
1868. Impact of insulin resistance and obesity on elevated blood pressure in Chinese children and adolescents: The BCAMS study
1869. Impact of insulin resistance and obesity on intracytoplasmic sperm injection outcomes in young women with polycystıc ovary syndrome
1870. Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond
1871. Impact of obesity and insulin-resistance on bone mineral density in Tunisian postmenopausal women
1872. Impact of obesity and insulin-resistance on cirrhosis and portal hypertension
1873. Impact of obesity on IL-12 family gene expression in insulin responsive tissues
1874. Impact of obesity on insulin action in NIDDM
1875. Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity
1876. Impact of obesity on maternal and neonatal outcomes in insulin-resistant pregnancy
1877. Impact of obesity on MMTV-Wnt-1 Mammary Cancer: Role of The insulin-Like Growth Factor-1 (IGF-1)/Akt/mTOR Pathway
1878. Impact of obesity on MMTV-Wnt-1 mammary cancer: role of the insulin-like growth factor-1 (IGF-1)/Akt/mTOR pathway
1879. Impact of obesity on Plasma C1q/TNF-Related Protein 3 and insulin Resistance in Newly Diagnosed T_2DM Patients
1880. Impact of obesity on resting metabolic rate and glucose-induced thermogenesis in non-insulin dependent diabetes mellitus.
1881. Impact of obesity, hepatic steatosis, and insulin resistance on hepatitis C treatment outcomes
1882. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C
1883. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study
1884. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and …
1885. Impact of proteinase 3 and insulin growth factor BP-3 proteolysis in obesity-induced cardiometabolic risk
1886. Impact of reduced ATGL-mediated adipocyte lipolysis on obesity-associated insulin resistance and inflammation in male mice
1887. Impact of sex on microvascular reactivity in a murine model of diet-induced obesity and insulin resistance
1888. Impact of Uncoupling Protein 3 Deficiency on High-Fat Diet-Induced obesity and insulin Resistance
1889. Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity
1890. Impaired activation of skeletal muscle glycogen synthase in non-insulin-dependent diabetes mellitus is unrelated to the degree of obesity
1891. Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance
1892. Impaired fat tolerance as a risk factor of insulin resistance in young patients with obesity
1893. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance
1894. IMPAIRED GHRELIN SECRETION IN obesity: THE KEY ROLE OF insulin RESISTANCE
1895. Impaired glucose tolerance in obesity is associated with insensitivity to insulin in multiple aspects of metabolism as assessed by a low dose incremental insulin …
1896. Impaired growth hormone response to growth hormone releasing factor and insulin‐hypoglycaemia in obesity
1897. Impaired insulin action in subcutaneous adipocytes from women with visceral obesity
1898. Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients
1899. Impaired macrophage autophagy induces systemic insulin resistance in obesity
1900. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance
1901. Impaired phagocytosis as a key mechanism underlying obesity‐induced inflammation and insulin resistance
1902. Impaired platelet sensitivity to the anti-aggregating effects of adenosine in obesity and obese non-insulin-dependent diabetes mellitus
1903. Impaired protein metabolism: interlinks between obesity, insulin resistance and inflammation
1904. Impaired Transient Receptor Potential Vanilloid Type-1 Signaling Promotes obesity and Leptin/insulin Resistance In Mice
1905. Implication of inflammatory signaling pathways in obesity-induced insulin resistance
1906. Implication of MAP kinases in obesity-induced inflammation and insulin resistance
1907. Implication of obesity-induced miR-96 in hepatic insulin resistance
1908. Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity
1909. Importance of lean muscle maintenance to improve insulin resistance by body weight reduction in female patients with obesity
1910. Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high‐fat diet‐induced obesity
1911. IMPORTANCE OF SHIP2 GENE IN obesity INDUCED MUSCLE insulin RESISTANCE: FOCUS ON PALMITATE
1912. Importance of TNF-alpha and leptin in obesity and insulin resistance: a hypothesis on the impact of physical exercise.
1913. Imprinted insulin predisposes children to obesity
1914. Improved insulin sensitivity after exercise training is linked to reduced plasma C 14: 0 ceramide in obesity and type 2 diabetes
1915. Improved insulin sensitivity with angiotensin receptor neprilysin inhibition in individuals with obesity and hypertension
1916. Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action
1917. Improvement of heart rate variability after decreased insulin resistance after sleeve gastrectomy for morbidly obesity patients
1918. Improvement of hyperandrogenism and insulin resistance in females with severe obesity after weight loss through bariatric surgery
1919. Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures
1920. Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity
1921. Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance
1922. Improvement of obesity-linked skeletal muscle insulin resistance by strength and endurance training
1923. Improving obesity and insulin Resistance by Targeting Skeletal Muscle MKP-1
1924. In addition to insulin resistance and obesity, brachial-ankle pulse wave velocity is strongly associated with metabolic syndrome in Chinese-a population-based study …
1925. In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a …
1926. In addition to obesity and insulin resistance, microalbuminuria and diminished insulin secretion are linked with the metabolic syndrome in community-dwelling …
1927. IN FOCUS: Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance
1928. In normoglycaemic siblings of type 2 diabetic patients, obesity accounts for decreased insulin sensitivity but not for hypertension.
1929. In patients with coronary artery disease the NCEP-defined metabolic syndrome, insulin resistance and obesity are all associated with decreased adiponectin …
1930. In the article entitled “Increased Susceptibility to insulin Re-sistance Associated with Abdominal obesity in Aging Rats,”
1931. in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 Loci With insulin Release, insulin Sensitivity, and obesity in a Population-Based Sample …
1932. In Vivo Changes in Central and Peripheral insulin Sensitivity in a Large Animal Model of obesity
1933. In vivo kinetics of islet compensation and dysfunction in a mouse model of diet-induced obesity and insulin resistance
1934. In-silico study of the immune systems associated genes in case of type-2 diabetes with insulin action and resistance and in obesity
1935. Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice
1936. Inactivation of insulin in Livers from Mice with Goldthioglueose obesity.
1937. Inactivation of MARK4, an AMP-activated protein kinase (AMPK)-related kinase, leads to insulin hypersensitivity and resistance to diet-induced obesity
1938. Inactivation of PKCθ leads to increased susceptibility to obesity and dietary insulin resistance in mice
1939. Inactivation of SOCS3 in leptin receptor-expressing cells protects mice from diet-induced insulin resistance but does not prevent obesity
1940. Inadequacy of Vitamin D Nutritional Status in Individuals with Metabolically Unhealthy obesity Phenotype: The Relevance of insulin Resistance
1941. Incidence of obesity does not appear to be increased after treatment of acute lymphoblastic leukemia in Brazilian children: role of leptin, insulin, and IGF-1
1942. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution
1943. Increase in insulin secretion with age: its clinical importance in evaluating abnormal secretions focused on diabetes type II and obesity
1944. Increase insulin sensitivity by PTP1B deletion abolished obesity‐induced hypertension in mice
1945. Increased 4E-BP1 expression protects against diet-induced obesity and insulin resistance in male mice
1946. Increased abdominal obesity, insulin and glucose levels in nondiabetic subjects with a T29C polymorphism of the transforming growth factor-β1 gene
1947. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus
1948. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance
1949. Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity
1950. Increased adipocyte S-nitrosylation targets anti-lipolytic action of insulin: relevance to adipose tissue dysfunction in obesity
1951. Increased adipose tissue expression of IL‐18R and its ligand IL‐18 associates with inflammation and insulin resistance in obesity
1952. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
1953. Increased adrenal androgen levels in patients with Prader-Willi syndrome are associated with insulin, IGF-I, and leptin, but not with measures of obesity
1954. Increased binding of insulin to mononuclear blood cells following gastric bypass for morbid obesity
1955. Increased body mass index increase and insulin resistance parameters in dyslipidemia. Risk and positive correlation in essential obesity
1956. Increased C-jun N terminal kinase (JNK) activity may link insulin resistance and inflammation in human central obesity
1957. INCREASED EXPRESSION OF IL-18R AND IL-18 IN THE ADIPOSE TISSUE IS ASSOCIATED WITH insulin RESISTANCE (HOMA-IR) IN obesity
1958. Increased expression of triggering receptor expressed on myeloid cells‐1 in the population with obesity and insulin resistance
1959. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study
1960. Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance
1961. Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer’s disease mouse model
1962. Increased hepatic PDGF-AA signaling mediates liver insulin resistance in obesity-associated type 2 diabetes
1963. Increased insulin requirement may contribute to risk of obesity in children and young people with Type 1 Diabetes Mellitus
1964. Increased insulin resistance compounded by reduced insulin sensitivity drives the” Fat Aussie”(Alms1foz/foz) model of Alström syndrome towards obesity and type 2 …
1965. Increased insulin resistance in obese, glucose-intolerant Southwestern American Indians: evidence for a defect not explained by obesity
1966. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene
1967. Increased insulin Sensitivity by High-Altitude Hypoxia in Mice with High-Fat Diet-Induced obesity Is Associated with Activated AMPK Signaling and Subsequently …
1968. Increased insulin translation from an insulin splice-variant overexpressed in diabetes, obesity, and insulin resistance
1969. Increased maternal insulin resistance promotes placental growth and decreases placental efficiency in pregnancies with obesity and gestational diabetes mellitus
1970. Increased mitochondrial oxidative phosphorylation in the liver is associated with obesity and insulin resistance
1971. Increased muscle blood supply and transendothelial nutrient and insulin transport induced by food intake and exercise: effect of obesity and ageing
1972. Increased obesity resistance and insulin sensitivity in mice lacking the isocitrate dehydrogenase 2 gene
1973. Increased oxidative stress precedes the onset of high-fat diet–induced insulin resistance and obesity
1974. Increased serum dihomo-γ-linolenic acid levels are associated with obesity, body fat accumulation, and insulin resistance in Japanese patients with type 2 diabetes
1975. Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance
1976. Increased serum resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance
1977. Increased Susceptibility to insulin Resistance Associated with Abdominal obesity in Aging Rats**
1978. Increasing peripheral insulin sensitivity by protein tyrosine phosphatase 1B deletion improves control of blood pressure in obesity
1979. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin
1980. Independent effects of obesity and insulin resistance on postprandial thermogenesis in men.
1981. Independent relationships of obesity and insulin resistance with serum proinsulin level in prepubertal children with normal glucose tolerance
1982. Independent tissue contributors to obesity-associated insulin resistance
1983. Indices of insulin Resistance in Children with Simple obesity.
1984. Indices of insulin resistance in paediatric obesity
1985. Indices of obesity, dyslipidemia, and insulin resistance in apparently healthy Caribbean subjects
1986. Indomethacin treatment prevents high fat diet-induced obesity and insulin resistance but not glucose intolerance in C57BL/6J mice
1987. Induction of adipose and hepatic SWELL1 expression is required for maintaining systemic insulin-sensitivity in obesity
1988. Induction of obesity and insulin Resistance in Mice using a Modified Diet
1989. Inflamed Host: Serine/Threonine Phosphorylation Signaling Pathway that Links obesity and insulin Resistance and Worse Prognosis for COVID-19
1990. Inflammasome is a central player in the induction of obesity and insulin resistance
1991. Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
1992. Inflammation and obesity: STAMPing out insulin resistance?
1993. Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease
1994. Inflammation and the IKK β/I κ B/NF-κ B axis in obesity-and diet-induced insulin resistance
1995. Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly
1996. Inflammation in obesity is a common link between defects in fatty acid metabolism and insulin resistance
1997. Inflammation is not a contributing factor in the development of insulin resistance in diet induced obesity in rats
1998. Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity
1999. Inflammation‐mediated obesity and insulin resistance as targets for nutraceuticals
2000. Inflammation, insulin resistance, and obesity
2001. Inflammation: the link between insulin resistance, obesity and diabetes
2002. Inflammatory and metabolic role of Kupffer cells in diet-induced obesity and insulin resistance
2003. Inflammatory biomarkers associated with obesity and insulin resistance: a focus on lipocalin-2 and adipocyte fatty acid-binding protein
2004. Inflammatory Cross-Talk Between Short Sleep Duration and obesity in Development of insulin Resistance: Narrative Review
2005. Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages
2006. Inflammatory Responses to obesity and insulin Resistance
2007. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance
2008. Influence of a mini-trampoline rebound exercise program on insulin resistance, lipid profile and central obesity in individuals with type 2 diabetes.
2009. Influence of acupuncture on insulin resistance in simple obesity patients
2010. Influence of Acupuncture on Leptin, insulin-resistance and Adiponectin of Type 2 Diabetic obesity Rats [J]
2011. Influence of catgut implantation at acupoints on leptin and insulin resistance in simple obesity rats
2012. Influence of Diet and Exercise Comprehensive Correction on Plasma insulin in obesity Complicated with Menopausal Syndrome Patients
2013. Influence of dietary protein upon the development of obesity, insulin resistance (IR) and energy metabolism (EM) in malnourished mice fed a high fat diet (HFD)
2014. Influence of duration of obesity on the insulin resistance of obese non-diabetic patients
2015. Influence of electronic acupuncture on serum leptin and insulin of rats with simple obesity
2016. Influence of G1359A polymorphism of the cannabinoid receptor gene on anthropometric parameters and insulin resistance in women with obesity
2017. Influence of insulin resistance on renal function in patients with abdominal obesity.
2018. Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: the Normative Aging Study.
2019. Influence of maternal obesity on insulin sensitivity and secretion in offspring
2020. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver
2021. Influence of morbid obesity and non-insulin-dependent diabetes mellitus on high-density lipoprotein composition and subpopulation distribution
2022. Influence of nutritional state and obesity on pituitary control of insulin secretion
2023. Influence of obesity and family history of type 2 diabetes mellitus on serum ferritin and insulin levels in young adults
2024. Influence of obesity and insulin resistance on left atrial size in children
2025. Influence of obesity and insulin resistance on scavenger receptor CD36 expression on monocytes in young women
2026. Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue
2027. Influence of obesity and insulin sensitivity on phospholipid transfer protein activity
2028. Influence of obesity in the miRNome landscape: miR-4454, a-tissue-specific regulator of insulin response
2029. Influence of obesity in the miRNome: miR-4454, a key regulator of insulin response via splicing modulation in prostate
2030. Influence of obesity on first-phase insulin secretion in individuals with different glucose tolerance
2031. Influence of obesity on insulin and C-peptide levels in elderly diabetic patients [J]
2032. Influence of obesity on insulin‐mediated dilation in the human microcirculation
2033. Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion.
2034. Influence of obesity on the relationship between insulin and triglyceride levels in endogenous hypertriglyceridemia
2035. Influence of obesity to glucose tolerance, insulin, blood lipid and fribrinogen level in middle-aged and elderly men
2036. Influence of reversible obesity on eating behavior, blood glucose, and insulin in the rat
2037. Influence of risk factors on insulin resistance in patients with overweight and obesity.
2038. Influence of Various Diets on Diurnal Levels of Plasma Glucose, insulin, and Lipids in obesity and insulin-Independent Diabetics
2039. Influence of weight reduction on plasma high-density-lipoprotein cholesterol concentrations in severe obesity: interrelationships with plasma insulin levels
2040. Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity
2041. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 ameliorates obesity-related insulin resistance
2042. Inhibition of 72 kDa inositol polyphosphate 5-phosphatase E improves insulin signal transduction in diet-induced obesity
2043. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance
2044. Inhibition of cyclooxygenases attenuates diet-induced obesity and compensatory increased glucose-stimulated insulin secretion in C57BL/6J mice
2045. Inhibition of Hepatic Glucocorticoid Availability in Response to the Development of Diet Induced obesity and insulin Resistance in Mice.
2046. Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus
2047. Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats
2048. Inhibition of P2Y6 signaling in AgRP neurons reduces food intake and improves systemic insulin sensitivity in obesity
2049. Inhibition of platelet-collagen interaction: an in vivo action of insulin abolished by insulin resistance in obesity
2050. Inhibition of Stearoyl-CoA Desaturase 1 (SCD1) dissociates insulin resistance and obesity from atherosclerosis
2051. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus
2052. Innate immune pathway links obesity to insulin resistance
2053. Inorganic nitrite improves components of the metabolic syndrome independent of weight change in a murine model of obesity and insulin resistance
2054. iNOS promotes hypothalamic insulin resistance associated with deregulation of energy balance and obesity in rodents
2055. Insights into obesity and insulin resistance from the study of extreme human phenotypes
2056. Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance
2057. Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance
2058. insulin access to skeletal muscle is impaired during the early stages of diet‐induced obesity
2059. insulin access to skeletal muscle is preserved in obesity induced by polyunsaturated diet
2060. insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus
2061. insulin action and resistance in obesity and type 2 diabetes
2062. insulin action in brown adipose tissue is compromised during diet-induced obesity
2063. insulin action in morbid obesity: a focus on muscle and adipose tissue
2064. insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity
2065. insulin action in the brain and how this may cause/exacerbate obesity or diabetes
2066. insulin Action on Endothelial Cells Limits Leukocyte-Endothelial Interaction through CXCR4 and Counteracts Intestinal Tumor Formation in obesity
2067. insulin and blood pressure in obesity.
2068. insulin AND CYCLICAL obesity IN THE DORMOUSE, GLIS GLIS.
2069. insulin and glucose transporter gene expression in obesity and diabetes
2070. insulin and growth hormone balance: implications for obesity
2071. insulin and human obesity.
2072. insulin and hyperaminoacidemia regulate by a different mechanism leucine turnover and oxidation in obesity
2073. insulin and hypertension: lessons from obesity
2074. insulin and hypertension: relationship to obesity and glucose intolerance in Pima Indians
2075. insulin and IGFs in obesity-related breast cancer
2076. insulin and leptin action: roles in diabetes and obesity.
2077. insulin and leptin relations in obesity: a multimedia approach
2078. insulin and obesity in the Zucker genetically obese rat “fatty”
2079. insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state
2080. insulin as a factor of increased androgen production in women with obesity and polycystic ovaries
2081. insulin attenuates cardiac dysfunction in a rodent model of diet induced obesity and insulin resistance
2082. insulin based combination treatments of patients with obesity and type 2 diabetes
2083. insulin binding and action in isolated rat hepatocytes: effect of obesity and fasting
2084. insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding
2085. insulin clearance in obesity
2086. insulin deficiency: a possible link between obesity and cognitive function
2087. insulin Degradation by Adipose Human obesity
2088. insulin degradation by adipose tissue is increased in human obesity
2089. insulin degradation by adipose tissue is increased in human obesity
2090. insulin dependent diabetes mellitus: the affect of obesity on blood glucose control
2091. insulin downregulates M 2-muscarinic receptors in adult rat atrial cardiomyocytes: a link between obesity and cardiovascular complications
2092. insulin dysregulation in a population of Finnhorses and associated phenotypic markers of obesity
2093. insulin dysregulation in horses with induced obesity
2094. insulin gene variable number of tandem repeats (INS VNTR) genotype and metabolic syndrome in childhood obesity
2095. insulin hypoglycemia, a functional test of the state of the hypothalamo-hypophyseo-adrenal system in obesity
2096. insulin impairs regulatory T cell function: implications for obesity (P1020)
2097. insulin inhibits IL-10–mediated regulatory T cell function: implications for obesity
2098. insulin levels during pregnancy or obesity in normoglycemic women with a positive history of diabetes mellitus
2099. insulin measurement is also inappropriate in paediatric obesity
2100. insulin metabolism in hypothalamic obesity
2101. insulin normalization as an approach to the pharmacological treatment of obesity
2102. insulin production and resistance in different models of diet-induced obesity and metabolic syndrome
2103. insulin receptor binding and insulin action in human fat cells: effects of obesity and fasting
2104. insulin receptor binding in obesity: a reassessment
2105. insulin receptor deficiency in genetic and acquired obesity
2106. insulin receptor kinase activity in muscles and white adipose tissue during course of VMH obesity
2107. insulin receptor substrate‐1 inhibits high‐fat diet‐induced obesity by browning of white adipose tissue through miR‐503
2108. insulin receptor variants and obesity-related cancers in the Framingham Heart Study
2109. insulin receptor: role in the resistance of human obesity to insulin
2110. insulin receptors in adipose tissue of rats with monosodium glutamate-induced obesity
2111. insulin reduces reaction of follicular granulosa cell to FSH stimulation in obesity-related infertility women during IVF
2112. insulin reduces reaction of follicular granulosa cells to FSH stimulation in women with obesity-related infertility during IVF
2113. insulin regulation of glucose and lipid metabolism in massive obesity
2114. insulin regulation of monoamine signaling: pathway to obesity
2115. insulin relaxes bladder via PI3K/AKT/eNOS pathway activation in mucosa: unfolded protein response‐dependent insulin resistance as a cause of obesity‐associated …
2116. insulin release in response to oral glucose in obesity: The effect of reduction of body weight
2117. insulin Resistance & Inflammatory Markers in obesity.
2118. insulin Resistance Affects both insulin and Exercise Stimulated Glucose Uptake in obesity Independent of Glucose Delivery. In vivo Studies Using [[sup. 15] O]-[H. sub …
2119. insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls
2120. insulin resistance and changes in plasma concentration of TNFα, IGF1, and NEFA in dogs during weight gain and obesity
2121. insulin RESISTANCE AND COMPENSATORY HYPERinsulinEMIA: THE LINCHPIN BETWEEN obesity AND CARDIOVASCULAR
2122. insulin Resistance and Glucose Metabolism in Childhood obesity
2123. insulin Resistance and High TNF [Alpha] Concentrations Precede obesity in Rats Fed High Carbohydrate Diet during Suckling Period
2124. insulin resistance and hunger in childhood obesity: a patient and physician’s perspective
2125. insulin resistance and hypersecretion in obesity. European Group for the Study of insulin Resistance (EGIR).
2126. insulin resistance and impaired glucose tolerance in overweight/obese adolescents attending an obesity clinic in Belgium
2127. insulin Resistance and Inflammation: Links Between obesity and Cardiovascular Disease
2128. insulin Resistance and its Relevance with Age, Sex, Season and obesity in Darehshori Horse Breed
2129. insulin resistance and low metabolic rate: do they cause obesity?
2130. insulin resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus and obesity
2131. insulin resistance and metabolic disorders in women with morbid obesity
2132. insulin resistance and metabolic syndrome in children with obesity
2133. insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis
2134. insulin resistance and not BMI is the major determinant of early vascular impairment in patients with morbid obesity
2135. insulin resistance and obesity
2136. insulin resistance and obesity
2137. insulin resistance and obesity affect lipid profile in the salivary glands
2138. insulin resistance and obesity affect monocyte-derived dendritic cell phenotype and function
2139. insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
2140. insulin resistance and obesity in a mouse model of systemic lupus erythematosus
2141. insulin resistance and obesity in childhood
2142. insulin Resistance and obesity in Lupus
2143. insulin Resistance and obesity in Mexican Youth
2144. insulin resistance and obesity‐related factors in Prader–Willi syndrome: Comparison with obese subjects
2145. insulin resistance and obesity, and their association with depression in relatively young people
2146. insulin resistance and obesity, and their association with depression in relatively young people: findings from a large UK birth cohort
2147. insulin resistance and obesity: how do they affect tau pathology?
2148. insulin resistance and obesity: resistin, a hormone secreted by adipose tissue
2149. insulin resistance and parental obesity as predictors to response to therapeutic life style change in obese children and adolescents 10–18 years old
2150. insulin Resistance and Systemic Inflammation in Patients with Osteoarthrosis Associated with obesity: The Effectiveness of Symptomatic Slow-Acting Drugs
2151. insulin resistance and the metabolic syndrome are related to the severity of steatosis in the pediatric population with obesity
2152. insulin resistance and the metabolic syndrome in obese children referred to an obesity center
2153. insulin resistance and the persistence of obesity from childhood into adulthood
2154. insulin resistance and the renin-angiotensin-aldosterone system in metabolic syndrome and obesity-related hypertension
2155. insulin resistance and the severity of coronary artery disease based on obesity status in stable-angina patients: A cross-sectional analysis
2156. insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with …
2157. insulin resistance and upper-body obesity in polycystic ovary syndrome
2158. insulin resistance and visceral fat obesity in hyperlipidemia
2159. insulin resistance as a characteristic of hypertension with overweight/obesity in Shanghai Chinese
2160. insulin resistance as common molecular denominator linking obesity to Alzheimer’s disease
2161. insulin resistance as key factor for linking modulation of gut microbiome to health claims and dietary recommendations to tackle obesity
2162. insulin resistance associated to obesity: the link TNF-alpha
2163. insulin resistance associates with hepatic lobular inflammation in subjects with obesity
2164. insulin resistance contributes to obesity-related proteinuria
2165. insulin resistance contribution to pathogenesis of cardiac remodeling in patients with hypertension in combination with obesity and type 2 diabetes
2166. insulin resistance due to obesity
2167. insulin Resistance for Adolescents with obesity in Latvia
2168. insulin resistance in aging is related to abdominal obesity
2169. insulin Resistance in Aging ls Related to Abdominal obesity
2170. insulin resistance in childhood obesity
2171. insulin resistance in childhood obesity.
2172. insulin Resistance in Children and Adolescents with Exogen-Constitutional obesity
2173. insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity
2174. insulin resistance in children and teenagers with exogenous constitutive obesity
2175. insulin resistance in Chinese patients with type 2 diabetes is associated with C-reactive protein independent of abdominal obesity
2176. insulin resistance in kidney disease: is there a distinct role separate from that of diabetes or obesity
2177. insulin resistance in Mexican Americans—A precursor to obesity and diabetes?
2178. insulin resistance in morbid obesity: reversal with intramyocellular fat depletion
2179. insulin resistance in obesity
2180. insulin resistance in obesity and hypertension: an important link with cardiovascular disease
2181. insulin resistance in obesity and its molecular control
2182. insulin resistance in obesity and metabolic syndrome: is there a connection with platelet l-arginine transport?
2183. insulin resistance in obesity and noninsulin dependent diabetes mellitus.
2184. insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies
2185. insulin resistance in obesity as analyzed by the response of glucose kinetics to glucagon infusion
2186. insulin resistance in obesity as the underlying cause for the metabolic syndrome
2187. insulin resistance in obesity can be reliably identified from fasting plasma insulin
2188. insulin resistance in obesity is associated with elevated basal lactate levels and diminished lactate appearance following intravenous glucose and insulin
2189. insulin resistance in obesity, type II diabetes and stress
2190. insulin resistance in obesity: a critical analysis at enzyme level. A review.
2191. insulin resistance in obesity: an overview of fundamental alterations
2192. insulin resistance in obesity: body-weight or energy balance?
2193. insulin resistance in obesity: metabolic mechanisms and measurement methods
2194. insulin resistance in obesity: pathogenesis and effects
2195. insulin resistance in obesity: Targeting the Molecular Mechanisms of Metabolic Disease
2196. insulin resistance in patients with stroke is related to visceral fat obesity and adipocytokines
2197. insulin Resistance in Pima Indians: A Combined Effect of Genetic Predisposition and obesity‐related Skeletal Muscle Cell Hypertrophy
2198. insulin Resistance In Semi-Urban South Western Nigeria And It’s Relationship With Indices Of obesity
2199. insulin resistance in the defense against obesity
2200. #VALUE!
2201. insulin resistance in type 2 diabetes and obesity: implications for endothelial function
2202. insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation
2203. insulin resistance in very low birth weight infants progresses during childhood without aggravation of obesity or dyslipidaemia
2204. insulin resistance in visceral obesity
2205. insulin resistance in women with polycystic ovary syndrome contributed to cardiovascular disease risk factors independent of obesity.
2206. insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity
2207. insulin resistance is a characteristic feature of primary hypertension independent of obesity
2208. insulin Resistance Is a Late Manifestation of Ovariectomy in Mice That Occurs in the Absence of obesity but Is Associated With Adipose Tissue Inflammation
2209. insulin resistance is associated with arterial stiffness independent of obesity in male adolescents
2210. insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese
2211. insulin resistance is associated with gut permeability without the direct influence of obesity in young adults
2212. insulin resistance measured by QUICKI and obesity in type 2 diabetic patients
2213. insulin resistance measured by the triglyceride-glucose index and risk of obesity-related cancers: An epidemiological investigation in more than 500,000 individuals.
2214. insulin resistance might link obesity and congestive heart failure
2215. insulin resistance modifies the association between obesity and current asthma in adults
2216. insulin Resistance Modifies the Association Between obesity and Current Asthma in Adults
2217. insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
2218. insulin resistance of human adipose tissue in obesity measured with [18F] FDG and PET
2219. insulin resistance pathogenesis in metabolic obesity
2220. insulin resistance study in diabetes mellitus type II and its correlation with obesity
2221. insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications
2222. insulin resistance syndrome and Alzheimer’s disease: age-and obesity-related effects on memory, amyloid, and inflammation
2223. insulin resistance syndrome and obesity
2224. insulin RESISTANCE SYNDROME IN PAEDIATRIC obesity.
2225. insulin resistance syndrome including obesity, premature pubarche and polycystic ovary syndrome
2226. insulin resistance versus insulin secretion in the hypertension of obesity.
2227. insulin resistance via modification of PGC1α function identifying a possible preventive role of vitamin D analogues in chronic inflammatory state of obesity. A double …
2228. insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess
2229. insulin resistance without obesity induced by cotton pellet granuloma in mice
2230. insulin resistance–a physiopathological condition with numerous sequelae: non-insulin-dependent diabetes mellitus (NIDDM), android obesity, essential …
2231. insulin Resistance-associated Impairment Of Preadipocyte Differentiation In Human Abdominal obesity
2232. insulin resistance, atherogenic dyslipidemia and other atherogenic factors in simple obesity and obesity with Acanthosis nigricans (an) in childhood
2233. insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus
2234. insulin resistance, central obesity, and risk of colorectal adenomas
2235. insulin resistance, endothelial function, fibrinolytic activity, and markers of obesity in children
2236. insulin resistance, glucose regulation, obesity and mood: A review of the literature.
2237. insulin resistance, glucose regulation, obesity, and mood.
2238. insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity
2239. insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity
2240. insulin resistance, hyperinsulinemia, and LH: relative roles in peripubertal obesity-associated hyperandrogenemia
2241. insulin Resistance, Hyperinsulinemia, and LH: Relative Roles in Peripubertal obesity-Associated Hyperandrogenemia
2242. insulin resistance, hyperinsulinemia, and obesity-associated hypertension.
2243. insulin resistance, impaired postprandial lipid metabolism and abdominal obesity
2244. insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (orCCL2) in the regulation of metabolism
2245. insulin resistance, insulin response, and obesity as indicators of metabolic risk
2246. insulin resistance, low cardiorespiratory fitness, and increased exercise blood pressure: contribution of abdominal obesity
2247. insulin resistance, obesity and breast cancer risk
2248. insulin resistance, obesity and diabetes: the connection
2249. insulin resistance, obesity and hypertension
2250. insulin resistance, obesity and hypertension: an overview
2251. insulin resistance, obesity and hypertension: is the link waist circumference?
2252. insulin resistance, obesity and hypovitaminosis D adversely affect pregnancy utcome: Can Supplemental vitamin D cut this risk?
2253. insulin resistance, obesity and lipotoxicity
2254. insulin resistance, obesity and the metabolic syndrome.
2255. insulin resistance, obesity and the metabolic syndrome. Is there a therapeutic role for endothelin-1 antagonists?
2256. insulin resistance, obesity indices and lipid profile in Nigerian patients with type 2 diabetes mellitus
2257. insulin resistance, obesity, and liver cancer
2258. insulin resistance, obesity, and metabolic syndrome among non-diabetic pre-and post-menopausal women in North Taiwan
2259. insulin Resistance, obesity, Body Fat Distribution, and Risk of Cardiovascular Disease
2260. insulin resistance, obesity, hypertension, and renal sodium transport
2261. insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age< or= 14 years, 13 with …
2262. insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions
2263. insulin resistance, obesity, metabolic syndrome, and lifestyle modification
2264. insulin resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatric obesity
2265. insulin resistance, serum uric acid and metabolic syndrome are linked to cardiovascular dysfunction in pediatric obesity
2266. insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis)
2267. insulin resistance, systemic and regional inflammation in subcutaneous adipose tissue during weight loss in a population with obesity
2268. insulin RESISTANCE, TUMOR NECROSIS FACTOR-ALPHA IN obesity-ASSOCIATED HYPERTENSION: PP. 34.367
2269. insulin resistance, β-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus
2270. insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis
2271. insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
2272. insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1
2273. insulin resistance: Lessons from animal models of obesity
2274. insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus
2275. insulin Resistance: The Linchpin Between obesity and obesity-Related Metabolic Abnormalities
2276. insulin resistance: the link between obesity and cardiovascular disease
2277. insulin resistance: the metabolic link between non-insulin-dependent diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular …
2278. insulin response to a rapid intravenous injection of dextrose in patients with anorexia nervosa and obesity
2279. insulin response to a spontaneously ingested standard meal during the development of obesity in GTG-injected mice.
2280. insulin response to an intravenous glucose load during development of obesity in gold thioglucose-injected mice
2281. insulin response to glucagon: the opposing effects of diabetes and obesity
2282. insulin response to high intensity interval training versus resistive training in post menopusal obesity
2283. insulin responsiveness in vitro of diaphragm and adipose tissue from weanling rats with hypothalamic obesity
2284. insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity
2285. insulin secretion and body composition in obesity
2286. insulin secretion and carbohydrate tolerance in childhood obesity
2287. insulin secretion in childhood obesity
2288. insulin secretion in experimental obesity
2289. insulin secretion in human obesity: effects of prolonged fasting and refeeding.
2290. insulin secretion in hypothalamic obesity: Diurnal variation and the effect of naloxone
2291. insulin secretion in obesity
2292. insulin secretion in obesity after exercise
2293. insulin secretion in obesity and diabetes: an illustrative case
2294. insulin secretion, insulin resistance, and obesity
2295. insulin secretion, obesity, and potential behavioral influences: results from the insulin Resistance Atherosclerosis Study (IRAS)
2296. insulin secretion, peripheral insulin sensitivity and insulin-receptor binding in subjects with different degrees of obesity
2297. insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue
2298. insulin sensitivity affects propensity to obesity in an ethnic-specific manner: results from two controlled weight loss intervention studies
2299. insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women: the insulin Resistance and Atherosclerosis Study
2300. insulin sensitivity and carbohydrate metabolism of rats with hypothalamic obesity
2301. insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma
2302. insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain
2303. insulin sensitivity deteriorates after short-term lifestyle intervention in the insulin sensitive phenotype of obesity
2304. insulin sensitivity from preschool to school age in patients with severe obesity
2305. insulin sensitivity in anorexia nervosa: a mirror image of obesity?
2306. insulin sensitivity in Chinese: Inter-relations with obesity and other components of the metabolic syndrome.
2307. insulin sensitivity M ratio and IRI/G ratio in patients with hypertension and obesity
2308. insulin sensitivity of adipocytes from inbred mouse strains resistant or sensitive to diet-induced obesity
2309. insulin sensitivity of the body in experimental hypothalamic obesity
2310. insulin sensitivity predictions in individuals with obesity and type II diabetes mellitus using mathematical model of the insulin signal transduction pathway
2311. insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study
2312. insulin Sensitization and Anti‐obesity Effects of Astragalus Polysaccharide on High Fat Diet‐fed C57BL/6J Mice
2313. insulin signal transduction and glucose transport in human adipocytes: effects of obesity and low calorie diet
2314. insulin status and vascular responses to weight loss in obesity
2315. insulin suppresses TNF-dependent early osteoarthritic changes associated with obesity and type 2 diabetes
2316. insulin translates unfavourable lifestyle into obesity
2317. insulin Treatment, Type 2 Diabetes and obesity
2318. insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?
2319. insulin-and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations
2320. insulin-dependent activation of MCH neurons impairs locomotor activity and insulin sensitivity in obesity
2321. insulin-dependent metabolism of branched-chain amino acids in obesity
2322. insulin-Induced Free IGF-I Suppression is Lost in obesity
2323. insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
2324. insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone
2325. insulin-like growth factor 1 related to chronic low-grade inflammation in patients with obesity and early change of its levels after laparoscopic sleeve gastrectomy
2326. insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children
2327. insulin-like growth factor and its dynamics in babies born from mothers with obesity
2328. insulin-like growth factor binding protein-1, non-alcoholic fatty liver disease, and its relationship with fructose consumption in children with obesity
2329. insulin-like growth factor binding protein-3 (IGFBP-3) enhances obesity-related breast tumorigenesis
2330. insulin-like growth factor binding protein-3 links obesity and breast cancer progression
2331. insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children
2332. insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity
2333. insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why)
2334. insulin-mediated sympathoexcitation in obesity and type 2 diabetes
2335. insulin-mimicking bioactivities of acylated inositol glycans in several mouse models of diabetes with or without obesity
2336. insulin-receptor interaction on liver cell membranes and isolated adipocytes of rats in experimental obesity
2337. insulin-regulated aminopeptidase in adipocyte is Cys-specific and affected by obesity
2338. insulin-sensitive obesity
2339. insulin-Sensitive obesity
2340. insulin-sensitive obesity in humans–a ‘favorable fat’phenotype?
2341. insulin-Sensitive obesity: Prospective and Interventional Studies
2342. insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes
2343. insulin-stimulated protein kinase C λ/ζ activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction
2344. insulin-treated Zucker diabetic fatty rats retain the hypertriglyceridemia associated with obesity
2345. insulin‐like growth factor type I receptor gene expression and obesity in esophageal adenocarcinoma
2346. insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders
2347. insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in obesity
2348. insulin, central dopamine D2 receptors, and monetary reward discounting in obesity
2349. insulin, ghrelin and early return of hunger in women with obesity and polycystic ovary syndrome
2350. insulin, insulin resistance, obesity, and cancer
2351. insulin, Leptin and Ghrelin in obesity with and without Hypertension.
2352. insulin, obesity, and triglyceride interrelationships in sixteen children with familial hypertriglyceridemia.
2353. Integrated concentrations of growth hormone, insulin, C-peptide and prolactin in human obesity
2354. Interacting epidemics? Sleep curtailment, insulin resistance, and obesity
2355. Interaction between corticosterone and insulin in obesity: regulation of lard intake and fat stores
2356. Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity
2357. Interaction connecting Leptin-obesity–insulin dependent diabetes mellitus
2358. Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with obesity and lifestyle factors on postmenopausal breast cancer risk
2359. Interaction of sex steroid hormones and obesity on insulin resistance and type 2 diabetes in men: the Third National Health and Nutrition Examination Survey
2360. Interactions among glucose delivery, transport, and phosphorylation that underlie skeletal muscle insulin resistance in obesity and type 2 diabetes: studies with …
2361. Interactions among insulin resistance, inflammation factors, obesity-related gene polymorphisms, environmental risk factors, and diet in the development of gestational …
2362. Interactions between glucocorticoid metabolism and inflammation in obesity and insulin resistance.
2363. Interactions between insulin and glucocorticoids in the maintenance of genetic obesity
2364. Interactions of obesity and glucose-stimulated insulin secretion in familial hypertriglyceridemia
2365. Interactions of obesity, and glucose and insulin levels in hypertriglyceridemia
2366. INTERACTIVE EFFECTS OF obesity AND OVARIAN STEROIDS ON insulin PHYSIOLOGY IN CATTLE AND SHEEP.
2367. Intercellular adhesion molecule 1, ICAM-1, in polycystic ovary syndrome: relationship to insulin resistance or obesity
2368. Intercellular adhesion molecule-1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in Mexican Americans
2369. Interferon activated gene 202b (Ifi202b) promotes Zfp432 expression and suppresses the thermogenic gene program resulting in obesity and insulin resistance
2370. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance
2371. Interferon tau alleviates obesity-induced adipose tissue inflammation and insulin resistance by regulating macrophage polarization
2372. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents
2373. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss
2374. Interleukin-6 depletion selectively improves hepatic insulin action in obesity
2375. Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance
2376. Interleukin-6 signaling promotes alternative macrophage activation to limit obesity-associated insulin resistance and endotoxemia
2377. INTERLEUKIN‐10 DEFICIENCY LIMITS THE DEVELOPMENT OF obesity AND insulin RESISTANCE PRODUCED BY A HIGH FAT DIET
2378. Intermedin/adrenomedullin 2 polypeptide promotes adipose tissue browning and reduces high-fat diet-induced obesity and insulin resistance in mice
2379. Intermittent hypoxia and diet-induced obesity: effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure
2380. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance
2381. Interplay between gut microbiota and p66Shc affects obesity‐associated insulin resistance
2382. Interplay of an obesity-based genetic risk score with dietary and endocrine factors on insulin resistance
2383. Intertissue communication in the pathogenesis of insulin resistance in obesity and type 2 diabetes
2384. Intestinal FABP2 A54T Polymorphism: Association with insulin Resistance and obesity in Women
2385. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
2386. Intestinal Microbiota and Bacterial Translocation: Impact of Diet, obesity and insulin Resistance
2387. Intestinal microbiota contributes to energy balance, metabolic inflammation, and insulin resistance in obesity
2388. Intestinal Microbiota, obesity and insulin Resistance—What Are the Relationships?
2389. Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
2390. Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice
2391. Intra-Placental Gene Transfer of Human insulin-Like Growth Factor-1 Prevents obesity in an Intra-Uterine Growth Restricted Model Exposed to High Fat Diet …
2392. Intra-Placental Gene Transfer of Human insulin-Like Growth Factor-1 Reprograms Fetal Predisposition to obesity in Intra-uterine Growth Restriction
2393. Intracellular hyperinsulinism: a metabolic characteristic of obesity with and without type 2 diabetes: intracellular insulin in obesity and Type 2 diabetes
2394. Intracellular lipid accumulation and insulin sensitivity in muscle and liver: Fighting against “intracellular obesity”
2395. Intracerebroventricular glucocorticoid infusion in normal rats: induction of parasympathetic‐mediated obesity and insulin resistance
2396. Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity
2397. Intramuscular lipid metabolism, insulin action, and obesity
2398. Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity
2399. Intranasal targeting of hypothalamic PTP1B and TCPTP reinstates leptin and insulin sensitivity and promotes weight loss in obesity
2400. Intrauterine influences on obesity and insulin resistance in pre-pubertal children.
2401. Inverse relationship of the CMKLR1 relative expression and chemerin serum levels in obesity with dysmetabolic phenotype and insulin resistance
2402. Investigating the onset of insulin resistance and non-alcoholic fatty liver disease in obesity-induced cardiac dysfunction
2403. Investigating the role of Class-1 Phosphoinositide 3 Kinases (PI3Ks) in insulin signaling and obesity
2404. Investigating the role of insulin-like growth factor binding protein-2 (IGFBP-2) in childhood obesity and Type 2 Diabetes
2405. Investigating the Wnt/β-catenin Pathway in Conventional Dendritic cells in obesity-Induced Tissue Inflammation and insulin Resistance
2406. Investigation of DNA Methylation in obesity and its Underlying insulin Resistance
2407. Investigation of Relationship between Leptin and insulin Resistance in obesity [J]
2408. Investigation of the association between obesity and insulin-induced gene 1 polymorphism at 7q36. 3 region in Uygur population in Xinjiang, China
2409. Investigation of the relationship between genetic and environmental risk factors associated with obesity and insulin resistance in South African patients with non …
2410. Investigation on the relationships among blood zinc, copper, insulin and thyroid hormones in non-insulin dependent diabetes mellitus and obesity
2411. Involvement of adipocytokines in pathogenesis of insulin resistance, obesity, and metabolic syndrome
2412. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.
2413. Involvement of protein phosphatase 5 (pp5) in diet-induced obesity and insulin resistance
2414. Inward Glucose Transfer Accounts for insulin‐Dependent Increase in Brain Glucose Metabolism Associated with Diet‐Induced obesity
2415. Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity
2416. iRhom2 serves as a facilitator in obesity by enhancing adipose inflammation and insulin resistance
2417. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance
2418. Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrations
2419. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance
2420. Is Absence of Carbohydrate Metabolism Disorders in Patients with Prolonged History of obesity due to Low insulin Resistance or Preserved insulin Secretion?
2421. Is Exposure to Bisphenol‐A and Phthalates Associated with obesity, Metabolic Disturbances and insulin Resistance among US adults?
2422. Is insulin the link between hypertension and obesity?
2423. Is insulin-dependent diabetes and obesity a predisposition for endometrial and pancreatic carcinoma?
2424. Is insulin-like growth factor 1 a determinant of renal haemodynamics in obesity hypertension?
2425. #VALUE!
2426. Is leptin the link between obesity and insulin resistance?
2427. Is obesity an absolute evil? Increase in adipose tissue does not always decrease insulin sensitivity
2428. Is obesity-related insulin status the cause of blunted growth hormone secretion in turner’s syndrome?
2429. Is salivary gland function altered in noninsulin-dependent diabetes mellitus and obesity–insulin resistance?
2430. #VALUE!
2431. Is there a relationship between leptin and insulin sensitivity independent of obesity? A population-based study in the Indian Ocean nation of Mauritius
2432. Islet adaptation to obesity and insulin resistance in WNIN/GR-Ob rats
2433. Islet insulin secretion, β-cell mass, and energy balance in a polygenic mouse model of type 2 diabetes with obesity
2434. Jaboticaba peel powder and jaboticaba peel aqueous extract reduces obesity, insulin resistance and hepatic fat accumulation in rats
2435. Jejunal T cell inflammation in human obesity correlates with decreased enterocyte insulin signaling
2436. JNK activation of BIM promotes hepatic oxidative stress, steatosis, and insulin resistance in obesity
2437. JNK at the crossroad of obesity, insulin resistance, and cell stress response
2438. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation
2439. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity
2440. Joint Effects of obesity and Vitamin D Deficiency on insulin Resistance and Type 2 Diabetes
2441. Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001–2006
2442. #VALUE!
2443. Ketone body kinetics in humans: the effects of insulin-dependent diabetes, obesity, and starvation.
2444. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity
2445. Kinome profiling reveals abnormal activity of kinases in skeletal muscle from adults with obesity and insulin resistance
2446. KLF10 Deficiency in CD4+ T Cells Triggers obesity, insulin Resistance, and Fatty Liver
2447. Knockdown of ANT2 reduces adipocyte hypoxia and improves insulin resistance in obesity
2448. Korean diet prevents obesity and ameliorates insulin resistance in mice fed a high-fat diet
2449. KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation
2450. L-PGDS-produced PGD 2 in premature, but not in mature, adipocytes increases obesity and insulin resistance
2451. L-pGDs-produced pGD2 in premature, but not in mature, adipocytes increases obesity and insulin resistance
2452. L-PGDS-produced PGD2 in premature, but not in mature, adipocytes increases obesity and insulin resistance
2453. Labrador tea (Rhododendron groenlandicum) attenuates insulin resistance in a diet-induced obesity mouse model
2454. Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis
2455. Lack of association between endothelial nitric oxide synthase glu298Asp variation, visceral obesity and insulin related phenotypes in Turkish type 2 diabetic …
2456. Lack of association between the fatty acid binding protein 2 (FABP2) polymorphism with obesity and insulin resistance in two aboriginal populations from Chile
2457. Lack of dietary regulation of jejunal glycolytic enzymes and disaccharidases in obesity: the role of insulin
2458. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance
2459. Lack of Uncoupling Protein 3 Protects from High‐Fat Diet‐Induced obesity, Systemic Inflammation and insulin Resistance in Rats
2460. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity.
2461. Lactobacillus plantarum strain Ln4 attenuates diet-induced obesity, insulin resistance, and changes in hepatic mRNA levels associated with glucose and lipid …
2462. Laparoscopic sleeve gastrectomy improves body composition and alleviates insulin resistance in obesity related acanthosis nigricans
2463. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome …
2464. Latent inflammation and defect in adipocyte renewal as a mechanism of obesity-associated insulin resistance
2465. Lauric Acid versus Palmitic Acid: Effects on Adipose Tissue Inflammation, insulin Resistance, and Non-Alcoholic Fatty Liver Disease in obesity
2466. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance
2467. Lecithin cholesterol acyltransferase deficiency protects from diet-induced insulin resistance and obesity—novel insights from mouse models
2468. Lecithin cholesterol acyltransferase null mice are protected from diet-induced obesity and insulin resistance in a gender-specific manner through multiple …
2469. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance
2470. LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance
2471. Leisure time and occupational physical activity in relation to obesity and insulin resistance: a population-based study from the Skaraborg Project in Sweden
2472. Lemon Balm Extract ALS-L1023 Regulates obesity and Improves insulin Sensitivity via Activation of Hepatic PPARα in High-Fat Diet-Fed Obese C57BL/6J Mice
2473. Leptin and insulin resistance in patients with osteoarthritis combined with obesity and the dynamics of their levels on the background of treatment with symptomatic …
2474. Leptin and its relation to obesity and insulin in the SHR/N-corpulent rat, a model of type II diabetes mellitus
2475. Leptin in relation to hypertension: The role of obesity in the insulin resistance atherosclerosis study (IRAS)
2476. Leptin Indicates obesity and insulin Resistance in Men
2477. Leptin-to-adiponectin ratio is related to low grade inflammation and insulin resistance independent of obesity in non-diabetic Taiwanese: a cross-sectional …
2478. Leptin, adiponectin, and their ratio as markers of insulin resistance and cardiometabolic risk in childhood obesity
2479. Leptin, insulin, and obesity‐related Phenotypes: Genetic Influences on Levels and Longitudinal Changes
2480. Letter regarding article,“Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis”
2481. Leucocyte sodium pump activity after meals or insulin in normal and obese subjects: cause for increased energetic efficiency in obesity?
2482. Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance
2483. Level of beta endorphins and insulin in blood of obese subjects. Effect of surgical treatment for obesity on higher exchange parameters
2484. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors
2485. Lifestyle modification in the management of insulin resistance states in overweight/obesity: the role of exercise training
2486. Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey …
2487. Lifestyle, obesity, and insulin resistance
2488. Limited contribution of insulin resistance and metabolic parameters to obesity-associated increases in ambulatory blood pressure in a black African …
2489. Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity
2490. Link between omentin‐1, obesity and insulin resistance in children: Findings from a longitudinal intervention study
2491. Link between the obesity and insulin resistance with lipid profile in women polycystic ovary syndrome
2492. Linking gut microbiota and inflammation to obesity and insulin resistance
2493. Linking maternal obesity to early insulin resistance
2494. Links between body mass index, total body fat, cholesterol, high‐density lipoprotein, and insulin sensitivity in patients with obesity related to depression, anger, and …
2495. Links between inflammation and insulin resistance in children with morbid obesity and metabolic syndrome
2496. Links between obesity-induced brain insulin resistance, brain mitochondrial dysfunction, and dementia
2497. Lipid induced macrophage inflammation: implications for obesity induced insulin resistance
2498. Lipid partitioning, incomplete fatty acid oxidation, and insulin signal transduction in primary human muscle cells: effects of severe obesity, fatty acid incubation, and …
2499. Lipid-adjusting Therapy can Enforce insulin Sensitivity of Type 2 Diabetes Mellitus Patients with obesity [J]
2500. Lipidomics reveals associations of phospholipids with obesity and insulin resistance in young adults
2501. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity
2502. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans
2503. Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance
2504. Lipopolysaccharide-binding protein plasma levels as a biomarker of obesity-related insulin resistance in adolescents
2505. Lipoprotein abnormalities in hirsute women II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity
2506. Lipoprotein insulin resistance score in nondiabetic patients with obesity after bariatric surgery
2507. Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity
2508. Liquid sucrose consumption promotes obesity and impairs glucose tolerance without altering circulating insulin levels
2509. Lisofylline mitigates cardiac inflammation in a mouse model of obesity through improving insulin secretion and activating cardiac AMPK signaling pathway
2510. Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance
2511. Liver attenuation, pericardial adipose tissue, obesity, and insulin resistance: the Multi‐Ethnic Study of Atherosclerosis (MESA)
2512. Liver fibrosis and insulin resistance in patients with hypertension, associated with obesity
2513. Liver insulin receptor tyrosine kinase activity in a rat model of type II diabetes mellitus and obesity
2514. Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance
2515. Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity
2516. Liver‐specific suppressor of cytokine signaling‐3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity 1
2517. LncRNA TUG1 reduces inflammation and enhances insulin sensitivity in white adipose tissue by regulating miR-204/SIRT1 axis in obesity mice
2518. LNK deficiency decreases obesity-induced insulin resistance by regulating GLUT4 through the PI3K-Akt-AS160 pathway in adipose tissue
2519. Localization of insulin-2 (Ins-2) and the obesity mutant tubby (tub) to distinct regions of mouse chromosome 7
2520. Long non-coding RNA Meg3 deficiency impairs glucose homeostasis and insulin signaling by inducing cellular senescence of hepatic endothelium in obesity
2521. Long term but not short term exposure to obesity related microbiota promotes host insulin resistance
2522. Long-term changes in carbohydrate tolerance, insulin secretion and action in African-American patients with obesity and history of hyperglycemic crises
2523. Long-term consumption of Platycodi radix ameliorates obesity and insulin resistance via the activation of AMPK pathways
2524. Long-term dysbiosis promotes insulin resistance during obesity despite rapid diet-induced changes in the gut microbiome of mice
2525. Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis
2526. Long-Term Ingestion of Monosodium L-Glutamate Did Not Induce obesity, Dyslipidemia or insulin Resistance: A Two-Generation Study in Mice
2527. Long-term metformin treatment in adolescents with obesity and insulin resistance, results of an open label extension study
2528. Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity
2529. Long‐Term β‐galacto‐oligosaccharides Supplementation Decreases the Development of obesity and insulin Resistance in Mice Fed a Western‐Type Diet
2530. Longitudinal study of depressive symptoms and progression of insulin resistance in youth at risk for adult obesity
2531. Loss of Epac2 results in premature obesity and insulin resistance
2532. Loss of estrogen receptor α signaling leads to insulin resistance and obesity in young and adult female mice
2533. Loss of FoxOs in muscle reveals sex-based differences in insulin sensitivity but mitigates diet-induced obesity
2534. Loss of fractalkine-CX3CR1 signaling exacerbates obesity-induced adipose tissue inflammation and insulin resistance through M1 dominant shift in macrophages
2535. Loss of function mutation in toll-like receptor-4 does not offer protection against obesity and insulin resistance induced by a diet high in trans fat in mice
2536. Loss of growth hormone–mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity
2537. Loss of hepatic CEACAM1: a unifying mechanism linking insulin resistance to obesity and non-alcoholic fatty liver disease
2538. Loss of insulin response to ingested amino acids after jejunoileal bypass surgery for morbid obesity
2539. Loss of intestinal GATA4 prevents diet-induced obesity and promotes insulin sensitivity in mice
2540. Loss of iRhom2 accelerates fat gain and insulin resistance in diet-induced obesity despite reduced adipose tissue inflammation
2541. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling
2542. Loss of Mbd2 Protects Mice Against High-Fat Diet–Induced obesity and insulin Resistance by Regulating the Homeostasis of Energy Storage and Expenditure
2543. Loss of mitochondrial protease ClpP protects mice from diet‐induced obesity and insulin resistance
2544. Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Induced obesity and insulin Resistance despite Long-Chain Acylcarnitine Accumulation
2545. Loss of nucleobindin-2 causes insulin resistance in obesity without impacting satiety or adiposity
2546. Loss of prion protein is associated with the development of insulin resistance and obesity
2547. Loss of protein kinase Cβ function protects mice against diet‐induced obesity and development of hepatic steatosis and insulin resistance
2548. Loss of regulator of G protein signaling 5 exacerbates obesity, hepatic steatosis, inflammation and insulin resistance
2549. Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis
2550. Loss of transcriptional repression by BCL6 confers insulin sensitivity in the setting of obesity
2551. Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling
2552. Loss of Uncoupling Protein 3 Attenuates Western Diet–Induced obesity, Systemic Inflammation, and insulin Resistance in Rats
2553. Loss-of-function mutation in myostatin reduces tumor necrosis factor α production and protects liver against obesity-induced insulin resistance
2554. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance
2555. Low 25‐hydroxyvitamin D does not affect insulin sensitivity in obesity after bariatric surgery
2556. Low advanced Glycation end product diet improves the central obesity, insulin resistance and inflammatory profiles in Iranian patients with metabolic syndrome: a …
2557. #VALUE!
2558. Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia
2559. Low concentrations of insulin-like growth factor-I in abdominal obesity.
2560. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes
2561. Low doses of cocoa extract supplementation ameliorate diet-induced obesity and insulin resistance in rats
2562. Low insulin-like growth factor-1 level in obesity nephropathy: a new risk factor?
2563. Low intrinsic aerobic fitness increases susceptibility to OVX‐induced obesity and insulin resistance in the absence of adipose tissue inflammation (1028.3)
2564. Low number of insulin receptors but high receptor protein content in adipose tissue of rats with monosodium glutamate-induced obesity
2565. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome
2566. Low serum adiponectin concentrations are associated with insulin sensitivity independent of obesity in Sudanese subjects with type 2 diabetes mellitus
2567. Low-calorie sweeteners augment tissue-specific insulin sensitivity in a large animal model of obesity
2568. Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths
2569. Low-density lipoprotein receptor-related protein 1 deficiency in cardiomyocytes reduces susceptibility to insulin resistance and obesity
2570. Low-energy total diet replacement intervention in patients with type 2 diabetes mellitus and obesity treated with insulin: a randomized trial
2571. Low-grade inflammation, obesity, and insulin resistance in adolescents
2572. Low-molecular-weight acid phosphatase (ACP1), obesity, and blood lipid levels in subjects with non-insulin-dependent diabetes mellitus
2573. Low-Molecular-Weight Acid Phosphatase (ACPI), obesity, and Blood Lipid Levels in Subjects with Non-insulin-Dependent Diabetes Mellitus
2574. Low‐dose diet supplement of a natural flavonoid, luteolin, ameliorates diet‐induced obesity and insulin resistance in mice
2575. Lower circulating B12 is associated with higher obesity and insulin resistance during pregnancy in a non-diabetic white British population
2576. Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity
2577. Lower Leg Fat Depots Are Associated with Albuminuria Independently of obesity, insulin Resistance, and Metabolic Syndrome (Korea National Health and …
2578. Lower NLRP3 inflammasome activity in NAG‐1 transgenic mice is linked to a resistance to obesity and increased insulin sensitivity
2579. Lower serum magnesium concentration is associated with diabetes, insulin resistance, and obesity in South Asian and white Canadian women but not men
2580. Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: implications for the obesity paradox
2581. Lowering effects of a preparation containing fibres and lactulose on glucose and insulin levels in obesity.
2582. Lowering saturated fat and increasing vegetable and fruit intake may increase insulin sensitivity 2 years later in children with a family history of obesity
2583. LTB4 causes macrophage–mediated inflammation and directly induces insulin resistance in obesity
2584. Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity
2585. Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages
2586. #VALUE!
2587. Lycopene Alleviates obesity‐Induced Inflammation and insulin Resistance by Regulating M1/M2 Status of Macrophages
2588. Lysophosphatidic acid inhibits insulin signaling in primary rat hepatocytes via the LPA3 receptor subtype and is increased in obesity
2589. Lysophosphatidic acid signaling in obesity and insulin resistance
2590. Lysophosphatidic Acid Signaling in obesity and insulin Resistance
2591. Lysosomal Nitrosative Stress Contributes to Hepatic insulin Resistance in obesity
2592. M2 macrophages infusion ameliorates obesity and insulin resistance by remodeling inflammatory/macrophages’ homeostasis in obese mice
2593. Macronutrient-mediated inflammation and oxidative stress: relevance to insulin resistance, obesity, and atherogenesis
2594. Macrophage cannabinoid 1 receptor promotes obesity-induced insulin resistance and inflammation
2595. Macrophage function in obesity-induced inflammation and insulin resistance
2596. Macrophage gene expression in adipose tissue is associated with insulin sensitivity and serum lipid levels independent of obesity
2597. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity
2598. Macrophage lamin A/C regulates inflammation and the development of obesity-induced insulin resistance
2599. Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities
2600. Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity
2601. Macrophage VLDLR mediates obesity-induced insulin resistance with adipose tissue inflammation
2602. Macrophage-specific de novo synthesis of ceramide is dispensable for inflammasome-driven inflammation and insulin resistance in obesity
2603. Macrophages and adipocytes in human obesity: adipose tissue gene expression and insulin sensitivity during calorie restriction and weight stabilization
2604. Macrophages in obesity and insulin resistance
2605. Macrophages, inflammation, adipose tissue, obesity and insulin resistance
2606. Making of a unique birth control vaccine against hCG with additional potential of therapy of advanced stage cancers and prevention of obesity and insulin resistance
2607. Mammalian life-span determinant p66shcA mediates obesity-induced insulin resistance
2608. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).
2609. Management of obesity in non-insulin-dependent diabetes mellitus
2610. Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
2611. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations
2612. Manganese [III] tetrakis [5, 10, 15, 20]-benzoic acid porphyrin reduces adiposity and improves insulin action in mice with pre-existing obesity
2613. Map4k4 impairs energy metabolism in endothelial cells and promotes insulin resistance in obesity
2614. Marked resistance of the ability of insulin to decrease arterial stiffness characterizes human obesity.
2615. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss
2616. Markers of Iron Status as Predictors, Effect Modifiers and Outcomes in an RCT of Growth Hormone and Rosiglitazone for obesity and insulin Resistance in Adults …
2617. Mass spectrometry for measuring protein secretion from insulin sensitive tissues during obesity
2618. Maternal adipokines and insulin as biomarkers of pregnancies complicated by overweight and obesity
2619. Maternal diet-induced obesity during suckling period programs offspring obese phenotype and hypothalamic leptin/insulin resistance
2620. Maternal diet‐induced obesity alters muscle mitochondrial function in offspring without changing insulin sensitivity
2621. Maternal endotoxemia results in obesity and insulin resistance in adult male offspring
2622. Maternal exercise attenuates the lower skeletal muscle glucose uptake and insulin secretion caused by paternal obesity in female adult rat offspring
2623. Maternal folate status and obesity/insulin resistance in the offspring: a systematic review
2624. Maternal lipids are associated with newborn adiposity, independent of GDM status, obesity and insulin resistance: a prospective observational cohort study
2625. Maternal obesity Affects the Glucose-insulin Axis During the First Trimester of Human Pregnancy
2626. Maternal obesity and Excessive Gestational Weight Gain Alter the Maternal-Fetal insulin-Like Growth Factor Axis
2627. Maternal obesity and western-style diet impair fetal and juvenile offspring skeletal muscle insulin-stimulated glucose transport in nonhuman primates
2628. Maternal obesity associates with foetoplacental vascular dysfunction involving endoplasmic reticulum stress and altered insulin vascular reactivity
2629. Maternal obesity at conception and insulin sensitivity in late gestation alters placental structure but not fetal biometry at birth in the horse
2630. Maternal obesity causes fetal hypothalamic insulin resistance and disrupts development of hypothalamic feeding pathways
2631. Maternal obesity has sex‐dependent effects on insulin, glucose and lipid metabolism and the liver transcriptome in young adult rat offspring
2632. Maternal obesity in ewes results in reduced fetal pancreatic β-cell numbers in late gestation and decreased circulating insulin concentration at term
2633. Maternal obesity increases insulin resistance, low-grade inflammation and osteochondrosis lesions in foals and yearlings until 18 months of age
2634. Maternal obesity leads to an inflammatory response and insulin resistance in ovarian tissuse
2635. Maternal obesity results in decreased syncytiotrophoblast synthesis of palmitoleic acid, a fatty acid with anti‐inflammatory and insulin‐sensitizing properties
2636. Maternal obesity-impaired insulin signaling in sheep and induced lipid accumulation and fibrosis in skeletal muscle of offspring
2637. Maternal pregravid obesity changes gene expression profiles toward greater inflammation and reduced insulin sensitivity in umbilical cord
2638. Maternal prepregnancy obesity and insulin treatment during pregnancy are independently associated with delayed lactogenesis in women with recent gestational …
2639. Maternal taurine supplementation in the late pregnant rat stimulates postnatal growth and induces obesity and insulin resistance in adult offspring
2640. Maternally inherited diabetes with deafness and obesity: body weight reduction response to treatment with insulin analogues
2641. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62
2642. Maturity-onset diabetes of the young: recent findings indicate insulin resistance/obesity are not factors
2643. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
2644. McArdle’s disease with insulin resistance caused by obesity
2645. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2646. Meal-related increases in microvascular vasomotion are impaired in obese individuals: a potential mechanism in the pathogenesis of obesity-related insulin …
2647. Measurement of obesity by anthropometry and bioelectric impedance analysis: correlation with fasting lipids and insulin resistance in an Asian population.
2648. Mechanism of action of magnesium lithospermate B against aging and obesity-induced ER stress, insulin resistance, and inflammsome formation in the liver
2649. Mechanism of ER stress and inflammation for hepatic insulin resistance in obesity
2650. Mechanism of hyperglycaemia coexistence with hypertension: obesity interaction with insulin resistance approach.
2651. Mechanism of insulin-resistance in the adipose cell in the aging-rat model of obesity
2652. #VALUE!
2653. Mechanism of programmed obesity: altered central insulin sensitivity in growth-restricted juvenile female rats
2654. Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity.
2655. Mechanism Research of Reducing obesity-Induced insulin Resistance in the White Adipose Tissue by Knockdown of Neuropeptide Y Expression in the Dorsomedial …
2656. Mechanism, treatment, and evaluation of obesity-induced insulin resistance and type 2 diabetes
2657. Mechanisms in obesity-related hypertension: role of insulin and catecholamines
2658. Mechanisms linking obesity to insulin resistance and type 2 diabetes
2659. Mechanisms linking the adipocyte renin angiotensin system to obesity, inflammation and insulin resistance
2660. Mechanisms mediating beneficial effects of Eicosapentaenoic Acid (EPA) in insulin resistance and obesity: Studies in muscle
2661. Mechanisms of agouti-induced obesity: Effects on adipocyte metabolism and interaction with insulin.
2662. Mechanisms of cardiovascular diseases development in obesity and insulin resistance: focus on atherothrombosis
2663. Mechanisms of coronary dysfunction in obesity and insulin resistance
2664. Mechanisms of insulin action and identification of defects leading to insulin resistance in maternal obesity and gestational diabetes
2665. Mechanisms of insulin Resistance at the Crossroad of obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction
2666. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
2667. Mechanisms of insulin resistance in obesity
2668. Mechanisms of insulin resistance in obesity
2669. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes
2670. Mechanisms of macrophage activation in obesity-induced insulin resistance
2671. Mechanisms of obesity-associated insulin resistance: many choices on the menu
2672. Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies
2673. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM
2674. Mechanisms underlying obesity-related insulin resistance
2675. Mechanistic links between obesity, insulin, and cancer
2676. Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity
2677. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings
2678. Mediators of Impaired Adipogenesis in obesity-Associated insulin Resistance and T2DM
2679. MEDITERRANEAN DIET ADHERENCE. WHICH RELATIONSHIP WITH obesity AND insulin RESISTANCE
2680. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance
2681. Memory impairment in obese Zucker rats: an investigation of cognitive function in an animal model of insulin resistance and obesity.
2682. #VALUE!
2683. Merchanism of obesity-related hypertension: from insulin to leptin
2684. Mesenteric fat lipolysis mediates obesity-associated hepatic steatosis and insulin resistance
2685. META060 protects against diet-induced obesity and insulin resistance in a high-fat–diet fed mouse
2686. METABOLIC CHANGES ASSOCIATED WITH obesity AND THE ROLE OF insulin
2687. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity
2688. Metabolic concomitants of hypophagia during recovery from insulin-induced obesity in rats
2689. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges
2690. Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance
2691. Metabolic dysregulation of the insulin–glucose axis and risk of obesity-related cancers in the Framingham heart study-offspring cohort (1971–2008)
2692. Metabolic endotoxemia initiates obesity and insulin resistance
2693. Metabolic factors in the insulin resistance in human obesity
2694. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance
2695. Metabolic inflammation and insulin resistance in obesity
2696. Metabolic inflammation: connecting obesity and insulin resistance
2697. Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus
2698. Metabolic perturbations in Welsh Ponies with insulin dysregulation, obesity, and laminitis
2699. Metabolic predispositions to laminitis in horses and ponies: obesity, insulin resistance and metabolic syndromes
2700. Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the diogenes study and the Maastricht study
2701. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes
2702. Metabolic syndrome and insulin resistance are associated with chronic kidney disease in nondiabetic adults with abdominal obesity
2703. Metabolic syndrome and insulin resistance in subjects with morbid obesity
2704. Metabolic syndrome in humans and horses: The relationship between obesity and insulin resistance
2705. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer
2706. Metabolic syndrome: relationship between obesity, insulin resistance and systemic hypertension in small animals.
2707. Metabolically activated macrophages in obesity and insulin resistance
2708. Metabolism of sphingolipids in experimental obesity and insulin resistance
2709. Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance
2710. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non‐insulin‐dependent diabetes
2711. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index …
2712. Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density
2713. MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice
2714. MGL1 promotes adipose tissue inflammation and insulin resistance by regulating 7/4hi monocytes in obesityMGL1 and obesity-induced inflammation
2715. Mice deficient for the Sam68 RNA binding protein are protected from dietary obesity and insulin resistance
2716. Mice deficient in the respiratory chain gene Cox6a2 are protected against high-fat diet-induced obesity and insulin resistance
2717. Mice Expressing Human insulin Receptors In Skeletal Muscle Are Resistant To The Development Of obesity
2718. Mice expressing reduced levels of hepatic glucose-6-phosphatase-α activity do not develop age-related insulin resistance or obesity
2719. Mice heterozygous for tumor necrosis factor-α converting enzyme are protected from obesity-induced insulin resistance and diabetes
2720. Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
2721. Mice Lacking OPA1 in Adipose Tissue Are Resistant to Diet-Induced obesity and insulin Resistance
2722. Mice lacking sialyltransferase ST3Gal-II develop late-onset obesity and insulin resistance
2723. Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity
2724. Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity
2725. Microarray gene expression profiling in obesity and insulin resistance
2726. MicroRNA-125a-3p expression in abdominal adipose tissues is associated with insulin signalling gene expressions in morbid obesity: observations in Taiwanese
2727. microRNA-dependent control of MODY gene expression contributes to obesity-associated insulin resistance
2728. MicroRNAs in insulin resistance and obesity
2729. Microvascular dysfunction as a link between obesity, insulin resistance and hypertension
2730. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension
2731. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity‐associated insulin resistance and hypertension
2732. Microvascular dysfunction: an emerging pathway in the pathogenesis of obesity-related insulin resistance
2733. Microvascular dysfunction: Potential role in the pathogenesis of obesity-associated hypertension and insulin resistance
2734. Microvascular insulin resistance in skeletal muscle and brain occurs early in the development of juvenile obesity in pigs
2735. Mid-upper arm circumference as a simple tool for identifying central obesity and insulin resistance in type 2 diabetes
2736. Midkine, a potential link between obesity and insulin resistance
2737. Mifepristone promotes adiponectin production and improves insulin sensitivity in a mouse model of diet-induced-obesity
2738. Mild suppression of hyperinsulinemia to treat obesity and insulin resistance
2739. Mind over metabolism: the cephalic phase in relation to non-insulin-dependent diabetes and obesity
2740. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice
2741. Mineralocorticoids and cardiovascular disease in females with insulin resistance and obesity
2742. Minor diplotypes of FMO3 might protect children and adolescents from obesity and insulin resistance
2743. MiR-130b promotes obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through alleviating M2 macrophage polarization via …
2744. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions
2745. miR-26b is decreased in obesity and is associated with insulin resistance and visfatin levels
2746. miR-30a remodels subcutaneous adipose tissue inflammation to improve insulin sensitivity in obesity
2747. MiR-377 promotes white adipose tissue inflammation and decreases insulin sensitivity in obesity via suppression of sirtuin-1 (SIRT1)
2748. miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease
2749. miRNA signatures of insulin resistance in obesity
2750. Mitochondrial DNA content and function, childhood obesity, and insulin resistance
2751. Mitochondrial dysfunction in the pathogenesis of insulin resistance associated with obesity, diabetes, and aging
2752. Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance
2753. Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice
2754. Mitogen-Activated Protein Kinases, Inhibitory-κB Kinase, and insulin Signaling in Human Omental Versus Subcutaneous Adipose Tissue in obesity
2755. MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity
2756. Model of high-fat diet-induced obesity associated to insulin resistance and glucose intolerance
2757. Moderate caloric restriction in lactating rats protects offspring against obesity and insulin resistance in later life
2758. Moderate Lactate Administration Activates Adipose Tissue Macrophage PKA-AMPKα1 Pathway to Alleviate obesity-Associated insulin Resistance in Mice
2759. Moderate weight reduction in an outpatient obesity intervention program significantly reduces insulin resistance and risk factors for cardiovascular disease in …
2760. Moderating role of cognitive ability on the obesity: inflammation: insulin resistance triplet
2761. Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and …
2762. Modulation of cell-mediated immunity to prevent high-fat diet-induced obesity and insulin resistance
2763. Modulation of cell-mediated immunity to suppress high fat diet-induced obesity and insulin resistance
2764. Modulation of endothelial cell migration by ER stress and insulin resistance: a role during maternal obesity?
2765. Modulation of heat shock factor 1 activity through silencing of Ser303/Ser307 phosphorylation supports a metabolic program leading to age-related obesity and insulin …
2766. Modulation of HSF1 Activity Through Silencing of Ser303/Ser307 Phosphorylation Supports A Metabolic Program Leading to Age-related obesity and insulin …
2767. Modulation of obesity and insulin Resistance by the Redox Enzyme and Adaptor Protein p66Shc
2768. Molecular analysis of the mouse agouti gene and the role of dominant agouti-locus mutations in obesity and insulin resistance
2769. Molecular Aspects of obesity and insulin Resistance in Metabolic Syndrome and Neurological Disorders
2770. Molecular aspects of the link between obesity, insulin resistance and breast cancer.
2771. Molecular Basis of Inflammation and insulin Resistance in obesity
2772. Molecular interactions between inflammation and insulin resistance in obesity.
2773. Molecular investigation of genetic factors associated with insulin resistance and obesity in a South African population
2774. Molecular mechanism of insulin resistance and obesity
2775. Molecular mechanism of insulin resistance in human obesity
2776. Molecular mechanism of insulin resistance in obesity and type 2 diabetes
2777. Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach
2778. Molecular mechanisms mediating the beneficial metabolic effects of [Arg4] tigerinin-1R in mice with diet-induced obesity and insulin resistance
2779. Molecular mechanisms of insulin action in human skeletal muscle and adipose tissue: Implications for diabetes and obesity
2780. Molecular mechanisms of insulin resistance in obesity
2781. Molecular mechanisms of insulin resistance in obesity and type 2 diabetes mellitus
2782. Molecular mechanisms of insulin resistance, obesity and metabolic syndrome
2783. Molecular mechanisms underlying obesity-induced hypothalamic inflammation and insulin resistance: pivotal role of resistin/TLR4 pathways
2784. Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus
2785. Molecular pathways linking adipose innervation to insulin sensitivity in obesity and type 2 diabetes
2786. Molecular screening of the human melanocortin-4 receptor gene: identification of a missense variant showing no association with obesity, plasma glucose, or insulin
2787. Monocyte chemoattractant protein 1 in obesity and insulin resistance
2788. Monocyte chemoattractant protein‐1 in obesity and type 2 diabetes. insulin sensitivity study
2789. Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity
2790. Monomeric Tartrate Resistant Acid Phosphatase Induces insulin Sensitive obesity
2791. Monounsaturated fatty acid–enriched high-fat diets impede adipose NLRP3 inflammasome–mediated IL-1β secretion and insulin resistance despite obesity
2792. Morbid obesity is associated with hepatic inflammation independent of liver fat content and insulin sensitivity
2793. Moringa olifeira Lam. stimulates activation of the insulin-dependent akt pathway. Antidiabetic effect in a diet-induced obesity (DIO) mouse model
2794. Morning circadian misalignment is associated with insulin resistance in girls with obesity and polycystic ovarian syndrome
2795. MR Spectroscopy in obesity and its Complications: Diabetes and insulin Resistance
2796. mRNA expression of diacylglycerol kinase isoforms in insulin‐sensitive tissues: effects of obesity and insulin resistance
2797. MRP14 enhances the ability of macrophage to recruit T cells and promotes obesity-induced insulin resistance
2798. Mucosa-associated microbiota in the jejunum of patients with morbid obesity: alterations in states of insulin resistance and metformin treatment
2799. Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity
2800. Multiple Abnormalities of Myocardial insulin Signaling in Pigs with Diet-Induced obesity
2801. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short-and long …
2802. Multiple Sclerosis and obesity. insulin Impairs IL-10-Mediated Regulatory T Cell Function (P1. 372)
2803. Munc18c in adipose tissue is downregulated in obesity and is associated with insulin
2804. Muramyl dipeptide-based postbiotics mitigate obesity-induced insulin resistance via IRF4
2805. Muscle insulin Resistance in Youth with obesity and Normoglycemia is Associated with Altered Fat Metabolism
2806. Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment
2807. Muscle mitochondrial oxidative phosphorylation activity, but not content, is altered with abdominal obesity in sedentary men: synergism with changes in insulin …
2808. Muscular resistance, hypertrophy and strength training equally reduce adiposity, inflammation and insulin resistance in mice with diet-induced obesity
2809. Myeloid cell TRAF3 promotes metabolic inflammation, insulin resistance, and hepatic steatosis in obesity
2810. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance
2811. Myeloid RAGE Downregulates Lipid Metabolism in Obese Adipose Tissue and Increases Whole-Body obesity and insulin Resistance
2812. Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity
2813. Myeloperoxidase deletion prevents high-fat diet–induced obesity and insulin resistance
2814. Myeloperoxidase: a therapeutic target for preventing insulin resistance and the metabolic sequelae of obesity?
2815. Myocardial metabolism and cardiac performance in obesity and insulin resistance
2816. Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance
2817. Myostatin as a Potential Therapeutic Target for obesity and insulin Resistance
2818. Myostatin blockade with a form of the ActRIIB receptor has potent anti‐obesity and insulin sensitizing actions
2819. Myostatin knockout mice are protected from high-fat diet induced obesity and insulin resistance.
2820. Myricanol modulates skeletal muscle–adipose tissue crosstalk to alleviate high‐fat diet‐induced obesity and insulin resistance
2821. Myricetin-induced brown adipose tissue activation prevents obesity and insulin resistance in db/db mice
2822. N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?
2823. N-stearoylethanolamine restores pancreas lipid composition in obesity-induced insulin resistant rats
2824. Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance
2825. NADPH Oxidase and (-)-Epicatechin in the Modulation of obesity-Associated insulin Resistance
2826. NDUFAB1 protects against obesity and insulin resistance by enhancing mitochondrial metabolism
2827. Neck and wrist circumferences propose a reliable approach to qualify obesity and insulin resistance
2828. Nedd4 haploinsufficient mice display moderate insulin resistance, enhanced lipolysis, and protection against high-fat diet-induced obesity
2829. Negative regulation of hepatic fat mass and obesity associated (Fto) gene expression by insulin
2830. Neonates from women with pregestational maternal obesity show reduced umbilical vein endothelial response to insulin
2831. Nesfatin-1 in childhood and adolescent obesity and its association with food intake, body composition and insulin resistance
2832. NESFATINEMIA AND insulin RESISTANCE IN PATIENTS WITH ARTERIAL HYPERTENSION AND obesity
2833. Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity
2834. Netrin-1 Promotes Macrophage Accumulation and insulin Resistance in obesity
2835. Networking pathways unveils association between obesity and non-insulin dependent diabetes mellitus
2836. Neural correlates of stress-and food cue–induced food craving in obesity: association with insulin levels
2837. Neuroendocrine factors regulating blood glucose, plasma FFA and insulin in the development of obesity
2838. NEUROENDOCRINE MODEL OF obesity WORSEN insulin RESISTANCE OF SPONTANEOUSLY HYPERTENSIVE RATS: A NEW MODEL OF TYPE 2 …
2839. Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity
2840. Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity
2841. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance
2842. Neutrophil elastase is a key player in inflammation, obesity, and insulin resistance
2843. New developments in diabetes obesity and insulin resistance.
2844. New insights into adipose tissue VEGF-A actions in the control of obesity and insulin resistance
2845. New insights into the role of serum amyloid A (SAA) on obesity and insulin resistance
2846. New insights into TNFα/PTP1B and PPARγ pathway through RNF213-a link between inflammation, obesity, insulin resistance, and Moyamoya disease.
2847. New insights into TNFα/PTP1B and PPARγ pathway through RNF213-a link between inflammation, obesity, insulin resistance, and Moyamoya disease
2848. Newly identified set of obesity‐related genotypes and abdominal fat influence the risk of insulin resistance in a Korean population
2849. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the …
2850. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity
2851. NK cells in human visceral adipose tissue contribute to obesity‐associated insulin resistance through low‐grade inflammation
2852. NK cells induce hepatic ER stress to promote insulin resistance in obesity through osteopontin production
2853. NK cells link obesity-induced adipose stress to inflammation and insulin resistance
2854. NK cells link obesity-induced adipose tissue stress to inflammation and insulin resistance
2855. NLRP3 inflammasome regulates obesity induced systemic inflammation and insulin signaling (117.4)
2856. No acute effect of physiological insulin increase on dehydroepiandrosterone sulfate in women with obesity and/or polycystic ovarian disease
2857. No decrease in free IGF‐I with increasing insulin in obesity‐related insulin resistance
2858. No evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hsaa1+ …
2859. No evidence for involvement of the calpain-10 genehigh-risk’haplotype combination for non-insulin-dependent diabetes mellitus in early onset obesity
2860. No evidence of attenuation of placental insulin-stimulated Akt phosphorylation and amino acid transport in maternal obesity and gestational diabetes mellitus
2861. No need to sweat: is dieting enough to alleviate insulin resistance in obesity?
2862. No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity
2863. NO to Lysosomes: A Signal for insulin Resistance in obesity
2864. NO to obesity: does nitric oxide regulate fat oxidation and insulin sensitivity?
2865. Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice
2866. Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss
2867. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?
2868. Non-insulin-dependent (Type II) diabetes mellitus and obesity in Asians in UK-scope for future studies
2869. Non-insulin-dependent diabetes and obesity in the black and Hispanic population: culturally sensitive management
2870. Non-insulin-dependent diabetes mellitus and visceral obesity: Italian epidemiologic study and analysis of risk factors
2871. Non-insulin-dependent diabetes mellitus in the elderly: influence of obesity and physical inactivity
2872. Non-invasive evaluation of endothelial dysfunction in uncomplicated obesity: relationship with insulin resistance
2873. Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics
2874. Nonerythropoietic erythropoietin-derived peptide suppresses adipogenesis, inflammation, obesity and insulin resistance
2875. Nonirritative lesions of VMH: effects on plasma insulin, obesity, and hyperreactivity
2876. Norathyriol reverses obesity-and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B
2877. Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country
2878. #VALUE!
2879. Normalization of obesity-associated insulin resistance through immunotherapy
2880. NOV/CCN3: a new adipocytokine involved in obesity-associated insulin resistance
2881. Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance
2882. Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11–14 year olds: The HEALTHY Study
2883. Novel mechanisms of insulin resistance and weight gain in diet induced obesity
2884. Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with ‘exercise mimetics’
2885. Novel phosphorylation of PPARγ ameliorates obesity-induced adipose tissue inflammation and improves insulin sensitivity
2886. NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study
2887. Nuclear factor-κB (NF-κB) expression in high fat diet-induced obesity and insulin resistance in rats.
2888. Nuclear orphan receptor TAK1/TR4-deficient mice are protected against obesity-linked inflammation, hepatic steatosis, and insulin resistance
2889. Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated …
2890. Nucleic acid-targeting pathways promote inflammation in obesity-related insulin resistance
2891. Nutritional and endocrine modulation of intracellular calcium: implications in obesity, insulin resistance and hypertension
2892. Nutritional modulation of gut microbiota in the context of obesity and insulin resistance: Potential interest of prebiotics
2893. Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice
2894. NYGGF4 as a new therapeutic target for obesity-associated insulin resistance
2895. O-1: The leptin-insulin axis: Interactions in the development of obesity and diabetes
2896. Obes Surg.: Metabolic syndrome and insulin resistance in subjects with morbid obesity
2897. obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions
2898. obesity affects myocardial vasoreactivity and coronary flow response to insulin
2899. obesity Alters Aortic Vasorelaxation Mediated by insulin and insulin‐like Growth Factor‐1
2900. obesity Amplifies the Sympathoexcitatory Response to insulin in Male, but not Female, Rats: Role of Neuropeptide Y Inputs into the Paraventricular Nucleus
2901. obesity and adipose tissue distribution in men: relation to sex steroids and insulin
2902. obesity and alcohol modulate the effect of apolipoprotein E polymorphism on lipids and insulin
2903. obesity and arterial hypertension. Relation between insulin secretion, peripheral insulin resistance and pressure indices
2904. obesity and autonomic neuropathy in non-insulin-dependent diabetes mellitus
2905. obesity and cancer risk: the role of the insulin–IGF axis
2906. obesity and cancer, a case for insulin signaling
2907. obesity and chronic leptin resistance foster insulin resistance: An analytical overview
2908. obesity and diabetes: pathophysiology of obesity-induced hyperglycemia and insulin resistance
2909. obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings
2910. obesity and fatty acids in the etiology of insulin resistance
2911. obesity and heredity in the etiology of non-insulin-dependent diabetes mellitus in 32,662 adult white women
2912. obesity and high blood pressure: a clinical phenotype for the insulin resistance syndrome in African Americans
2913. obesity and hypertestosteronaemia are independently and synergistically associated with elevated insulin concentrations and dyslipidaemia in pre-menopausal …
2914. obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver
2915. obesity and insulin levels
2916. obesity and insulin resistance
2917. obesity and insulin resistance
2918. obesity and insulin resistance
2919. obesity and insulin resistance
2920. obesity and insulin Resistance
2921. obesity and insulin resistance (IR) negativley impact cumulus oocyte complex (COC) quality
2922. obesity and insulin Resistance According to Age in Newly Diagnosed Type 2 Diabetes Patients in Korea
2923. obesity and insulin resistance after chemotherapy in patients with acute lymphoblastic leukemia
2924. obesity and insulin resistance among adolescents from Chiapas
2925. obesity and insulin resistance among infertile women with polycystic ovarian syndrome
2926. obesity and insulin resistance are associated with reduced activity in core memory regions of the brain
2927. obesity and insulin resistance are inversely associated with serum and adipose tissue carotenoid concentrations in adults
2928. obesity and insulin resistance are significant predictors of serum leptin levels
2929. obesity and insulin resistance are the central issues in prevention of and care for comorbidities
2930. obesity and insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome.
2931. obesity and insulin resistance as risk factors for chronic kidney disease
2932. obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS
2933. obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome
2934. obesity and insulin Resistance in Adolescents
2935. obesity and insulin Resistance in Adolescents
2936. obesity and insulin resistance in adolescents: impact of renin angiotensin system
2937. obesity and insulin resistance in apparently healthy Korean men
2938. obesity and insulin resistance in breast cancer–chemoprevention strategies with a focus on metformin
2939. obesity and insulin resistance in childhood
2940. obesity and insulin Resistance in Childhood
2941. obesity and insulin resistance in childhood and adolescence
2942. obesity and insulin resistance in children
2943. obesity and insulin resistance in children
2944. obesity and insulin resistance in children.
2945. obesity and insulin resistance in human growth hormone transgenic rats
2946. obesity and insulin resistance in humans: a dose-response study
2947. obesity and insulin resistance in nonalcoholic fatty liver
2948. obesity and insulin resistance in patients with non-alcoholic fatty liver disease diagnosed by non invasive diagnostic methods
2949. obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy
2950. obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy.
2951. obesity and insulin resistance in resistant hypertension: implications for the kidney
2952. obesity and insulin resistance in Swedish subjects
2953. obesity and insulin resistance in the obese-hyperglycemic mouse (obob)
2954. obesity and insulin resistance in women with polycystic ovary syndrome
2955. obesity and insulin resistance increase plasma viscosity in young women with polycystic ovary syndrome
2956. obesity and insulin resistance increases sensitivity to sepsis-induced hepatotoxicity
2957. obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet
2958. obesity and insulin resistance is associated with lower atp binding cassette transporter A1 (Abca1) expression in visceral adipose tissue
2959. obesity and insulin resistance promote atherosclerosis through an IFNγ-regulated macrophage protein network
2960. obesity and insulin Resistance Rates in a Population Under 40 Years Old Who Admitted to a Family Medicine Outpatient Clinic
2961. obesity and insulin resistance screening tools in American adolescents: National Health and Nutrition Examination Survey (NHANES) 1999 to 2010
2962. obesity and insulin Resistance Status: The Impact of Using Different International Growth Standards in Romanian Children.
2963. obesity and insulin resistance syndrome
2964. obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects
2965. obesity and insulin Resistance, Not Polycystic Ovary Syndrome, Are Independent Predictors of Bone Mineral Density in Adolescents and Young Women
2966. obesity and insulin resistance, risk factors for gingivitis in children?
2967. obesity and insulin Resistance: A Review of Molecular Interactions
2968. obesity and insulin resistance: An abridged molecular correlation
2969. obesity and insulin resistance: an ongoing saga
2970. obesity and insulin resistance: associations with chronic inflammation, genetic and epigenetic factors
2971. obesity and insulin resistance: effects on cardiac structure, function, and substrate metabolism
2972. obesity and insulin resistance: is it due to body fat, energy balance, or gut factors?
2973. obesity and insulin resistance: lessons learned from the Pima Indians
2974. obesity and insulin Resistance: Management in Diabetes.
2975. obesity and insulin resistance:“window” to myocardial dysfunction
2976. obesity and insulin secretion in fasting high school students
2977. obesity and insulin sensitivity effects on cardiovascular risk factors: Comparisons of obese dysglycemic youth and adults
2978. obesity and insulin-like growth factor-I in African Americans and whites
2979. obesity and intestinal epithelial deletion of the insulin receptor, but not the IGF 1 receptor, affect radiation-induced apoptosis in colon
2980. obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic …
2981. obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin
2982. obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF 1
2983. obesity and non-insulin dependent diabetes mellitus. 22-23 April 1998, The Royal Society, London, UK.
2984. obesity and non-insulin-dependent diabetes mellitus in Swiss-Webster mice associated with late-onset hepatocellular carcinoma
2985. obesity and non-insulin-dependent diabetes mellitus. Considerations on an epidemiological study
2986. obesity and Plasma Levels of insulin and Growth Hormone
2987. obesity and sex influence insulin resistance and total and multimer adiponectin levels in adult neutered domestic shorthair client-owned cats
2988. #VALUE!
2989. obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: a longitudinal study
2990. obesity and the insulin resistance syndrome
2991. obesity and the insulin resistance syndrome
2992. obesity and the Risk of Recurrent Vascular Events in Patients with Ischemic Stroke: Insights from the insulin Resistance Intervention after Stroke (IRIS) Trial
2993. obesity and the use of insulin: a study of patients with type 2 diabetes in the UK
2994. obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis
2995. obesity and type 2 diabetes mellitus (T2DM) have been associated with increased levels of circulating branched-chain amino acids (BCAAs) that may be …
2996. obesity and Type 2 Diabetes Mellitus: Adipocytokines as Markers of insulin Resistance
2997. obesity as a risk factor for developing non-insulin dependent diabetes mellitus–obesity and insulin resistance
2998. obesity as a risk factor for non-insulin-dependent diabetes mellitus in Korea.
2999. obesity as associated factors for insulin, Fasting blood sugar, and Hemoglobin A1c in Korean adults
3000. obesity associated insulin resistance occurs in hypopituitary subjects
3001. obesity attenuates the contribution of African admixture to the insulin secretory profile in peripubertal children: a longitudinal analysis
3002. obesity blunts insulin-mediated microvascular recruitment in human forearm muscle
3003. obesity does not aggravate osteoporosis or osteoblastic insulin resistance in orchiectomized rats
3004. obesity Does Not Equal insulin Resistance
3005. obesity does not influence the unique pharmacological properties of different biphasic insulin aspart preparations in patients with type 2 diabetes
3006. obesity does not modulate insulin secretion in Indian patients with non-insulin-dependent diabetes in the young
3007. obesity Effect on Homeostasis Model Assessment of insulin Resistance (HOMA-IR) Value in Various Metabolic Syndrome (MS) Components
3008. obesity genes and insulin resistance
3009. obesity hypertension, salt sensitivity and insulin resistance.
3010. obesity Improves Myocardial Ischaemic Tolerance and ‘RISK’Signalling in Middle-aged insulin-insensitive Rats
3011. obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats
3012. obesity in insulin receptor substrate‐2–deficient mice: disrupted control of arcuate nucleus neuropeptides
3013. obesity in MENX rats is accompanied by high circulating levels of ghrelin and improved insulin sensitivity
3014. obesity in Osborne-Mendel and S 5B/Pl rats: effects of sucrose solutions, castration, and treatment with estradiol or insulin
3015. obesity in polycystic ovary syndrome: insulin sensitizing therapy
3016. obesity in relation to inflammatory biomarkers, adiponectin gene variability, and insulin resistance among middle-aged Egyptian women
3017. obesity in Spanish schoolchildren: relationship with lipid profile and insulin resistance
3018. #VALUE!
3019. obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic …
3020. obesity Increases the Risk of Developing insulin Resistance and Promote Metabolic Syndrome: A Study among Obese and On-Obese Non-Diabetic Subjects
3021. obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a …
3022. obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs.
3023. obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs.(Abstracts: recently published abstracts)
3024. obesity induced by high-fat diet promotes insulin resistance in the ovary
3025. obesity induced infertility rescued by ovarian theca cellspecific knockout of the insulin receptor.
3026. obesity induced insulin resistance and oxidative stress in mice fed a high fat diet
3027. obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia
3028. obesity Influence on insulin Activity and Resting Metabolic Rate in Type 2 Diabetes
3029. obesity is a critical risk factor for worsening of glucose tolerance in a family with the mutant insulin receptor
3030. obesity is associated with activated and insulin resistant immune cells
3031. obesity is associated with altered metabolic and reproductive activity in the mare: effects of metformin on insulin sensitivity and reproductive cyclicity
3032. obesity is associated with impaired insulin-mediated potassium uptake
3033. obesity is associated with increased basal and postprandial β-cell insulin secretion even in the absence of insulin resistance
3034. obesity is associated with increased seminal insulin and leptin alongside reduced fertility parameters in a controlled male cohort
3035. obesity is associated with insulin resistance and components of the metabolic syndrome in Lebanese adolescents
3036. obesity is associated with insulin resistance but not skeletal muscle dysfunction or all-cause mortality
3037. obesity is the main determinant of insulin resistance more than the circulating pro-inflammatory cytokines levels in rheumatoid arthritis patients
3038. obesity is the major cause of alterations in insulin secretion and calcium fluxes by isolated islets from aged rats
3039. obesity is the major factor determining insulin sensitivity and androgen production in women with anovulary cycles
3040. obesity leads to impairments in the morphology and organization of human skeletal muscle lipid droplets and mitochondrial networks, which are resolved with gastric …
3041. obesity May Connect insulin Resistance to Decreased Neuronal Viability in Human Diabetic Brain
3042. obesity may have more pronounced effect on the occurrence of insulin resistance than hypertension
3043. obesity mediates the association between Mediterranean diet consumption and insulin resistance and inflammation in US adults
3044. obesity modifies the association between serum 25-hydroxyvitamin D and insulin resistance in Korean general population without increased fasting glucose levels
3045. obesity modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes and insulin sensitivity
3046. obesity Modulates the Association among APOE Genotype, insulin, and Glucose in Men
3047. obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice
3048. obesity preventive function of novel edible mushroom, Basidiomycetes-X (Echigoshirayukidake): Manipulations of insulin resistance and lipid metabolism
3049. obesity provides a permissive milieu in inflammation-associated carcinogenesis: analysis of insulin and IGF pathways
3050. obesity rather than severity of sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children
3051. obesity Related to insulin Response and Counterregulatory Hormones in NIDDM Patients
3052. obesity resistance and enhanced insulin sensitivity in Ahnak-/-mice fed a high fat diet are related to impaired adipogenesis and increased energy expenditure
3053. obesity status affects the relationship between protein intake and insulin sensitivity in late pregnancy
3054. obesity status influences the relationship among serum osteocalcin, iron stores and insulin sensitivity
3055. obesity type and clustering of insulin resistance-associated cardiovascular risk factors in middle-aged men and women
3056. obesity with insulin resistance increase thrombosis in wild-type and bone marrow-transplanted Zucker Fatty rats
3057. obesity with insulin resistance: experimental insights
3058. obesity—insulin resistance–type 2 diabetes mellitus
3059. obesity-associated extracellular and ultrastructural changes in adipocytes: Impact on insulin sensitivity
3060. obesity-associated family with sequence similarity 13, member A (FAM13A) is dispensable for adipose development and insulin sensitivity
3061. obesity-associated gingival vascular inflammation and insulin resistance
3062. obesity-Associated Inflammation And Its Role In insulin Resistance
3063. obesity-associated insulin resistance adversely affects skin function
3064. obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity
3065. obesity-associated insulin resistance is correlated to adipose tissue vascular endothelial growth factors and metalloproteinase levels
3066. obesity-associated interleukin-6 contributes to hepatic insulin resistance in mice
3067. obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery
3068. obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation
3069. obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation
3070. obesity-induced adipose tissue inflammation and insulin resistance
3071. obesity-induced Brain insulin Resistance Exacerbates TBI Outcome
3072. obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance
3073. obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance
3074. obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell
3075. obesity-Induced Inflammation and insulin Resistance
3076. obesity-induced inflammation and insulin resistance
3077. obesity-induced inflammation and insulin resistance: A mini-review on T-cells
3078. obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms
3079. obesity-Induced insulin Resistance in Human Skeletal Muscle Is Characterised by
3080. obesity-induced insulin resistance in human skeletal muscle is characterised by defective activation of p42/p44 MAP kinase
3081. obesity-induced insulin resistance via changes in the DNA methylation profile of insulin pathway genes
3082. obesity-induced insulin resistance via changes in the DNA methylation profile of insulin pathway genes
3083. obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling
3084. obesity-induced mouse benign prostatic hyperplasia (BPH) is improved by treatment with resveratrol: implication of oxidative stress, insulin sensitivity and neuronal …
3085. obesity-induced overexpression of miR-802 impairs insulin transcription and secretion
3086. obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism
3087. obesity-induced p53 activation in insulin-dependent and independent tissues is inhibited by beta-adrenergic agonist in diet-induced obese rats
3088. obesity-induced reduced expression of the lncRNA ROIT impairs insulin transcription by downregulation of Nkx6. 1 methylation
3089. obesity-inducing hypothalamic knife cuts: effects on lipolysis and blood insulin levels
3090. obesity-linked insulin resistance in children–an emerging problem: The EarlyBird Study (31)
3091. obesity-Linked insulin Resistance: Is Interleukin-6 a Friend or Foe?
3092. obesity-linked PPARγ S273 phosphorylation promotes insulin resistance through Growth Differentiation Factor 3
3093. obesity-prone rats have preexisting defects in their counterregulatory response to insulin-induced hypoglycemia
3094. obesity-related changes in the vascular actions of insulin
3095. obesity-related diseases and syndromes: insulin resistance, type 2 diabetes mellitus, non-alcoholic fatty liver disease, cardiovascular disease, and metabolic …
3096. obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent
3097. obesity-related hypertension and the insulin resistance syndrome.
3098. obesity-Related Hypertension and the Role of insulin and Leptin in High-Fat–Fed Rabbits
3099. obesity-related hypertension: role of the sympathetic nervous system, insulin, and leptin
3100. obesity-related hypoxia via miR-128 decreases insulin-receptor expression in human and mouse adipose tissue promoting systemic insulin resistance
3101. obesity-related insulin resistance in adolescents: a systematic review and meta-analysis of observational studies
3102. obesity-related insulin resistance is reversible after weight loss
3103. obesity-related insulin resistance: implications for the surgical patient
3104. obesity-related insulin resistance: implications for the surgical patient
3105. obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome
3106. obesity-related thyroiditis in childhood: relationship with insulin resistance
3107. obesity-Related Vascular Functional Change is Associated with insulin Resistance in Children
3108. obesity-stroke paradox exists in insulin-resistant patients but not insulin sensitive patients
3109. obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins
3110. obesity‐induced insulin resistance and macrophage infiltration of the adipose tissue: A vicious cycle
3111. obesity‐induced miR‐15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes
3112. obesity–insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J mice
3113. obesity, abdominal obesity, and insulin resistance
3114. obesity, acanthosis nigricans, insulin resistance, and hyperandrogenemia: pediatric perspective and natural history
3115. obesity, adipocytokines, and insulin resistance in breast cancer
3116. obesity, adipogenesis and insulin resistance
3117. obesity, adipogenesis and insulin resistance
3118. obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM).
3119. obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women
3120. obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance
3121. obesity, Body Composition and insulin Resistance in Women with and without Bipolar Disorder
3122. obesity, body fat distribution and other risk factors of non-insulin-dependent diabetes mellitus in different ethnic groups living in East Anglia
3123. obesity, body fat distribution, insulin resistance and link with type 2 diabetes mellitus
3124. obesity, body fat distribution, insulin sensitivity and islet β-cell function as explanations for metabolic diversity
3125. obesity, diabetes and insulin resistance. Alterations of insulin signalling
3126. obesity, diabetes, and insulin resistance: implications from molecular biology, epidemiology, and experimental studies in humans and animals. Synopsis of the …
3127. obesity, Dyslipidemia and insulin Resistance in Survivors of Childhood Cancer
3128. obesity, ectopic lipids, and insulin resistance Tissue-specific defects in nutrient handling
3129. obesity, fasting plasma insulin, and c‐reactive protein levels in healthy children
3130. obesity, free fatty acids, and insulin resistance
3131. obesity, hyperinsulinemia, and portal blood flow: a theoretic study of the effects of increased portal blood flow upon fasting peripheral insulin concentrations
3132. obesity, HYPERinsulinEMIA, THE insulin AND insulin-LIKE GROWTH FACTOR 1 RECEPTORS, AND RISK OF COLORECTAL CANCER
3133. obesity, hyperlipidemia and non-insulin-dependent diabetes: A unified theory
3134. obesity, hypertension and insulin resistance
3135. obesity, hypertension and insulin resistance in childhood–a pilot study
3136. obesity, HYPERTENSION AND insulin RESISTANCE IN CHILDHOOD.
3137. obesity, hypertension, and insulin resistance
3138. obesity, independent of insulin resistance, is a major determinant of blood pressure in normoglycemic Hong Kong Chinese
3139. obesity, inflammation and insulin resistance: role of gp 130 receptor ligands
3140. obesity, inflammation, and insulin resistance
3141. obesity, inflammation, and insulin resistance
3142. obesity, inflammation, and insulin resistance
3143. obesity, inflammation, and insulin resistance–a mini-review
3144. obesity, insulin and chemoresistance in colon cancer
3145. obesity, insulin and hypertension
3146. obesity, insulin and triglycerides
3147. obesity, insulin resistance and assisted conception
3148. obesity, insulin resistance and breast cancer outcomes
3149. obesity, insulin resistance and cancer risk
3150. obesity, insulin Resistance and Cancer: The PI3K connection
3151. obesity, insulin resistance and comorbidities? Mechanisms of association
3152. obesity, insulin resistance and diabetes in the sand rat exposed to a hypercaloric diet; possible protective effect for IL1-β
3153. obesity, insulin resistance and diabetes—a worldwide epidemic
3154. obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors
3155. obesity, insulin resistance and endometrial cancer risk
3156. obesity, insulin Resistance and Exercise [J]
3157. obesity, insulin resistance and hepatic perfusion
3158. obesity, insulin resistance and increase in adipokines levels: importance of the diet and physical activity
3159. obesity, insulin Resistance and insulin.
3160. obesity, insulin resistance and isolated low high‐density‐lipoprotein cholesterol in Chinese subjects
3161. obesity, insulin resistance and kidney disease risk: insights into the relationship
3162. obesity, insulin resistance and lifestyle factors: implications for prostate cancer screening
3163. obesity, insulin Resistance and Loss of Dipping are Associated With Pulse Wave Velocity in Prepubertal Children
3164. obesity, insulin resistance and oxidative stress: implication for breast carcinogenesis.
3165. obesity, insulin Resistance and Pediatric Bone
3166. obesity, insulin Resistance and Placental Dysfunction Ā Foetal Growth
3167. obesity, insulin resistance and Polycystic ovary syndrome
3168. obesity, insulin resistance and pregnancy outcome
3169. obesity, insulin resistance and skeletal muscle characteristics
3170. obesity, insulin resistance and the implication of thiazolidinediones
3171. obesity, insulin resistance and the prevalence of atopy and asthma in US adults
3172. obesity, insulin resistance and type 2 diabetes: risk factors for breast cancer
3173. obesity, insulin Resistance Pathway Factors, and Colon Cancer
3174. obesity, insulin resistance, adipocytokines and breast cancer: New biomarkers and attractive therapeutic targets
3175. obesity, insulin resistance, adiponectin, and PPAR-γ gene expression in broiler chicks fed diets supplemented with fat and green tea (Camellia sinensis) extract
3176. obesity, insulin resistance, and Alzheimer’s disease
3177. obesity, insulin resistance, and cancer prognosis: implications for practice for providing care among cancer survivors
3178. obesity, insulin resistance, and capillary recruitment
3179. obesity, insulin resistance, and cardiovascular disease
3180. obesity, insulin resistance, and colorectal cancer: could miRNA dysregulation play a role?
3181. obesity, insulin resistance, and HCV: implications for pathogenesis
3182. obesity, insulin resistance, and hyperandrogenism mediate the link between poor diet quality and ovarian dysmorphology in reproductive-aged women
3183. obesity, insulin resistance, and incident small vessel disease on magnetic resonance imaging: atherosclerosis risk in communities study
3184. obesity, insulin resistance, and inflammaging
3185. obesity, insulin resistance, and its link to non-insulin-dependent diabetes mellitus
3186. obesity, insulin resistance, and metabolic syndrome: a study in WNIN/Ob rats from a pancreatic perspective
3187. obesity, insulin resistance, and microvascular adaptation
3188. obesity, insulin resistance, and microvessel density
3189. obesity, insulin resistance, and nocturnal systolic blood pressure
3190. obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease
3191. obesity, insulin resistance, and renal function
3192. obesity, insulin resistance, and skeletal muscle nitric
3193. obesity, insulin resistance, and skeletal muscle nitric oxide synthase
3194. obesity, insulin resistance, and skeletal muscle nitric oxide synthase
3195. obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks
3196. obesity, insulin resistance, and the pathway to type 2 diabetes
3197. obesity, insulin resistance, and the renal circulation
3198. obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population
3199. obesity, insulin resistance, and the risk of colonic adenoma
3200. obesity, insulin resistance, and type 1 diabetes mellitus
3201. obesity, insulin resistance, and type 2 diabetes in children and adolescents
3202. obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications
3203. obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension …
3204. obesity, insulin resistance, hypertension and sleep in the child
3205. obesity, insulin resistance, NASH and hepatocellular carcinoma
3206. obesity, insulin resistance, oxidative stress, and inflammation in mouse models of the metabolic syndrome and atherosclerosis
3207. obesity, insulin resistance, type 2 diabetes and free fatty acids
3208. obesity, insulin resistance, β-cell autoimmunity, and the changing clinical epidemiology of childhood diabetes
3209. obesity, insulin secretion and insulin action: reinterpreting the disposition index
3210. obesity, insulin, and colon cancer.
3211. obesity, insulin, and hypertension: why outliers count
3212. obesity, insulin, sex steroids and ovulation
3213. obesity, leptin resistance, and the effects of insulin reduction
3214. obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery
3215. obesity, metabolic syndrome, and insulin resistance in urban high school students of minority race/ethnicity
3216. obesity, NIDDM, Adipogenesis and insulin Resistance-IBC’s Ninth International Conference.
3217. obesity, non-insulin-dependent diabetes mellitus and age, but not estrogen, were associated with changes of (delta) 6 and (delta) 5 desaturase enzyme activity …
3218. obesity, occupational work and parental history as risk factors for non-insulin-dependent diabetes mellitus
3219. #VALUE!
3220. obesity, oxidative stress, and their effect on serum heme oxygenase-1 concentrations and insulin in children aged 3 to 5 years in a pediatric hospital of the Ministry of …
3221. obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan
3222. obesity, syndrome X, and diabetes: the role of HISS-dependent insulin resistance altered by sucrose, an antioxidant cocktail, and age
3223. obesity, type 2 diabetes, and cancer: the insulin and IGF connection
3224. obesity, Type 2 Diabetes, and Cancer: The insulin and insulin-Like Growth Factor Connection.
3225. obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1
3226. obesity, weight change, fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast cancer: the Rancho Bernardo …
3227. obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels
3228. obesity: Adipogenesis and insulin Resistance.
3229. obesity: changes in lipid metabolism and the role of insulin
3230. obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
3231. obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans
3232. #VALUE!
3233. Obstructive sleep apnea and insulin resistance in children with obesity
3234. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin …
3235. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity
3236. OGTT, insulin Releasing Test and Changes of Plasma Lipids in obesity
3237. Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high …
3238. Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high …
3239. Omega-3 index, obesity and insulin resistance in children
3240. Omega-3 PUFA and probiotics as a single formulation for insulin resistance and obesity: Evidence from animals to randomized clinical studies
3241. Omental adipose tissue fibrosis and insulin resistance in severe obesity
3242. On the paradox insulin resistance/insulin hypersensitivity and obesity: two tales of the same history
3243. On the pathogenesis of type II diabetes with special reference to diminished insulin response and obesity: a 5-12 year follow-up study of subjects with borderline …
3244. #VALUE!
3245. OPA 1 deficiency promotes secretion of FGF 21 from muscle that prevents obesity and insulin resistance
3246. Operative risk factors in the metabolic syndrome: Is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?
3247. Optimal waist circumference cutoff value based on insulin resistance and visceral obesity in Koreans with type 2 diabetes
3248. OR-43: A neuroendocrine model of obesity worsen insulin resistance of spontaneously hypertensive rats: a new model of type 2 diabetes
3249. OR01-3 microRNA-34a-mediated FGF21 resistance in the adipose tissue contributes to insulin resistance and hypoadiponectinemia in diet-induced obesity
3250. OR26-03 Lower Serum Myostatin Levels Are Associated with Higher insulin Sensitivity in Adults with Overweight/obesity
3251. Oral administration of alkylglycerols differentially modulates high-fat diet-induced obesity and insulin resistance in mice
3252. Oral glutamine supplementation reduces obesity, pro-inflammatory markers, and improves insulin sensitivity in DIO wistar rats and reduces waist circumference in …
3253. Oral hormonal therapy with ethinylestradiol–levonorgestrel improves insulin resistance, obesity, and glycogen synthase kinase-3 independent of circulating …
3254. Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota
3255. Original Research Article Correlation between insulin resistance and metabolic syndrome in obesity adolescents
3256. Osteocalcin reverses endoplasmic reticulum stress and improves impaired insulin sensitivity secondary to diet-induced obesity through nuclear factor-κB signaling …
3257. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice
3258. Osteoprotegerin and insulin resistance in childhood obesity: a new interplay?
3259. Osteoprotegerin in relation to insulin resistance and blood lipids in sub-Saharan African women with and without abdominal obesity
3260. Over Expression of the insulin Like Growth Factor Type 1 Receptors in Endothelial Cells Protects Against the Development of obesity
3261. Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction
3262. Overactivation of the adipose tissue renin angiotensin system contributes to insulin resistance in high‐fat diet‐induced obesity
3263. Overall and abdominal obesity with insulin sensitivity and secretion in a Han Chinese population: a Mendelian randomisation study
3264. Overall and central obesity with insulin sensitivity and secretion in a Han Chinese population: a Mendelian randomization analysis
3265. Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass
3266. Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young …
3267. Overexpression of C-type natriuretic peptide in endothelial cells protects against insulin resistance and inflammation during diet-induced obesity
3268. Overexpression of c‐myc in the liver prevents obesity and insulin resistance
3269. Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity
3270. Overexpression of interleukin-15 in mice promotes resistance to diet-induced obesity, increased insulin sensitivity, and markers of oxidative skeletal muscle …
3271. Overexpression of superoxide dismutase 3 gene blocks high-fat diet-induced obesity, fatty liver and insulin resistance
3272. Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity‐related insulin resistance
3273. Overfeeding-induced obesity in rats: insulin sensitivity and autonomic regulation of metabolism
3274. Overview: low density lipoprotein subclass phenotype B as a biochemical marker for visceral obesity and insulin resistance
3275. Overweight and obesity in infants of mothers with long-term insulin-dependent diabetes or gestational diabetes
3276. Overweight, obesity and features of metabolic syndrome in children with diabetes treated with insulin pump therapy
3277. Overweight, obesity, and their associations with insulin resistance and β-cell function among Chinese: a cross-sectional study in China
3278. OX40 promotes obesity-induced adipose inflammation and insulin resistance
3279. Oxidative modifications of mitochondrial complex II are associated with insulin resistance of visceral fat in obesity
3280. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance
3281. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance.
3282. Oxidative stress is associated with C‐reactive protein in nondiabetic postmenopausal women, independent of obesity and insulin resistance
3283. Oxidized LDL is associated with metabolic syndrome traits independently of central obesity and insulin resistance
3284. #VALUE!
3285. P-135: obesity, insulin resistance, cardiac structure, and renin-angiotensin system genes in essential hypertension
3286. P-138: Bmi-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity
3287. P-443: Preliminary results of topiramate in an experimental model of obesity, insulin resistance and hypertension (obese Zucker rats)
3288. P-495: Relationships between endogenous insulin secretion and insulin resistance and blood pressure in obesity
3289. P-572: Clinical study on the role of leptin and insulin resistance in the pathogenesis of obesity related hypertension
3290. P-77: Risk of cardiovascular morbidity is correalted with insulin resistance, but not with obesity in a bariatric surgical population
3291. p-Coumaric Acid Enriched-Peanut Sprout Improves High Fat Diet-Induced obesity and insulin Resistance by Inhibiting Macrophage Recruitment
3292. P-selectin glycoprotein ligand-1 deficiency is protective against obesity-related insulin resistance
3293. P‐selectin deficiency protects against high‐fat diet‐induced obesity and insulin resistance (641.1)
3294. P2-03-01: Genetic Reduction of Circulating insulin-Like Growth Factor (IGF)-1 Differentially Impacts the Effects of Diet-Induced obesity and Calorie Restriction on …
3295. P20 Study of insulin cardiovascular resistance in an animal model of childhood obesity by over-feeding during lactation
3296. P2X7 Receptor in the Management of Energy Homeostasis: Implications for obesity, Dyslipidemia, and insulin Resistance
3297. P5. 64 Effect of morbid obesity in skeletal muscle and its association with insulin resistance
3298. P5299 Epicardial obesity as a significant predictor of leptino and insulin resistance
3299. P649 A possible role for the ATM protein in the myocardial pathology associated with obesity and insulin resistance.
3300. p66 (ShcA): linking mammalian longevity with obesity-induced insulin resistance
3301. p66ShcA: linking mammalian longevity with obesity-induced insulin resistance
3302. P704 obesity and insulin resistance are not associated with endothelial dysfunction in rat aortas.
3303. PAI-1, obesity, and insulin resistance
3304. PAI-1, obesity, insulin resistance and risk of cardiovascular events
3305. Pancreastatin inhibitor PSTi8 attenuates hyperinsulinemia induced obesity and inflammation mediated insulin resistance via MAPK/NOX3-JNK pathway
3306. Pancreastatin inhibitor PSTi8 protects the obesity associated skeletal muscle insulin resistance in diet induced streptozotocin-treated diabetic mice
3307. Pancreastatin-dependent inflammatory signaling mediates obesity-induced insulin resistance
3308. Pancreatic acinar cell-specific overexpression of group 1B phospholipase A 2 exacerbates diet-induced obesity and insulin resistance in mice
3309. Pancreatic beta-cell insulin signaling in genetic and dietary models of obesity and insulin resistance
3310. Pancreatic β-cell adaptive plasticity in obesity increases insulin production but adversely affects secretory function
3311. Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: a cross-sectional analysis in middle-aged men and premenopausal women
3312. Parathyroid Hormone and insulin Resistance in Distinct Phenotypes of Severe obesity: A Cross-Sectional Analysis in Middle-Aged Men and Premenopausal Women
3313. Parthenolide Reverses obesity-Induced insulin Resistance [J]
3314. Partial reversal of obesity-induced insulin resistance owing to anti-inflammatory immunomodulatory potential of flaxseed oil
3315. Partly replacing meat protein with soy protein alters insulin resistance and blood lipids in postmenopausal women with abdominal obesity
3316. Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus
3317. Past and Present obesity, Parameters of Body Fat and Blood Pressure in Korean Patients with Non-insulin Dependent Diabetes Mellitus (NIDDM)
3318. Pathogenesis and clinical features of obesity and insulin resistance
3319. Pathogenesis of insulin resistance and glucose intolerance in childhood obesity
3320. Pathogenesis of insulin resistance in metabolic obesity
3321. PATHOGENESIS OF insulin RESISTANCE IN PREGNANT WOMEN WITH obesity PATOGENEZA insulinOOPORNOŚCI U KOBIET CIĘŻARNYCH Z …
3322. Pathogenetic Relationship Between insulin Resistance, insulin Secretion and Impaired Glucose Tolerance in Patients With obesity
3323. Pathogenic role of inflammatory cytokines in obesity: from insulin resistance to diabetes mellitus
3324. Pathologic Remodeling of Myocardial Cardiolipin in a Porcine Model of Diet-Induced obesity and insulin Resistance
3325. Pathomechanism of insulin resistance in men with central obesity: correlation of GGT, GPx, hs-CRP and plasma total cysteine
3326. Pathophysiological connections between gallstone disease, insulin resistance, and obesity
3327. Pathophysiology and Management of Dyslipidemias Associated with obesity, Type 2 Diabetes, and Other insulin-Resistant States
3328. Pathophysiology in Animal models of Diet-Induced obesity: A critical Role for insulin Resistance
3329. Pathophysiology of diabetes mellitus type 2: roles of obesity, insulin resistance and β-cell dysfunction
3330. Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus
3331. Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system.
3332. Pathways involved in lipid-induced insulin resistance in obesity
3333. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
3334. Pattern of plasma lipids and insulin blood levels in male patients with non-insulin-dependent diabetes mellitus and moderate obesity
3335. Patterns of glycemia during the insulin resistance of pregnancy: obesity, gestational diabetes and relationship to neonatal adiposity
3336. PBI-4547 Improves Glucose Metabolism and insulin Resistance, and Reduces Liver Damage in a High-Fat Diet Mouse Model of obesity and Metabolic Syndrome
3337. PC4 CONSEQUENCE OF CARBOHYDRATE AND FAT CONTENT OF WEANING DIET ON DEVELOPMENT OF obesity, BLOOD insulin, LEPTIN AND LIPIDS …
3338. PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma
3339. PDK4 augments ER–mitochondria contact to dampen skeletal muscle insulin signaling during obesity
3340. Peculiarities of asthma and insulin resistance depending on the types of obesity
3341. Peculiarities of cardiovascular syndrome in children and adolescents with obesity in dependence of level of insulin resistance
3342. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification
3343. Percentage fractions of urinary di (2-ethylhexyl) phthalate metabolites: Association with obesity and insulin resistance in Korean girls
3344. Perforin is a novel immune regulator of obesity-related insulin resistance
3345. Pericardial fat, insulin resistance, and left ventricular structure and function in morbid obesity
3346. Perinatal growth failure: the road to obesity, insulin resistance and cardiovascular disease in adults
3347. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
3348. Peripheral insulin Resistance Accounts for Endothelial Dysfunction in obesity
3349. Peripheral sgp130-mediated trans-signaling blockade induces obesity and insulin resistance in mice via PPARα suppression
3350. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance
3351. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
3352. Peroxisome proliferator-activated receptor y2 Pro115Gln and G972R insulin substrate receptor-1 variants in obesity and insulin resistance
3353. Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development
3354. Persistent adipose tissue insulin responsiveness during fasting of weanling rats with hypothalamic obesity
3355. Personalized dietary management of overweight and obesity based on measures of insulin and glucose
3356. PERTURBATION IN IMMUNE-METABOLIC FUNCTION ASSOCIATED WITH obesity INDUCED insulin RESISTANCE IN HUMANS
3357. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue
3358. Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment
3359. Pharmacological effects of palmitoylethanolamide on hypertension, insulin-resistance and obesity in murine models
3360. Pharmacological glycerol-3-phosphate acyltransferase inhibition decreases food intake and adiposity and increases insulin sensitivity in diet-induced obesity
3361. Pharmacological Inhibition of NLRP3 Inflammasome by Parthenolide Improves obesity-Induced insulin Resistance in Diet-Induced Obese Mice
3362. Pharmacological Strategies for insulin Sensitivity in obesity and Cancer: Thiazolidinediones and Metformin
3363. Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity
3364. Pharmacological treatment of insulin resistance in obesity.
3365. Pharyngeal collapsibility during sleep is elevated in insulin-resistant females with morbid obesity
3366. Phenotypic characterisation of human amylin transgenic mice: altered hormone signalling in the brain underlying obesity and insulin resistance
3367. Phenotypic characterization of insulin-resistant and insulin-sensitive obesity
3368. Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
3369. Phosphatidylinositol-4-phosphate-5-kinase α deficiency alters dynamics of glucose-stimulated insulin release to improve glucohomeostasis and decrease obesity in …
3370. PHOSPHO1 is a skeletal regulator of insulin resistance and obesity
3371. PHOSPHO1, a novel skeletal regulator of insulin resistance and obesity
3372. Phospholipid transfer protein (PLTP) deficiency attenuates high fat diet induced obesity and insulin resistance
3373. Phospholipid Transfer Protein Deficiency Attenuates High-Fat Diet–Induced obesity and insulin Resistance
3374. Phosphorylation status of fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance
3375. Physical activity energy expenditure is associated with 2-h insulin independently of obesity among Inuit in Greenland
3376. Physical activity impacts insulin sensitivity post metabolic bariatric surgery in adolescents with severe obesity
3377. Physical activity, eating patterns, and insulin resistance in obesity
3378. Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity
3379. Physical and Metabolic Characteristics of p62 Knockout Mouse: A New Animal Model of obesity/insulin Resistance
3380. Physical inactivity and obesity underlie the insulin resistance of aging
3381. Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus
3382. Physical Training in Human obesity II. Effects on Plasma insulin in Glucose-Intolerant Subjects without Marked Hyperinsulinemia
3383. Physical training in hyperplastic obesity. V. Effects of atropine on plasma insulin.
3384. Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome
3385. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and …
3386. Physiopathology and Possible Etiology of Hormonal Dysregulations and insulin Resistance in Obese Rats: a Potential Model for Some Human obesity
3387. Phytosterols do not change susceptibility to obesity, insulin resistance, and diabetes induced by a high-fat diet in mice
3388. PI3Kγ activity in leukocytes promotes adipose tissue inflammation and early-onset insulin resistance during obesity
3389. PI3Kγ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance
3390. Pigment epithelium-derived factor contributes to insulin resistance in obesity
3391. Pituitary lesions, obesity, and mesenteric Lipomas in insulin-resistant horses
3392. PKCβ-induced Selective IRS1 Dysfunction and insulin Resistance in Renal Glomeruli of Rodent Models of Diabetes and obesity
3393. Plasma Active Ghrelin Level in Patients with Type 2 Diabetes Mellitus and its Interrelationship with insulin resistance, Hypertension, Dyslipidemia and obesity
3394. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians
3395. Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans
3396. Plasma amino acid levels and insulin secretion in obesity
3397. Plasma amino acids and insulin levels in obesity: response to carbohydrate intake and tryptophan supplements
3398. Plasma B-cell tropin, insulin secretion and obesity
3399. Plasma cell glycoprotein-1, interleukin-6 and tumor necrosis factor-alfa as candidate genes for insulin resistance, obesity and type 2 diabetes (PC-1 …
3400. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
3401. Plasma concentrations of insulin and free fatty acids in dietary-induced obesity of Wistar-rats before and after glucose stimulation.
3402. Plasma CTRP-3 concentrations in Chinese patients with obesity and type II diabetes negatively correlate with insulin resistance
3403. Plasma free fatty acids do not provide the link between obesity and insulin resistance or β‐cell dysfunction: results of the Reading, Imperial, Surrey, Cambridge, Kings …
3404. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels
3405. Plasma high-density lipoprotein cholesterol but not apolipoprotein AI is a good correlate of the visceral obesity—insulin resistance dyslipidemic syndrome
3406. Plasma insulin A-chain in obesity and diabetes
3407. Plasma insulin and growth hormone levels in obesity and diabetes
3408. Plasma insulin changes in obesity with or without abnormal glucose tolerance
3409. Plasma insulin in patients with coronary sclerosis and in obesity.
3410. Plasma insulin levels during pregnancy, in obesity and potential diabetes
3411. Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients.
3412. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men
3413. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus
3414. Plasma Leptin and insulin Resistance Correlation with obesity in Pre Pubertal Children.
3415. Plasma leptin concentration, obesity, and insulin resistance in healthy Korean population
3416. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan—The Taipei Children Heart Study
3417. Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1
3418. Plasma Leptin, insulin Resistance, and obesity Index of Type 2 Diabetics and Normal Subjects among Koreans.
3419. Plasma levels of ghrelin, des-acyl ghrelin and LEAP2 in children with obesity: correlation with age and insulin resistance
3420. Plasma levels of insulin and leptin in patients with morbid obesity and anorexia nervosa after weight loss or gain, respectively
3421. Plasma lipid profiling of tissue-specific insulin resistance in human obesity
3422. Plasma PAF acetylhydrolase in non-insulin dependent diabetes mellitus and obesity: effect of hyperinsulinemia and lovastatin treatment
3423. Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects
3424. Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity
3425. Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome
3426. Plasma profiles of glucose, insulin and lipids in the male WBN/Kob-Leprfa rat, a new model of type 2 diabetes with obesity
3427. Plasma progranulin concentrations are increased in patients with type 2 diabetes and obesity and correlated with insulin resistance
3428. Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity
3429. Plasma retinol-binding protein 4 and insulin resistance in overweight and obesity: effect of weight loss
3430. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance
3431. Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity
3432. Plasma tocopherols and carotenes are decreased in spanish children and adolescents with insulin resistance, independently of obesity
3433. Plasma visfatin concentrations in childhood obesity: relationships with insulin resistance and anthropometric measurements indices
3434. Plasmalemmal fatty acid transport is regulated in heart and skeletal muscle by contraction, insulin and leptin, and in obesity and diabetes
3435. Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk
3436. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM
3437. Platelet-endothelial interactions in atherosclerosis-prone arteries in a non-human primate model of obesity and insulin resistance
3438. Plenary 3 Role of inflammation in the etiology of obesity induced insulin resistance and Type 2 diabetes
3439. PLTP Deficiency Attenuates High Fat Diet Induced obesity and insulin Resistance
3440. POCU1b, the n-Butanol Soluble Fraction of Polygoni Cuspidati Rhizoma et Radix, Attenuates obesity, Non-Alcoholic Fatty Liver, and insulin Resistance via Inhibitions …
3441. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity
3442. Polycystic ovaries, obesity and insulin resistance in women with epilepsy
3443. Polycystic ovary syndrome and anti‐Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins
3444. Polycystic Ovary Syndrome is Associated with insulin Resistance Independent of obesity, Vitamin D Status and Inflammatory Activation
3445. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth
3446. Polycystic Ovary Syndrome, obesity and insulin Resistance
3447. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
3448. Polymorphism of the tumor necrosis factor-alpha receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated …
3449. Polymorphisms in inflammatory pathway markers and their association with obesity and insulin resistance in populations of the African diaspora
3450. Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity
3451. Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the insulin Resistance Atherosclerosis Family …
3452. Polyunsaturated fatty acids attenuate diet induced obesity and insulin resistance, modulating mitochondrial respiratory uncoupling in rat skeletal muscle
3453. Pomegranate seed oil prevents diet induced obesity and insulin resistance in mice
3454. Pomegranate seed oil, a rich source of punicic acid, prevents diet-induced obesity and insulin resistance in mice
3455. Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians
3456. Populus balsamifera extract and its active component salicortin reduce obesity and attenuate insulin resistance in a diet-induced obese mouse model
3457. Populus balsamifera L.(Salicaceae) mitigates the development of obesity and improves insulin sensitivity in a diet-induced obese mouse model
3458. Positive association between musclin and insulin resistance in obesity: evidence of a human study and an animal experiment
3459. Positive association of obesity and insulin resistance with bone mineral density in Tunisian postmenopausal women
3460. Possible criteria for obesity based on insulin resistance in Japanese college athletes
3461. Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia.
3462. Possible role of pancreatic insulin and glucagon in the hyperlipidemia and obesity of obese strain of chicken
3463. Possible Treatment Options for insulin Resistance in obesity via Branched-Chain Amino Acid Pathway
3464. Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance
3465. Postnatal deficiency of essential fatty acids in mice results in resistance to diet-induced obesity and low plasma insulin during adulthood
3466. Postnatal environment overrides genetic and prenatal factors influencing offspring obesity and insulin resistance
3467. Postprandial changes in cytosolic free calcium and glucose uptake in adipocytes in obesity and non-insulin-dependent diabetes mellitus
3468. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance
3469. Postprandial Dyslipidemia and Intestinal Dysfunction in Adolescents with obesity and insulin Resistance
3470. Postprandial oscillatory patterns of blood glucose and insulin in NIDDM: Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity
3471. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects
3472. Potential cellular and genetic mechanisms for insulin resistance in the common disorders of diabetes and obesity
3473. Potential epigenetic biomarkers of obesity-related insulin resistance in human whole-blood
3474. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression
3475. Potential Mechanism (s) of obesity-Induced insulin Resistance in Skeletal Muscle: The Role of Exercise
3476. Potential Role Of Endoplasmic Reticulum Redox Changes In Endoplasmic Reticulum Stress And Impaired Protein Folding In obesity-Associated insulin Resistance
3477. Potential Role of insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for obesity-Related insulin Resistance
3478. Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy
3479. Potential Roles of Adipocyte Extracellular Vesicle–Derived miRNAs in obesity-Mediated insulin Resistance
3480. Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance
3481. PP. 28.18: insulin RESISTANCE IN PATIENTS WITH ARTERIAL HYPERTENSION AND ABDOMINAL obesity DEPENDING ON ACE AND PPAR-GAMMA2 …
3482. PP180. Maternal plasma endotoxin increases significantly across pregnancy with no association with obesity, inflammation, or insulin sensitivity
3483. PPAR-γ2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity
3484. PPAR-γ2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity
3485. PPARγ2 protects against obesity by means of a mechanism that mediates insulin resistance
3486. Praliciguat, a clinical-stage sGC stimulator, improved glucose tolerance and insulin sensitivity and lowered triglycerides in a mouse diet-induced obesity model
3487. PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity
3488. Pre-sarcopenia is associated with renal hyperfiltration independent of obesity or insulin resistance: Nationwide Surveys (KNHANES 2008–2011)
3489. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study
3490. Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons
3491. Predictive Models of insulin Resistance Derived from Simple Morphometric and Metabolic Measurements Related to obesity in Baboons.
3492. Predictors of insulin resistance in children versus adolescents with obesity
3493. Predictors of insulin Resistance in Indonesian Adolescents with obesity
3494. Predictors of insulin resistance in obesity and type 2 diabetes mellitus—The role of magnesium
3495. Predictors of insulin resistance in patients with obesity: a pilot study
3496. Predisposition to insulin resistance and obesity due to staple consumption of rice: Amylose content versus germination status
3497. Predominance of insulin Resistance Over Beta-Cell Dysfunction as a Diabetes Risk Factor in Chinese Adults: Impact of obesity in a Nationwide Prospective Study
3498. Predominant role of obesity/insulin resistance in oxidative stress development
3499. Pregnancy, obesity and insulin resistance: maternal overnutrition and the target windows of fetal development
3500. Preliminary evidence for obesity and elevations in fasting insulin mediating associations between cortisol awakening response and hippocampal volumes and frontal …
3501. Preliminary evidence for obesity-associated insulin resistance in adolescents without elevations of inflammatory cytokines
3502. Preoperative revelation of insulin resistance as a criterion of debulking necessity in patients with obesity
3503. Preperitoneal fat thickness in childhood obesity: association with serum insulin concentration
3504. Preserved endothelial function in human obesity in the absence of insulin resistance
3505. Pressure overload exacerbates insulin resistance in obesity and type 2 diabetes
3506. Preteen insulin levels interact with caloric intake to predict increases in obesity at ages 18 to 19 years: a 10-year prospective study of black and white girls
3507. Prevalence and clinical characteristics of children and adolescents with metabolically healthy obesity: Role of insulin sensitivity
3508. Prevalence and correlates of obesity in insulin dependent diabetic patients.
3509. Prevalence and Regional Differences of obesity in Young Women Latent obesity and insulin Resistance
3510. Prevalence and treatment of depression are differentially associated with insulin resistance and obesity
3511. Prevalence of Atherogenic Index and Its Relationship to Abdominal obesity, Hypertension and insulin Resitance in Obese Pediatric Patients of South Bronx
3512. Prevalence of insulin Resistance and Impaired Glucose Tolerance among Children and Adolescents with obesity.
3513. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity
3514. Prevalence of insulin Resistance and its Association with obesity and Alcoholism in Male Medical Students of Bhopal
3515. Prevalence of insulin resistance in urban Indian school going children with overweight/obesity: A cross-sectional study
3516. Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight
3517. Prevalence of obesity in Korean Adult insulin-Dependent Diabetic Patients
3518. Prevalence of obesity in Korean non-insulin-dependent diabetic patients
3519. Prevalence of obesity, Dyslipidemia, and insulin Resistance in Childhood Cancer Survivors
3520. Prevalence of obesity, hyperlipemia and insulin resistance in children with suprasellar brain tumors
3521. Prevalence of the insulin resistance syndrome in obesity
3522. Preventing high fat diet-induced obesity and improving insulin sensitivity through neuregulin 4 gene transfer
3523. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid–binding resin
3524. Prevention of obesity and insulin resistance by estrogens requires ERα activation function-2 (ERαAF-2), whereas ERαAF-1 is dispensable
3525. Prevention of obesity and insulin resistance by glucokinase expression in skeletal muscle of transgenic mice
3526. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1
3527. Preventive effects of Salvia officinalis leaf extract on insulin resistance and inflammation in a model of high fat diet-induced obesity in mice that responds to …
3528. Preventive effects of salvia officinalis leaf extract on insulin resistance and inflammation, in high fat diet-induced-obesity mice model
3529. Preventive effects of salvia officinalis leaf extract on insulin resistance and inflammation, in high fat diet-induced-obesity mice model
3530. Pro-inflammatory adipocytokines, oxidative stress, insulin, Zn and Cu: interrelations with obesity in Egyptian non-diabetic obese children and adolescents
3531. Pro-inflammatory CD11c+ CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity
3532. Probiotic and omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance, improves glycemia and obesity parameters in individuals with type 2 …
3533. Probiotics improve obesity-associated dyslipidemia and insulin resistance in high-fat diet-fed rats
3534. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome
3535. Programmed cell death-4 deficiency prevents diet-induced obesity, adipose tissue inflammation, and insulin resistance
3536. Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation
3537. Programming of infant neurodevelopment by maternal obesity: potential role of maternal inflammation and insulin resistance
3538. Progress and controversies: treating obesity and insulin resistance in the context of hypertension
3539. Progress in the Study of the Association between Adipocyte Fatty Acid Binding Protein and PTEN and Their Correlation with obesity and insulin Resistance
3540. Progression of obesity-induced insulin resistance in response to a high-fat diet is delayed in IL-1 receptor type I-knock-out mice
3541. Progressive defect of insulin action on glycogen synthase in obesity and diabetes
3542. Progressive obesity alters ovarian insulin, phosphatidylinositol-3 kinase, and chemical metabolism signaling pathways and potentiates ovotoxicity induced by …
3543. Prohibitin-induced, obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC
3544. Prohibitin: a prime candidate for a pleiotropic effector that mediates sex differences in obesity, insulin resistance, and metabolic dysregulation
3545. Promising Effect of Irisin in Reduction of obesity And insulin Resistance: A Review
3546. Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster …
3547. Proteasome dysfunction associated to oxidative stress and proteotoxicity in adipocytes compromises insulin sensitivity in human obesity
3548. Proteasome dysfunction mediates obesity-induced endoplasmic reticulum stress and insulin resistance in the liver
3549. Protection against diet-induced obesity and obesity– related insulin resistance in Group 1B PLA2-deficient mice
3550. Protection from diet‐induced obesity and insulin resistance in mice lacking CCL19‐CCR7 signaling
3551. Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1
3552. Protection From obesity and Systemic insulin Resistance by Hepatocyte Growth Factor in Mice
3553. Protection from obesity-induced insulin resistance in mice lacking TNF-α function
3554. Protective role for B-1b B cells and IgM in obesity-associated inflammation, glucose intolerance, and insulin resistance
3555. Protein inhibitor of activated STAT 1 (PIAS1) protects against obesity-induced insulin resistance by inhibiting inflammation cascade in adipose tissue
3556. Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance
3557. Protein oxidation in obesity and insulin resistance
3558. Protein-restriction diet during the suckling phase programs rat metabolism against obesity and insulin resistance exacerbation induced by a high-fat diet in adulthood
3559. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance
3560. Proteomic analysis of malignant and benign endometrium according to obesity and insulin-resistance status using Reverse Phase Protein Array
3561. Proteomic and biochemical analysis of adipose protein carbonylation in obesity linked insulin resistance
3562. PS1-1. TLR-3 is highly expressed in human adipocytes, but deficiency of TLR3 does not protect against obesity-induced inflammation and insulin resistance in mice
3563. PS15-78. Increased adipose tissue oxygen tension in obesity is accompanied by insulin resistance, impaired adipose tissue capillarisation and inflammation
3564. PS19-89. Absence of JNK1 protects mice against age-induced obesity and insulin resistance
3565. PS2-9. Effect of B-and T-cell deficiency on obesity-induced inflammation and insulin resistance
3566. PS8-44. FcR-γ-chain-/-mice are protected against diet-induced obesity and diet-induced insulin resistance
3567. PS8-45. insulin resistance in 4-5 year old children with overweight and obesity
3568. PTEN Mutations as a Cause of Constitutive insulin Sensitivity and obesity
3569. PTEN mutations as a cause of constitutive insulin sensitivity and obesity in human beings
3570. PTEN mutations increase insulin sensitivity and obesity
3571. PTEN targeting: the search for novel insulin sensitisers provides new insight into obesity research
3572. PTPRT regulates high-fat diet-induced obesity and insulin resistance
3573. Pu’erh tea extract-mediated protection against hepatosteatosis and insulin resistance in mice with diet-induced obesity is associated with the induction of de novo …
3574. Purified Betacyanins from Hylocereus undatus Peel Ameliorate obesity and insulin Resistance in High-Fat-Diet-Fed Mice
3575. PWD/PhJ and WSB/EiJ mice are resistant to diet-induced obesity but have abnormal insulin secretion
3576. PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice
3577. Pyruvate attenuate lipid metabolic disorders and insulin resistance in obesity induced in rats
3578. PYY (3–36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity
3579. QTL mapping of genes controlling plasma insulin and leptin concentrations: metabolic effect of obesity QTLs identified in an F2 intercross between C57BL/6J and …
3580. Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer
3581. Quantitative trait loci for obesity and insulin resistance (Nob1, Nob2) and their interaction with the leptin receptor allele (LeprA720T/T1044I) in New Zealand obese …
3582. Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7.
3583. Race affects the association of obesity measures with insulin sensitivity
3584. Race, Childhood insulin, Childhood Caloric Intake, and Class 3 obesity at Age 24: 14‐Year Prospective Study of Schoolgirls
3585. Racial differences in peripheral insulin sensitivity and mitochondrial capacity in the absence of obesity
3586. Radiologic evidence that hypothalamic gliosis is associated with obesity and insulin resistance in humans
3587. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin
3588. Rapid development of cardiac dysfunction in a canine model of insulin resistance and moderate obesity
3589. Raspberry alleviates obesity-induced inflammation and insulin resistance in skeletal muscle through activation of AMP-activated protein kinase (AMPK) α1
3590. #VALUE!
3591. Re: Maternal lipids are associated with newborn adiposity independent of GDM status, obesity and insulin resistance: a prospective observational cohort study …
3592. Recent advances in obesity-induced inflammation and insulin resistance
3593. Recent advances in the relationship between obesity, inflammation, and insulin resistance
3594. Recessive Inheritance of obesity in Familial Non—insulin-Dependent Diabetes Mellitus, and Lack of Linkage to Nine Candidate Genes
3595. Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance
3596. Red pitaya betacyanins protects from diet‐induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice
3597. Red wine polyphenols do not improve obesity‐associated insulin resistance: A randomized controlled trial
3598. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle
3599. Reduced [Beta]-cell Compensation to insulin Resistance Associated with obesity in Familial Type 2 Diabetes
3600. Reduced access to insulin-sensitive tissues in dogs with obesity secondary to increased fat intake
3601. Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity
3602. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet
3603. Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.
3604. Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity
3605. Reduced Cardiolipin Synthesis Protects Against the Development of obesity and insulin Resistance
3606. Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross …
3607. Reduced gene expression of sirtuins and active AMPK levels in children and adolescents with obesity and insulin resistance
3608. Reduced gluteal expression of adipogenic and lipogenic genes in black South African women is associated with obesity-related insulin resistance
3609. Reduced heart rate variability correlates with insulin resistance but not with measures of obesity in population undergoing laparoscopic Roux-en-Y gastric bypass
3610. Reduced hepatic insulin clearance in rats with dietary-induced obesity
3611. Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels
3612. Reduced insulin suppression of glucose appearance is related to susceptibility to dietary obesity in rats
3613. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans
3614. Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance
3615. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.
3616. Reduction in adiposity, β-cell function, insulin sensitivity, and cardiovascular risk factors: a prospective study among Japanese with obesity
3617. Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice
3618. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 …
3619. Reductions in adipose tissue mitochondrial content in high fat diet‐induced obesity and lean models of insulin resistance
3620. Reevaluation of fatty acids, obesity, and insulin resistance
3621. Regular alcohol consumption improves insulin resistance in healthy Japanese men independent of obesity
3622. Regulated membrane transport of free fatty acids in adipocytes: role in obesity and non-insulin dependent diabetes mellitus.
3623. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance
3624. Regulation of Autotaxin and its Role in obesity-Induced Tissue insulin Resistance
3625. Regulation of B‐type natriuretic peptide synthesis by insulin in obesity in male mice
3626. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity
3627. Regulation of HIF-1α activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia
3628. Regulation of human adipose tissue gene expression in relation to obesity and insulin resistance
3629. Regulation of human adipose tissue gene expression in relation to obesity and insulin resistance
3630. Regulation of human vascular redox state in obesity and insulin resistance
3631. Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice
3632. Regulation of insulin-response element binding protein-1 in obesity and diabetes: potential role in impaired insulin-induced gene transcription
3633. Regulation of mouse hepatic genes in response to diet induced obesity, insulin resistance and fasting induced weight reduction
3634. Regulation of Nephron Afferent Arteriole Resistance in obesity: Role of insulin and Connecting Tubule Glomerular Feedback
3635. REGULATION OF obesity AND insulin RESISTANCE BY FOENICULUM VULGARE AND ANETHUM GRAVEOLENS EXTRACT IN HIGH-FAT DIET-INDUCED …
3636. Regulation of obesity and insulin resistance by hypoxia-inducible factors
3637. Regulation of obesity and insulin resistance by nitric oxide
3638. Regulation of obesity-related insulin resistance with gut anti-inflammatory agents
3639. Regulatory function of interferon regulatory factor 3 in obesity, inflammation and insulin resistance (HUM7P. 287)
3640. Regulatory role of CD40 in obesity-induced insulin resistance
3641. Relating smoking, obesity, insulin resistance and ovarian biomarker changes to the final menstrual period (FMP)
3642. Relation between abdominal obesity, insulin resistance and left ventricular hypertrophy diagnosed by electrocardiogram and magnetic resonance imaging in …
3643. Relation between cytokines (TNF-alpha, IL-1 and 6) and homocysteine in android obesity and the phenomenon of insulin resistance syndromes
3644. Relation between obesity in young adulthood and risk of non-insulin-dependent diabetes mellitus
3645. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians
3646. Relation of Chemerin to insulin Resistance, Inflammation and obesity in Egyptian Type II Diabetics
3647. Relation of circulating oxidized LDL to obesity and insulin resistance in children
3648. Relation of circulating resistin to insulin resistance in type 2 diabetes and obesity: a systematic review and meta-analysis
3649. Relation of depot-specific adipose inflammation to insulin resistance in human obesity
3650. Relation of insulin resistance to left ventricular hypertrophy and diastolic dysfunction in obesity
3651. Relation of obesity and Chronic Inflammation, insulin Resistance
3652. Relation of obesity to insulin secretion and clearance in adolescents: the Bogalusa Heart Study.
3653. Relation of plasma kisspeptin levels with obesity and insulin resistance in polycystic ovary syndrome
3654. Relation of the degree of obesity in childhood to adipose tissue insulin resistance
3655. Relation of the white blood cell count to obesity and insulin resistance: effect of race and gender
3656. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men
3657. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D
3658. Relationship among obesity, blood lipids and insulin resistance in Bangladeshi adults
3659. Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome
3660. Relationship among resistance to the insulin and obesity in Zacatecas population
3661. Relationship among serum adiponectin level, obesity and insulin resistance.
3662. Relationship between adiponectin, obesity and insulin resistance
3663. Relationship between alteration of serum leptin level and insulin resistance in simple obesity patients
3664. Relationship between beta~ 3-AR gene and obesity, type 2 diabetes, insulin resistance in Chiness Hans population
3665. Relationship between Body Mass Index and insulin Resistance and Beta Cell Function by obesity Type in Obese Middle-Aged Men
3666. Relationship between degree of obesity and in vivo insulin action in man
3667. Relationship between expression of resistin and insulin resistance in diet-induced obesity and obesity resistant rats [J]
3668. Relationship between Fat Distribution and Leptin-insulin: Needle-Knife Treatment for Simple obesity-A Clinical Study.
3669. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men
3670. Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity
3671. Relationship between immunoreactive insulin and plasma somatomedin-C/insulin-like growth factor-I concentration in childhood obesity
3672. Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity.
3673. Relationship between insulin and somatotropin in obesity.
3674. Relationship between insulin Resistance and Blood Lipids Level in Children with Simple obesity [J]
3675. Relationship between insulin resistance and free fatty acids in children with simple obesity [J]
3676. Relationship between insulin resistance and serum high sensitivity C-reactive protein, blood lipids level in adult with simple obesity [J]
3677. Relationship between insulin resistance and serum levels of adiponectin and resistin with childhood obesity
3678. Relationship between insulin Resistance and Tumor Necrosis Factor-alpha in Children with Simple obesity
3679. Relationship between insulin resistance, incidence of fatty liver and serum ferritin level in adults with simple obesity
3680. Relationship between insulin resistance, inflammation and liver cell apoptosis in patients with severe obesity
3681. Relationship between insulin resistance, insulin secretion and insulin metabolism in simple obesity.
3682. Relationship between insulin Resistance, obesity and Lipid Profile in Diabetic Women with Polycystic Ovarian Syndromes (POS)
3683. Relationship between insulin resistance, obesity and serum prostate-specific antigen levels in healthy men
3684. Relationship between insulin sensitivity and degree of obesity in mild hypertension
3685. Relationship between insulin sensitivity, obesity, body fat distribution and β-endorphinaemia in obese women
3686. Relationship between insulin-sensitive obesity and retinal microvascular abnormalities.
3687. Relationship between Intra-abdominal obesity and insulin Resistance
3688. Relationship between leptin level, index of insulin resistance and the main indicators of carbohydrate and lipid metabolism in patients with varying degrees of obesity
3689. Relationship between Metabolic Syndrome, Metabolic Syndrome Score, insulin Resistance and Beta Cell Function in Korean Adults with obesity
3690. Relationship between obesity and concordance rate for type 2 (non-insulin-dependent) diabetes mellitus among twins
3691. Relationship between obesity and insulin and lipoprotein metabolism in postmenopausal women
3692. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in man
3693. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians.
3694. Relationship between obesity and related indicators with insulin resistance among the residents over 50-year-old in Wuxi area
3695. Relationship between obesity and serun insulin and C-peptide levels in long-term female psychiatric inpatients [J]
3696. Relationship between obesity and the increased risk of major complications in non‐insulin‐dependent diabetes mellitus
3697. Relationship between obesity-associated non-ovulation menstruation dysfunction and insulin resistance
3698. Relationship between obesity, IL-17 and IL-23 and insulin resistance
3699. Relationship between obesity, inflammation and insulin resistance: new concepts
3700. Relationship between obesity, insulin resistance and adipokines in morbidly obese women
3701. Relationship between obesity, insulin resistance, and coronary heart disease risk
3702. Relationship between obesity, metabolic syndrome and insulin resistance in children [J]
3703. Relationship between plasma membrane glycoprotein gene and obesity, type 2 diabetes mellitus, insulin resistance in Chinese population
3704. Relationship between plasma membrane glycoprotein geneand obesity, insulin resistance
3705. Relationship between plasma progranulin and insulin resistance in patients with type 2 diabetes mellitus and obesity
3706. Relationship between preclinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a Color Doppler Imaging Study
3707. Relationship between serum adiponectin, obesity and insulin resistance in nonalcoholic fatty liver disease
3708. Relationship between Serum Leptin Level and RAAS, insulin Sensitivity in Patients with obesity-related Hypertension
3709. Relationship between serum levels of 1-84 parathormone (PTH1-84) and obesity, HOMA insulin-sensitivity or beta-cells function (HOMA-B) in type 2 diabetic patients
3710. Relationship between serum lipoprotein ratios and insulin resistance in obesity
3711. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity
3712. Relationship between serum tumor necrosis factor-aand insulin in the obesity
3713. Relationship between Simple obesity and Risk Factors of insulin Resistance Syndrome in Children [J]
3714. Relationship between skeletal muscle insulin resistance, insulin-mediated glucose disposal, and insulin binding. Effects of obesity and body fat topography.
3715. Relationship between sub-clinical abnormalities of global and regional left ventricular function and insulin resistance in severe obesity: a color Doppler imaging study …
3716. Relationship between the plasma resistin, obesity and insulin resistance in nonalcoholic fatty liver disease patients.
3717. Relationship between TNF-α, obesity and insulin Resistant in Patients with Type Ⅱ Diabetes Mellitus
3718. Relationship between urinary sodium-creatinine ratios and insulin resistance in Korean children and adolescents with obesity
3719. Relationship between visceral obesity and insulin resistance in SD rats induced by high fat diets
3720. #VALUE!
3721. #VALUE!
3722. Relationship of abdominal obesity measured by DXA and waist circumference with insulin sensitivity in Hispanic and non‐Hispanic white individuals: The San Luis …
3723. Relationship of dopamine type 2 receptor binding potential with fasting neuroendocrine hormones and insulin sensitivity in human obesity
3724. RELATIONSHIP OF HUMAN SERUM LEPTIN WITH insulin SERUM LIPIDS AND obesity [J]
3725. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity
3726. Relationship of Internalized Racism to Abdominal obesity and Blood Pressure in Black Women: Implications for the insulin Resistance Syndrome in African Americans
3727. Relationship of islet function to insulin action in human obesity
3728. Relationship of Low-Density Lipoprotein Particle Size to Plasma Lipoproteins, obesity, ana insulin Resistance in Japanese Men
3729. Relationship of monocyte chemoattractant protein 1 (MCP-1) with insulin resistance and body mass index, but not with thermogenetic hormones in obesity
3730. Relationship of obesity and insulin resistance with the cerebrovascular reactivity: a case control study
3731. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors
3732. Relationship of obesity to adipose tissue insulin resistance
3733. Relationship of obesity to insulin resistance in Egyptian women: role of leptin
3734. Relationship of obesity with insulin resistance in polycystic ovarian syndrome
3735. Relationship of plasma insulin concentration and insulin sensitivity to blood pressure. Is it modified by obesity?
3736. Relationship of proinsulin and insulin with noninsulin-dependent diabetes mellitus and coronary heart disease in Japanese-American men: impact of obesity–clinical …
3737. Relationship of serum CXCL5 with obesity and insulin resistance
3738. Relationship of serum resistin with insulin resistance and obesity
3739. Relationships among autonomic dysfunction, obstructive sleep apnea, and insulin resistance in childhood obesity
3740. Relationships among B-endorphin (B-EP), insulin and atrial natriuretic peptide (ANP) in patients with simple obesity
3741. Relationships among inflammatory cytokines, obesity, and insulin sensitivity in the horse,
3742. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk
3743. Relationships Among Left Ventricular Geometry, Arterial-Ventricular Stiffening and insulin Resistance in Childhood obesity
3744. Relationships among obesity, inflammation, and insulin resistance in African Americans and West Africans
3745. Relationships among obesity, inflammation, and insulin resistance in African Americans and West Africans.
3746. #VALUE!
3747. Relationships between diet, obesity and insulin dysregulation in horses and ponies
3748. Relationships between glycaemic abnormalities, obesity and insulin resistance in nondiabetic Polynesians of New Caledonia
3749. Relationships between HDL2-C subfractions and obesity in non-insulin-dependent diabetics
3750. Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity.
3751. Relationships between obesity, body composition and continuous glucose monitoring parameters in subjects with type 2 diabetes on insulin therapy
3752. Relationships between Parameters of insulin Sensitivity, obesity and Liver Aminotransferases in Patients with Nonalcoholic Fatty Liver Disease
3753. Relationships between Plasma Carnitine, Free Fat Acid Levels and insulin Resisitance in Children with Simple obesity
3754. Relationships between Plasma Carnitine, Free Fat Acid Levels and insulin Resisitance in Children with Simple obesity [J]
3755. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the K orean S arcopenic O besity S tudy
3756. Relationships of body composition and liver fat content with insulin resistance in obesity‐matched adolescents and adults
3757. Relationships of obesity indices to serum insulin and lipoproteins in relatives of black patients with noninsulin-dependent diabetes mellitus (NIDDM).
3758. Relationships of Serum Leptin, Tumor Necrosis Factor-? and insulin Resistance in Simple obesity Children
3759. Relationships of Serum Leptin, Tumor Necrosis Factor-alpha and insulin Resistance in Simple obesity Children
3760. Relationships of the systolic blood pressure response during exercise with insulin resistance, obesity, and endurance fitness in men with type 2 diabetes mellitus
3761. Relative adipose tissue failure in Alström syndrome drives obesity-induced insulin resistance
3762. Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women
3763. Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome
3764. Relative importance and conjoint effects of obesity and physical inactivity for the development of insulin resistance
3765. REMOVED: insulin resistance and obesity in childhood and long term consequences during aging
3766. Renal hemodynamics in Otsuka Long-Evans Tokushima fatty rat, a model rat of spontaneous non-insulin-dependent diabetes mellitus with obesity
3767. Renal insulin sensitizing effect of exenatide in a high-fat diet obesity rat model
3768. Renin-angiotensin system blockers protect pancreatic islets against diet-induced obesity and insulin resistance in mice
3769. Replication data for: Modest weight loss improves leptin to adiponectin ratio and induces insulin and leptin resensitivization in individuals with obesity.
3770. Reply to Letter:“Concerning the Article Assessment of Different Bariatric Surgeries in the Treatment of obesity and insulin Resistance in Mice”
3771. Reproductive tissues maintain insulin sensitivity in diet-induced obesity
3772. Reprogrammed functional brown adipocytes ameliorate insulin resistance and dyslipidemia in diet-induced obesity and type 2 diabetes
3773. Requirement of JIP1-mediated c-Jun N-terminal kinase activation for obesity-induced insulin resistance
3774. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor
3775. Rescue of obesity‐induced infertility in female mice due to an ovarian theca cell‐specific knockout of the insulin receptor
3776. Research data supporting” obesity and insulin Resistance are Associated with Reduced Activity in Core Memory Regions of the Brain”
3777. Research for the Relationship between obesity, blood sugar, insulin and Type 2 Diabetes in Kunming
3778. RESEARCH IN EFFECTS OF FAT DISTRIBUTION ON insulin SECRETION AND insulin RESISTANCE IN METABOLIC obesity NORMAL-WEIGHT
3779. Research Methodology of Aerobic Compared to Resistance Training to Reduce insulin Resistance in obesity
3780. Research on Character of Glucose and Lipid Metabolism and insulin Sensitivity in Simple obesity Children
3781. RESEARCH ON THE RELATIONSHIP BETWEEN insulin RESISTANCE AND SUSCEPTIBILITY OF obesity
3782. RESEARCH ON THE RELATIONSHIP OF SERUM TUMOR NECROTIC FACTOR AND insulin LEVEL IN PATIENTS WITH obesity
3783. Research progress in aberrant sphingolipid metabolism and obesity and obesity-mediated insulin resistance
3784. Research progress of Ghrelin and obesity, insulin resistance and type 2 diabetes mellitus
3785. Research progress of mechanism of vitamin D in regulating obesity and insulin resistance on children
3786. Research Progress of Relationship between Estrogen Decrease and Abdominal obesity and insulin Resistance [J]
3787. Research Progress of the Omega-3 Fatty Acids in the Treatment of insulin Resistance, obesity, Diabetes
3788. Research Progress on Pathogenesis of obesity-Induced insulin Resistance and Its Therapeutic Targets: PPARα/γ
3789. Resistance of adipose tissue lipoprotein lipase to insulin action in rats fed an obesity-promoting diet
3790. Resistance to Diet-Induced obesity and Improved insulin Sensitivity in Mice With a Regulator of G Protein Signaling–Insensitive G184S Gnai2 Allele
3791. Resistance to diet-induced obesity and improved insulin sensitivity in mice with an RGS insensitive G184S Gnai2 allele
3792. Resistance to diet-induced obesity: food intake, pancreatic sympathetic tone, and insulin
3793. Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency
3794. Resistance to high-fat diet–induced obesity but exacerbated insulin resistance in mice overexpressing Preadipocyte Factor-1 (Pref-1): a new model of partial …
3795. Resistance to insulin-mediated glucose disposal in patients with noninsulin-dependent diabetes mellitus in the absence of obesity or microalbuminuria–a Clinical …
3796. Resistant starch ameliorated insulin resistant in patients of type 2 diabetes with obesity: a systematic review and meta-analysis
3797. Resistin activity in mice and humans affecting obesity, insulin resistance and T2DM: Blocking resistin action by resistin antagonis
3798. Resistin and obesity-associated insulin resistance
3799. Resistin-a mediator of obesity-associated insulin resistance or an innocent bystander?
3800. Resistin, obesity, and insulin resistance—the emerging role of the adipocyte as an endocrine organ
3801. Resistin’s, obesity and insulin resistance: the continuing disconnect between rodents and humans
3802. Response gene to complement 32 deficiency protects against high‐fat diet‐induced insulin resistance and obesity with decreased hepatic lipogenesis in mice (767.7)
3803. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension
3804. Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and …
3805. Response to insulin Resistance and obesity in a Mouse Model of Systemic Lupus Erythematosus
3806. Response to the association between obesity and nighttime blood pressure in obese children by adjustments of insulin resistance and arterial stiffness
3807. Resting energy expenditure, insulin resistance and UCP1 expression in human subcutaneous and visceral adipose tissue of patients with obesity
3808. Resting whole body energy metabolism in class 3 obesity; from preserved insulin sensitivity to overt type 2 diabetes
3809. RET on Blood Glucose Profile and obesity of a Type II Diabetic Treated with insulin Therapy
3810. Retinal microperimetry: a useful tool for detecting insulin resistance-related cognitive impairment in morbid obesity
3811. Retinoic acid activation of peroxisome proliferation-activated receptor δ represses obesity and insulin resistance
3812. Retinoid and Related Molecules as Biomarkers in obesity and insulin Resistance
3813. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats
3814. Retinol as a cofactor for PKCδ‐mediated impairment of insulin sensitivity in a mouse model of diet‐induced obesity
3815. Retinol binding protein 4 and adiponectin multimers in obesity: influence on insulin resistance and effects of weight reduction
3816. Retraction: Pid1 Induces insulin Resistance in Both Human and Mouse Skeletal Muscle during obesity
3817. Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2
3818. Reversal of diet-induced obesity increases insulin transport into cerebrospinal fluid and restores sensitivity to the anorexic action of central insulin in male rats
3819. Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice
3820. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ
3821. Reversal of obesity-and Diet-Induced insulin Resistance with Salicylates or Targeted Disruption….
3822. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice
3823. Review on the established links between obesity and insulin resistance, with honey as an agent in the management of the disease
3824. Rewiring of Lipid Metabolism in Adipose Tissue Macrophages in obesity: Impact on insulin Resistance and Type 2 Diabetes
3825. RGC-32 deficiency protects against high fat diet-induced obesity and insulin resistance in mice
3826. Rheological determinants and red cell lipidic pattern in essential obesity, in obese subjects with non-insulin-dependent diabetes mellitus (NIDDM) and in obese …
3827. RhoA, Rho kinase, JAK2, and STAT3 may be the intracellular determinants of longevity implicated in the progeric influence of obesity: insulin, IGF-1, and leptin may all …
3828. #VALUE!
3829. Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C> G) in the development of fatty liver
3830. Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C> G) in the development of fatty liver
3831. Role hyperleptinemia, insulin resistance and hyperestrogenemia in the development of ovarian failure in women with obesity
3832. Role of 20-HETE in Diet-Induced obesity and insulin Resistance: Interference with insulin Signaling
3833. Role of abdominal obesity in pathogenesis of insulin resistance syndrome
3834. Role of adipocytokines in obesity-associated insulin resistance
3835. Role of altered gut microbiota in the development of obesity, insulin resistance and type 2 diabetes mellitus
3836. Role of cardiotrophin-1 in obesity and insulin resistance
3837. Role of circulating levels of palmitate and palmitoleate in development of beta cell dysfunction and insulin resistance in pediatric obesity
3838. Role of costimulation in obesity-induced adipose inflammation and insulin resistance: pro-or anti-inflammatory?(P3105)
3839. Role of Endoplasmic Reticulum Stress on the insulin Response in the Fetoplacental Vasculature from Pregestational Maternal obesity
3840. Role of endoplasmic reticulum stress on the insulin response in the fetoplacental vasculature from pregestational maternal obesity.
3841. Role of fatty liver in the association between obesity and reduced hepatic insulin clearance
3842. Role of G protein-coupled receptor kinase 2 (GRK2) in insulin resistance and obesity
3843. Role of Glutathione S-transferase P in High Fat Diet-Induced obesity: Dissociation of Endothelial Dysfunction from insulin Resistance
3844. Role of glycogen synthase kinase 3 (GSK-3) and its substrate proteins in the development of cardiomyopathy associated with obesity and insulin resistance
3845. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding
3846. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity
3847. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity
3848. Role of hypovitaminosis D in the pathogenesis of obesity-induced insulin resistance
3849. Role of IL-6 trans-signalling in obesity induced insulin resistance and metabolic disease
3850. Role of immune cells in obesity induced low grade inflammation and insulin resistance
3851. Role of inflammation in the pathogenesis of insulin resistance in obesity: specific role of reactive oxygen and reactive nitrogen species
3852. Role of insulin and glucagon in obesity
3853. Role of insulin and norepinephrine in the hypertension of obesity
3854. Role of insulin receptors in obesity-related diabetes
3855. ROLE OF insulin VARIABLE NUMBER TANDEM REPEAT POLYMORPHISM IN CHILDHOOD obesity
3856. Role of intestinal inflammation as an early event in obesity and insulin resistance
3857. Role of intracellular free calcium in the obesity and insulin resistance associated with dominant agouti mutations
3858. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes
3859. Role of macrophage migration inhibitory factor in obesity, insulin resistance, type 2 diabetes, and associated hepatic co-morbidities: a comprehensive review …
3860. Role of macrophage tissue infiltration in obesity and insulin resistance
3861. Role of metabolic endotoxemia in insulin resistance and obesity. The Buffering Efficiency Hypothesis
3862. Role of microRNAs on adipogenesis, chronic low-grade inflammation, and insulin resistance in obesity
3863. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance
3864. Role of natural killer T cells in the development of obesity and insulin resistance: insights from recent progress
3865. Role of NKG2D in obesity-induced adipose tissue inflammation and insulin resistance
3866. Role of NO/VASP signaling pathway against obesity-related inflammation and insulin resistance
3867. Role of O-GlcNAcylation and endoplasmic reticulum stress on obesity and insulin resistance
3868. Role of obesity and fat distribution in non-insulin-dependent diabetes mellitus in Mexican Americans and non-Hispanic whites
3869. Role of obesity and hyperinsulinemia in the insulin resistance of obese subjects with the clinical triad of polycystic ovaries, hirsutism and acanthosis nigricans
3870. Role of obesity, insulin resistance, and steatosis in hepatitis C virus infection
3871. Role of phosphorylated fetuin-A in insulin action, insulin resistance, obesity, and moderate weight loss
3872. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance
3873. Role of PKC and CaV1. 2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice
3874. Role of PKC and CaV1. 2 in Detrusor Overactivity in a Model of obesity Associated with insulin Resistance in Mice
3875. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation
3876. Role of protein tyrosine phosphatases in the modulation of insulin signaling and their implication in the pathogenesis of obesity-linked insulin resistance
3877. Role of PYK2 in the development of obesity and insulin resistance
3878. Role of regulatory T cells in obesity and insulin resistance
3879. Role of resistin in obesity, insulin resistance and Type II diabetes
3880. Role of the fatty acid binding protein mal1 in obesity and insulin resistance
3881. Role of the Monocyte/Macrophage Cell Lineage in obesity-Related insulin Resistance
3882. Role of the Neutral Amino Acid Transporter Slc7a10 in Adipocyte Lipid Storage, obesity and insulin Resistance
3883. Role of-55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity
3884. Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease
3885. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations
3886. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk
3887. Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease
3888. Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity
3889. Rosiglitazone Improves insulin Sensitivity and Baroreflex Gain in Rats with Diet‐induced obesity
3890. S-296: The association of atherosclerosis and combination of fatty liver, insulin resistance and obesity
3891. S-Nitrosoglutathione reductase dysfunction contributes to obesity-associated hepatic insulin resistance via regulating autophagy
3892. S100B serum levels in schizophrenia are presumably related to visceral obesity and insulin resistance
3893. Safflomide Increases the Expression of Adiponectin in Vitro and in Vivo: Potential Implication for Hypoadiponectemia, Visceral obesity, and insulin Resistance
3894. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity
3895. Sar1b transgenic male mice are more susceptible to high-fat diet-induced obesity, insulin insensitivity and intestinal chylomicron overproduction
3896. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008–2011)
3897. Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III
3898. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys …
3899. Sarcopenia, sarcopenic obesity and insulin resistance
3900. Sarcopenic obesity and cognitive functioning: the mediating roles of insulin resistance and inflammation?
3901. Sarcopenic obesity and insulin resistance: application of novel body composition models
3902. Sarcopenic obesity and insulin resistance: Application of novel body composition models
3903. Sarcopenic obesity and insulin resistance: Application of novel body composition models
3904. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences
3905. Sargassum fusiforme Fucoidan Alleviates High-Fat Diet-Induced obesity and insulin Resistance Associated with the Improvement of Hepatic Oxidative Stress and Gut …
3906. Sasa veitchii extract reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet
3907. SAT-245 Estimated insulin Sensitivity Score Predicts Post-OSTT insulin Secretion and GI Hormone Differences in Adolescents with obesity and PCOS
3908. Saturated free fatty acids activate a c-Src-JNK1 axis within lipid rafts: Implications for the development of insulin resistance, obesity, and obesity-associated cancer
3909. SBP2 deficiency in adipose tissue macrophages drives insulin resistance in obesity
3910. SCD1 deficiency prevents obesity‐induced macrophage recruitment into white adipose tissue and improves the associated adipose insulin resistance
3911. SCIENTIFIC: FRUCTOSE: A HIGHLY LIPOGENIC NUTRIENT IMPLICATED IN THE EPIDEMIC OF insulin RESISTANCE, obesity AND TYPE 2 DIABETES
3912. Screening survivors of childhood acute lymphoblastic leukemia for obesity, metabolic syndrome, and insulin resistance
3913. Sea cucumber saponin liposomes ameliorate obesity-induced inflammation and insulin resistance in high-fat-diet-fed mice
3914. Seafood intake and the development of obesity, insulin resistance and type 2 diabetes
3915. Search for the Causal Genes of obesity-Induced insulin Resistance by Analyzing the Expression Profile in Human Adipose Tissues.
3916. Selective activation of estrogen receptor α activation function-1 is sufficient to prevent obesity, steatosis, and insulin resistance in mouse
3917. Selective inactivation of c-Jun NH2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal …
3918. Selective Kv1. 3 channel blocker as therapeutic for obesity and insulin resistance
3919. Selective Macrophage Ablation Attenuates Diet-Induced obesity and insulin Resistance and Reverses Diabetic Cardiomyopathy
3920. Selenoprotein P is elevated in individuals with obesity, but is not independently associated with insulin resistance
3921. Semaphorin-induced Inflammation Contributes to insulin Resistance in Dietary obesity
3922. Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity
3923. Sensitivity of the isolated adipose tissue to insulin in obesity with presence or absence of diabetes mellitus
3924. Serum 25-hydroxyvitamin D is associated with insulin resistance independently of obesity in children ages 5–17
3925. Serum adiponectin is associated with family history of diabetes independently of obesity and insulin resistance in healthy Korean men and women
3926. Serum adiponectin levels and its association with insulin resistance and obesity in women with poly cystic ovarian syndrome.
3927. Serum amino acid concentrations are modified by age, insulin resistance, and BCAT2 rs11548193 and BCKDH rs45500792 polymorphisms in subjects with obesity
3928. Serum asprosin concentrations are increased and associated with insulin resistance in children with obesity
3929. Serum autotaxin/ENPP 2 correlates with insulin resistance in older humans with obesity
3930. Serum C1q/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin …
3931. Serum CCN3 levels are increased in type 2 diabetes mellitus and associated with obesity, insulin resistance and inflammation
3932. Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: the influence of very …
3933. Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo-and hypertensive patients …
3934. Serum CTRP3 Levels In Obese Children: A Potential Protective Adipokine Of obesity, insulin Sensitivity And Pancreatic β Cell Function
3935. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation
3936. Serum IL‐36 cytokines levels in type 2 diabetes mellitus patients and their association with obesity, insulin resistance, and inflammation
3937. Serum Immunoreactive insulin (IRI) and Its Relationship to obesity, Body Fat Distribution, Blood Pressure and Fasting Blood Glucose in Egyptian Women
3938. Serum insulin and leptin levels in children with epilepsy on valproate-associated obesity
3939. Serum insulin and leptin levels in valproate‐associated obesity
3940. Serum insulin in obesity and diabetes mellitus
3941. Serum insulin, leptin and growth hormone levels are associated with body mass index and obesity index in adolescents
3942. Serum insulin, obesity, and the incidence of type 2 diabetes in black and white adults: the atherosclerosis risk in communities study: 1987–1998
3943. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity
3944. Serum Interleukin-6 Levels and Its Correlation with insulin Resistance, Sytemic Hypertension in obesity
3945. Serum irisin level is higher and related with insulin in acanthosis nigricans-related obesity
3946. Serum leptin and insulin resistance in obesity and effects of sibutramine on them
3947. Serum leptin and insulin tests in obesity
3948. Serum leptin concentration and insulin sensitivity in men with abdominal obesity
3949. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study
3950. Serum level of insulin-like growth factor-I in type 2 diabetic patients: impact of obesity
3951. Serum Levels and significance of insulin-like growth factors binding protein in obesity
3952. Serum levels of spexin and kisspeptin negatively correlate with obesity and insulin resistance in women
3953. #VALUE!
3954. #VALUE!
3955. Serum lipids and lipoproteins in 157 insulin dependent diabetic children and adolescents in relation to metabolic regulation, obesity and genetic hyperlipoproteinemia
3956. Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults
3957. #VALUE!
3958. Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome: relationships to insulin resistance and obesity
3959. Serum Osteoprotegerin, a Potential Novel Marker of Systemic Inflammation: The Influence of obesity, insulin Sensitivity and Oral Glucose Loading on its Circulating …
3960. Serum paraoxonase-1 activity in children: the eff ects of obesity and insulin resistance
3961. Serum progranulin levels in relation to insulin resistance in childhood obesity
3962. Serum R-Spondin 1 is a new surrogate marker for obesity and insulin resistance
3963. Serum resistin concentrations are higher in human obesity but independent from insulin resistance
3964. Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents
3965. Serum resistin levels are associated with obesity but not with insulin resistance in children and adolescents
3966. Serum Resistin Levels are Associated with obesity but not with insulin Resistance in Children and Adolescents
3967. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
3968. Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy
3969. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes
3970. Serum sex hormone–binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women
3971. Serum soluble tumor necrosis factor-α receptor 2 is elevated in obesity but is not related to insulin sensitivity: a study in identical twins discordant for obesity
3972. Serum visfatin concentration in obesity and impaired glucose tolerance-relationship with insulin resistance, blood pressure and proinflammatory factors
3973. Serum visfatin is associated with type 2 diabetes mellitus independent of insulin resistance and obesity
3974. Serum zinc level and its relation to insulin resistance and lipid profile in childhood and adolescent obesity
3975. Serum-to-saliva transfer of the immunoreactive insulin (IRI) in children with obesity associated with insulin-resistance.
3976. Severe obesity and insulin Resistance due to Deletion of the Maternal Gsα Allele Is Reversed by Paternal Deletion of the Gsα Imprint Control Region
3977. Sex differences in obesity-related glucose intolerance and insulin resistance
3978. Sex differences in the association between dietary restraint, insulin resistance and obesity
3979. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation
3980. Sex steroid hormones, upper body obesity, and insulin resistance
3981. Sex-dependent differences in rat hepatic lipid accumulation and insulin sensitivity in response to diet-induced obesity
3982. Sex-related differences in the relations of insulin resistance and obesity to left ventricular hypertrophy in Japanese hypertensive patients
3983. Sex-specific role of adipose-derived lipocalin-2 in diet-induced obesity and insulin resistance
3984. Sfrp5 serum concentration is associated with measures of glucose homeostasis and insulin sensitivity in human obesity
3985. SGI‐1252, a TGF‐beta inhibitor, protects against diet‐induced obesity and insulin resistance in mice
3986. Shaping the stress response: interplay of palatable food choices, glucocorticoids, insulin and abdominal obesity
3987. SHHF/Mcc-cp Rat: Model of obesity, Non-insulin-dependent Diabetes, and Congestive Heart Failure
3988. SHIP2, a factor associated with diet-induced obesity and insulin sensitivity, attenuates FGF signaling in vivo
3989. Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and insulin resistance
3990. Short stature, abdominal obesity, insulin resistance and alterations in lipid profile in very low-income women living in Macei¾, north-eastern Brazil.
3991. Short stature, abdominal obesity, insulin resistance and alterations in lipid profile in very low-income women living in Maceió, north-eastern Brazil
3992. Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice
3993. Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y …
3994. Short-Term Effects of Early Menopause on Adiposity, Fatty Acids Profile and insulin Sensitivity of a Swine Model of Female obesity
3995. Sicyos angulatus prevents high-fat diet-induced obesity and insulin resistance in mice
3996. Signal transduction links intramyocellular triglycerides to muscle insulin resistance in obesity
3997. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
3998. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
3999. Single and concurrent effects of endurance and resistance training on plasma visfatin, insulin, glucose and insulin resistance of non-athlete men with obesity
4000. Sirt1 rescues the obesity induced by insulin‐resistant constitutively‐nuclear FoxO1 in POMC neurons of male mice
4001. SIRT3 deficiency induces endothelial insulin resistance and blunts endothelial-dependent vasorelaxation in mice and human with obesity
4002. #VALUE!
4003. Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans
4004. Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus
4005. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss
4006. Skeletal muscle inflammation and insulin resistance in obesity
4007. Skeletal muscle insulin resistance in hamsters with diabetes developed from obesity is involved in abnormal skeletal muscle LXR, PPAR and SREBP …
4008. Skeletal muscle insulin resistance in morbid obesity: the role of interleukin-6 and leptin
4009. Skeletal muscle insulin resistance in obesity-associated type 2 diabetes in monkeys is linked to a defect in insulin activation of protein kinase C-ζ/λ/ι
4010. Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes
4011. Skeletal muscle mitochondrial bioenergetics and morphology in high fat diet induced obesity and insulin resistance: focus on dietary fat source
4012. Skeletal muscle Nur77 and NOR1 insulin responsiveness is blunted in obesity and type 2 diabetes but improved after exercise training
4013. Skeletal muscle peroxisome proliferator-activated receptor-gamma expression in obesity and non-insulin-dependent diabetes mellitus.
4014. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice
4015. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity
4016. Skeletal muscle tissue Trib3 links obesity with insulin resistance by autophagic degradation of AKT2
4017. Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?
4018. Skeletal muscle–specific deletion of MKP-1 reveals a p38 MAPK/JNK/Akt signaling node that regulates obesity-induced insulin resistance
4019. Ski Overexpression in Skeletal Muscle Modulates Genetic Programs That Control Susceptibility to Diet‐Induced obesity and insulin Signaling
4020. Slc6a19 deficiency improves insulin sensitivity and preserves cardiac function in mice during diet-induced obesity
4021. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia
4022. Sleep apnea and its association with the stress system, inflammation, insulin resistance and visceral obesity
4023. Sleep disorders and the development of insulin resistance and obesity
4024. Sleep disorders in a sample of students in Taif University, Saudi Arabia: The role of obesity, insulin resistance, anemia and high altitude
4025. Sleep duration, obesity and insulin resistance in a multi-ethnic UK population at high risk of diabetes
4026. Sleep duration, obesity, and insulin resistance for children
4027. Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes
4028. Slower activation of insulin action in hypertension associated with obesity
4029. Slower activation of insulin action in upper body obesity
4030. Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet
4031. Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance
4032. Small artery remodeling in obesity and insulin resistance
4033. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity
4034. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity
4035. Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes
4036. Smilax chinensis Linn.(Liliaceae) root attenuates insulin resistance and ameliorate obesity in high diet induced obese rat
4037. Smoking in Relation to obesity, Inflammation, insulin Resistance and Adipokines in Men with Type 2 Diabetes.
4038. Smoking, fasting serum insulin, and obesity are the predictors of carotid atherosclerosis in relatively young subjects
4039. Smoking, obesity and body fat distribution are independently associated with insulin resistance and other cardiovascular risk factors
4040. SNPs in the insulin-like growth factor gene and obesity impact on colorectal cancer in Egyptians
4041. So what comes first: the obesity or the insulin resistance? And which is more important?
4042. SO023 HEPATOCYTE GROWTH FACTOR (HGF) PRECLUDE HIGH-FAT DIET-INDUCED obesity AND IMPROVED insulin RESISTANCE IN MICE
4043. Socioeconomic status, obesity and non‐insulin dependent diabetes in Mexican Americans in Starr County, Texas
4044. SOD3 Is Secreted by Adipocytes and Mitigates High-Fat Diet-Induced obesity, Inflammation, and insulin Resistance
4045. Sodium butyrate epigenetically modulates high‐fat diet‐induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome …
4046. Solidago chilensis Meyen hydroalcoholic extract reduces JNK/IκB pathway activation and ameliorates insulin resistance in diet-induced obesity mice
4047. SORLA facilitates insulin receptor signaling in adipocytes and exacerbates obesity
4048. Soy protein isolates prevent loss of bone quantity associated with obesity in rats through regulation of insulin signaling in osteoblasts
4049. Soy protein reduces insulin resistance in skeletal muscle of obese zucker fa/fa rats or in diet induced obesity (DIO)
4050. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors
4051. Specific insulin sensitivity and leptin responses to a nutritional treatment of obesity via a combination of energy restriction and fatty fish intake
4052. Specific relation between abdominal obesity and early-phase hyperglycemia is modulated by hepatic insulin resistance in healthy older women
4053. Sphk2−/− mice are protected from obesity and insulin resistance
4054. Spinophilin-deficient mice are protected from diet-induced obesity and insulin resistance
4055. Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity
4056. Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
4057. Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistance
4058. Splenectomy attenuates obesity and decreases insulin hypersecretion in hypothalamic obese rats
4059. Spontaneous obesity and weight loss: insulin action in the dormouse
4060. Spontaneous obesity and weight loss: insulin binding and lipogenesis in the dormouse
4061. SRT1720 attenuates obesity and insulin resistance but not liver damage in the offspring due to maternal and postnatal high-fat diet consumption
4062. ß-Cell function or insulin resistance was associated with the risk of type 2 diabetes among women with or without obesity and a history of gestational diabetes.
4063. Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier
4064. STAT1 Ablation in CD11c+ Cells Protects Mice from obesity-Induced insulin Resistance
4065. STAT1 dissociates adipose tissue inflammation from insulin sensitivity in obesity
4066. STAT4 deficiency reduces obesity-induced insulin resistance and adipose tissue inflammation
4067. Statement of Retraction. Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced obesity and insulin Resistance. Diabetes 2007; 56: 1986–1998
4068. Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro
4069. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice
4070. Steroid metabolomic signature of insulin resistance in childhood obesity
4071. Stilbenes: Beneficial Effects of Resveratrol Metabolites in obesity, Dyslipidemia, insulin Resistance, and Inflammation
4072. Stimulating brown fat: a potential future therapeutic approach for obesity and insulin resistance
4073. Strain-specific Differences in the Effects of Lymphocytes on the Development of insulin Resistance and obesity in Mice
4074. Strategies to reverse diet-and age-induced obesity and insulin resistance
4075. Stressed out about obesity and insulin resistance
4076. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats
4077. Structural equation modeling of the associations between the home environment and obesity-related cardiovascular fitness and insulin resistance among Hispanic …
4078. Studies of insulin and growth hormone secretion in human obesity
4079. Studies of insulin sensitivity in vivo in weanling rats with hypothalamic obesity
4080. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects
4081. Studies on diabetogenic action of obesity in mice congenital insulin resistance of KK mice
4082. Studies on fat cell function in human obesity and insulin resistance
4083. STUDIES ON obesity I. THE insulin-GLUCOSE TOLERANCE CURVE
4084. Studies on obesity. III. Effect of ascorbic acid on the insulin-glucose tolerance curve
4085. STUDIES ON THE MECHANISMS OF insulin RESISTANCE IN CHILDHOOD obesity
4086. Study of association between common variation in the insulin-like growth factor 2 gene and indices of obesity and body size in middle-aged men and women
4087. Study of carnitine palmitoyltransferase 1A (CPT1A) in adipose tissue. Effects on obesity, inflammation and insulin resistance
4088. Study of combined therapy of Qiwei Baizhu powder and Buyang Huanwu decoction for type 2 diabetes mellitus with obesity and insulin resistance [J]
4089. Study of Genetic Variation in the STAT3 on obesity and insulin Resistance in Male Adults
4090. Study of insulin sensitivity and β-cell function in non-obesity first degree relative in type 2 diabetic families
4091. Study of insulin-like growth factor I in human obesity
4092. Study of relationship between T+ 45G in Adiponectin gene polymorphism with insulin resistance and obesity in non-alcoholic fatty liver patients
4093. Study of the effects of monacolin k and other constituents of red yeast rice on obesity, insulin-resistance, hyperlipidemia, and nonalcoholic steatohepatitis …
4094. Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance
4095. Study of the relationship between obesity and insulin sensitive index in children [J]
4096. Study of the relevance in plasma homo cysteine level, obesity and insulin resistance in old male with type 2dia betes accompanying hypertension
4097. Study of the role of vegf overexpression in adipose tissue in diet-induced obesity and insulin resistance
4098. Study on correlation between distribution of abdominal adipose tissue and insulin resistance in patients type 2 diabetes mellitus complicating obesity
4099. Study on insulin receptor substrate in children with obesity and type 2 diabetes
4100. Study on insulin Secretion’s Characteristic of Stagnation of Liver Qi and Stomach Heat of obesity Type 2 Diabetes
4101. Study on insulin sensitivity and islet p cell’s function in obesity and non-obesity type 2 diabetes
4102. Study on insulin sensitivity and islet# bate# cell’s function in obesity an d non-obesity type 2 diabetes
4103. Study on lipid compositions of the skeletal and liver tissues in animals with the induced alimentary obesity and insulin resistance
4104. Study on some biochemical parameters in peripheral blood of animals upon diet-induced obesity and insulin resistance modeling
4105. Study on the Correlation of Fibroblast Growth Factor 21 Level with the obesity, Lipid Metabolism and insulin Resistance in Patients with Non-Alcoholic Fatty …
4106. Study on the Influence of catgut implantation at acupoint on simple obesity Leptin and insulin resistance [J]
4107. Study on the insulin Resistance According to obesity in the Patients with Polycystic Ovarian Syndrome
4108. Study on the obesity and insulin resistance of polycystic ovary syndrome
4109. Study on the Relationship between TCM Syndrome Differentiation and insulin Resistance in Simple obesity Patients
4110. Study on the relationship between the serum adiponectin and insulin levels in female children with simple obesity
4111. Study on the relationships of childhood obesity and the duration of sleep as well as insulin resistance
4112. Study Progress of Low-Grade Inflammation in Pathogenesis of Children with obesity and insulin Resistance
4113. #VALUE!
4114. Subcapsular steatonecrosis in response to peritoneal insulin delivery: a clue to the pathogenesis of steatonecrosis in obesity.
4115. Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 …
4116. Subclinical atherosclerosis in youth: relation to obesity, insulin resistance, and polycystic ovary syndrome
4117. Subcutaneous adipose tissue imaging of human obesity reveals two types of adipocyte membranes: insulin-responsive and-nonresponsive
4118. Subcutaneous adipose tissue PAI-1 gene expression has a diurnal variation and it correlates with obesity and insulin resistance
4119. Subcutaneous Fat Fibrosis Links obesity to insulin
4120. Subcutaneous fat fibrosis links obesity to insulin resistance in Chinese Americans
4121. Subjugation of hypothalamic NPY and cohorts with central leptin gene therapy alleviates dyslipidemia, insulin resistance, and obesity for life-time
4122. Submucosal fat accumulation in human colorectal tissue and its association with abdominal obesity and insulin resistance
4123. Substrate interactions in the development of insulin resistance in type II diabetes and obesity
4124. Success of laparoscopic ovarian wedge resection is related to obesity, lipid profile, and insulin levels
4125. Successful kidney transplantation is associated with weight gain from truncal obesity and insulin resistance
4126. Successful symptomatic tazarotene treatment of juvenile acanthosis nigricans of the familial obesity-associated type in insulin resistance
4127. Successful symptomatic tazarotene treatment of juvenile familial obesity-associated acanthosis nigricans associated with insulin-resistance
4128. Successful treatment of obesity and insulin resistance via ketogenic diet status post Roux-en-Y
4129. Sucrose feeding in mouse pregnancy leads to hypertension, and sex-linked obesity and insulin resistance in female offspring
4130. Sugar-induced obesity and insulin resistance are uncoupled from shortened survival in Drosophila
4131. SUN-LB103 The Relationship Between Alcohol Consumption Patterns and insulin Sensitivity in obesity
4132. Sunflower oil supplementation has proinflammatory effects and does not reverse insulin resistance in obesity induced by high-fat diet in C57BL/6 mice
4133. Supplement. obesity, hypertension, insulin resistance and lipid disorders: Cross-sectional and longitudinal studies in Japanese adolescents and middle-aged men
4134. Supplemental arginine above the requirement during suckling causes obesity and insulin resistance in rats
4135. #VALUE!
4136. Suppression of adaptive immune cell activation does not alter innate immune adipose inflammation or insulin resistance in obesity
4137. Suppression of body weight gain preserves acute insulin response to glucose in the portal vein of spontaneously type 2 diabetic rats with visceral obesity
4138. Suppression of insulin secretion by protein deprivation in obesity
4139. Suppression of insulin Secretion in the Treatment of obesity: A Systematic Review and Meta‐Analysis
4140. Suppression of whole body and regional lipolysis by insulin: effects of obesity and exercise
4141. Suppressive effects of insulin on tumor necrosis factor–dependent early osteoarthritic changes associated with obesity and type 2 diabetes mellitus
4142. Surrogates of insulin sensitivity and indices of cardiometabolic profile in obesity
4143. Susceptibility to oxidative stress, insulin resistance, and insulin secretory response in the development of diabetes from obesity
4144. Swim exercise inhibits hemostatic abnormalities in a rat model of obesity and insulin resistance
4145. Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance
4146. Sympathetic nervous system and insulin resistance: from obesity to diabetes
4147. Symptoms at the menopausal and premenopausal years: their relationship with insulin, glucose, cortisol, FSH, prolactin, obesity and attitudes towards sexuality
4148. Synergistic effects of male sex and obesity on hepatic insulin dynamics in SHR/Mcc-cp rat
4149. Systemic and white adipose tissue inflammation in obesity and insulin resistance
4150. Systemic fatty acid uptake and skeletal muscle inflammatory pathway activation may contribute to the variability in insulin sensitivity found in obesity
4151. Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity
4152. T-008 IMPACT OF insulin RESISTANCE AND obesity ON ELEVATED BLOOD PRESSURE IN CHILDREN AND ADOLESCENTS: THE BCAMS STUDY
4153. T-cell costimulation protects obesity-induced adipose inflammation and insulin resistance
4154. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance
4155. T1/T2: CS1–Central or Peripheral Regulation in obesity and insulin Sensitivity?
4156. Targeted ablation of GIP-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet
4157. Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a …
4158. Targeted deletion of thioesterase superfamily member 1 promotes energy expenditure and protects against obesity and insulin resistance
4159. Targeted delivery of CRISPR interference system against Fabp4 to white adipocytes ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance
4160. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle
4161. Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer …
4162. Targeting BCAA catabolism to treat obesity-associated insulin resistance
4163. Targeting CITED2 for Angiogenesis in obesity and insulin Resistance
4164. Targeting inhibition of CCR5 on improving obesity-associated insulin resistance and impairment of pancreatic insulin secretion in high fat-fed rodent models
4165. Targeting insulin resistance with selected antidiabetic agents prevents menopausal associated central obesity, dysglycemia, and cardiometabolic risk
4166. Targeting mitochondrial biogenesis and mitochondrial substrate utilization to treat obesity and insulin resistance, respectively-two data-driven hypotheses
4167. Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients
4168. Targeting obesity, insulin resistance and Type 2 diabetes with immunotherapy: the challenges ahead
4169. Targeting TGF-β signaling for obesity/insulin resistance-associated hepatocellular carcinoma
4170. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study
4171. Telmisartan attenuates obesity-induced insulin resistance via suppression of AMPK mediated ER stress
4172. Telomere length in relation to insulin resistance, inflammation and obesity among Arab youth
4173. Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance
4174. Temporal changes in skeletal muscle capillary responses and endothelial-derived vasodilators in obesity-related insulin resistance
4175. Temporal relations between obesity and insulin: longitudinal data from the Normative Aging Study
4176. Testing the carbohydrate-insulin model of obesity in a 5-month feeding study: the perils of post-hoc participant exclusions
4177. Testosterone deficiency, insulin-resistant obesity and cognitive function
4178. Testosterone, obesity and insulin resistance in young males: evidence for an association between gonadal dysfunction and insulin resistance during puberty
4179. TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental insulin Resistance in Aging and obesity
4180. TG: HDL-C ratio is a good marker to identify children affected by obesity with increased cardiometabolic risk and insulin resistance
4181. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease
4182. The abdominal obesity phenotype and insulin resistance are associated with abnormalities of the hypothalamic-pituitary-adrenal axis in humans
4183. The activity of the pyruvate dehydrogenase complex in heart and liver from mice during the development of obesity and insulin resistance
4184. The adipocyte fatty acid-binding protein links obesity and insulin resistance
4185. The adipokin visfatin insulin sensitivity, inflammation regulator in patients with hypertension and obesity
4186. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance
4187. The adipose transcriptional response to insulin is determined by obesity, not insulin sensitivity
4188. The Adipose Transcriptional Response to insulin Is Determined by obesity, Not insulin Sensitivity
4189. The aging rodent: insulin resistance, obesity, and metabolic compensation
4190. The allelic variant of LAR gene promoter–127 bp T→ A is associated with reduced risk of obesity and other features related to insulin resistance
4191. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice
4192. The antilipolytic effect of insulin in human adipose tissue in obesity, diabetes mellitus, hyperinsulinemia, and starvation
4193. The apelinergic system: sexual dimorphism and tissue-specific modulations by obesity and insulin resistance in female mice
4194. The Association among vitamin D, insulin resistance, and obesity in Turkish women
4195. The association between bone age advancement and insulin in prepubertal children with obesity
4196. The association between dyslipidaemia and obesity in Chinese men after adjustment for insulin resistance
4197. The Association Between Migraine, Metabolic Syndrome, insulin Resistance, and obesity in Women: A Case-Control Study
4198. The Association Between obesity and Nighttime Blood Pressure in Obese Children by Adjustments of insulin Resistance and Arterial Stiffness
4199. The Association between obesity–insulin Resistance and Depression-Anxiety: One Center, Cross-Sectional Study
4200. The association between plasma adiponectin and insulin sensitivity in humans depends on obesity
4201. The association between polymorphismsin insulin and obesity related genesand risk of colorectal cancer
4202. The Association between SOCS1− 1656G> A Polymorphism, insulin Resistance and obesity in Nonalcoholic Fatty Liver Disease (NAFLD) Patients
4203. The association between vitamin D receptor polymorphisms and tissue-specific insulin resistance in human obesity
4204. The association beween insulin resistance and patterns of obesity in Korean adults
4205. The Association of a Rare Variant of-93,-53 Promoter Gene Polymorphisms of Lipoprotein Lipase Gene with obesity and insulin Resistance
4206. The association of brain natriuretic peptide and insulin resistance in obesity-related hypertension
4207. The association of cysteine with obesity, inflammatory cytokines and insulin resistance in Hispanic children and adolescents
4208. The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women
4209. The association of obesity with insulin resistance in male patients with obstructive sleep apnea syndrome in Korea
4210. The association of plasma levels of miR-34a AND miR-149 with obesity and insulin resistance in obese children and adolescents
4211. The associations between VDR BsmI polymorphisms and risk of vitamin D deficiency, obesity and insulin resistance in adolescents residing in a tropical …
4212. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat
4213. The bad association: obesity, periodontal disease, inflammation and insulin resistance. Review and personal findings.
4214. The big picture on obesity and insulin resistance
4215. The cannabinoid Δ 9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
4216. The carbohydrate-insulin model of obesity is difficult to reconcile with current evidence
4217. The carbohydrate-insulin model of obesity: beyond “calories in, calories out”
4218. The causal effect of obesity on prediabetes and insulin resistance reveals the important role of adipose tissue in insulin resistance
4219. The CC genotype of the GNAS T393C polymorphism is associated with obesity and insulin resistance in women with polycystic ovary syndrome
4220. The changes of serum leptin and insulin contents in elderly male patients with obesity-related hypertension
4221. The cholesterol transporter Abcg1, a candidate gene for obesity: deletion of Abcg1 in mice corrects diet-induced insulin resistance
4222. The clinical effect of the insulin glargine pins acarbose and/or metformin in treating type 2 diabetes mellitus with obesity
4223. The complex interactions among serotonin, insulin, leptin, and glycolipid metabolic parameters in human obesity
4224. The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity
4225. The correlation between circulating ghrelin and insulin resistance in obesity: a meta-analysis
4226. The correlation of intra-abdominal fat area with insulin resistance in male with abdominal obesity
4227. #VALUE!
4228. The Correlation Study on Childhood obesity, insulin Resistance and Androgens
4229. The correlationship between serum free fatty acid and insulin resistanse in overweight and obesity subjects [J]
4230. The cross-link between adipokines, insulin resistance and obesity in offspring of diabetic pregnancies
4231. The crucial role of a phosphatase in insulin resistance and obesity
4232. The dual amylin‐and calcitonin‐receptor agonist KBP‐042 increases insulin sensitivity and induces weight loss in rats with obesity
4233. The dual-specificity phosphatase 2 (DUSP2) does not regulate obesity-associated inflammation or insulin resistance in mice
4234. The dualistic effect of COX-2-mediated signaling in obesity and insulin resistance
4235. The E3 ubiquitin ligase Pellino3 protects against obesity-induced inflammation and insulin resistance
4236. The early origins of obesity and insulin resistance: timing, programming and mechanisms
4237. The Economic Burden of insulin Resistance, obesity, and Cardiovascular Disease in Medicare Beneficiaries 65 Years of Age and Older
4238. The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin?
4239. The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women
4240. The effect of aerobic exercise on epicardial adipose tissue, insulin resistance, and some liver enzymes in high-fat diet-induced obesity male wistar rat
4241. The effect of BVT. 2733 on insulin resistance and inflammation in obesity mice
4242. The effect of dietary fiber and other factors on insulin response: role in obesity.
4243. The effect of different intensities running on serum glucose and insulin concentrations in two types of obesity
4244. The effect of exercise on paraoxonase-1 activity and lipid profile in obesity and insulin resistance conditions
4245. The Effect of High insulin Resistance and obesity on serum level of IL-12 in a sample of Iraqi patients with Type 2 Diabetes Mellitus
4246. The effect of insulin resistance and obesity on low− density lipoprotein particle size in children
4247. The effect of insulin secretion function on the development of impaired glucose tolerance and diabetes mellitus in obesity
4248. The effect of intrahippocampal insulin infusion on spatial cognitive function and markers of neuroinflammation in diet-induced obesity
4249. The effect of long-term treatment with fosinopril on degree of obesity, insulin sensitivity and metabolism in patients with essential hypertension
4250. The effect of maternal obesity on pregnancy outcomes of women with gestational diabetes controlled with diet only, glyburide, or insulin
4251. The effect of mazindol on insulin and glucagon secretion in rats with ventromedial hypothalamic obesity
4252. The effect of metformin on serum visfatin in relation to polycystic ovarian syndrome, obesity and insulin resistance
4253. The effecT of N-sTearoyleThaNolamiNe oN adipocyTes free cholesTerol coNTeNT aNd phospholipid composiTioN iN raTs wiTh obesity-iNduced insulin …
4254. The effect of N-stearoylethanolamine on adipocytes free cholesterol content and phospholipid composition in rats with obesity-induced insulin resistance
4255. The effect of N-stearoylethanolamine on cholesterol content, fatty acid composition and protein carbonylation level in rats with alimentary obesity-induced insulin …
4256. The effect of N-stearoylethanolamine on liver phospholipid composition of rats with insulin resistance caused by alimentary obesity
4257. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
4258. THE EFFECT OF obesity AND insulin RESISTANCE ON ENDOPLASMIC RETICULUM STRESS
4259. The effect of obesity and insulin Resistance on Liver Enzymes in Type2 Diabetes Mellitus
4260. The effect of obesity and insulin resistance on macular choroidal thickness in a pediatric population as assessed by enhanced depth imaging optical coherence …
4261. The effect of obesity on ovarian function. I. Serum insulin and insulin dependent protein concentrations in obese patients with polycystic ovary syndrome
4262. The Effect of obesity on Serum Growth Factors, and insulin-like Growth Factor Binding Protein-3 Proteolysis in Children with Simple obesity.
4263. The effect of obesity on testicular function by insulin-like factor 3, inhibin B, and leptin concentrations in obese adolescents according to pubertal stages
4264. The effect of physical training on insulin production in obesity
4265. The effect of processed Tempeh Gembus to triglycerides levels and insulin resistance status in women with obesity
4266. The effect of sibutramine on plasm leptin and insulin levels in obesity [J]
4267. The Effect of Succinate on Skeletal Muscle Respiration in Diet Induced obesity and insulin Resistance
4268. The effect of succinic acid on the metabolic profile in high‐fat diet‐induced obesity and insulin resistance
4269. The Effect of the −308A Allele of the TNF‐α Gene on insulin Action Is Dependent on obesity
4270. The Effect of Tianmaixiaoke Tablet on obesity with insulin Resistance in Women with Polycystic Ovary Syndrome
4271. The effect of unsweetened pomegranate juice on insulin resistance, high sensitivity c-reactive protein and obesity among type 2 diabetes patients
4272. The effects of a green rooibos extract on the reproductive function of obesity-induced insulin resistant or hypertensive male wistar rats
4273. The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
4274. The Effects of Acusector Needling at Certain Time on the insulin Levels of Female with Simple obesity [J]
4275. The effects of acute and chronic exercise on insulin sensitivity in obesity and type 2 diabetes
4276. The effects of diet-induced obesity on hepatocyte insulin signaling pathways and induction of non-alcoholic liver damage
4277. #VALUE!
4278. The effects of genes, environment and ethnicity on insulin resistance and obesity in aboriginal and non-aboriginal South American populations
4279. The effects of high fat diet-induced obesity and interval and continuous exercise training on visceral fat SIRT1 and insulin resistance in male rats
4280. The Effects of Hypertension, obesity, and insulin Resistance on Myocardial Structure, Function, and insulin Signaling
4281. The effects of Jiao-Tai-Wan on sleep, inflammation and insulin resistance in obesity-resistant rats with chronic partial sleep deprivation
4282. The Effects of Mori folium on insulin Resistance and Adipose Tissue Inflammation in an Experimental Mouse Model of obesity
4283. The Effects of obesity on Spontaneously Hypertensive Rats at Aspects of insulin Leptin and Endothelin
4284. The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus
4285. The Effects of obesity on the Relationships Among insulin-like Growth Factor 1 and Markers of Diabetes
4286. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-γ target genes, in dogs
4287. THE EFFECTS OF PHENFORMIN ON PERIPHERAL GLUCOSE UTILIZATION AND insulin ACTION IN obesity AND DIABETES MELLITUS*
4288. The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus
4289. The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes.
4290. The effects of starch‐entrapped microsphere supplementation on obesity and insulin resistance in C57BL/6J mice
4291. The endocannabinoid system, obesity, and insulin resistance
4292. #VALUE!
4293. The enteric enhancement of glucose-stimulated insulin release: the role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus
4294. The epidemic of type 2 diabetes mellitus: its links to obesity, insulin resistance, and lipotoxicity
4295. The equine metabolic syndrome: Studies on the pathophysiology of obesity, insulin resistance, and laminitis in equids
4296. The equine model to study the influence of obesity and insulin resistance in human ovarian function
4297. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice
4298. The etiology of obesity-induced insulin resistance
4299. The Experimental Study on the Relationship Between insulin Resistance and Leptin Resistance and Hypertension with obesity
4300. The expression of TNF-αconverting enzyme gene, TNF-αgene in omental adipose tissue of obesity and insulin resistance patients
4301. The Fasting Serum Glucose, insulin and C-peptide Levels in Children with obesity.
4302. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
4303. The forkhead transcription factor Foxo1: a possible link between obesity and insulin resistance
4304. The frequent UCP2− 866G> A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among …
4305. The full capacity of AICAR to reduce obesity-induced inflammation and insulin resistance requires myeloid SIRT1
4306. THE FUNCTION OF insulin RECEPTOR (IRF) IN EVOLUTION OF obesity, CORRELATION WITH ADIPOCYTES DIAMETERS
4307. The G-308A variant of the Tumor Necrosis Factor-α (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution
4308. The genetic ablation of SRC-3 protects against obesity and improves insulin sensitivity by reducing the acetylation of PGC-1α
4309. The glucoregulatory and antilipolytic actions of insulin in abdominal obesity with normal or impaired glucose tolerance: an in vivo and in vitro study
4310. The glucose-dependent insulinotropic polypeptide and glucose-stimulated insulin response to exercise training and diet in obesity
4311. The growth hormone (GH)-binding protein in obesity with varying glucose tolerance: relationship with body fat distribution, insulin, GH-insulin-like growth factor (IGF)-I …
4312. The Growth Hormone/insulin-like Growth Factor System in the Management of Diabetes and obesity
4313. The gut microbiota, obesity and insulin resistance
4314. The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits visceral obesity and insulin resistance by upregulating …
4315. The herbal extract ALS-L1023 from Melissa officinalis alleviates visceral obesity and insulin resistance in obese female C57BL/6J mice
4316. THE HERITABILITY STUDY OF HYPERTENSION, obesity AND HYPERLIPIDEMIA WITH insulin RESISTANCE.
4317. The Il-4/STAT6 Signaling Pathway in the Development of obesity Induced insulin Resistance
4318. The imbalance of fatty acids metabolism under obesity and diabetes mellitus type II in women with insulin resistance
4319. The immune-metabolic regulatory roles of epoxyeicosatrienoic acids on macrophages phenotypic plasticity in obesity-related insulin resistance
4320. The impact of activation of the renin-angiotensin system in the development of insulin resistance in experimental models of obesity
4321. The impact of bariatric surgery in the levels of IGF-I, glucose, insulin and insulin resistance among patients with morbid obesity
4322. The Impact of Bariatric Surgery on obesity related Metabolic Traits with Specific Emphasis on Glucose, insulin and Proinsulin
4323. The Impact of Diet on insulin Dynamics over a 2-Year Period in Children with a Family History of obesity
4324. The impact of exercise training compared to caloric restriction on hepatic and peripheral insulin resistance in obesity
4325. The Impact of IGFBP-3/IGFBP-3R System on obesity-associated insulin Resistance
4326. The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning
4327. The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C
4328. The impact of insulin-independent, glucagon-induced suppression of total ghrelin on satiety in obesity and type 1 diabetes mellitus
4329. The impact of maternal obesity, age, pre-eclampsia and insulin dependent diabetes on severe maternal morbidity by mode of delivery—a register-based cohort study
4330. The impact of myeloid cell-restricted insulin receptor deficiency on obesity-induced insulin resistance
4331. The impact of obesity and insulin resistance on iron and red blood cell parameters: a single center, cross-sectional study
4332. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome
4333. The impact of obesity and insulin resistance on thyroid cancer: a systematic review
4334. The impact of obesity on insulin sensitivity and secretion during pubertal progression: a longitudinal study
4335. The Impact of obesity on State of insulin Resistant in Non-Diabetic Subjects
4336. The Impact of obesity on the Relationship of Serum 25-Hydroxyvitamin D with insulin Sensitivity and Beta Cell Function.
4337. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone
4338. The Impact of Serum Leptin, Leptin Receptor and insulin on Maternal obesity
4339. The importance of cyclooxygenase 2-mediated oxidative stress in obesity-induced muscular insulin resistance in high-fat-fed rats
4340. The importance of dietary modulation of cAMP and insulin signaling in adipose tissue and the development of obesity
4341. The imprinted gene Delta like non-canonical notch ligand 1 (Dlk1) associates with obesity and triggers insulin resistance through inhibition of skeletal muscle …
4342. THE INCIDENCE OF obesity AND insulin RESISTANCE IN OFFSPRING OF DIABETIC MOTHERS
4343. THE INDICATORS OF insulin RESISTANCE IN PATIENTS WITH NONALCHOLIC STEATOHEPATITIS WITH obesity AND SECONDARY HYPERTENSIVE …
4344. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II
4345. The influence of atorvastatin on omentin-1 level and insulin resistance in patients with coronary artery disease and obesity
4346. The Influence of Catgut Implantation at Acupoint on insulin Resistance of Simple obesity
4347. The influence of different fats and fatty acids on obesity, insulin resistance and inflammation
4348. The influence of effective treatment of diabetes mellitus and obesity on the plasma concentration of immunoreactive insulin
4349. The influence of high fat diet on plasma incretins and insulin concentrations in Sprague-Dawley rats with diet-induced obesity and glucose intolerance undergoing …
4350. The influence of insulin on the raised plasma fibronectin concentration in human obesity
4351. The influence of insulin resistance and obesity on left atrial size in Japanese hypertensive patients
4352. The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow
4353. The influence of insulin, insulin resistance, and leptin on the effectiveness of weight reduction therapy in simple obesity
4354. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease
4355. The influence of obesity and diabetes in the monkey on insulin and glucagon binding to liver membranes
4356. The influence of obesity on puberty and insulin resistance in Mexican children
4357. The influence of obesity on the development of non-insulin-dependent diabetes mellitus
4358. The Influence of Physical Activity on the Bioactive Lipids Metabolism in obesity-Induced Muscle insulin Resistance
4359. The Influence of T4 Conversion to T3 and insulin on the Hyperglycemia and Central obesity
4360. The insulin gene variable number of tandem repeats (INS VNTR) genotype and sleep disordered breathing in childhood obesity
4361. The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity
4362. The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes
4363. The insulin Receptor in Circulating Cells, with Special Reference to the Red Blood Cells. Its Characteristics in Some Disease States (obesity and Diabetes Mellitus)
4364. The insulin receptor in obesity and other states of altered insulin sensitivity
4365. The insulin Receptor Substrate-1 (IRS-1) Gly972Arg Polymorphism Is Associated with obesity in the Quebec Family Study (QFS)
4366. The insulin receptor: its role in insulin resistance of obesity and diabetes
4367. The insulin resistance indices and tissue damage markers in obesity, impaired glucose tolerance and type 2 diabetes mellitus
4368. The insulin resistance—dyslipidemic syndrome of visceral obesity: effect on patients’ risk
4369. The insulin resistant-dyslipidemic syndrome of visceral obesity: An atherogenic cluster
4370. The insulin sensitivity and adiponectin in patients with obesity and hypertension
4371. The insulin-like growth factor axis, adipokines, physical activity, and obesity in relation to breast cancer incidence and recurrence
4372. The insulin-like growth factor system in obesity, insulin resistance and type 2 diabetes mellitus
4373. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature
4374. The insulin-like growth factors in adipogenesis and obesity
4375. The integrative role of leptin, oestrogen and the insulin family in obesity‐associated breast cancer: potential effects of exercise
4376. The interaction between immune cells and adipocytes in obesity and its relation to insulin resistance
4377. The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood …
4378. The interactions of obesity, inflammation and insulin resistance in breast cancer
4379. The interconnections of molecular mechanisms of hormone actions and their role in pathogenesis of obesity, insulin resistance, and diabetes mellitus
4380. The interplay between cyclic AMP and insulin during obesity development
4381. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.
4382. The interrelationships among obesity, insulin sensitivity, and bone phenotype in pre-pubertal girls
4383. The Interrelationships between Fasting Serum insulin Level, obesity and Blood Pressure in Women: Results from across-Sectional Population Study of Women in …
4384. The intestinal immune system in obesity and insulin resistance
4385. The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes
4386. The Involvement of Perivascular Adipose Tissue in obesity-Associated Microvascular Dysfunction and insulin Resistance
4387. The levels of leptin and insulin in obese rats and obesity resistant rats induced by high fat diet
4388. The Levels of Plasma insulin and Erythrocyte insulin Receptors in Children with Acanthosis Nigricans Associated with obesity
4389. The Levels of Serum Irisin as a Predictor of insulin Resistance in Han Chinese Adults with Metabolically Healthy obesity.
4390. The Link between obesity and insulin Resistance with Alterations of Left Ventricular Structure and Function in Obese Women
4391. The lipocalin-type prostaglandin D2 synthase knockout mouse model of insulin resistance and obesity demonstrates early hypothalamic-pituitary-adrenal axis …
4392. The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment
4393. The liver X receptor agonist T0901317 protects mice from high fat diet-induced obesity and insulin resistance
4394. The long-term ingestion of a diet high in extra virgin olive oil produces obesity and insulin resistance but protects endothelial function in rats: a preliminary …
4395. The lymphatic system in obesity, insulin resistance, and cardiovascular diseases
4396. THE MACROPHAGE A2B ADENOSINE RECEPTOR REGULATES obesity-INDUCED TISSUE insulin SENSITIVITY
4397. The magnolia bioactive constituent 4-O-methylhonokiol protects against high-fat diet-induced obesity and systemic insulin resistance in mice
4398. The Mechanisms and Impact of obesity and insulin Resistance on Breast Cancer Incidence
4399. The metabolic disorders in membrane of erythrocytes and insulin-binding activity of blood cells in patients under obesity and diabetes mellitus type II
4400. The Metabolic Effects of Diet-induced obesity and Growth Hormone Treatment in Long-lived Mice with Altered insulin and insulin-like Growth Factor-1 Signaling
4401. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity
4402. The metabolic syndrome—from insulin resistance to obesity and diabetes
4403. The Metabolic Syndrome—The Link Between obesity, insulin Resistance and Cardiovascular Disease
4404. The metabolic syndrome, obesity, and insulin resistance
4405. The metabolism of lipids in obesity. 2. The influence of insulin on unesterified fatty acids of blood plasma.
4406. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
4407. The molar ratio of C-peptide to insulin after two consecutive stimulations with glucagon in obesity.
4408. The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes
4409. The neglected insulin: IGF-II, a metabolic regulator with implications for diabetes, obesity, and cancer
4410. The neutrophil-lymphocyte ratio and its relationship with insulin resistance in obesity
4411. The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function
4412. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
4413. The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance
4414. The ob gene and insulin: a relationship leading to clues to the understanding of obesity
4415. The obese Göttingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile
4416. The obesity-induced adipokine sST2 exacerbates adipose Treg and ILC2 depletion and promotes insulin resistance
4417. The obesity-Linked Gene Nudt3 Drosophila Homolog Aps Is Associated With insulin Signaling
4418. The operative risk factors in the metabolic syndrome: Is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity?
4419. The Pathobiology of Osteoarthritis in obesity: The Role of Synovial Inflammation, Joint insulin Resistance, and Dysbiosis of the Gut Microbiome
4420. The pathogenesis of pancreatic islet cell hyperplasia and insulin insensitivity in obesity
4421. The Pleiotropic Effect of the ENPP1 (PC-1) Gene on insulin Resistance, obesity, and Type 2 Diabetes
4422. The potential of phototherapy to reduce body fat, insulin resistance and “metabolic inflexibility” related to obesity in women undergoing weight loss treatment
4423. The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance
4424. The Preliminary Study on insulin resistant of Childhood obesity.
4425. The Pro12Ala PPARγ2 gene missense mutation is associated with obesity and insulin resistance in Swedish middle‐aged men
4426. The problem of prevention and treatment of insulin resistance, obesity and carbohydrate metabolism disorders, preservation of reproductive potential in athletes with …
4427. The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity
4428. The prostaglandin E2 receptor EP4 regulates obesity-related inflammation and insulin sensitivity
4429. The protective effects of Chinese yam polysaccharide against obesity-induced insulin resistance
4430. The protein S100A4 as a novel marker of insulin resistance in prepubertal and pubertal children with obesity
4431. The Q 2 relationship between obesity, insulin and arsenic methylation capability in 2 Taiwan adolescents
4432. The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance
4433. The regulation of insulin signaling and Akt/PKB activity by obesity
4434. The relation between insulin and adipocyte insulin receptors during treatment of human obesity
4435. The relation between obesity and Periodontitis; Emphasis on the inflammatory state and insulin resistance
4436. The relation of leptin and insulin with obesity-related cardiovascular risk factors in US adults
4437. THE RELATION OF obesity, insulin RESISTANCE AND CARDIOVASCULAR RISK IN TYPE 2 DIABETIC PATIENTS IN SUDAN
4438. The Relationship Among obesity, Inflammation, and insulin Resistance
4439. The relationship between adipocytokines and insulin resistance in the patients with obesity and type 2 diabetes mellitus [J]
4440. The relationship between adiposopathy and glucose-insulin homeostasis is not affected by moderate-intensity aerobic training in healthy women with obesity
4441. The relationship between apelin serum levels and insulin resistance in children with simple obesity
4442. The relationship between apelin serum levels and insulin resistance in children with simple obesity [J]
4443. The relationship between circulating andorgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian …
4444. The Relationship between Epicardial Adipose Tissue and insulin Resistance in Overweight and obesity Adults
4445. The relationship between human plasma leptin and obesity as well as plasma insulin concentration [J]
4446. The relationship between human plasma leptin levels and obesity, plasma glucose as well as insulin concentrations
4447. #VALUE!
4448. The Relationship between insulin Resistance and Plasma Level of IL-18 in obesity Type 2 Diabetes Mellitus Patients
4449. The relationship between insulin resistance assessed by HOMA-IR and serum osteoprotegerin levels in obesity
4450. The relationship between insulin resistance, obesity, and endotrophin
4451. THE RELATIONSHIP BETWEEN insulin RESISTANCE, obesity, AND INFLAMMATION
4452. The relationship between insulin-sensitive obesity and cardiovascular diseases in a Chinese population: results of the REACTION study
4453. The relationship between juvenile serum leptin levels and obesity, serum glucose as well as insulin concentrations [J]
4454. The relationship between leptin resistance and insulin resistance in men with obesity
4455. The relationship between obesity, insulin and arsenic methylation capability in Taiwan adolescents
4456. The Relationship between obesity, insulin resistance and aldosterone levels
4457. The relationship between obesity, insulin resistance, and conjunctival impression cytology
4458. The relationship between obesity, plasma immunoreactive insulin concentration and blood pressure in newly diagnosed Indian type 2 diabetic patients
4459. The relationship between obesity, vascular reactivity and endothelial dysfunction in subjects with non-insulin dependent diabetes mellitus.
4460. The relationship between obesity. insulin resistance and serum homocysteince (Hcy) level in patients with type 2 diabetes mellitus [J]
4461. The relationship between plasma androgens (testosterone and dehydroepiandrosterone sulfate), insulin resistance and visceral obesity in elderly men
4462. #VALUE!
4463. The relationship between poor growth rate and increased risk of Type 2 diabetes, insulin resistance and obesity
4464. The relationship between postprandial abnormal serum triglyceride metabolism and insulin resistance in obesity and hypertensive patients
4465. The relationship between renin-aldosterone system and obesity in non-insulin dependent diabetes mellitus (NIDDM).
4466. The relationship between serum leptin and type 2 diabetes mellitus, obesity and insulin resistance [J]
4467. The relationship between serum leptin levels and insulin resistance in hypertensive and obesity patients.
4468. The relationship between serum magnesium levels wıth childhood obesity and insulin resistance: a review of the literature
4469. The relationship between serum phosphate levels with childhood obesity and insulin resistance
4470. The relationship between testosterone and dehydroepiandrosterone sulfate concentrations, insulin resistance and visceral obesity in elderly men
4471. The relationship between the hyperplastic pancreatic islet and insulin insensitivity in obesity
4472. The relationship between the immune system and the inflammatory mechanisms in obesity with insulin resistance.
4473. The relationship between the obesity and insulin resistance
4474. The relationship between% body fat and obesity, plasma glucose as well as insulin concentrations
4475. The relationship of adiponectin, leptin and ghrelin to insulin resistance and cardiovascular risk factors in human obesity
4476. #VALUE!
4477. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men.
4478. The Relationship of Gastrin Levels with obesity Anthropometrics, Lipid, Glucose, and insulin Levels in Children and Adolescents with obesity
4479. The relationship of obesity and growth hormone to serum insulin levels
4480. The relationship of serum ghrelin expression and insulin resistance in patients with obesity
4481. The Relationship of the Plasma ATGL level with obesity and insulin Resistance in Patients with Type 2 Diabetes Mellitus
4482. The Relationship of the Serum Resistin Level, Lipid Level, obesity and insulin Resistance in Patients with Metabolic Syndrome
4483. #VALUE!
4484. The relative effects of obesity and insulin resistance on cardiovascular risk factors in nondiabetic and normotensive men
4485. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance
4486. The renin‐angiotensin system: a link between obesity, inflammation and insulin resistance
4487. The retinoic acid receptor‐related orphan nuclear receptor γ1 (RORγ1): a novel player determinant of insulin sensitivity in morbid obesity
4488. The risk of developing obesity, insulin resistance, and metabolic syndrome in former power-sports athletes-Does sports career termination increase the risk
4489. The role and research progress of the balance and interaction between regulatory T cells and other immune cells in obesity with insulin resistance
4490. #VALUE!
4491. The role of ACE2/Ang 1–7/Mas axis in the white adipose tissue for the prevention of obesity and insulin resistance through aerobic exercise training
4492. The role of adipocyte hypertrophy and hypoxia in the development of obesity-associated adipose tissue inflammation and insulin resistance
4493. The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids
4494. The Role of Adipokine in obesity and insulin Resistance (Summary)
4495. The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity
4496. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance
4497. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.
4498. The Role of Ankrd2 in obesity‐Induced Inflammation and insulin Resistance
4499. The role of dietary fat in hypothalamic insulin and leptin resistance and the pathogenesis of obesity
4500. The role of dietary fat in obesity-induced insulin resistance
4501. The role of dietary fats in hypertension, obesity and insulin resistance: a comparative study of animals and humans in fetal and adult life
4502. The role of different adipocyte size populations in the mediation of obesity-related insulin resistance and inflammation
4503. The role of energy & fatty acid metabolism in obesity and insulin resistance
4504. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus
4505. The role of ghrelin in obesity and insulin resistance (Greliinin merkitys lihavuudessa ja insuliiniresistenssissä)
4506. The role of glycogen synthase kinase-3 (GSK-3) protein in the development of myocardial hypertrophy in a rat model of diet induced obesity and insulin resistance
4507. The Role of Heat Shock Protein 72 in Preventing obesity-induced insulin Resistance
4508. The role of high fat diets and liver peptidase activity in the development of obesity and insulin resistance in wistar rats
4509. The role of IGF-1 resistance in obesity and type 2 diabetes-mellitus-related insulin resistance and vascular disease
4510. #VALUE!
4511. The role of IL-29 in obesity-induced inflammation and insulin resistance
4512. The Role of Inflammation and Dipeptidyl Peptidase IV in the Developmental Programming of obesity and insulin Resistance
4513. The role of inflammation and oxidative stress in the association of obesity and insulin resistance
4514. The role of insulin and insulin-like growth factor-1/FoxO-mediated transcription for the pathogenesis of obesity-associated dementia
4515. The role of insulin in relation to stress and nutritional state: glucose homeostasis after surgery in obesity and in old age
4516. The role of insulin-like growth factor-1 and insulin like growth factor-1 receptor in obesity and oesophageal cancer
4517. The Role of Intramyocellular Fatty Acids on the Etiology of the insulin Resistance of obesity
4518. The Role of JNk Signaling Pathway in obesity
4519. The role of key adipokines in obesity and insulin resistance in cats
4520. The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children
4521. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity
4522. THE ROLE OF LYSOPHOSPHATIDIC ACID AND AUTOTAXIN IN obesity-INDUCED CARDIAC insulin RESISTANCE
4523. The role of macrophage accumulation in adipose tissue in the development of obesity-induced insulin resistance
4524. The role of Nrf2: adipocyte differentiation, obesity, and insulin resistance
4525. The role of obesity in insulin resistance
4526. The role of obesity‐related genetic loci in insulin sensitivity
4527. The role of perilipin in human obesity and insulin resistance
4528. The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance
4529. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction
4530. The role of PPARs in obesity and other insulin resistance associated disorders
4531. The role of PPARγ in high-fat diet-induced obesity and insulin resistance
4532. The role of production of adipsin and leptin in the development of insulin resistance in patients with abdominal obesity
4533. The role of resistin in obesity-induced insulin resistance.
4534. The role of stearoyl‐CoA desaturase in obesity, insulin resistance, and inflammation
4535. The role of the immune system in obesity and insulin resistance
4536. The Role of the Intestinal Immune System in Diet-Induced obesity and insulin Resistance
4537. The role of the novel adipokines WISP1 and sFRP4 in obesity and type 2 diabetes and their impact on insulin action and energy metabolism in muscle and liver
4538. The role of the Nrf2 signaling in obesity and insulin resistance
4539. The Role of the Prostaglandin E2 EP3 Receptor in obesity, insulin Resistance, and Glycemic Control
4540. The role of the renin-angiotensin system in obesity and insulin resistance
4541. The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice
4542. The role of TNFα and TNF receptors in obesity and insulin resistance
4543. The role of tumor necrosis factor alpha and leptin in obesity and insulin resistance
4544. The role of tumour necrosis factor (TNF)-alpha resistance in obesity and insulin resistance
4545. The role of uncoupling protein 2 in macrophages and its impact on obesity-induced adipose tissue inflammation and insulin resistance
4546. The role of uric acid in the insulin resistance in children and adolescents with obesity
4547. The Role of Vitamin D in obesity and Diabetes: Ca2+ Signaling, insulin Secretion, Adipocyte Apoptosis, and Bone Mineralization
4548. The Role of White Adipose Tissue in the Development of obesity-associated insulin Resistance and Endogenous Fat Mass Control
4549. The roles of c‐Jun NH2‐terminal kinases (JNKs) in obesity and insulin resistance
4550. The roles of IL-6, IL-10, and IL-1RA in obesity and insulin resistance in African-Americans
4551. The Roles of IL-6, IL-10, and IL-1RA in obesity and insulin Resistance in African-Americans
4552. The Roles of insulin, obesity, and Fat Distribution in the Elevation of Cardiovascular Risk Factors in Impaired Glucose Tolerance The San Luis Valley Diabetes Study
4553. The safety and efficacy of a controlled low-energy (‘very-low-calorie’) diet in the treatment of non-insulin-dependent diabetes and obesity
4554. The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus
4555. The serum concentration of tumor necrosis factor alpha is not an index of growth-hormone-or obesity-induced insulin resistance
4556. The sliding set-point: how insulin and diet interact to explain the obesity epidemic (and how to fix it)
4557. The State of blood lipid spectrum and the indicators of insulin resistance in patients with nonalcholic steatohepatitis with obesity and hypertensive disease
4558. The study of insulin resistance and leptin resistance on the model of simplicity obesity rats by curcumin
4559. The Study of Relationship Between Adiponectin and insulin Resistance in Type 2 Diabetic Patients with obesity [J]
4560. The study of the relationship between obesity and insulin resistance in Kazakans
4561. The subunit assembly state of the Mediator complex is nutrient-regulated and is dysregulated in a genetic model of insulin resistance and obesity
4562. The Synthetic Polyphenol and AMPK Activator, S17834, Improves Diet-Induced obesity, insulin Resistance, Hyperlipidemia, and Atherosclerosis in LDL Receptor …
4563. The T lymphocyte insulin receptor in diabetes and obesity: an intrinsic binding defect
4564. The thrifty ‘catch-up fat’phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome
4565. The transcriptional coactivators p/CIP and SRC-1 control insulin resistance through IRS1 in obesity models
4566. The Transition From obesity with insulin Resistance to Type-2 Diabetes Mellitus Is Associated With Progressively Worsening In Myocardial Substrate Metabolism
4567. The treatment effects of dietary oils on diet-induced obesity, lipidemia, and insulin resistance in skeletal muscle tissue of obese prone rats
4568. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers
4569. The use of antimicrobials as adjuvant therapy for the treatment of obesity and insulin resistance: Effects and associated mechanisms
4570. The use of U‐500 regular insulin in the management of patients with obesity and insulin resistance
4571. The variation of fasting plasma insulin and free fatty acid In overweight or obesity patients with type 2 diabetes mellitus
4572. The vicious cycle of myostatin signaling in sarcopenic obesity: myostatin role in skeletal muscle growth, insulin signaling and implications for clinical trials
4573. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury.
4574. The β3-Adrenergic Receptor and Susceptibility to obesity, the insulin Resistance Syndrome, and Noninsulin-Dependent Diabetes Mellitus
4575. Theabrownin from Pu-erh tea together with swinging exercise synergistically ameliorates obesity and insulin resistance in rats
4576. Therapeutic Inhibition of miR-33 Does Not Promote obesity, insulin Resistance or Hepatic Lipid Accumulation
4577. Therapeutic Potential of insulin-sensitizing Drugs in the Treatment of Prostate Cancer with Coexisting obesity
4578. Therapeutic silencing of fat-specific protein 27 improves glycemic control in mouse models of obesity and insulin resistance
4579. Therapy-resistant hypertension associated with central obesity, insulin resistance, and large muscle fibre area
4580. Thermic effect of infused glucose and insulin in man. Decreased response with increased insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
4581. Thiazolidinediones, insulin resistance and obesity: finding a balance
4582. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus
4583. Thiol/disulphide homeostasis, ischemia modified albumin, and ferroxidase as oxidative stress markers in women with obesity with insulin resistance
4584. Thrombospondin-1 (TSP1) Is an Adipokine Associated with obesity and insulin Resistance.
4585. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance
4586. Thrombospondin‐1 (TSP1) is an adipokine associated with obesity, insulin resistance and inflammation
4587. Thrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin sensitivity in a diet-induced obese mouse model
4588. Thyroid hormone status in women at mid-life: Its roles in insulin resistance, obesity and inflammation
4589. Thyroid hormone-regulated skeletal muscle Glut4 glucose transporter trafficking during fasting in diet-induced obesity and insulin resistance
4590. Thyroid stimulating hormone, insulin resistance and leptin in patients with obesity after bariatric surgery
4591. Time course of plasma free fatty acid concentration in response to insulin: effect of obesity and physical fitness
4592. Time-restricted feeding improves insulin resistance and hepatic steatosis in a mouse model of postmenopausal obesity
4593. Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion
4594. Tissue specific regulation of insulin signalling: a mechanism of glucocorticoid induced obesity?
4595. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity
4596. Tissue Triglycerides, insulin Resistance, and insulin Production: Implications for Hyperinsulinemia of obesity
4597. Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes
4598. Tissue-specific regulation of recycling between cortisol and cortisone by insulin and obesity
4599. Tissue‐Specificity and Ethnic Diversity in obesity‐Related Risk of Cancer May Be Explained by Variability in insulin Response and insulin Signaling Pathways
4600. TLR4 expression in bone marrow-derived cells is both necessary and sufficient to produce the insulin resistance phenotype in diet-induced obesity
4601. TLR4 in bone marrow-derived cells mediates obesity-induced insulin resistance
4602. TNF-alpha Converting Enzyme heterozygous mice are protected from obesity-induced insulin resistance and diabetes
4603. TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl) purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway
4604. To Study the Association of Free insulin Levels, obesity Markers & Lipid Profile Parameters in Newly Diagnosed Patients of Type 2 Diabetes Mellitus in Tertiary …
4605. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity
4606. Toll‐like receptor 4 deficiency attenuates insulin resistance and endothelial dysfunction associated with obesity and diabetes in mice
4607. TonEBP/NFAT5 promotes obesity and insulin resistance by epigenetic suppression of white adipose tissue beiging
4608. Topiramate treatment improves hypothalamic insulin and leptin signaling and action and reduces obesity in mice
4609. Towards the insulin resistance and obesity diagnosis: A dimensional analysis approach
4610. Tracking changes of the parameters of glucose-insulin homeostasis during the course of obesity in B6D2F1 mice
4611. Traditional bone matrix proteins in obesity, insulin resistance and diabetes: state of the art and perspectives
4612. TRAF3IP2 (TRAF3 Interacting Protein 2) Mediates obesity-Associated Vascular insulin Resistance and Dysfunction in Male Mice
4613. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys
4614. Trans-fatty acids aggravate obesity, insulin resistance and hepatic steatosis in C57BL/6 mice, possibly by suppressing the IRS1 dependent pathway
4615. Transcriptional analysis of FOXO1, C/EBP-α and PPAR-γ2 genes and their association with obesity-related insulin resistance
4616. Transcriptomic Identification of ADH1B as a Novel Candidate Gene for obesity and insulin Resistance in Human Adipose Tissue in Mexican Americans from …
4617. Transgenerational epigenetics, paternal obesity, and insulin resistance
4618. Transgenic expression of cholesterol 7α‐hydroxylase in the liver prevents high‐fat diet–induced obesity and insulin resistance in mice
4619. Transgenic expression of CYP7A1 in the liver prevents high fat diet‐induced obesity and insulin resistance in mice
4620. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance
4621. Transgenic hyperinsulinemia: a mouse model of insulin resistance and glucose intolerance without obesity
4622. Transgenic mice with dominant negative PKC‐theta in skeletal muscle: A new model of insulin resistance and obesity
4623. Transient Activation of Skeletal Muscle Rac1 in obesity-Related insulin Resistance
4624. Transient receptor potential vanilloid type‐1 channel regulates diet‐induced obesity, insulin resistance, and leptin resistance
4625. Translational Physiology: Chronic kidney disease and obesity bias surrogate estimates of insulin sensitivity compared with the hyperinsulinemic euglycemic …
4626. Traumatic brain injury and obesity induce persistent central insulin resistance
4627. Treatment of insulin resistance in obesity-associated type 2 diabetes mellitus through adiponectin gene therapy
4628. Treatment of obesity as an insulin resistance
4629. Treatment of obesity by controlled fasting in patients with type 1 diabetes mellitus effect on insulin sensitivity and glucose metabolism
4630. Treatment options in insulin resistance obesity–related acanthosis nigricans
4631. Treatment with a catalytic superoxide dismutase (SOD) mimetic improves liver steatosis, insulin sensitivity, and inflammation in obesity-induced type 2 diabetes
4632. Treatment with metformin improves erectile dysfunction in a murine model of obesity associated with insulin resistance
4633. Tregs facilitate obesity and insulin resistance via a Blimp-1-IL-10 axis
4634. Trehalose prevents adipocyte hypertrophy and mitigates insulin resistance in mice with established obesity
4635. TREM2 regulates obesity-induced insulin resistance via adipose tissue remodeling in mice of high-fat feeding
4636. Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice
4637. TRPA1 in obesity and insulin resistance
4638. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure
4639. Tumor necrosis factor alpha (TNF-alpha) gene G-308A polymorphism relationship to insulin resistance and lipid abnormalities in children with obesity
4640. Tumor necrosis factor-alpha-238 and-308 polymorphisms do not associated with traits related to obesity and insulin resistance.
4641. Tumor necrosis factor-alpha; a possible pathogenic factor in obesity in insulin resistant and non-insulin-dependent diabetes mellitus?
4642. Tumor necrosis factor-α as a mediator of the insulin resistance of obesity
4643. Tumor necrosis factor-α, insulin resistance, the lipoprotein metabolism and obesity in humans
4644. Tumor necrosis factor-Α, interleukin-6, C-reactive protein levels and insulin resistance associated with type 2 diabetes in abdominal obesity women
4645. Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance
4646. Type 2 diabetes mellitus in childhood: obesity and insulin resistance
4647. Type 2 Diabetes, obesity, and risk for dementia: recent insights into brain insulin resistance and hypometabolism
4648. Type 3 diabetes and physical exercise: intercourses on obesity, insulin resistance and cognitive disorders/DIABETES MELLITUS TIPO 3 E EXERCICIO FISICO …
4649. Type II NKT cells stimulate diet-induced obesity by mediating adipose tissue inflammation, steatohepatitis and insulin resistance
4650. Ubc13 haploinsufficiency protects against age-related insulin resistance and high-fat diet-induced obesity
4651. Ubiquitin ligase Cbl-b and obesity-induced insulin resistance
4652. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and b3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no …
4653. UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects
4654. Unacylated ghrelin improves insulin sensitivity in the early phase of obesity
4655. Unacylated, acylated ghrelin and obestatin levels are differently inhibited by oral glucose load in pediatric obesity: association with insulin sensitivity and metabolic …
4656. Uncoupling of insulin resistance from obesity by overexpressing the A (1) adenosine receptor in adipose tissue.
4657. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein
4658. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, β cell dysfunction, and type 2 diabetes
4659. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion
4660. Understanding Mechanisms of insulin Resistance in Diabetes and obesity
4661. Uninephrectomy and class II PI3K‐C2β inactivation synergistically protect against obesity, insulin resistance and liver steatosis in mice
4662. Unmasking the janus faces of autophagy in obesity‐associated insulin resistance and cardiac dysfunction
4663. Unraveling the Pathophysiology of obesity-Related insulin Resistance—A Perspective on “Adipose Tissue Inflammation Is Directly Linked to obesity-Induced insulin …
4664. Unsaturated fatty acids and insulin resistance in childhood obesity
4665. Untargeted profiling of concordant/discordant phenotypes of high insulin resistance and obesity to predict the risk of developing diabetes
4666. Unusual suspects in the development of obesity-induced inflammation and insulin resistance: NK cells, iNKT cells, and ILCs
4667. Up-regulation of PPARγ coactivator-1α as a strategy for preventing and reversing insulin resistance and obesity
4668. Upper abdominal obesity, insulin resistance and breast cancer risk
4669. Upregulation of PTEN Gene Expression in Adipocytes by Oxidized Low Density Lipoprotein: Implication for Impairment of insulin Signaling in obesity.
4670. Uptake of long chain free fatty acids is selectively up-regulated in adipocytes of Zucker rats with genetic obesity and non-insulin-dependent diabetes mellitus
4671. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity–insulin resistance syndrome: the Normative Aging Study
4672. Urinary biomarkers of oxidative stress and insulin resistance in childhood obesity
4673. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance
4674. Urinary bisphenol A is associated with insulin resistance and obesity in reproductive‐aged women
4675. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese
4676. Urinary markers of nucleic acid oxidation increase with age, obesity and insulin resistance in Danish children and adolescents
4677. Urocortin 3 transgenic mice exhibit a metabolically favourable phenotype resisting obesity and insulin resistance on a high fat diet
4678. Use of a variable insulin infusion to assess insulin action in obesity: defects in both the kinetics and amplitude of response
4679. Use of insulin Sensitizers as a Novel Treatment for Major Depressive Disorder: A Pilot Study of Pioglitazone for Major Depression Accompanied by Abdominal obesity
4680. Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity
4681. Using metabolomic profiles as biomarkers for insulin resistance in childhood obesity: a systematic review
4682. Utility of obesity and metabolic dyslipidemia (a non‐insulin based determinate of the metabolic syndrome and insulin resistance) in predicting arterial stiffness
4683. Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a …
4684. Vagotomy diminishes obesity in cafeteria rats by decreasing cholinergic potentiation of insulin release
4685. Val1483Ile in FASN Gene Is Linked to Central obesity and insulin Sensitivity in Adult White Men
4686. Valproate-induced insulin resistance and obesity in children
4687. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans …
4688. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in Caucasian Italian subjects
4689. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects
4690. Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects
4691. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects
4692. Vascular abnormalities and low-grade chronic inflammation in women with polycystic ovary syndrome: Relationships with insulin resistance, obesity and …
4693. Vascular actions of insulin in obesity
4694. Vascular dysfunction in obesity and insulin resistance
4695. Vascular endothelial regulation of obesity-associated insulin resistance
4696. Vascular insulin-like growth factor-I resistance and diet-induced obesity
4697. Vascular responses to insulin are impaired after diet-induced obesity whereas responses to IGF-1 are maintained
4698. Vascular stiffness in insulin resistance and obesity
4699. Vaspin (serpinA12) in obesity, insulin resistance, and inflammation
4700. Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance
4701. Vaspin promotes insulin sensitivity in elderly muscle and is upregulated in obesity
4702. Very high bone mineral density in a monogenic form of obesity-associated insulin resistance
4703. Very low calorie diet-induced weight loss reverses exaggerated insulin secretion in response to glucose, arginine and glucagon in obesity.
4704. Very low calorie diets and recently developed anti-obesity drugs for treating overweight in non-insulin dependent diabetics.
4705. Very low calorie diets and recently developed anti-obesity drugs for treating overweight in non-insulin-dependent diabetics.
4706. Vimentin deficiency prevents high-fat diet-induced obesity and insulin resistance in mice
4707. Virus-induced interferon-γ causes insulin resistance in skeletal muscle and derails glycemic control in obesity
4708. Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity
4709. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity
4710. Visceral adiposity is closely correlated with neck circumference and represents a significant indicator of insulin resistance in WHO grade III obesity
4711. Visceral obesity & Metabolic Syndrome: insulin resistance
4712. Visceral obesity and chronic pain: effect of a 4-week rehabilitation program on adipokines and insulin resistance
4713. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women
4714. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross-sectional, case–control study
4715. Visceral obesity and insulin resistance in type 2 diabetes
4716. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-α in men
4717. Visceral obesity in men: associations with glucose tolerance, plasma insulin, and lipoprotein levels
4718. Visceral obesity induced by a high-calorie diet leads to dyslipidemia, insulin resistance and impairs adrenal function in male rabbits
4719. Visceral obesity is a better predictor than generalized obesity for basal insulin requirement at the initiation of insulin therapy in patients with type 2 diabetes
4720. Visceral obesity without insulin resistance in late-onset obesity rats
4721. Visceral obesity, metabolic syndrome, insulin resistance and cancer
4722. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review
4723. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome, and cardiovascular diseases: A meta-analysis and systemic review
4724. Visfatin Level and its Relation with obesity and insulin Resistance In Iraqi Type 2 Diabetes Mellitus Patients
4725. #VALUE!
4726. Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: cause or effect?
4727. Vitamin D and tissue-specific insulin sensitivity in humans with overweight/obesity
4728. Vitamin D deficiency in childhood obesity is associated with high levels of circulating inflammatory mediators, and low insulin sensitivity
4729. Vitamin D deficiency in obesity and its relationship to insulin resistance and plasma leptin levels–preliminary study
4730. Vitamin D deficiency in the aetiology of obesity‐related insulin resistance
4731. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance
4732. Vitamin D Insufficiency is Associated with Greater obesity‐Related insulin Resistance
4733. Vitamin D insufficiency is associated with insulin resistance independently of obesity in primary schoolchildren. The healthy growth study
4734. Vitamin D status is not related to insulin resistance in different phenotypes of moderate obesity
4735. Vitamin D, inflammation, and relations to insulin resistance in premenopausal women with morbid obesity
4736. Voluntary wheel running in the late dark phase ameliorates diet-induced obesity in mice without altering insulin action
4737. Waist circumference increased risk of benign prostatic hyperplasia through an increase in the level of interleukin-6 and insulin resistance in abdominal obesity …
4738. Waist Height Ratio as a Marker of obesity and insulin Resistance in Adolescents
4739. Waist-to-hip ratio is the most relevant obesity index at each phase of insulin secretion among obese patients
4740. Water soluble fraction from ethanolic extract of Clausena lansium seeds alleviates obesity and insulin resistance, and changes the composition of gut microbiota in …
4741. Weight loss on low‐fat vs. low‐carbohydrate diets by insulin resistance status among overweight adults and adults with obesity: a randomized pilot trial
4742. Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes
4743. #VALUE!
4744. Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities
4745. Weight-dependent differential contribution of insulin secretion and clearance to hyperinsulinemia of obesity
4746. What causes the insulin resistance underlying obesity?
4747. Wheat alkylresorcinols suppress high-fat, high-sucrose diet-induced obesity and glucose intolerance by increasing insulin sensitivity and cholesterol excretion in male …
4748. Wheat bran with unbound ferulic acid does not alter obesity, insulin resistance or fatty liver in obese rats compared to wheat bran with bound ferulic acid (829.22)
4749. Wheat germ supplementation alleviates insulin resistance and cardiac mitochondrial dysfunction in an animal model of diet-induced obesity
4750. Which comes first? The obesity or the insulin? The behavior or the biochemistry?
4751. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia
4752. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice
4753. Whole Egg Consumption Impairs insulin Sensitivity in a Rat Model of obesity and Type 2 Diabetes
4754. Whole grain intake and its cross-sectional association with obesity, insulin resistance, inflammation, diabetes and subclinical CVD: The MESA Study
4755. Whole sorghum flour improves glucose tolerance, insulin resistance and preserved pancreatic islets function in obesity diet-induced rats
4756. Whole-body insulin resistance in the absence of obesity in FVB mice with overexpression of Dgat1 in adipose tissue
4757. WISP-2-A Novel Adipokine Related to obesity and insulin resistance
4758. With Upper Body obesity and Non-insulin-Dependent Diabetes Mellitus
4759. Withaferin A protects against high-fat diet–induced obesity via attenuation of oxidative stress, inflammation, and insulin resistance
4760. WKY fatty rat as a model of obesity and non-insulin-dependent diabetes mellitus
4761. WNT5A-JNK regulation of vascular insulin resistance in human obesity
4762. WSF-7 inhibits obesity-mediated PPARγ phosphorylation and improves insulin sensitivity in 3T3-L1 adipocytes
4763. XMetA, an allosteric monoclonal antibody to the insulin receptor, improves glycaemic control in mice with diet‐induced obesity
4764. Xylitol: Sweet Revenge Against Tooth Decay, obesity and insulin Spikes.
4765. Yacon syrup: beneficial effects on obesity and insulin resistance in humans
4766. Yogurt Consumption Improves insulin Sensitivity and Hepatic insulin Action in a Diet Induced Mouse Model of obesity and Type 2 Diabetes
4767. Zhu C, Zhou H, Liu X, Viollet B, Wu C, Huo Y. AMP-activated protein kinase a1 protects against diet-induced insulin resistance and obesity. Diabetes 2012; 61: 3114 …
4768. Zinc levels in different degree simple obesity children and the relation between zinc level and insulin resistance
4769. Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo …
4770. Zinc supplementation reduces diet-induced obesity and improves insulin sensitivity in rats
4771. Zinc, iron and vitamins A, C and E are associated with obesity, inflammation, lipid profile and insulin resistance in Mexican school-aged children
4772. β-Cell function or insulin resistance was associated with the risk of type 2 diabetes among women with or without obesity and a history of gestational diabetes
4773. β-Endorphin and insulin/glucose responses to different meals in obesity
4774. β3-adrenoceptor gene variant in obesity and insulin resistance
4775. γδ T cells promote inflammation and insulin resistance during high fat diet‐induced obesity in mice
4776. … -6-methoxycyclohexa-2, 5-diene-1, 4-dione isolated from Averrhoa Carambola L.(Oxalidaceae) roots on high-fat diet-induced obesity and insulin resistance in mice
4777. … -and Brown-Rice Supplementation Improves insulin Tolerance, Brown Fat Activation, Energy Expenditure, and Changes the Gut Microflora in Diet-Induced obesity
4778. … -binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years
4779. … -blind, placebo-controlled, multinational, multicenter trial in individuals with overweight or obesity and type 2 diabetes treated with basal insulin and£ 2 oral …
4780. … -Calorie Diet on insulin-Like Growth Factor-I and insulin-Like Growth Factor Binding Protein-3 Serum Concentrations in Premenopausal Women with obesity
4781. … -free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin …
4782. … -modified enzyme-resistant forms of glucose-dependent insulinotropic polypeptide is associated with significant antihyperglycaemic activity in spontaneous obesity …
4783. … -ovulation or anovulation and hyperandrogenemia contribute to the decreased serum adiponectin levels in normal-weight women with PCOS with obesity and insulin …
4784. … -P: Mice with Muscle-Specific insulin Receptor Overexpression Are Protected from Diet-Induced obesity and Glucose Intolerance but Develop Post-Receptor insulin …
4785. … -P: Praliciguat, a clinical-stage sGC stimulator, improves insulin sensitivity, lipid tolerance, and energy utilization in a mouse diet-induced obesity model housed at …
4786. … -term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance: a model for weight gain with intensive insulin …
4787. … -Veledo, Federico Mayor, and Margarita Lorenzo. G Protein-Coupled Receptor Kinase 2 Plays a Relevant Role in insulin Resistance and obesity. Diabetes 2010; 59 …
4788. … -β hydroxysteroid dehydrogenase (11-βHSD1) 4478T>G and tumor necrosis factor-α (TNF-α)-308G>A polymorphisms with obesity and insulin resistance in Asian …
4789. … ‐3 Polyunsaturated Fatty Acid Supplementation Does Not Influence Body Composition, insulin Resistance, and Lipemia in Women With Type 2 Diabetes and obesity
4790. … , a marker for insulin resistance, is unknown among high-risk children and adolescents. We examined the clinical utility of TG: HDL-C ratio as a marker of insulin …
4791. … , and bone-specific alkaline phosphatase are related to insulin resistance in children and adolescents, independent of their association with growth and obesity
4792. … , and Eli Lilly & Company. An assessment of the efficacy and safety of orlistat for the long-term management of obesity-Molecular regulation of insulin-like growth factor …
4793. … , Arterial Hypertension, Glucose Tolerance, Plasma insulin, C Peptide, GGT, S-Adenosylmethionine, Plasma Lipids and obesity: insulin Receptor Damage and …
4794. … : a simple clinical parameter predicting impaired fasting glucose plus type 2 diabetes mellitus, insulin, glucose, insulin resistance, and centripetal obesity from age 19 …
4795. … : l-glutamine supplementation induces insulin resistance in adipose tissue and improves insulin signalling in liver and muscle of rats with diet-induced obesity
4796. … : Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity
4797. … : Perspectives on the storage and plasma concentration of islet amyloid polypeptide (IAPP) in rodent models of obesity and non-insulin-dependent diabetes mellitus …
4798. … : reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity
4799. … (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity
4800. … (GH)-Binding Protein in obesity with Varying Glucose Tolerance: Relationship to Body fat Distribution Sex Hormones, insulin and GH-insulin-Like Growth Factor (IGF) …
4801. … (Gnetum gnemon L.) seed extract induces uncoupling protein 1 expression in brown fat and protects mice against diet-induced obesity, inflammation, and insulin …
4802. … )-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin …
4803. … )-α gene and serum TNF-α levels with measures of obesity, intra-abdominal and subcutaneous abdominal fat, subclinical inflammation and insulin resistance in Asian …
4804. … [ORAL PRESENTATION ABSTRACTS] OP-01 ASSOCIATION OF SERUM MIDKINE LEVELS WITH insulin RESISTANCE AND obesity IN POLYCYSTIC OVARIAN
4805. … 16 glycine polymorphism in β2-adrenergic receptor gene is associated with obesity, hyperlipidemia, hyperleptinemia, and insulin resistance in saudis
4806. … 2 domain containing protein tyrosine phosphatase as the possible mechanism of metformin-assisted amelioration of obesity induced insulin resistance in high fat diet …
4807. … abnormalities in the initial phase of insulin resistance syndrome. Value of the study of variability of cardiac rate and blood pressure on a model of nutritional obesity
4808. … ACTIVATED RECEPTOR GAMMA AGONIST ON OXIDATIVE STRESS BIOMARKERS AND insulin RESISTANCE IN HIGH FAT DIET INDUCED obesity
4809. … Adenoviruses (ADV36+ and ADV 37+): no additive effect on overweight‐obesity and on insulin Resistance (IRHOMA). The microbiome across the obesity and into the …
4810. … Adiponectin Concentrations on AMP Kinase (AMPK)/Acetyl-CoA Carboxylase (ACC) Signaling and Metabolic Indices in a Rat Model of Polygenic obesity and insulin …
4811. … adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the …
4812. … against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice’and’Myostatin-deficient mice exhibit reduced insulin …
4813. … AMELIORATION OF insulin RESISTANCE INDUCED BY DIETARY POTASSIUM SUPPLEMENTATION IN A NEUROENDOCRINE MODEL OF VISCERAL obesity …
4814. … analysis: measurement of insulin sensitivity, glucose effectiveness, and insulin secretory capacity from pancreatic islet cells in children with simple obesity or type 2 …
4815. … and endurance exercise share potent anti-inflammatory function in adipose tissues in ameliorating diet-induced obesity and insulin resistance in mice
4816. … and intermittent active interruptions to prolonged sitting on postprandial glucose, insulin, and triglycerides in adults with obesity: a randomized crossover trial
4817. … and not enough: school year sleep duration, timing, and circadian misalignment are associated with reduced insulin sensitivity in adolescents with overweight/obesity
4818. … and Risks of Cardiovascular Disease Among Obese Subjects in Calabar, Nigeria: Inflammation, insulin Resistance and Cardiovascular Risks in obesity
4819. … and scarce micronutrients intakes increase inflammatory mediators and insulin resistance in prepubertal and pubertal obese children independently of obesity
4820. … AND THE INDICATORS OF insulin RESISTANCE IN PATIENTS WITH NONALCHOLIC STEATOHEPATITIS WITH obesity AND HYPERTENSIVE DISEASE
4821. … and the insulin resistance syndrome: association of low birth weight with truncal obesity and raised plasminogen activator inhibitor-1 but not with abdominal obesity or …
4822. … and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: results from the Nutrient Gene Interactions in Human obesity …
4823. … apolipoprotein B100 transgenic and brown adipose tissue deficient (hApoBtg/BATless) mice as a model of perturbed HDL metabolism in obesity‐induced insulin …
4824. … APOPTOSIS INDUCED BY PALMITATE IN PREADIPOCYTES THROUGH THE ER STRESS PATHWAY, A POTENTIAL LINK BETWEEN obesity AND insulin …
4825. … Are the Determinants of insulin Resistance (IR) and How Effective Is the Sub-Saharan Africa-Specific Threshold of Abdominal obesity (AO-SSA) Identifying IR …
4826. … ASSOCIATION DIABETES COMMITTEE (COUNCIL ON NUTRITION, PHYSICAL ACTIVITY, AND METABOLISM). obesity, insulin RESISTANCE, DIABETES, AND …
4827. #VALUE!
4828. … atorvastatin or the combination of atorvastatin and nicotinamide ameliorate insulin resistance and left ventricular diastolic dysfunction in a murine model of obesity
4829. … based on regular exercise and a balanced diet on high molecular weight adiponectin, resistin levels, and insulin resistance in adolescents with severe obesity
4830. … behaviors and socioeconomic factors predict successful weight loss at 12-and 24-months in adolescents with obesity and insulin resistance participating in a …
4831. … between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other …
4832. … between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
4833. … between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment …
4834. … Between Serum Adiponectin, Tumor Necrosis Factor− Alpha, Leptin Levels and insulin Sensitivity in Childhood and Adolescent obesity: Adiponectin is a …
4835. … breve BR03 and Bifidobacterium breve B632 favoured weight loss and improved insulin metabolism in children and adolescents with obesity in the BIFI-OBESE cross …
4836. … but not hyperinsulinemia or hyperglycemia, is a key driver of obesity‐induced monocytosis revealing that inflammatory monocytes correlate with insulin in obese male …
4837. … carotid intima-media thickness in pre-pubertal children with constitutional leanness and severe obesity: the speculative role of insulin sensitivity, oxidant status …
4838. … characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin …
4839. … childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity
4840. … Chitosan, and N-[(2-Hydroxy-3-N,N-dimethylhexadecyl ammonium)propyl] Chitosan Chloride on Overweight and insulin Resistance in a Murine Diet-Induced obesity
4841. … chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity …
4842. … clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity.” …
4843. … Convertase Subtilisin/Kexin Type 9 (PCSK9) and insulin Resistance and the Components of Atherogenic Lipoprotein Phenotype in Males with Central obesity
4844. … cyclooxygenase‐2 and prostaglandin E2‐prostaglandin E receptor 3 signaling in the development of obesity‐induced adipose tissue inflammation and insulin …
4845. … DECREASED insulin SECRETORY CAPACITY COMPENSATED BY INCREASED insulin SENSITIVITY, AND RESISTANCE TO DIET-INDUCED obesity
4846. … DELETION OF XANTHINE OXIDOREDUCTASE AUGMENTS ADIPOGENESIS IN WHITE ADIPOSE TISSUE AND INDUCES obesity WITH insulin RESISTANCE
4847. … Demiroğlu| The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity …
4848. … determinants of serum resistin level in type 2 diabetic patients are renal function and inflammation not presence of microvascular complication, obesity and insulin …
4849. … dietary sodium partially blunts the amelioration of insulin resistance induced by dietary potassium supplementation in a neuroendocrine model of visceral obesity
4850. … dietary supplementation with low‐dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet‐induced obesity
4851. … distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa
4852. … dose-dependent effect of aqueous leaf extract of Annona squamosal (L.) leaves on body weight gain, food intake and insulin sensitivity in high-fat diet-induced obesity …
4853. … early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity
4854. #VALUE!
4855. … Education Program-Adult Treatment Panel Ill Guidelines Overestimates the Association between insulin Resistance and Central obesity in African American Women.
4856. … Effects of Chronic Ingestion of Refined Sugars versus Natural Sweeteners on insulin Resistance and Hepatic Steatosis in a Rat Model of Diet-Induced obesity
4857. … effects of n-3 polyunsaturated fatty acid on lipid metabolism, ischemic myocardial lesions and glomerulosclerosis in a rodent model of obesity and insulin …
4858. … efficacious pharmacotherapy for obesity in the form of agonism at triple drug receptors: glucagon, Glucagon like peptide1 (GLP1), glucose dependent insulin …
4859. … efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity
4860. … emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity
4861. … enhanced bioactivity compared to monomeric and polymeric cocoa procyanidins for preventing the development of obesity, insulin resistance, and impaired …
4862. … Evaluation of Vascular Inflammation with Molecular Imaging of Endothelial Cell Adhesion Molecule Expression in a Non-human Primate Model of obesity and insulin …
4863. … exercise promotes memory capability by enhancing hippocampal mitochondrial functions and inhibiting apoptosis in obesity-induced insulin resistance by high fat …
4864. … EXHIBITS INCREASED insulin SENSITIVITY AND RESISTANCE TO DIET-INDUCED obesity, WHILE WILD-TYPE MICE FED EXCESS IRON ARE insulin …
4865. … extract and flavonoid glycosides extract from seabuckthorn leaves ameliorates adiposity, hepatic steatosis, insulin resistance, and inflammation in diet-induced obesity
4866. … factor-binding proteins produced by cultured fibroblasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity
4867. … for the coordinated research project on’Application of nuclear techniques in the prevention of degenerative diseases (obesity and non-insulin dependent diseases) in …
4868. … for the development of non‐insulin‐dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity
4869. … from DocynIa Indica (Wall.) Decne by HSCCC, compared with whole extract, phlorizin and non-phlorizin fragment ameliorate obesity, insulin resistance, and improves …
4870. … function impairment in patients with normal-weight obesity: contribution of abdominal fat deposition, profibrotic state, reduced insulin sensitivity, and proinflammatory …
4871. … Function Tests, insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with obesity
4872. … gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus …
4873. … GEOMETRY AND MORTALITY PREDICTION BY DIFFERENT INDEXATION METHODS FOR LEFT VENTRICULAR MASS BY obesity STATUS IN 47,865 …
4874. … girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin …
4875. … Glucagon-Like Peptide-1 Receptor Agonists Synergize to Attenuate Hepatic Inflammation and Fibrosis in a Rodent Model of obesity, insulin Resistance, and NASH
4876. … glucose and lower glucose effectiveness are responsible for the worsening of intravenous glucose tolerance in healthy subjects independently of the degree of obesity
4877. … glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus
4878. … hematopoietic ABCA1 and ABCG1 re-configures the plasma membrane against inflammation, insulin resistance and atherosclerosis in diet-induced obesity
4879. … Hormone Deficiency Accompanied by Clinical Anophthalmia, Hypoplastic Orbits, Digital Dysplasia, Short Stature, obesity and insulin-resistant Diabetes Mellitus
4880. … hypercholesterolaemia impairs glucose homeostasis and insulin secretion in low-density lipoprotein receptor knockout mice independently of high-fat diet and obesity
4881. … hypothalamic-pituitary-adrenal axis activation, 5 [alpha]-reductase activity and insulin resistance distinguishes polycystic ovary syndrome from simple obesity
4882. … in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 …
4883. … IN ADIPOSE TISSUE AND BLOOD SERUM WITH INDICATORS OF CARBOHYDRATE AND LIPID METABOLISM IN WOMEN WITH obesity AND insulin …
4884. … in Aging and Metabolic Diseases: Oxidative modifications of mitochondrial complex II are associated with insulin resistance of visceral fat in obesity
4885. … in G-protein expression, Gi function and stimulatory receptor-mediated regulation of adipocyte adenylyl cyclase in a model of insulin-resistant diabetes with obesity
4886. … IN insulin RESISTANCE AND MYOCARDIAL TOLERANCE TO ISCHEMIA-REPERFUSION INJURY IN RAT MODEL OF HIGH FAT DIET INDUCED obesity
4887. … in the setting of diet-induced obesity normalises the inflammatory phenotype in mothers and reverses metabolic dysfunction and impaired insulin sensitivity in offspring
4888. … INDICES OF insulin RESISTANCE HOMA-IR, QUICKI AND CARO IN PATIENTS WITH CHRONIC PANCREATITIS COMBINED WITH obesity AND TYPE 2 …
4889. … induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation …
4890. … influence of hormones on adenylyl cyclase systems in the myocardium and brain of rats with obesity and type 2 diabetes mellitus and effect of intranasal insulin on it
4891. … inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin …
4892. … Inhibitors of Protein Tyrosine Phosphatase 1B (PTP 1B), a Key Enzyme in the insulin Signaling Pathway and Novel Therapeutic Target for obesity and Type 2 …
4893. … insulin activities in pancreas and serum of mice with spontaneous (“obese” and “New Zealand obese”) and induced (goldthioglucose) obesity and hyperglycemia, with …
4894. … insulin resistance and circulating complement C3 is partly explained by plasma alanine aminotransferase, independent of central obesity and general inflammation …
4895. … insulin Secretion nor Genotype Pattern Modify 12-Month Weight Loss Effects of Healthy Low-Fat vs. Healthy Low-Carbohydrate Diets Among Adults with obesity
4896. … insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, obesity and …
4897. … is associated with greater impact on physical fitness, insulin sensitivity and muscle mitochondrial content in males with overweight/obesity, as opposed to …
4898. … is the mediator of feecling‐related thermogenesis: insulin resistance and/or deficiency results in a thermogenic defect which contributes to the pathogenesis of obesity
4899. … J, Törnell J: Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia …
4900. … Knockout Mice Have Decreased NCC‐mediated Sodium Reabsorption and Reduced Sensitivity to Mineralocorticoid‐induced Hypertension in obesity and insulin …
4901. … leisure-time exercise affect insulin sensitivity, cardiorespiratory fitness and intra-abdominal fat? A randomised controlled trial in individuals with overweight and obesity
4902. … leptin signaling in the lateral hypothalamus and ventral premammillary nucleus alters insulin and glucagon secretion and protects against diet-induced obesity
4903. … long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 …
4904. … low-density lipoprotein receptors involved in the disturbed lipid metabolism of patients with non—insulin-dependent diabetes mellitus are independent of obesity
4905. … microarray design reveals the response to obesity is largely tissue specific: analysis of common and divergent responses to diet-induced obesity in insulin-sensitive …
4906. … Model Assesment of insulin Resistance), Inflammation (High Sensitivity C-Reactive Protein) and HDL Cholesterol Concentration in Individuals with Visceral obesity
4907. … muscle liver kinase B1 alters gene expression, mitochondrial content, inflammation and oxidative stress without affecting high-fat diet-induced obesity or insulin …
4908. … NcoI Polymorphism at Position-308 of the Promoter Influences insulin Resistance, and Increases Serum Triglycerides after Postprandial Lipaemia in Familiar obesity
4909. … NECROSIS FACTOR ALPHA INFLUENCE ON insulin RESISTANCE AND LEPTIN LEVEL IN PATIENTS WITH obesity-ASSOCIATED HYPERTENSIONquest;: P1 …
4910. … Number of the Salivary Amylase Gene (AMY1) Is Associated with obesity, Dyslipidemia, and Chronic Low-Grade Inflammation but Not insulin Sensitivity and Secretion
4911. … obesity and Overnutrition Is Associated with Reduced Systemic Progesterone During the Estrous Cycles of Adult Female Offspring and a Marked Increase in insulin …
4912. … obesity syndrome and acanthosis nigricans. Acanthosis nigricans is a common cosmetic problem providing epidemiological clues to the obesity syndrome, the insulin …
4913. … obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa
4914. … of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity
4915. … of abdominal subcutaneous and visceral fat with insulin resistance and secretion differ between men and women: the Netherlands epidemiology of obesity study
4916. … of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic …
4917. … of changes in blood glucose, insulin resistance indices, and adipokine levels in diabetic and nondiabetic subjects with morbid obesity after laparoscopic adjustable …
4918. … of Colchicine on insulin Resistance, Pancreatic Beta-Cell Function, and Aspects of the Metabolic Syndrome (MetS) in Adults with obesity, MetS, and Inflammation: A …
4919. … of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women–a hyperinsulinemic euglycemic insulin clamp …
4920. … of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity
4921. … of Electroacupuncture on Electrical Activity of Neurons of Hypothalamic Perifornical Nucleus and on Hypothalamic and Plasma Leptin and insulin Levels in obesity …
4922. … of function and metabolism of subcutaneous insulin-dependent adipocytes on stages of phylogenesis. The etiologic factor and pathogenesis of obesity as a pandemic
4923. … of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice
4924. … of insulin like growth factor-1 and IGF binding protein-3 in healthy Indian girls from Delhi and their correlation with age, pubertal status, obesity and thyroid hormonal …
4925. … of insulin Like Growth Factor-1 Receptors in Endothelial Cells Leads to Favourable Changes in White Adipose Tissue in the Response to Nutritional obesity
4926. … of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity …
4927. … of leptin, resistin, and high-molecular-weight adiponectin levels with psoriasis area and severity index scores, obesity, and insulin resistance in psoriasis …
4928. … of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: the SCALE insulin randomized controlled trial
4929. … of magnitude of visceral adipose tissue reduction: Impact on insulin resistance, hyperleptinemia and cardiometabolic risk in adolescents with obesity after long-term …
4930. … of New Zealand blackcurrant extract improves insulin sensitivity and free-living postprandial glucose excursions in individuals with overweight or obesity
4931. … of oxidative stress and current status of antioxidant system in adolescents of different age groups with obesity, complicated by insulin resistance and without it
4932. … OF PIOGLITAZONE AND METFORMIN ON REDUCING insulin RESISTANCE IN 8 TO 15 YEARS OLD CHILDREN WITH obesity IN GORGAN BETWEEN 2012 …
4933. … of potential preventive effects of pomegranate flower, peel and seed oil on insulin resistance and inflammation in high-fat and high-sucrose diet-induced obesity mice …
4934. … of serum leptin and their relationships with insulin resistance in patients with simple obesity and patients with type 2 diabetes mellitus complicated with obesity
4935. … of Serum Resistin Level in Type 2 Diabetic Patients are Renal Function and Inflammation not Presence of Microvascular Complication, obesity and insulin Resistance
4936. … of the adenylyl cyclase signaling system in myocardium and brain of rats with obesity and types 2 diabetes mellitus and the effect of long-term intranasal insulin …
4937. … of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in …
4938. … of the apolipoprotein B/apolipoprotein AI ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity
4939. … of the complex treatment conducted in the rehabilitation center in the city of Loznitsa on oral glucose tolerance and insulin secretion in patients with morbid obesity
4940. … of the Genetic and Nutritional Control of obesity and Type 2 Diabetes in a Novel Mouse Model on Chromosome 7: An Insight into insulin Signaling and Glucose …
4941. … of the GIP‐R antagonist (Pro3) GIP in streptozotocin‐induced diabetes suggests that insulin‐dependent mechanisms are critical to anti–obesity‐diabetes actions of …
4942. … of the overexpression of the high mobility group-AT-hook-1 (HMGA1) protein in adipose tissue and its implications in the development of obesity and insulin …
4943. … of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) in obesity and insulin …
4944. … of the rs1862513 variant of resistin gene on insulin resistance and resistin levels after two hypocaloric diets with different fat distribution in subjects with obesity
4945. … of the uncoupling protein 2 gene in obese NIDDM patients: impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insulin …
4946. … of Thrifty Protein-energy Metabolism Cross-linked with insulin Resistance During Catch-up Growth: A Risk Factor for Later obesity and Cardiometabolic Diseases
4947. … of visceral adipose tissue on improvement in insulin sensitivity following Roux-en-Y gastric bypass: a study in Chinese diabetic patients with mild and central obesity
4948. … of weight loss during a very low carbohydrate diet on specific adipose tissue depots and insulin sensitivity in older adults with obesity: a randomized clinical …
4949. … of whey protein and dietary fiber intake on insulin sensitivity, body composition, energy expenditure, blood pressure, and appetite in subjects with abdominal obesity
4950. … on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and …
4951. #VALUE!
4952. … on the relationship between changes of serum true insulin (Tl) C-peptide, GAD-Ab, INS-Ab contents and age, course of disease, degree of obesity in patients with …
4953. … on: Elias et al. Adipose Tissue Overexpression of Vascular Endothelial Growth Factor Protects Against Diet-Induced obesity and insulin Resistance. Diabetes 2012; …
4954. … on: Elias et al. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes 2012; 61 …
4955. … or ascending stair exercise on body composition, insulin sensitivity, and inflammatory markers in young Chinese women with obesity: A randomized controlled trial
4956. … partial PPARγ ligand, decreases visceral adiposity and induces the expression of thermogenesis‐related genes in mice with obesity and insulin resistance induced by …
4957. … patients with coronary artery disease: a strong association with persistently elevated plasma insulin, increased insulin resistance, and abdominal obesity
4958. … pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus.
4959. #VALUE!
4960. … Polymorphism of theβ 3-Adrenergic Receptor Gene and the− 3826 A→ G Variant of the Uncoupling Protein-1 Gene on Features of obesity and insulin Resistance in a …
4961. … polymorphism the Gly972Arg variant insulin receptor substrate-1 (IRS-1) gene, and G-308A TNF-alpha gene on obesity and insulin resistance in children with obesity
4962. #VALUE!
4963. … possess enhanced bioactivity compared to monomeric and polymeric cocoa procyanidins for preventing the development of obesity, insulin resistance, and impaired …
4964. … possess enhanced bioactivity compared to monomeric and polymeric cocoa procyanidins for preventing the development of obesity, insulin resistance, and impaired …
4965. … prevention of the risk of obesity): study design. A randomized trial of metformin versus placebo in the correction of the metabolic abnormalities associated with insulin …
4966. … proteins produced by cultured fibro-blasts from patients with noninsulin-dependent diabetes mellitus, insulin-dependent diabetes mellitus, or obesity by S. Giannini, S …
4967. … Ratio of Prepubertal Growth Period Leads to a Long-Term Susceptibility for obesity and insulin Resistance in obesity-Prone and obesity-Resistant Sprague Dawley …
4968. … receptor action by daily (Pro3) GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related …
4969. … receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high …
4970. … regulation of adenylyl cyclase signaling system in the myocardium and brain of rats with obesity and type 2 diabetes mellitus as affected by long-term intranasal insulin …
4971. … relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non‐alcoholic …
4972. … Represent a Genetic Model of insulin Resistance Associated with Diet‐Induced obesity and Altered Glucose Uptake via Both insulin‐Dependent and Independent …
4973. … Responses by Furanocembranolides: Leptolide Diminishes Microglial Inflammation in Vitro and Ameliorates Gliosis In Vivo in a Mouse Model of obesity and insulin …
4974. … restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high …
4975. … reticulum stress-mediated induction of tribbles homologue 3: a potential link between dietary fat composition and the pathophysiological outcomes of obesity
4976. … review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity
4977. … risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population …
4978. … SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS IN ADOLESCENTS WITH obesity FROM GUANAJUATO: ASSOCIATIONS WITH insulin …
4979. … stimulates glucose uptake in skeletal muscle and improves glucose homeostasis, insulin resistance and hepatic steatosis in mice with diet-induced obesity
4980. … suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
4981. … term, very‐low‐calorie diet on insulin‐like growth factor‐I and insulin‐like growth factor binding protein‐3 serum concentrations in premenopausal women with obesity
4982. … the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin …
4983. … the fetal origins of the metabolic syndrome and its amplification by obesity; high fat feeding potentiates the programming of hepatic insulin resistance by antenatal …
4984. … THE SYSTEM OF OXIDATIVE STRESS–ANTIOXIDANT PROTECTION ON insulin RESISTANCE IN PATIENTS WITH ESSENTIAL HYPERTENSION AND obesity
4985. … therapy on pancreatic islet function, insulin resistance and cardiovascular function in patients with mixed prediabetes and obesity: Randomized Clinical Trial
4986. … to 3% Thymoquinone Potentiates Omega-3 Protection against obesity-Induced Oxidative Stress, Inflammation, and Markers of insulin Resistance Accompanied with …
4987. … to Comment on Francés et al. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, obesity, and insulin Resistance. Diabetes 2015; 64 …
4988. … to Comment on: Lassenius et al. Bacterial Endotoxin Activity in Human Serum Is Associated With Dyslipidemia, insulin Resistance, obesity, and Chronic Inflammation …
4989. … Traits, Adipose Tissue DNA Methylation, and Gene Expression Identifies Epigenetic Regulatory Mechanisms of insulin Resistance and obesity in African Americans
4990. … Traits, Adipose Tissue DNA Methylation, and Gene Expression Identifies Epigenetic Regulatory Mechanisms of insulin Resistance and obesity in African Americans
4991. … treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs-the …
4992. … vagal afferent neurons including those innervating pancreas via insulin cascade and Ca 2+ influx: its dysfunction in IRS2-KO mice with hyperphagic obesity
4993. … with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin …
4994. … with Parkinsonia aculeata combats insulin resistance-induced oxidative stress through the increase in PPARγ/CuZn-SOD axis expression in diet-induced obesity …
4995. … Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism
4996. … ε-(Carboxymethyl)lysine-Receptor for Advanced Glycation End Product Axis Is a Key Modulator of obesity-Induced Dysregulation of Adipokine Expression and insulin …
4997. “Staircase” Glucose Stimulation of insulin Secretion in obesity: Measure of Beta-cell Sensitivity and Capacity
4998. (−)‐Epicatechin Mitigates High‐fat‐associated obesity and insulin Resistance
4999. (18) Fenretinide treatment for high fat diet-induced obesity and insulin sensitivity
5000. [PP. 07.01] MIR-483-5P ASSOCIATES WITH obesity AND insulin RESISTANCE AND INDEPENDENTLY PREDICTS NEW ONSET DIABETES MELLITUS AND …
5001. 1 () obesity and insulin Resistance
5002. 1 insulin action, thermogenesis and obesity
5003. 10 Mechanisms Mediating obesity-Induced Inflammation and insulin Resistance
5004. 10 Visceral obesity, insulin Resistance, and Dyslipidemia: Contribution of Endurance Exercise Training to the Treatment of the Plurimetabolic Syndrome
5005. 10-Hydroxy-2-decenoic acid, a natural product, improves hyperglycemia and insulin resistance in obese/diabetic KK-Ay mice, but does not prevent obesity
5006. 1027-190 Whole-body insulin resistance precedes vascular insulin resistance in a murine model of diet-induced obesity
5007. 1102-P: High vs. Standard Starting Dose of insulin Glargine 100 U/ml in Patients with Overweight/obesity and Type 2 Diabetes Uncontrolled with Oral Antidiabetic …
5008. 1155-P: Effect of Endoscopic Duodenal-Jejunal Bypass Liner on Parameters of insulin Sensitivity and Secretion in Subjects with Type 2 Diabetes Mellitus and obesity
5009. 1174-P: Improvements of insulin and Leptin Sensitivity for Type 2 Diabetes and obesity by Cyclo-(His-Pro) plus Zinc Treatment
5010. 11β‐hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity
5011. 12: IL-37 protects against obesity-induced inflammation and insulin resistance
5012. 13 Pathogenesis of insulin Resistance and Glucose Intolerance in Childhood obesity
5013. 1328-P: Infant Mesenchymal Stem Cell insulin Sensitivity Is Associated with Maternal Plasma-Free Fatty Acids, Independent of obesity Status: The Healthy Start Study
5014. 13C/31P NMR studies on the mechanism of insulin resistance in obesity.
5015. 14 obesity insulin Resistance and Gut Hormones
5016. 1726-P: Male Mice Lacking Estrogen Receptor Beta Develop obesity but Are Protected from Diet-Induced insulin Resistance in Skeletal Muscle
5017. 1727-P: Mice Deficient in Myeloid Cell-Derived Interleukin-1a Are Protected from Diet-Induced obesity and insulin Resistance
5018. 1729-P: insulin Resistance Cutoff for High Probability of Blood Glucose Normalization in T2DM Patients with obesity after Bariatric Surgery
5019. 1730-P: Thromboxane Signaling and obesity-Related insulin Resistance
5020. 1747-P: MicroRNA-30a Exerts Antifibrotic Effects in Subcutaneous White Adipose Tissue to Preserve insulin Sensitivity in obesity
5021. 1760-P: Brain Sh2b1 Protects against obesity and insulin Resistance through Multiple Hypothalamic Neural Circuits
5022. 1889-P: Light Exercise and Liraglutide Synergistically Improve Muscle insulin Action in Diet-Induced obesity
5023. 1892-P: Hepatic Agpat5 Regulates Plasma insulin in obesity
5024. 1927-P: Protective Role of DNAJB3 Cochaperone against obesity-Induced insulin Resistance and Diabetes
5025. 1948-P: STING in Hematopoietic Cells Promotes obesity-Associated Adipose Tissue Inflammation and Systemic insulin Resistance in Mice
5026. 1955-P: Interleukin-1ß Orchestrates Non–Glucose Dependent Cephalic Phase insulin Release in Health and obesity
5027. 1960-P: A Novel Nitric Oxide Releasing Nanomatrix Gel Prevents High-Fat Diet-Induced obesity and insulin Resistance
5028. 1991-P: Mammary Tumors Increase Diet-Induced obesity and insulin Resistance in Female MMTV-PyMT Mice
5029. 1992-P: Early and Chronic Exposure to Penicillin Increases obesity and insulin Resistance in High-Fat Diet-Fed Mice
5030. 1995 EASD Meetings: Immunology, insulin, Amylin, obesity, Retinopathy, and Neuropathy
5031. 2 Hepatic glucose metabolism and insulin resistance in NIDDM and obesity
5032. 2-Aminoadipic acid (2-AAA) as a potential biomarker for insulin resistance in childhood obesity
5033. 20-HETE and circulating insulin in essential hypertension with obesity
5034. 20-HETE interferes with insulin signaling and contributes to obesity-driven insulin resistance
5035. 2002-P: Waist-Hip Ratio: A Better obesity Measure Index Represents insulin Secretion among Obese Women with Different Glucose Metabolism Status
5036. 2031-P: obesity and insulin Resistance Alter the Biodistribution of Whole Body insulin-Stimulated Glucose Disposal
5037. 2090-P: Role of Thromboxane-Prostanoid Receptor in obesity Related insulin Resistance
5038. 2131 RELATIONSHIP BETWEEN insulin RESISTANCE, obesity AND SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS IN HEALTHY MEN
5039. 22: NOD2 immunity protects against obesity-induced inflammation and insulin resistance
5040. 25-Hydroxyvitamin D is associated with insulin resistance, obesity, and serum lipids in polycystic ovary syndrome
5041. 25‐Hydroxyvitamin D concentration correlates with insulin‐sensitivity and BMI in obesity
5042. 252 Combined soluble fiber improve the obesity phenotype and insulin sensitivity of diet-induced obese mice by regulating the intestinal microbial composition
5043. 265-LB: Mitochondria-Targeted DNA Repair Glycosylase OGG1 Protects Against HFD-Induced obesity and insulin Resistance in OGG1 Deficient Mice
5044. 269-LB: PVT1 Induces the insulin Resistance of obesity-Related Metabolic Diseases via Modulation of Transcription Factor Foxo1 through Binding with PTBP1
5045. 2WS08 obesity, insulin RESISTANCE AND ATHEROSCLEROSIS
5046. 3 Adipose Tissue, obesity and insulin
5047. 3-Hydroxyisobutyrate, a strong marker of insulin resistance in type 2 diabetes and obesity that modulates white and brown adipocyte metabolism
5048. 4-Hydroxyisoleucine from fenugreek (Trigonella foenum-graecum): effects on insulin resistance associated with obesity
5049. 401 Ppar-Gamma2 Pro12 Ala Variant, insulin Sensitivity and Plasma Fatty Acids in Childhood obesity
5050. 408 obesity, insulin Resistence and Metabolic Syndrome Related Components Among Spanish Children
5051. 47, XXY Klinefelter Syndrome Is Associated with an Increased Risk of insulin Resistance: The Impact of Hypogonadism and Visceral obesity
5052. 5209 Hematopoietic ABCA1 and ABCG1 regulate monocytosis, macrophage inflammation and insulin resistance in diet-induced obesity
5053. 6.3 Hypertension, serum insulin, obesity and the metabolic syndrome
5054. 65 obesity, DIABETES, AND insulin RESISTANCE: RELATION TO ELEVATED C-REACTIVE PROTEIN LEVELS IN AFRICAN AMERICANS.
5055. 67 MATERNAL obesity AT CONCEPTION AND insulin SENSITIVITY IN LATE GESTATION ALTERS PLACENTAL STRUCTURE BUT NOT FETAL BIOMETRY AT …
5056. 68 APOLIPOPROTEIN E POLYMORPHISM MODULATES THE ASSOCIATIONS OF obesity AND insulin RESISTANCE WITH C-REACTIVE PROTEIN IN YOUNG …
5057. 7.2 Relation between Adrenergic Tone, insulin Resistance and Left Ventricular Hypertrophy in Human obesity
5058. 8th Annual International Conference on obesity and Non-insulin Dependent Diabetes Mellitus: Novel Drug Developments
5059. 9th International Conference on obesity, NIDDM, adipogenesis and insulin resistance